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The  enzyme  dimethylarginine  dimethylaminohydrolase  (DDAH)  is  responsible  for  the 
metabolism of free asymmetric methylarginine residues (AMAs) to citrulline and mono- or di- 
methylamines. In mammals, the asymmetric methylarginines N^N1 1 -dimethylarginine (ADMA) 
and  N1 1 -methylarginine  (L-NMMA)  are  endogenous  inhibitors  of  all  nitric  oxide  synthase 
(NOS)  isoforms.  By  controlling  local  levels  of AMAs,  DDAH  activity  is  implicated  in  the 
regulation  of nitric  oxide  (NO)  production,  which  gives  rise  to  interest  in  the  therapeutic 
potential of this enzyme.
This work describes the application of NMR methodology to study the backbone dynamics of 
fVzDDAH and  interactions with ligands  and  inhibitors,  as this protein provides  an  attractive 
template  to further  investigate  the  structure-function  characteristics  of DDAH  isoforms  and 
(3/a-propeller enzymes in general.
To counter the relatively large size of the enzyme for NMR studies and the difficulties to obtain 
unambiguous  resonance  assignments  for  the  amide  backbone  resonances  of  the  58  kD 
homodimer, a monomeric and fully active variant of PaDDAH was engineered through rational 
design of site-directed mutation of two interfacial residues. The exclusively monomeric R40E- 
R98H double mutant protein proved more tractable by heteronuclear NMR than the wild-type 
homodimer.  1 5 N backbone relaxation studies of the mutant protein, analysed in the model-free 
formalism, revealed that the loop that closes down on the ligand in the active site displays low 
values  of the  generalised  N-H  bond  order  parameter  (S2)  consistent  with  a  high  degree  of 
mobility on the pico- to nanosecond timescale.
The  interaction  of  PaDDAH  with  a  variety  of  small  molecule  ligands  was  followed  by 
heteronuclear NMR experiments. A general observation is that ligands that act as inhibitors of 
the enzyme in vitro give rise to specific broadening of a subset of N-H cross peaks, including 
those of residues around the active site and in the loop that closes the ligand binding pocket. 
The results are interpreted to imply that in the bound state the dynamic profile of the backbone 
of  the  PaDDAH  enzyme  is  altered,  probably  with  ordering  of  the  loop  but  retaining  a 
component of conformational exchange that gives rise to residual line broadening, even in the 
saturated state.  A  similar result is obtained with a ligand covalently bound to Cys249 of the 
catalytic triad.
2“The real voyage of discovery consists not in seeking new landscapes,
but in having new eyes ” 
Marcel Proust
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15Chapter 1
DDAH in vivo and in vitro
Abstract
This  chapter  describes  the  role  of  asymmetric  methylarginine  (AMAs)  residues  in  the 
regulation of the production of nitric oxide (NO), an important signalling molecule implicated 
in the maintenance of the vasculature homeostasis. In mammals, asymmetric methylarginines 
(AMAs)  are  known  endogenous  inhibitors  of  nitric  oxide  synthase  (NOS),  the  enzyme 
responsible for the generation of NO in cells. Over the last decade, the interest in AMAs has 
increased as their accumulation in plasma and tissues with the subsequent impairment of NO 
production  has  been  linked to a number of pathologies affecting the cardiovascular system. 
The  metabolism  of  AMAs  is  controlled  by  the  enzyme  dimethylarginine 
dimethylaminohydrolase  (DDAH).  The  discovery  that  DDAH  is  indirectly  involved  in  the 
regulation of nitric oxide levels led to the assumption that this enzyme could represent a novel 
attractive therapeutic target. With the purpose of gaining structural information on this class of 
enzymes, the crystal structure of a bacterial DDAH homologue was solved. DDAH belongs to 
a  recently  identified  superfamily  of enzymes  that  modify  the  guanidino  moiety  of arginine 
residues. Several crystal structures of these enzymes are now available and will be described 
with  an  emphasis  on  their  structural  similarities.  Finally,  the  scope  of this  thesis  will  be 
outlined, as an effort to pursue further structural work on DDAH enzymes with the application 
of NMR methodology to assist in the discovery of the enzyme’s dynamic properties and in the 
development of new inhibitor molecules.
161.1  The L-arginine:nitric oxide pathway
The role of nitric oxide in the cardiovascular system
The  endothelium  regulates  vascular  homeostasis  by  producing  a  number  of  small 
molecules that act locally in the blood vessel wall and lumen. One of the most crucial 
mediators  in  the  maintenance of the  vascular tone  and structure is nitric  oxide  (NO) 
(for a review  see Vallance and Chan,  2001).  The release of NO from the endothelial 
cells  not  only  maintains  constant  vasodilation  against  a  number  of  endogenous 
vasoconstrictor  effectors  (Rees  et  al.,  1989),  but  also  prevents  the  adhesion  and 
aggregation  of platelets  and white  cells  to the endothelium  (Radomski  et al.,  1996), 
and  inhibits  smooth  muscle  cell  proliferation,  contributing  to  the  inhibition  of 
atherogenesis and vessel occlusion (Boger et al, 1996).
In  this  context  NO  is  formed  from  the  reaction  between  molecular  oxygen  and  L- 
arginine  catalysed  by  the  endothelial  isoform  of  nitric  oxide  synthase  (eNOS).  In 
addition to the eNOS enzyme, two other NOS isoforms exist, named according to the 
cell  type  and  conditions  under  which  they  were  first  identified  -   neuronal  NOS 
(nNOS) and inducible NOS  (iNOS). The effects mediated by NO are not confined to 
the cardiovascular system, as this molecule has also been implicated in neuronal signal 
transduction and in the immune response (Alderton et al., 2001).
NO has a short life time of less than 4 seconds as it is rapidly oxidized to nitrite and 
nitrate by oxygenated haemoglobin before being ultimately excreted in urine (Knowles 
and Moncada, 1992). In the cardiovascular system, the actions of NO are exerted in the 
vascular smooth  muscle  cells  where  it  activates  guanylate  cyclase  by  binding to  the 
heme moiety of the enzyme and subsequently inducing a rise in concentration of cyclic 
guanosine-3’-5-monophosphate  (cGMP).  cGMP  is  a  second  messenger  known  for 
mediating many of the biological effects of NO (Knowles and Moncada,  1992). 
Dysfunction  of  the  endothelial  L-arginine:nitric  oxide  pathway,  associated  with  a 
reduction in basal or stimulated NO mediated-vasodilation, is thought to be responsible 
for most cardiovascular diseases, such as coronary heart disease, hypertension, chronic 
heart failure, vasculopathies associated with diabetes mellitus, hyperhomocysteinemia 
and  artherosclerosis  in  general  (Vallance  and  Chan,  2001).  The  mechanisms  that 
account for the reduction of NO production in cardiovascular disease are still unclear, 
but  possibilities  include  a  deficiency  of eNOS  co-factors  due  to  cardiovascular  risk 
factors  such  as smoking (Katusic,  2001), the decline in NO bioavailability caused by
17its accelerated degradation by reactive oxygen species during oxidative stress  (Cai and 
Harrison,  2000),  and  overproduction  of  endogenous  inhibitors  of  NOS  in  certain 
disease states, such as in chronic renal failure (Vallance et al.,  1992).
The discovery of endogenous asymmetric methylarginines
In  1992,  Vallance  and  co-workers  first  described  the  presence  of  asymmetric 
methylarginines  (AMAs),  N^N^-dimethylarginine  (ADMA)  and  N^-methylarginine 
(L-NMMA), as endogenous inhibitors of NOS isoforms. Although L-NMMA had long 
been administered as a synthetic NOS inhibitor (Palmer et al,  1988), it was not known 
to be a naturally occurring compound in plasma and urine.  ADMA was subsequently 
found to exert a similar action to L-NMMA and was present in circulating plasma at 
concentrations 10 times greater than that of L-NMMA (Vallance et al., 1992).
The  existence  of ADMA  provided  an  explanation  for what  was  referred  as  the  “L- 
arginine paradox” (Tsikas et al., 2000a). It was known through a series of experiments 
led  by  Cooke  and  colleagues  that  the  administration  of L-arginine  in  rabbits  could 
reverse  the  endothelial  dysfunction  associated  with  hypercholesterolemia  through  an 
increase  in  NO  levels  (Cooke  et  al,  1991).  These  results  were  surprising  since 
endothelial  cells  were  found  to  contain  up  to  2  mM  L-arginine  and  human  plasma 
concentrations  could  range  from  40-100  pM  (Boger  and  Bode-Boger,  2001).  These 
levels are far higher than the eNOS A ^m  of ~3 pM for L-arginine (Pollock et al.,  1991). 
The enzyme  should have been saturated in endothelial cells and unable to respond to 
L-arginine supplementation. The presence of potent endogenous inhibitors of NOS  in 
human  plasma -  ADMA has  an  IC50 of ~4  pM against eNOS  in vitro  (Tsikas et al, 
2000b)  -   suggested  why  L-arginine  could  still  improve  endothelial  function  by 
displacing the inhibitory effects of asymmetric methylarginines.
1.2  Synthesis of methylarginines
Characterisation of  protein arginine methyltransferases (PRMTs)
The  methylation  of arginine  residues  in  proteins  is  a  post-translational  modification 
(PTM)  known  to  occur  in  most  eukaryotic  cells.  The  guanidino  nitrogens  of  the 
arginine  within  the polypeptide  sequence  are  modified to contain  one  or two  methyl 
groups  (Figure  1.1 A)  (Gary  and  Clarke,  1998).  The  enzymes  responsible  for  this
18reaction are protein arginine methyltransferases (PRMTs) and to date eight mammalian 
PRMTs  (PRMT  1-8)  have  been  characterised,  although  one  of  them,  PRMT  2, 
identified  by  homology  has  no  reported  activity.  Notably,  the  metabolic  cost  of 
methylation  is  high:  12 ATP molecules  are needed in the generation  of a methylated 
product. As a result it seems that the ultimate benefit of this reaction must outweigh its 
energetic cost for it to be retained through evolution (Gary and Clarke, 1998).
The  PRMT enzyme  family has  been  separated into  two  sub-groups  according to the 
reaction catalysed, the substrate specificity and the tissue distribution. Type I PRMTs 
catalyse  the  formation  of  the  asymmetric  monomethylarginine  L-NMMA  and 
dimethylarginine  ADMA  residues,  whereas  type  II  enzymes  generate  N^N*1  - 
symmetric  dimethylarginine  (SDMA),  but  they  can  also  form  mono-methylated  L- 
NMMA (Figure 1.1B). In both cases, the methyl groups added to the arginine residues 
come from the donor S-adenosylmethionine (S-AdoMet).
The substrate specificities of the two subtypes are different: the only known substrates 
of type II PRMT are the myelin binding protein (MBP), histones H4, H2A and H3 and 
spliceosomal  proteins  smDl,  smD3  and  SmB,  whereas  type  I PRMTs  show  broader 
substrate specificity, methylating multiple RNA-binding proteins, histones H4 and H3, 
and  several  other nuclear and heat  shock  proteins  (Bedford  and  Richard  2005).  The 
type  I  PRMTs  preferentially  target  proteins  with  an  arginine-glycine-glycine  (RGG) 
tripeptide motif.  However,  asymetrically methylated arginine residues have also been 
found in proteins with RXR and RG motifs (R- is the one-letter code for arginine and 
X- represents any amino acid). Conversely, symmetrically methylated Arg residues are 
flanked in  a GRG consensus  sequence,  identified in  MBP and in  spliceosomal  small 
nuclear ribonucleoproteins  (snRNP)  (Brahms et al.  2000),  suggesting the importance 
of residues  in  position  -1  and +2  for determining  substrate  specificity.  Three  crystal 
structures  of type  I  PRMTs  are  currently  available,  rat  PRMTs  1  and  3  (Zhang  and 
Cheng,  2003, Zhang et al.,  2000) and yeast RMTl/Hmtl  (Weiss et al.,  2000). These 
enzymes all share a conserved core structure which contains the binding domain of the 
S-AdoMet methyl  donor and an  acidic pocket for the binding of the protein  arginine 
residue (Weiss et al., 2000).
In  terms  of  distribution  in  the  cell,  PRMTs  are  generally  ubiquitously  expressed, 
although  a closer examination  of the mammalian  PRMT  1  and 3  expression  patterns 
show  that  PRMT  1   is  predominantly  localised  to  the  nucleus,  whilst  PRMT  3  is
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Figure  1.1. (A)  Structures of free (a) L-arginine, (b) asymmetric N^-methylarginine 
(L-NMMA),  (c)  asymmetric  Nn^-dimethylarginine  (ADMA)  and  (d)  symmetric 
N^N7 1 ’   dimethylarginine (SDMA).  The standard Greek numbering of the side chain 
carbon and nitrogen atoms is indicated on (a). (B) The PMRT family, type I and type 
II PMRTs generate L-NMMA. Type I alone generates ADMA and the production of 
SDMA is catalysed by type II PRMTs (adapted from Bedford and Richard, 2005).
20predominantly cytosolic (Tang et al  1998). Moreover, the newly characterised PRMT 
8  is distinguished from other type I PRMTs by presenting a myristoylation  site in  its 
N-terminal  extension,  anchoring  it  to  the  plasma  membrane.  This  enzyme  also  has 
more specific tissue distribution, being mainly expressed in the brain (Lee et al. 2005).
The nuclear substrates of PRMTs are highly abundant proteins and contain high levels 
of clustered methylated  arginine residues. The nuclear protein  fibrillarin  is known  to 
contain  at  least  4  mol%  ADMA  and  the  heterogenous  nuclear  ribonucleoprotein 
(hnRNP) complex contains  -.1  mol% ADMA. The proteolysis of these proteins is the 
major source  of asymmetric  methylarginines,  which  are  liberated in  the  cell  cytosol 
and plasma. However, it is unclear whether ADMA generation is constant, whether it 
is  influenced by  PRMT  activity  or dependent  on  rates  of protein  turnover.  There  is 
evidence  suggesting  that  the  inhibition  of  PRMT  1  expression  in  cultured  human 
endothelial cells reduces the production of ADMA in cells (Boger et al., 2000). More 
recently, PRMT  1  expression  levels,  which are elevated during shear stress, relate to 
increased  ADMA  concentration  in  endothelial  cells  of  the  cardiovascular  system 
(Osanai et al, 2003). Taken together these studies suggest a mechanism through which 
ADMA synthesis could be influenced by PRMT activity.
Arginine methylation as a dynamic regulatory process of  protein function 
From  a  functional  perspective,  arginine  methylation  has  been  suggested  to  be 
analogous  to  protein  phosphorylation  in  its  level  of complexity  in  protein  function 
regulation  (Clarke,  1993).  This  post-translational  modification  has  been  implicated 
over the years in several regulatory mechanisms such as RNA binding, transcriptional 
regulation,  DNA  repair,  protein  localization,  protein-protein  interaction,  signal 
transduction  and  recycling  or  desensitization  of  receptors  (Gary  and  Clarke,  1998, 
McBride  and  Silver,  2001,  Bedford  and  Richard,  2005).  A  long  debate  over  the 
reversibility of methylation has led to doubts as to whether arginine methylation could 
act as a dynamic regulatory process of gene expression, since arginine methylation was 
believed to be an irreversible and stable modification (Bannister et al, 2002). Studies 
had  indicated  that  arginine  and  lysine  methylation  of  histones  were  dynamically 
regulated (Bannister et al, 2002) but no proof of a demethylation mechanism existed. 
Evidence for the reversibility of methylation has only recently been documented.  An 
enzyme named peptidylarginine deiminase 4 (PAD4) was identified as able to convert
21all  four mono-methylarginine residues of the N-terminal domain of histone 3  (H3) to 
citrulline  (Wang  et a l,  2004,  Cuthbert  et  al.,  2004).  This  discovery  is  an  important 
development  in  the  understanding  of  arginine  methylation  and  demethylation 
processes, in which the PRMT/PAD pair may act in conjunction, similar to the manner 
in  which  other  cell  signalling  enzymes  operate,  such  as  kinases  and  phosphatases 
(Bannister and Kouzarides, 2005, Denman, 2005).
1.3  Metabolism of asymmetric methylarginines
Methylarginine clearance
Renal excretion was the first mechanism identified for methylarginine clearance. The 
relatively  high  quantities  of  ADMA  and  SDMA  found  in  urine  (Kakimoto  and 
Akazawa,  1970)  led  to  the  assumption  that  ADMA  and  SDMA  levels  were  good 
indicators  of  protein  turnover.  However,  further  investigations  showed  that  SDMA 
levels  in  urine  were  in  fact  thirty  times  higher  than  that  of  ADMA  and  L-NMMA 
(McDermott,  1976),  suggesting  a  possible  secondary  route  for  the  catabolism  of 
asymmetric methylarginines. These results prompted Ogawa and co-workers to isolate 
and  characterise  from  rat  kidney  a  new  enzyme,  N^N^-dimethylarginine 
dimethylaminohydrolase  (DDAH), capable of converting free ADMA  and L-NMMA 
residues but not SDMA residues to L-citrulline and methylamines, with Km values of 
180  pM and 360  pM respectively (Ogawa et al,  1989)  (Figure  1.2).  This enzyme is 
expressed in kidneys, pancreas, liver and brain (Kimoto et al, 1993) and its expression 
pattern was confirmed to correlate with that of endothelial NOS and neuronal isoforms 
in  rats.  The  cloning  of the rat DDAH enzyme  was  followed  by  the  purification  and 
identification  of  a  human  DDAH  homologue  (hDDAH),  with  95%  amino  acid 
sequence identity (Kimoto et al,  1998). However, the observations that human DDAH 
activity did not always correlate with the DDAH expression levels led to the discovery 
of a second novel hDDAH isoform (Leiper et al,  1999). DDAH II has 62 % sequence 
similarity to the first identified human DDAH sequence, now termed DDAH I (Figure 
1.3).  The  Km  of DDAH II for L-NMMA  is  510  pM  which  is  comparable  to that  of 
DDAH  I  (360  pM).  The  two  enzymes  have  different  tissue  expression  patterns 
accounting  for  the  initial  discrepancies  observed  between  activity  and  expression 
levels.  DDAH  I is  highly  expressed  in  brain  and kidney,  whereas DDAH II  is  more 
ubiquitously expressed but mostly found in heart, placenta and kidney. With respect to
22Figure  1.2.  Enzymatic  reactions  catalysed  by  dimethylarginine 
dimethylaminohydrolase (DDAH) with (a) monomethyl arginine (L-NMMA) and (b) 
asymmetric  dimethylarginine  (ADMA)  as  substrates,  L-citrulline  and  mono-  and 
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Figure  1.3.  Sequence based  alignment of rat and human DDAH  I  and DDAH  II  enzymes.  Hydrophobic residues  are coloured blue, polar 
residues are green, positively charged residues are red, negatively charged residues are violet, glycines are orange, prolines are yellow.their co-localisation with NOS isoform expression, DDAH I is found in tissues where 
mainly  nNOS  is  expressed  and  DDAH  II  is  expressed  where  eNOS  is  predominant 
(Leiper  et  al.,  1999).  A  summary  of the  metabolic  pathways  involving  DDAH  and 
NOS is presented in Figure 1.4.
Cellular and circulating ADMA levels
The Km values of DDAH for ADMA and L-NMMA are rather high compared to the 
overall  levels of these molecules  found in cells and plasma, which are usually in the 
low micromolar range for ADMA, and lower still for L-NMMA (Leiper and Vallance, 
1999). This discrepancy could be explained providing higher concentrations of either 
ADMA or L-NMMA could be reached intracellulary.  It has been shown that cultured 
endothelial  cells  re-populating  blood  vessels  have  higher  intracellular  ADMA 
concentrations than in control cells (Azuma et al., 1995). Additionally, as a result of L- 
NMMA  supplementation  to  cultured  endothelial  cells,  the  intracellular  levels  of L- 
NMMA have subsequently been  found to be five fold higher than in the surrounding 
medium  (Bogle  et  al,  1995).  ADMA  and  L-NMMA  consequently  appear  to  be 
generated and concentrated within cells.  This concentration of methylarginines could 
be due to their active transport through  the arginine  Y+ transporter system  (Bogle et 
al.,  1995),  in  such  a way that higher intracellular levels of methylarginines could be 
reached,  although  a  compartmentalisation  of these  molecules  has  not  been  proven. 
Conversely, it is not unreasonable to consider that the in vitro estimations of the A T m  of 
these enzymes do not reflect the actual values in vivo.  Undergoing research is aiming 
to identify DDAH binding partners  or possible phosphorylation  and  acetylation  sites 
that could increase DDAH affinity for its substrate and hence lower the KmS of these 
enzymes in  vivo (Dr J. Leiper, personal communication).
The very low plasma concentration of ADMA (in the order of 0.5-1.2  pM in healthy 
subjects  and  3  pM in  disease  states)  has  also been  a  matter of interest.  The  relative 
plasma concentration  of L-arginine is  60 to  100 times  higher than  that of ADMA,  a 
fact that raises questions as to whether the circulating levels of ADMA are biologically 
significant. However, contrary to these theoretical concerns, a recent study showed that 
very  small  amounts  of  ADMA,  infused  in  healthy  volunteers  in  order  to  reach  a 
systemic  plasma concentration  of ~2  pM,  induced an  increase  in  blood pressure  and 
vascular resistance,  a decrease  in  cardiac  output  and  a fall  in  cardiac  heart rate  as  a
25Citrulline:NO cycle
V   o2
L-Arginine
PROTEIN SYNTHESIS
I
BO
PROTEIN TURNOVER
Asymmetric 
methylarginines
L-citrulline
Methylamines
Renal 
excretion
L-NMMA ADMA
Figure  1.4.  Regulation  of  nitric  oxide  (NO)  and  asymmetric  methylarginine 
metabolism.  NO  is  formed  by  the  nitric  oxide  synthase  (NOS)  catalysed  reaction 
between molecular oxygen and free L-arginine. Free arginines are incorporated into 
proteins and can be methylated by protein arginine methyltransferases (PRMT). After 
protein turnover,  endogenous methylarginines  are liberated  into  the  cytoplasm,  but 
only asymmetric methylarginines  (ADMA  and  L-NMMA)  are known  inhibitors  of 
NOS.  Dimethylarginine  dimethylaminohydrolase  (DDAH)  converts  them  into  L- 
citrulline and monomethyl  and dimethylamines.  Alternatively, they can also follow 
the renal  excretion pathway.  L-citrulline is then  converted back  into  L-arginine by 
urea cycle enzymes (adapted from Leiper et al.  1999). The atoms shown are colour 
coded as follows: carbon -  grey, nitrogen -  blue, hydrogen -  white, oxygen -red and 
methyl groups are shown in magenta.
26direct  effect  on  NOS  systems  (Achan  et  al.,  2003).  These  results  are  conclusive 
evidence showing that ADMA plasma levels can in fact modulate NOS activity within 
the concentration range found in vivo.
The overall level of ADMA is thus balanced between PRMT activity, protein turnover, 
the active transport of ADMA in and out of cells and the metabolism by the enzyme 
DDAH. It is more likely that DDAH should be involved in the maintenance of ADMA 
levels within cells, as in rabbits and rats > 90% of all ADMA is metabolised by DDAH 
and not excreted (Vallance and Leiper, 2004).
1.4  Characterisation of DDAH isoforms as indirect regulators of NOS activity and 
cardiovascular development
The DDAH:ADMA:NOS pathway
The fact that DDAH activity controls the local levels of ADMA and L-NMMA, known 
inhibitors  of NOS  isoforms,  infers  that  this  enzyme  could  act  as  a  possible  indirect 
modulator of NO production. This hypothesis was in part verified by studies in which a 
synthetic  inhibitor of DDAH (4124W) was  administered to cultured endothelial cells 
causing  local  accumulation  of endogenous ADMA in the  supernatant (MacAllister et 
al.,  1994). Moreover, although a weak DDAH inhibitor in vitro 4124W also triggered 
endothelium-dependent contraction of a rat aortic ring, an effect that was reversed by 
supplementation of L-arginine. These preliminary findings were further confirmed by 
studies in transgenic mice where DDAH I was over expressed (Dayoub et al., 2003). 
The  conclusions  of  this  work  suggested  that  the  excess  of  DDAH  activity  was 
implicated  in  the  upregulation  of  NOS  activity  and  NO  production,  owing  to  a 
decrease  of  ADMA  plasma  levels,  which  were  reduced  by  half when  compared  to 
controls.  DDAH  transgenic  mice  have  lower  blood  pressure  and  physiological 
responses consistent with an increase in NO generation. Hence, DDAH is responsible 
for maintaining the levels of ADMA below the inhibitory concentrations of NOS and 
modest  changes  in  ADMA  levels  induced  by  DDAH  activity  can  have  significant 
effects in NO synthesis and cardiovascular pathology.
Although  the  human  DDAH  enzyme  expression  is  not  exclusively confined  to  cells 
and  tissues  expressing  NOS,  these  results  suggest  the  existence  of  a  mechanism 
through which human NOS isoforms could be potentially regulated in a tissue-specific
27manner  by  the  modulation  of asymmetric  methylarginine  concentrations.  In  fact,  in 
view of the systemic physiological effects of NO in mammals, a major pharmaceutical 
objective  is  to  obtain  isoform-specific  NOS  inhibitors.  High  levels  of NO  are  often 
reported  in  septic  shock,  neurodegenerative  diseases  and  certain  inflammatory 
conditions.  In  some  instances  the  blockade  of  overproduction  of  NO,  generally 
associated  with  the  expression  of  inducible  NOS  (iNOS),  is  of  pharmacological 
interest  (Hobbs  et al.,  1999).  A  potential  alternative  approach  to  inhibit  excess  NO 
production  is  to target the  activity of DDAH.  Although the inhibition  of one DDAH 
isoenzyme will  not inhibit a specific  NOS  isoform,  it might limit NO  synthesis in  a 
tissue-specific  manner  (Vallance  and  Leiper,  2002).  To  this  end,  several  selective 
substrate-based inhibitors  of the mammalian  DDAH enzymes  have  been  synthesised 
which  did not  inhibit  NOS  (Rossiter et al.,  2005).  Two  of the  designed compounds 
have  an  in  vitro  IC50  value  in  the  20  pM  range  which  is  a  significant  advance 
compared to the millimolar inhibitor 4124W.  These molecules are the first reversible 
DDAH inhibitors described to date and their use will be invaluable in the study of the 
relevant biological pathways involved.
The activity of DDAH I has been shown to be extremely sensitive to oxidative stress. 
Ito et al showed that challenging cultured endothelial cells with oxidized small density 
lipoproteins  (oxLDL)  and  tumor necrosis  factor-a  (TNF-a),  known  to  decrease  NO 
production  in  atherosclerosis,  significantly  decreased  DDAH  activity  and  hence 
induced the accumulation of ADMA in the cells (Ito et al., 1999).  The impairment of 
DDAH I activity is not coupled to a decrease in its expression level but rather to direct 
inhibition  of the  enzyme’s  catalytic  activity.  The  connection  between  homocysteine 
and ADMA is  also relevant.  Homocysteine (Hey) counters the endothelial-dependent 
vasodilation  of the brachial  artery through  a mechanism that is not fully understood. 
Hey was shown to inhibit DDAH activity via a redox mediated mechanism (Stiihlinger 
et al., 2003) and this reaction caused an increase in the levels of ADMA in cells. The 
authors concluded that this effect could be  a possible explanation  for Hey  actions  in 
vivo. Consistent with the belief that DDAH activity can be regulated through oxidative 
stress, it was demonstrated that the DDAH I enzyme was inactivated by S-nitrosylation 
(Leiper  et  al.,  2002).  The  nitroso  group  is  thought  to  modify  covalently  a  reactive 
cysteine  residue  in  the  active  site.  Although  speculative,  these  results  suggest  the
28potential  existence of an  elegant feedback mechanism through which high NO  levels 
up-regulate the levels of ADMA.
Additional modulators of DDAH 11 activity
Building  on  previous  analysis  of  DDAH  tissue  distribution,  a  later  more 
comprehensive  study  was  performed  in  order  to  estimate  effectively  DDAH  I  and 
DDAH II mRNA levels in 43  adult and 7 foetal human tissues. The quantification of 
the mRNA levels revealed that DDAH II is highly expressed in foetal tissue (Tran et 
al., 2000) and it is possible that DDAH II has an important role in cell differentiation 
and  cell  cycle  control.  Achan  and  co-workers  studied  the  effects  of  retinoic  acid 
(atRA)  on  endothelial  cell  lines.  AtRA  is  an  important  molecule  in  the  embryonic 
development of the cardiovascular system and is believed to convey beneficial effects 
in models of cardiovascular disease. Their data revealed that the implicated mechanism 
through  which  atRA  could  serve  as  a  potential  therapeutic  in  atherosclerosis  and 
angiogenesis involved the up-regulation of DDAH II expression and not of DDAH I, 
which ultimately produces the desired increase in the levels of NO in endothelial cells 
(Achan  et  al,  2002).  Further  support  for DDAH  II’s  role  in  cellular  differentiation 
showed that this enzyme is transcriptionally regulated by growth- and developmental- 
factors in processes in which NO is involved (Smith et al., 2003, Jones et al., 2003).
Another interesting point to note with respect to hDDAH isoform tissue distribution is 
the apparent lack of DDAH I in immune cells and tissues, such as leukocytes, lymph 
node and bone marrow, where DDAH II is detected. Tran et al.  observed that DDAH 
II localisation on chromosome 6p21.3 corresponds to a region containing several genes 
involved in the immune and inflammatory responses and responsible for the onset of 
autoimmune diseases, like arthritis or diabetes (Tran et al., 2000). These conditions are 
linked  to  an  increased  activity  of inducible  NOS  in  immune  cells,  where  DDAH  II 
gene  expression  could  be  implicated  in  the  regulation  of methylarginine  levels  and 
subsequently  NOS  expression.  The  DDAH  II  gene  has  therefore  been  called  a 
“housekeeping” gene or a “disease-susceptible” gene (Jones et al, 2003).
The  modulation  of  DDAH  activity  appears  to  be  subject  to  complex  regulatory 
processes.  The  enzyme  expression  levels  can  be  manipulated  with  drugs  such  as 
estrogens (Holden et al, 2003), as well as with retinoic acid. The utility of these agents
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becoming evident and will likely provide further insight into the biology of ADMA.
1.5  ADMA as a novel marker for endothelial dysfunction and cardiovascular risk
Pathophysiology
High plasma levels of ADMA have been described in a number of diseases associated 
with  the  disruption  of  cardiovascular  function,  including  hypercholestererolaemia 
(Boger  et  al.,  1998),  atherosclerosis  (Boger  et  al,  1997,  Miyazaki  et  al,  1999), 
hypertension  (Surdacki  et  al,  1999)  and  chronic  heart  failure  (Usui  et  al,  1998). 
Hypercholestererolaemia  is  a  dominantly  inherited  genetic  condition  that  results  in 
markedly elevated LDL (low-density lipoprotein) cholesterol levels beginning at birth 
and  resulting  in  premature  atherosclerosis  of  the  coronary  arteries.  The  studies 
conducted  by  Boger  and  co-workers  showed  that  high  cholesterol  levels  increased 
ADMA  concentration,  although  the  mechanism  responsible  for  this  association 
remains  unknown.  The  changes  in  ADMA  levels  reduced  NO  production  in 
hypercholestererolaemic  subjects  and in  atherosclerotic  patients,  substantiated by the 
reduced  urinary  nitrate  excretion  and  impaired  endothelium-dependent  NO 
vasodilation.  The  observation  that  ADMA  levels  also  increase  early  in  the 
development  of  atherosclerosis  suggests  that  ADMA  is  not  only  a  marker  of  but  a 
mediator of endothelial  dysfunction.  Moreover,  data favouring a role of ADMA as  a 
cardiovascular risk marker is emerging.  So far three prospective clinical  studies have 
been carried out with a focus on evaluating ADMA concentration in patients as well as 
a variety of other cardiovascular risk factors. The main conclusion  drawn  from these 
follow-up  cases  is  the  strong  correlation  between  elevated  ADMA  levels  and  the 
increased risk of the occurrence of a cardiovascular event (Boger, 2004).
However the highest concentrations of ADMA are found in patients with chronic renal 
failure.  In  such  individuals,  plasma  ADMA  and  SDMA  accumulate  as  they  can  no 
longer be excreted. In fact ADMA is present in lower amounts than SDMA, probably 
due to DDAH activity in the kidneys.  The rise in concentration of ADMA was linked 
to an overall decrease in NOS activity which ultimately led to endothelial dysfunction 
and unwanted cardiovascular effects (Zocalli et al, 2001). In this study ADMA levels, 
together  with  patient  age,  were  the  two  predictors  for  overall  mortality  and 
cardiovascular events  in  subjects  with  renal  impairment.  ADMA  is  not only  a novel
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the  kidney fails,  it  is  a guanidine  compound,  a product of protein  metabolism  and it 
disrupts several biological functions through its effects on NOS function (Kielstein and 
Zoccali, 2005)
Targets for treatment
One of the methods to counter the actions of ADMA in cardiovascular diseases is L- 
arginine supplementation. L-arginine has been shown to reverse the effects of ADMA 
by  restoring  NOS  activity  and  improving  endothelium-dependent  vasodilation  in 
hypercholesterolaemic individuals and in patients with congestive heart failure (Boger 
and Ron, 2005). Nutritional supplementation of L-arginine is sufficient in these cases 
to  restore  the  physiological  ratios  of L-arginine  to  ADMA,  as  it  was  shown  that L- 
arginine administration in healthy subjects had no effect on vasodilation.  However the 
scope of these studies is limited and the real potential of L-arginine as a drug remains 
to be further investigated. Another alternative route to restore ADMA levels is via the 
up regulation of DDAH activity. As previously shown, estrogens and retinoic acid can 
increase DDAH expression in experimental models (Holden et al., 2003, Achan et al, 
2002). Nevertheless, it is early days before the modulation of DDAH activity proves to 
be a truly effective therapeutic strategy. The utility of such an approach will certainly 
benefit from the development of specific inhibitors and activators of DDAH and from 
studies  with  animal  models  in  which  mice  knockouts  could  provide  conclusive 
evidence for the pathophysiological role of DDAH.
1.6  Evolutionary perspective
The  DDAH  enzymes  are  not  confined  to  eukaryotic  organisms,  the  discovery  of  a 
family of conserved DDAH enzymes in bacteria indicates the ancestral origin of these 
enzymes  (Santa-Maria et al.,  1999).  Curiously,  many  if not  all  bacteria that  harbour 
DDAH genes are known pathogens. In Mycobacterium tuberculosis the gene encoding 
DDAH  is  flanked  by  rocDl,  rocD2  and  rocE  operons,  which  encode  for  ornithine 
handling  enzymes  such  as  ornithine  aminotransferases  (OAT)  and  for  an 
arginine/ornithine  transporter.  Ornithine  is  a  biosynthetic  precursor  of  arginine 
residues, and OATs are important for its metabolism. In Pseudomonas aeruginosa, the 
DDAH gene is part of an operon where putative protein sequences involved in arginine
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asymmetric  methylarginine  residues  (for  example,  the  existence  of  PRMTs  in 
prokaryotes has not been established), the benefit that DDAH enzymes could convey 
to a bacterium are still unclear. DDAH expression could be a response mechanism to 
metabolise  effectively  exogenous  ADMA,  with  re-integration  of  the  L-citrulline 
residues formed into the general L-arginine metabolic pathway. In fact, P.  aeurginosa 
is commonly associated with urinary tract infections (Nicolle, 2002) and ADMA levels 
are  known  to  be  higher  than  those  of  L-arginine  in  human  urine  (Kakimoto  and 
Akazawa, 1970). Another point to consider is that bacterial DDAH could be implicated 
in  the  disruption  of  NO  production  in  the  host.  One  study  has  shown  that  P. 
aeruginosa  mediates  epithelial  damage  through  NO  production  but  the  mechanism 
through which this effect is achieved is unknown (Downling et al.  1998).
Interestingly,  a  recent  report  has  revealed  the  presence  of  a  NOS-like  enzyme  in 
Bacillus subtilis fully capable of producing NO (Adak et al., 2002a) and various NOS 
oxygenase-like domains have been discovered in other organisms (Adak et al., 2002b). 
The  possible  co-existence  of  NOS  and  DDAH-like  enzymes  early  on  in  evolution 
demonstrates that the metabolism of asymmetric methylarginines and the regulation of 
NOS iso-enzymes have remained of significant importance. Gene structure comparison 
of human DDAH I and DDAH II confirms that these two sequences originated from a 
tandem gene duplication event, proposed to have occurred ca.  450 million years ago 
(Tran et al., 2 0 0 0 ).
1.7  Structural characterisation of the Pseudomonas aeruginosa DDAH
Description of the overall fold of the Pseudomonas aeruginosa DDAH 
As  part  of  ongoing  efforts  to  derive  structural  information  for  DDAH,  the  crystal 
structure of the more tractable bacterial Pseudomonas aeruginosa DDAH (PaDDAH) 
homologue  has  been  solved  (Murray-Rust  et al.,  2001).  Since  expression  levels  for 
recombinant  mammalian  DDAH  never  reached  suitable  levels  for  either 
crystallographic  or NMR  studies,  attention  was focused  on the bacterial  homologue. 
The enzyme is composed of 254 amino acid residues and has 44% and 22% sequence 
homology  to  DDAH  I  and  DDAH  II  respectively.  The  overall  fold  of this  enzyme 
forms  a  propeller  comprised  of  five  modules  that  enclose  a  buried  active  site.  The 
modules are arranged in a pseudo five-fold rotational symmetry (Figure  1.5a,b). Each
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strand that makes a parallel arrangement with the other two p-strands. This motif has 
been described as the PPaP structural motif (Figure  1.5c-e). From a lateral view point 
of the enzyme  (with respect to the  axis  of the barrel),  the N-  and C-terminal  tails  of 
each  ppaP  module  protrude  from  the  bottom  end  of  the  protein.  The  polypeptide 
sequence  starts with the second p-strand plB  of module  1, followed by helix  al  and 
the third strand piC (residues  1-67). The polypeptide chain then continues through all 
the  successive  modules  finally  to  close  the  fold  with  the  C-terminal  P-strand  piA 
(residues 252-254) to complete the initial module  1  (Figure  1.5c,d). This arrangement 
of the  chain  is  often  termed  “Velcro  closure”  and  is  reminiscent  of the  p-propeller 
architecture  found in  a  variety of unrelated proteins.  More  recently,  Paoli  suggested 
that proteins with ppaP structural motifs such as that found in DDAH should be termed 
p/a-propellers  to  differentiate  them  from  the  canonical  P-propellers  which  are 
normally  composed  of motifs  with  purely  antiparallel  four-stranded  p-sheets  (Paoli, 
2001).
In terms of oligomeric state, PaDDAH exists as a homodimer in the crystallographic 
unit  cell.  Size  exclusion  chromatography  and  dynamic  light  scattering  (DLS) 
experiments confirmed the dimeric state of the enzyme. The protomer interface surface 
area  was  estimated  at  860  A2/protomer.  It  is  located  on  the  side  of  the  enzyme, 
between  helices  a l  and  a2  and  forming  an  extension  of  the  p-sheet  in  the  PPaP 
module 1  across the interface. A detailed description of the dimer interface interactions 
will be given in Chapter 3.
The catalytic triad and the active site of PaDDAH
Several  authors  have  shown  that  the  PaDDAH  p/a-propeller  fold  is  conserved  in  a 
variety  of  enzymes  that  catalyse  modifications  of  the  guanidino  group  of  arginine 
residues  (Leiper et  al.,  1999,  Murray-Rust  et  al.,  2001).  Structure  based-alignments 
showed  that  PaDDAH  has  sufficient  sequence  homology  to  aminidinotransferases 
(AT) from human and bacteria (discussed in detail  in Section  1.8) to provide insights 
into  the  residues  responsible  for  the  reaction  mechanism.  The  catalytic  triad  of 
PaDDAH was thereby identified as being composed of residues Cys 249, His  162 and 
Glu  114.  The  single  mutant  proteins  C249S,  H162F  and  E114Q  PaDDAHs  were 
correctly expressed in a folded form and they all lacked enzymatic activity. The C249S
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Figure  1.5.  3D  structure  of the  C249S  Pseudomonas  aeruginosa  dimethylarginine 
dimethylaminohydrolase  bound  to  L-citrulline  (PaDDAH;  PDB  code:  lh70).  (a) 
Lateral view of the 3D structure of a single protomer of PaDDAH with p(3a(3 modules 
coloured  individually  (Module  1   is  blue:  residues  1-67  and  249-254;  module  2  is 
yellow: 68-117; module 3 is red:  118-166; module 4 is orange:  167-205; module 5 is 
green: 206-248).  (b) plane view of a single subunit of PaDDAH coloured as (a).  3D 
structure  (c)  and  topology  (d)  of module  1  coloured  as  (a).  3D  structure  (e)  and 
topology  (f)  of module  3.  Figures  were  generated  with  MOLMOL  (Koradi  et  al, 
1996).
34PaDDAH  structure  was  solved  with  L-citrulline  and  ADMA  in  complex,  although 
only  the  L-citrulline-bound  structure  has  been  deposited  in  the  Protein  Data  Bank 
(PDB).  The active site cleft in the apo-form of the enzyme lies exposed to solvent in 
the  center of the  barrel.  Upon  ligand binding a loop  (LI)  between  residues  14-25  is 
believed to close down on the active site.  A single hydrogen bond is formed between 
the  carbonyl  oxygen  atom  of  Leu  18  and  the  amino  group  of  either  ADMA  or 
citrulline.  The  LI  loop  is  mobile  and  disordered  in  the  apo-state  of the  protein,  but 
becomes more ordered once either of the citrulline or ADMA complexes are formed, 
with  increased electron  density in this region  (Murray-Rust et al.,  2001).  In fact,  the 
active site entrance is composed of an  arrangement of loops, between residues 54-67 
(L2),  78-82  (L3),  107-113  (L4),  130-133  (L5),  157-161  (L6)  and  243-251  (L7). 
Curiously, the active site residues Glu  114 and His  162 lie in 3io-helix segments just 
adjacent to loops L4 and L6, and Cys 249 lies in the L6 loop.
In  each  of  the  ligand  complexes  with  C249S  PaDDAH,  the  citrulline  and  ADMA 
molecules  are  situated  in  a negatively charged active  site  pocket  (Figure  1.6A).  The 
residues Glu 66 and Asp 60 form hydrogen bonds with the side chain terminal end of 
both the citrulline and the ADMA molecules, more specifically with  nitrogen Ne and 
with the non-methylated Nn . The fact that these hydrogens bonds are present in both 
complexes  suggests that these atoms  are held in  place during catalysis.  Interestingly, 
the  specificity  of  PaDDAH  for  L-NMMA  and  ADMA  over  SDMA  as  substrate 
apparently is determined by the presence of Glu 66 and Asp 60. Where the methylated 
Nn  of SDMA should have been  located, the  steric  hindrance is therefore responsible 
for the failure of PaDDAH to metabolize SDMA molecules.
The carbon backbone of the citrulline and ADMA is flanked and protected between the 
side chains  of two hydrophobic  residues, Phe 63  and Leu  161  (Figure  1.6A).  The a- 
carboxylate group of these molecules is hydrogen bonded with the side chains of Arg 
132, Arg 85 and the a-amino group to the side chain of Asp 60 and the oxygen atom of 
the carbonyl groups of Arg 132 and Leu 18 (Figure 1.6A).
A  catalytic  mechanism  similar  to  that  of  AT  has  been  proposed,  in  which  the 
nucleophilic  attack  by  the  atom  SY   of  Cys  249  on  the  of  the  asymmetric 
dimethylarginine  substrate  is  followed  by  the  hydrolysis  of the  resulting  tetrahedral 
intermediate  into  citrulline  and  dimethylamines  (Murray-Rust  et  al,  2001)  (Figure 
1.6B). The accumulation of a covalent S-alkylthiouronium intermediate attached to the 
active  site cysteine  was  recently confirmed  by  acid trapping  and mass  spectrometric 
analysis (Stone et al, 2005a).
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Figure 1.6. (A) 3D view of the active site region of PaDDAH complexed with (a) L- 
citrulline and (b) ADMA molecules. Active site residues Cys 249, His  162 and Glu 
114  are  coloured  light  blue,  Phe  63  and  Leu  161  are  coloured  green.  A l  other 
residues  follow CPK colouring.  Hydrogen bonds  are  shown in orange.  Note, the  O 
atom  of Ser 249  in the PaDDAH pdb  file has been  coloured  yellow  to  reflect the 
presence  of  the  S  atom  of  Cys  249.  (B)  Proposed  reaction  mechanism  for  the 
PaDDAH enzyme (Murray-Rust et al., 2001). The C^ atom of the ADMA molecule 
undergoes  a  nucleophylic  attack  by  the  thiol  group  of  Cys  249.  The  reaction 
intermediate formed is S-alkylthiouronium which is ultimately hydrolysed to form L- 
citrulline and dimethylamine.
361.8  A superfamily of guanidino-modifying enzymes
The amidinotransferases
Sequence and structure similarity searches for PaDDAH have suggested the existence 
of a superfamily of arginine-modifying enzymes with strikingly similar (3/a-propeller 
folds,  although with low  sequence similarity scores  (Shirai et al., 2001)  (Figure  1.7). 
Among these enzymes are aminidinotransferases (AT; EC 2.1.4.1), such as the human 
L-arginine:glycine  amidinotransferase  (AGAT)  that  catalyses  the  transfer  of  the 
guanidino  group of L-arginine to glycine, producing L-omithine and guanidinoacetic 
acid (Figure  1.8).  These products  are intermediates  in the biosynthesis  of creatine in 
humans. AGAT has a catalytic triad similar to DDAH. It is composed of residues Cys 
407, His 303 and Asp 254, however the scissile bond of this reaction is different from 
that cleaved by DDAH enzymes, AGAT cleaves the C^-Ne bond of L-arginine residues 
(Humm  et  al.,  1997)  whereas  DDAH  cleaves  the  C^-N1 1   bond  of  asymmetric 
methylarginines. It is interesting to note that the orientation of the active site residues 
of  the  two  enzymes  is  conserved  when  the  backbone  atoms  are  superimposed  and 
consequently both scissile bonds overlap and have the same orientation relative to the 
active  site  residues,  even  though  the  overall  orientation  of the  substrates  differs  in 
transferases  and  hydrolases  (Murray-Rust  et  al.,  2001).  This  observation  tends  to 
validate the prediction of a similar reaction mechanism for these two enzymes.
A  second  amidinotransferase  with  structural  similarity  to  PaDDAH  is  L- 
arginine:inosamine-phosphate amidinotransferase from Streptomyces griseus (StrBl or 
IP  AT; EC 2.1.4.2). This enzyme is responsible for transferring the guanidino group of 
L-arginine  to  inosamine-phosphate  rings  to  form  an  intermediate  aminoglycoside  in 
the  biosynthesis  of the  antibiotic  streptomycin  (Figure  1.9).  The  StrBl  fold  is  very 
similar to  AGAT and PaDDAH  (Fritsche  et al.,  1998),  with  the conservation  of the 
secondary structural elements and position of the active site residues. For StrBl  these 
are Asp  179, His 227 and Cys 332 (Figure  1.7). However, the AGAT and StrBl  active 
site regions are shielded by the insertion of three extra a-helices (HI, H2 and H9) in 
AGAT, two a-helices in  StrBl  (HI  and H2) and two extra P-strands at the top end of 
both  molecules,  whereas  PaDDAH  structure  only  has  the  LI  loop  lying  across  the 
active site entrance (Figs 1.8b-1.9b).
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Figure  1.7.  Structure-based alignment of amino acid sequences from Pseudomonas aeruginosa dimethylarginine dimethylaminohydrolase 
(PaDDAH),  Pseudomonas  aeruginosa  arginine  deiminase  (PaADI),  human  peptidylarginine  deiminase  4  (HuPAD4),  human  L- 
arginine:glycine  amidinotransferase  (HuAGAT),  Streptomyces griseus  L-arginine:inosamine-phosphate  amidinotransferase  (SglPAT)  and 
Escherichia coli arginine succinyltransferase (PcASTR). The colour coding highlights individual  ppap structural motifs, module  lis blue, 
module 2 is yellow, module 3 is red, module 4 is orange, module 5 is green. Active site residues are colored light blue and are indicated with 
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Figure  1.8. (a) Chemical reaction catalysed by argininetglycine amidino transferase 
(AGAT) with L-arginine  and  L-glycine  as  substrates,  guanidinoacetic  acid  and  L- 
omithine as products.  The standard Greek numbering of the  side  chain carbon  and 
nitrogen  atoms  is  indicated  in  red.  (b)  Lateral  view  and  planee  view  of the  3D 
structure of human arginine: glycine amidinotransferase complexed with L-omithine 
(AGAT, pdb code: 3jdw). Module 1 is colored blue, 2 is yellow, 3 is red, 4 is orange 
and 5 is green. Secondary structural elements coloured in grey are insertions relative 
to PaDDAH sequence. The 300-flap and the a-helices H2 and H9 are shown.
40Figure  1.9.  (a)  Chemical  reaction  catalysed  by  arginineiinosamine-phosphate 
amidinotransferase  (AGAT)  with  L-arginine  and  scyZZo-inosamine  4-phosphate  as 
substrates and N-amidino-scyZZo-inosamine 4-phosphate and L-omithine as products,
(b)  Lateral  view  and  plane  view  of  the  3D  structure  of  Streptomyces  griseus 
arginine:inosamine-phosphate amidinotransferase (BPAT or StrBl, pdb code:  lbwd). 
The colour coding is the same as in Fig.  1.8.
41The  network  of surrounding  loops  is  another feature  which  is  not  conserved  among 
these three enzymes, but it seems that from crystallographic evidence, the “300-flap” 
loop between modules 3  and 4 in AGAT (as it is termed by the authors) undergoes a 
large  conformational  change  upon  binding  of  the  substrate  (Fritsche  et  al.,  1999), 
similar to the supposed closing of the PaDDAH LI loop (Figure 1.8b).
The arginine deiminases
Arginine  deiminases  (ADI;  EC  3.5.3.6)  are  members  of  a  second  class  of enzymes 
found to share structural homology with DDAH and amidinotransferases (Figure  1.7). 
These enzymes are involved in the first step of anaerobic degradation of arginine and 
are  mainly  found  in  prokaryotes  and  some  parasitic  protists.  The  fact  that  ADI 
enzymes  are  absent  from  higher  eukaryotic  genomes  makes  them  attractive 
antibacterial targets. ADI enzymes catalyse the hydrolysis of free L-arginine molecules 
into  L-citrulline  with  release  of  ammonia  (Figure  1.10A).  This  reaction  resembles 
closely that catalysed by PaDDAH since both enzymes target the same scissile bond, 
Cc-Nn.
Recently the crystal  structure of Pseudomonas aeruginosa ADI  (PaADI)  was  solved 
and revealed a five-fold ppap module arranged in a p/a-propeller topology (Galkin, et 
al., 2004). The main structural difference between the different classes of hydrolases is 
the unique insertion of an  additional  85-residue domain  between modules  1  and 2 of 
PaADI which  includes  five  a-helices,  a  short 3io-helix  and  a single  P-strand  (Figure 
1.10B).
PaDDAH and PaADI have the same active site residues (the PaADI catalytic triad is 
composed  of residues  Glu  224,  His  278  and  Cys  406)  which  closely  overlap  upon 
superimposition  of  the  two  structures.  In  addition,  the  orientations  of  five  other 
residues in the active site of both enzymes are also in conserved positions relative to 
the  bound  substrate  (Figure  1.11).  This  degree  of  conservation  is  rather  high 
eventhough  the  enzymes  are  capable  of  discriminating  their  substrates;  DDAH 
enzymes do not display significant arginine deiminase activity, as the estimated Km of 
PaDDAH  for  L-arginine  is  in  the  millimolar  range  (Stone  et  al.,  2005a).  The 
specificity  of DDAH  for  asymmetric  methyl arginine  residues  over L-arginine  arises 
from the positioning of residues Lys  164, Glu 65  and Ser 248 in the PaDDAH active 
site  which  are  replaced  by  counterparts  Asp  280,  Arg  165  and  His  405  in  PaADI
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Figure  1.10.  (A)  Chemical  reaction  catalysed  by  arginine  deiminase  (ADI)  with  L- 
arginine  as  substrate,  and  L-citrulline  and  ammonium  as products.  (B)  Lateral  view 
and  plane  view  of  the  3D  structures  of  (a)  Pseudomonas  aeruginosa  arginine 
deiminase  C406A mutant  complexed  with  L-arginine  (PaADI,  pdb  code:  2a9g),  (b) 
the  C-terminal  domain  of  human  peptidylarginine  deiminase  4  complexed  with 
benzoyl-L-arginine (PAD4, pdb code:  lwda). The colour coding is the same as in Fig.
1.8.Kt64^  ^
<3  ^
Figure  1.11. (a) 3D view of the active site region of C249S PaDDAH complexed 
with an ADMA molecule in juxtaposition with (b) the 3D view of the active site of 
C406A PaADI  complexed  with  an  arginine  residue.  Protein  side  chains  making 
contact  with  the  ligand  are  highlighted  in  stick  representation.  The  indicated 
residues in PaDDAH are Lys  164, Ser 248  and Glu 65,  and in PaADI, their non­
conserved  counterparts  are  Asp  280,  His  405  and  Arg  165  (see  text).  All  other 
active  site residues  are  conserved.  The  ligand  atoms  are  shown  in ball  and  stick 
representation and follow CPK colouring. Hydrogen bonds are shown in orange.
44(Figure  1.11). If residue Lys  164 in PaDDAH is artificially substituted by Asp 280 as 
seen in  ADI, the carboxyl  group of the  aspartic  acid side chain would clash with the 
methyl groups of the ADMA molecule. Instead the side chain of Lys  164 in PaDDAH 
is oriented away from the active site, forming a salt bridge with residue Glu 65, which 
greatly reduces the steric hindrance and accommodates the methylated arginine in the 
active  site  (Galkin  et  al.,  2005).  In  addition,  residue  Ser  248  in  DDAH,  which 
substitutes  His 405  in ADI,  allows  enough  space  for the positioning of the  aliphatic 
part of the Lys  164 side chain near to the hydrophobic N^N^-methyl groups of ADMA 
(Figure 1.11).
In order to identify possible structure rearrangements of ADI which could occur upon 
ligand binding, the crystal  structure of the C406A PaADI mutant was  also solved in 
complex with an arginine molecule (Galkin et al., 2005). This result revealed that the 
overall  fold is preserved but that conformational changes occur in four loops  around 
the active site. The authors suggest that this concerted loop motion serves to tighten the 
surroundings of the substrate, particularly the loop between residues 25-48 in PaADI, 
to shield the active site from solvent exposure, perhaps in a similar fashion to the LI 
loop over the PaDDAH active site. However, in contrast to other arginine-modifying 
enzymes,  PaADI  has  an  additional  residue  Arg  401  in  the  active  site  providing  a 
barrier to the substrate entrance. This residue needs to be entirely displaced in order to 
accommodate the arginine substrate. In fact, the end of Arg 401  side chain is displaced 
by more than 8 A upon L-arginine binding (Galkin et al., 2005).
The  PaADI  reaction  mechanism  has  been  investigated  in  detail  with  the  co­
crystallisation  of the inactive H278A ADI mutant with the alkylthiouronium reaction 
intermediate  (Galkin  et  al.,  2005).  The  side  chain  Cys  406  is  responsible  for  the 
nucleophilic  attack  on  the  carbon  of  arginine.  A  covalent  adduct  (Cys406-S- 
alkylthiouronium)  is  then  formed,  with  the  subsequent  release  of  ammonia.  The 
hydrolysis proceeds with a proton transfer to His 278 that enables the production of L- 
citrulline.
Peptidylarginine  deiminases  (PAD;  EC  3.5.3.15)  are  yet  another  family  of  arginine 
deiminases, which catalyse the conversion of protein arginine residues to citrulline and 
ammonia (Figure  1.7).  This conversion  is  termed citrullination  and is  part of a post- 
translational modification in vertebrates (Vossenaar et al., 2003). The crystal structure 
of the human PAD4 enzyme has been solved recently (Arita et al., 2004) and has two
45independent domains. The N-terminal domain consists of residues Met  1-Pro 300 and 
was shown to be composed of two immunoglobulin-like subdomains. The C-terminal 
domain comprises residues Asn 301-Pro 663 and has structural homology to the other 
enzymes  presented  so  far  with  five  ppap  modules  also  arranged  in  a  p/a-propeller 
(Figure  1.10B). This enzyme is the first in this class to require the binding of two Ca2+ 
ions for catalysis, and was solved in complex with a benzoyl-L-arginine molecule. It is 
noteworthy that  the  major backbone rearrangements  of this  enzyme  appear to  occur 
upon Ca2+ binding and not upon substrate binding (Arita et al., 2004). Candidates for 
the active site residues were deduced from the superimposition  of PAD4 and PaADI 
3D structures and were later confirmed to be Asp 350, His 471, Asp 473 and Cys 645. 
It is interesting to note that the C-terminal p/a-propeller domain has an exposed cavity 
and no loops  are believed to close down  on the  substrate in the  active site, probably 
due  to  the  fact  that  the  entrance  to  PAD4  the  active  site  needs  to  accommodate  a 
polypeptide  chain  attached to  the  substrate  arginine.  By corollary,  it  is possible that 
steric effects explain why ADI and AT enzymes can not bind protein arginine residues. 
Recently,  as  mentioned  in  Section  1.2,  Wang  et  al.  and  Cuthbert  et  al.  provided 
evidence  that  PAD4  can  also  convert  INP-monomethylarginine  residues  to  citrulline, 
which  would  imply  a  similar  active  site  arrangement  for  both  DDAH  and  PAD4 
enzymes (Wang et al., 2004, Cuthbert et al., 2004). However, in vitro studies carried 
out by  another group  showed that PAD4 poorly catalyses  the deimination of protein 
methylated arginine residues (Kearney et al., 2005). The authors argue that methylated 
arginines  are  poor  substrates  for  PAD4  since  the  active  site  is  too  small  to 
accommodate the methyl group. Nevertheless, the apparent contradiction might in part 
be due to the presence of interacting proteins in vivo that could enhance the ability of 
PAD4  to  catalyse  the  citrullination  of  methylated  arginines.  Another  argument  put 
forward  is  the  possibility  of PAD4  to  undergo  a post-translational  modification  that 
would also enhance PAD4 affinity for these  substrates  (Kearney et al.,  2005).  These 
studies  indicate  that  an  additional  level  of regulation  must  exist  in  vivo  so  that  the 
deimination of monomethylated arginine residues remain of physiological relevance as 
proven in Wang and Cuthbert’s independent works.
46The arginine succinyltransferase pathway
L-arginine  has  several  routes  for  catabolism  in  prokaryotes,  among  which  are  the 
arginase pathway, the arginine deiminase pathway (which was briefly described in the 
previous section) and the arginine succinyltransferase (AST) pathway.  In Escherichia 
coli the AST pathway accounts for 97% of arginine metabolism. The pathway consists 
of five catalytic  steps to convert arginine to glutamate.  One such intermediate step is 
the  conversion  of  A-succinylarginine  to  A-succinylomithine  catalysed  by 
succinylarginine  dihydrolase  (AstB,  EC  3.5.4.-)  (Figs.  1.7  and  1.12a).  This  enzyme 
was  predicted  to  be  a  member  of  the  guanidino-modifying  enzyme  superfamily 
through  the  use  of  a  combination  of  several  computer-based  fold  and  homology 
recognition tools  (Shirai  and Mizuguchi,  2003). The crystal  structure of E.  coli AstB 
solved recently confirmed these findings  and revealed the  same  five  PPaP  structural 
motifs arranged in a propeller and a conserved catalytic triad composed of residues Glu 
274,  His  248  and  Cys  365  (Tocilj  et  al,  2005,  Figure  1.12b).  Another  feature 
apparently  shared  between  AstB  and  DDAH  enzymes  is  the  presence  of  a  highly 
mobile loop, Ala 19 to Gin 34 in the apo-state of AstB, which becomes organized upon 
substrate and product binding.
AstB was proposed to catalyse two cycles of hydrolysis, removing successively the Nn 
and N1 1   groups from the guanidium moiety of the  arginine derivative  with release of 
ammonia,  CO2  and  leaving  the  ornithine  side  chain  as  a  product  (Figure  1.12a). 
Although AstB cleaves the C^-Ne bond just as ATs do, the side chains of AstB residues 
in the vicinity of the active site share similar environments to ADI active site residues. 
The  question  arises  as  to  what  keeps  AstB  from  catalysing  the  conversion  of  N- 
succinylarginine to N-succinylcitrulline but instead drives the reaction further through 
a second hydrolysis step. The only explanation presented by the authors focuses on a 
single  residue  substitution  in  the  active  site  region.  In  ADI  enzymes  the  residue  in 
question  is  an  aspartic  acid  (Asp  166  in  PaADI)  whereas  in  AstB  dihydrolases  the 
position is always occupied by an asparagine residue which forms only one hydrogen 
bond to  the  Ne  of the  arginyl  moiety.  Asp  166  in  ADI forms  instead two  hydrogen 
bonds to the arginine molecule with Ne and N1 1  hampering the second hydrolysis  step 
(Tocilj et al., 2005).
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Figure  1.12.  (a)  Chemical  reaction  catalysed  by  succinylarginine  dihydrolase 
(AstB),  with  L-succinylarginine  as  substrate,  L-succinylomithine,  ammonia  and 
carbon dioxide as products, (b) Lateral view and plane view of the 3D structures of 
Escherichia  coli  succinylarginine  dihydrolase  C365S  mutant  bound  to 
succinylarginine (AstB, pdb  code:  lyni).  The  colour coding is the  same  as in Fig.
1.8.
48Concluding remarks
The guanidino group of arginine residues has a high energy content for which nature 
has devised several pathways of catabolism. The set of enzymes presented here are just 
a  sample  of arginine  guanidino-modifying  enzymes  which  share  a  highly  conserved 
p/a-propeller  fold  and  related  reaction  mechanisms.  Despite  the  diverse  amino  acid 
sequences,  these  enzymes  may  have  evolved  from  a  small  number  of  common 
ancestors which would explain the limited variety of folds and of catalytic mechanisms 
described.  The  subtle  differences  in  the  active  site  residues  are  responsible  for  the 
modulation of the affinity for the arginine moiety together with the orientation of the 
targeted scissile bond for cleavage. Additionally a common structural feature presented 
by these enzymes is the presence of several loops at the entrance to the active site. The 
evidence from the crystal structures is that in most cases the active site is shielded from 
solvent upon ligand binding through a rearrangement of loop conformations.
1.9  Scope and perspectives of this thesis
The  existence  of a  superfamily  of enzymes  capable  of modifying  guanidino  groups 
together  with  the  discovery  of  different  DDAH  isoforms  in  several  organisms 
prompted  the  idea  for  a  pilot  project  focused  on  the  structural  characterisation  of 
DDAH.  At  the  time,  the  crystal  structures  of  both  amidinotransferases  AGAT  and 
SrtBl  existed  and  DDAH  was  suspected  to  share  common  structural  features  with 
these  enzymes.  The  fact  that  the  role  of  DDAH  in  the  regulation  of  nitric  oxide 
production was only beginning to emerge and that this enzyme could be employed as 
an additional strategy in the modulation of NO synthesis only confirmed the need for a 
superior structural characterization of the enzyme.  The efforts were successful in that 
following a preliminary investigation into the folding status of PaDDAH by !H NMR, 
the crystal  structure of the bacterial  Pseudomonas aeruginosa DDAH was  solved by 
colleagues  in  the  Bloomsbury  Centre  for  Structural  Biology  (Murray-Rust  et  al, 
2001), whilst ongoing work aiming to apply NMR methodology to the study of DDAH 
was being carried out in our laboratory.
From an NMR perspective, the further study of PaDDAH would have to overcome the 
large size of the homodimer enzyme (-58 kD), which resides in the upper limits for the 
useful  application  of NMR.  Signal  overlap,  increased  linewidth,  accelerated  loss  of 
phase  coherence,  and  low  signal-to-noise  (S/N)  ratio  are  some  of  the  problems
49encountered  when  dealing  with  progressively  larger  proteins  by  NMR.  However, 
recently  developed  NMR  experiments  such  as  transverse  relaxation  optimised 
spectroscopy  (TROSY)  (Pervushin  et  al.,  1997;  Riek  et  al.,  2000;  Fernandez  and 
Wider,  2003),  coupled  with  the  use  of  2H  isotope  labelling  of  non-exchangeable 
protons (Anglister et al.,  1993, Gardner et al.,  1998) represent a major breakthrough in 
overcoming  the  many  challenges  NMR  spectroscopists  face  when  studying  large 
proteins.  These  two  developments  have  allowed  the  complete  backbone  resonance 
assignments of a 110 kD homooctamer (Salzmann et al.  2000) and an 80 kD bacterial 
malate synthase G (Tugarinov et al. 2002), validating the concept that larger molecular 
weight proteins are tractable by NMR. However, the application of these techniques by 
a  predecessor  in  our  laboratory  failed  to  provide  a  complete  set  of  resonance 
assignments for PaDDAH (Plevin,  2003).  It was  supposed that the intrinsic physico­
chemical  properties  of  the  homodimer  contributed  to  the  apparent  absence  of  a 
significant  number  of  the  expected  cross  peaks.  Our  inability  to  pursue  the  NMR 
characterisation of the 58 kD homodimer led us to consider a different direction for our 
studies.
The  crystal  structure  of PaDDAH  revealed  that  the  interface  surface  area  between 
protomers  was  small  and  size  exclusion  chromatography  (SEC)  preliminary  results 
showed that PaDDAH exhibited  a monomer-dimer equilibrium  in  solution  (Murray- 
Rust et al.,  2001). These findings led us to speculate that the homodimeric nature of 
the protein could be an  artefact of crystallisation  and non-essential  for the biological 
activity of the enzyme.  In this respect, Chapter 3 will highlight the exploration of the 
interface surface area of PaDDAH. The identification of key residues in the protomer- 
protomer contact area allowed for the introduction of point mutations to design a fully 
active monomeric enzyme, essentially more tractable for heteronuclear NMR studies. 
Chapter  4  will  focus  on  the  successful  backbone  resonance  assignments  of  the 
engineered monomeric enzyme.  These  assignments  have helped us to understand the 
reasons  for  our  inability  to  obtain  unambiguous  assignments  of  the  wild-type 
PaDDAH.  In  Chapter  5,  the  intrinsic  backbone  dynamics  of  the  apo-state  of  the 
monomeric PaDDAH will be addressed through 15N relaxation studies. Lastly, Chapter 
6 will  assess the interaction of PaDDAH with a small library of compounds designed 
to derive specific inhibitors of mammalian and bacterial DDAH isoforms.
50Chapter 2
Material and Methods
Abstract
This chapter describes the experimental protocols and the techniques routinely employed  in 
this work. When further explanations are needed, the reader will  be referred to the relevant 
section of this thesis.
2.1  Chemicals and laboratory equipment
Chemicals used in this work have been purchased from Sigma-Aldrich, BDH AnalaR 
or Melford  Labs  Ltd.  All  buffers  and  solutions  were  prepared  with  deionised  water 
from a Elga Maxima Ultra pure water purification system.
Absorbance  measurements  were  obtained  with  a  Hitachi  U-1800  UV/Vis 
spectrophotometer. The extinction coefficients for PaDDAH proteins were calculated 
with the Expasy Server Sequence Analysis Tools (http://www.expasy.ch/tools/) based 
on the predicted amino acid sequence of the proteins.
Centrifugation steps were performed with a MSE microcentaur (all microfuge tubes), 
or with an Eppendorf 5810 or Heraeus Labofuge 400R (15 and 50 ml Falcon tubes), or 
Sorvall RC5B centrifuges (200 ml centrifuge tubes). In the latter case, SS34 and GS3 
rotors were used for centrifugation.
SDS-polyacrylamide  gel  electrophoresis  (SDS-PAGE)  was  performed  with  BioRad 
equipment  and  with  the  XCell  SureLock™  system  from  Invitrogen.  All  SDS- 
polyacrylamide  gels  were prepared as  indicated in  the  Sambrook manual  (Sambrook 
and Russell, 2000) using the BioRad self-assembly gel kit. Alternatively, pre-cast gels 
(NuPAGE®  Novex  4-12%  Bis-Tris  1.0  mm,  15  wells)  were  purchased  from 
Invitrogen.
512.2  General molecular biology protocols
Producing competent cells
E.  coli BL21(DE3) competent cells were prepared in  house.  100 ml  of Luria-Bertani 
(LB)  medium  (per  liter:  10  g  bacterial  peptone,  5  g  yeast  extract,  5  g  NaCl)  was 
inoculated with non-competent BL21(DE3)-type cells and grown overnight at 37°C at 
200 rpm. The cells were harvested by centrifugation at 2000 rpm for  10 minutes and 
gently  resuspended  in  20  ml  of  pre-chilled  sterile  0.1  M  CaCE  solution.  The 
suspension was left on ice for  10 minutes and centrifuged at  1500 rpm for 5 minutes. 
The cycle of resuspension on ice and centrifugation was repeated four times. The cells 
were finally resuspended in 4 ml of 0.1 M CaCh and 10 % glycerol. 250 pi aliquots of 
cells were snap frozen in liquid nitrogen and stored at -80°C.
Transformation of competent cells
Transformation of competent cells proceeded as follows:  2 pi of purified plasmid was 
added to 50 pi aliquots of thawed competent cells and left on ice for 30 minutes. The 
solution  was  subjected  to  a  heat  shock  dependent  on  the  cell  type.  BL21-type  cells 
were  heat  shocked  for  90  seconds  at  42°C  and  DH5a  cells  (Invitrogen)  were  heat 
shocked for 30 seconds at 37°C. Both cell types were then chilled on ice for 2 minutes 
before the addition of 250 pi of rich SOC medium (Sambrook and Russell, 2000). The 
cells were allowed to grow for 30 minutes to one hour at 37°C before being plated. 50 
to  100 pi of cell mixture was plated onto a carbenicillin selective 25 ml LB-agar plate 
and left overnight at 37°C.
Mutation of WT PaDDAH
The  cDNA  of  WT  PaDDAH  was  subjected  to  site-directed  mutagenesis  using  the 
Quickchange  methodology  (Stratagene).  Reaction  protocols  were  obtained  from  the 
manufacturer’s manual. The primers used to generate the mutations used in this thesis 
are  shown  in  Table  2.1.  Oligonucleotides  were  obtained  from  MWG-Biotech  AG 
(Ebersberg,  Germany).  All  PCR  steps  were  performed  on  a  MWG  Primus 
thermocycler.
52Table 2.1. PCR primers designed for site directed mutagenesis
Mutation Direction Primer Sequence ( 5 ’  to 3’)
N36W Forward G C C C T G G A G C A G C A C T G G G C C T A C A T C C G C G C C
Reverse G G C G C G G A T G T A G G C C C A G T G C T G C T C C A G G G C
R40E Forward G C A C A A C G C  C  T A C A T C G A G G C  C  T T G C A G A C  C  T G C  G
Reverse C G C A G G T C T G C A A G G C C T C G A T G T A G G C G T T G T G C
Q43R Forward C C T A C A T C C G C G C C T T G C G G A C C T G C G A C G T G G
Reverse C C A C G T C G C A G G T C C G C A A G G C G C G G A T G T A G G
R98H Forward G G A A A C C G T G C A G C A C T T C T A T C C G G G C
Reverse G C C C G G A T A G A A G T G C T G C A C G G T T T C C
The  DNA  reaction  mixture  was  transformed  into  XL21-Blue  supercompetent  cells 
(Stratagene).  Single  colonies,  showing  successfully  transformed  cells,  were  used  to 
inoculate  10 ml LB-carbenicillin medium and incubated overnight at 37°C,  250 rpm. 
After pelleting the cells by centrifugation (2000 rpm,  10 minutes) plasmid DNA was 
extracted  using  QIAprep  spin  miniprep  kits  (Qiagen)  as  instructed  in  the  product 
manual.  DNA  sequence  analysis  was  performed  by  MWG-Biotech  sequencing 
services.
2.3  Expression and purification of PaDDAH proteins
Expression vector for PaDDAH proteins
The  cDNA  insert  encoding  the  enzyme  dimethylarginine  dimethylaminohydrolase 
from  Pseudomonas  aeruginosa  has  been  cloned  into  the  pPROEX  Hta  plasmid 
(Invitrogen)  between  the  5’  EcoRl  and  the  3’  Hindlll  restriction  sites.  PaDDAH  is 
expressed with an N-terminal polyhistidine affinity tag and a tobacco etch virus (TEV) 
protease  cleavage  site  to  allow  the  removal  of  the  affinity  tag  (Figure  2.1).  The 
pPROEX vector contains the  P-lactamase gene to confer resistance to  ampicillin  and 
carbenicillin.
Large scale expression of unlabelled PaDDAH
A single colony selected from a plate of freshly transformed BL21(DE3) cells with the 
pPROEX Hta plasmid carrying the cDNA insert of PaDDAH was used to inoculate an 
overnight  5  ml  LB  culture  containing  100  pg/mL  carbenicillin.  The  cells  were 
incubated at 37°C and 250 rpm. The small culture was then used to inoculate one litre 
of LB-carbenicillin  medium  and  was  subsequently  incubated  at  37°C  and  180  rpm.
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Polyhistidine Tag  TEV protease
cleavage site
(b)  ^
V  /   f   ATGTTCAAGCACATCATCGCTCGCACGCCCGCCCGCAGCCTGGTCGACGGCCTGACCTCCAGCCACCTCGGCAAGCCGGACTACGCCAAGGCCCTGGAGCAGCACAACGCCTACATCCGC 
MFKHIIARTPARSLVDGLTSSHLGKPDYAKALEQHNAYIR
GCCTTGCAGACCTGCGACGTGGACATCACCCTGCTGCCGCCGGACGAACGCTTCCCCGACTCGGTGTTCGTCGAGGACCCGGTGCTCTGCACCTCGCGCTGCGCCATCATCACCCGCCCC
ALQTCDVDITLLPPDERFPDSVFVEDPVLCTSRCAIITRP
GGCGCCGAATCGCGGCGCGGCGAGACCGAGATCATCGAGGAAACCGTGCAGCGCTTCTATCCGGGCAAGGTCGAGCGCATCGAGGCACCCGGCACGGTGGAAGCCGGCGACATCATGATG
GAESRRGETEIIEETVQRFYPGKVERIEAPGTVEAGDIMM
GTCGGCGACCACTTCTACATCGGCGAATCGGCCCGCACCAACGCCGAGGGCGCCCGGCAGATGATCGCGATCCTGGAGAAACATGGCCTCAGCGGCTCGGTGGTGCGCCTGGAAAAGGTC
VGDHFYIGESARTNAEGARQMIAILEKHGLSGSVVRLEKV
CTGCACCTGAAGACCGGGCTCGCCTACCTGGAACACAACAACCTGCTGGCCGCCGGCGAGTTCGTCAGCAAGCCGGAGTTCCAGGACTTCAACATCATCGAGATCCCCGAAGAGGAGTCC
LHLKTGLAYLEHNNLLAAGEFVSKPEFQDFNIIEIPEEES
TACGCCGCCAACTGCATCTGGGTCAACGAAAGGGTGATCATGCCCGCCGGCTATCCCCGGACCCGCGAGAAGATCGCCCGCCTCGGCTACCGGGTGATCGAGGTGGACACCTCCGAATAT
YAANCIWVNERVIMPAGYPRTREKIARLGYRVIEVDTSEY
CGCAAGATCGACGGCGGCGTCAGTTGTATGTCGCTGCGCTTCTGA 
RKIDGGVSCMSLRF  S to p
Figure 2.1. (a) DNA and amino acid sequence of the PcoRI and Hindlll cloning sites of pPROEX Hta (green). The polyhistidine tag 
(red) and the TEV cleavage site (blue) are indicated, (b) DNA and amino acid sequence of the PaDDAH cDNA. The PaDDAH insert 
is situated between EcoRI and Hindlll restriction endonuclease cleavage sites (the excised section of the multiple cloning site has 
been omitted).When  the  optical  density  (OD)  of  the  larger  culture  reached  OD6oo  =  0.6-0.8  
absorbance  units  (A.U.),  the  expression  of PaDDAH  was  induced  for four  hours  at 
30°C  with  50  pg/mL  isopropyl-p-D-thiogalactopyranoside  (IPTG;  Melford 
Laboratories, UK).  After the expression period the cells were pelleted (6000 rpm for 
15  minutes), resuspended in Buffer A  (50 mM sodium phosphate buffer pH 8.0,  300 
mM NaCl) and frozen until further use.
Large scale expression of isotope-labelled PaDDAH proteins
The  expression  of  isotopically  enriched  PaDDAH  proteins  was  carried  out  in  M9 
medium (per litre:  6.5  g NaH2P0 4 ; 3.0 g KH2PO4; 0.5 g NaCl;  1.0 g (NFL^SCU;  5  g 
glucose;  1 0 0  mg carbenicillin;  1 0 mg thiamine;  1 0 mg biotin;  all filter sterilised and 
then supplemented with  100 pi  1 M CaCl2 and 200 pi  1M MgSC>4). For the expression 
of [15N]-labelled PaDDAH,  uniformly  [15N]-labelled  (NH4)2SC>4  (Cambridge  Isotope 
Laboratories)  was  used  at  1.0  g/L;  for  [13C]-labelled  PaDDAH,  uniformly  [13C]- 
labelled glucose (Cambridge Isotope Laboratories) was used at 2 g/L; and in the case 
of deuterium labelling the medium was made with  99.5  %  2H2 0  (Cambridge Isotope 
Laboratories).
Typically, one colony of freshly transformed BL21(DE3) cells carrying the vector with 
the  cDNA  insert  of PaDDAH  was  used  to  inoculate  5  ml  of LB-carbenicillin  (100 
pg/mL) medium.  The culture was incubated overnight at 37°C  and 250 rpm.  2 ml  of 
this culture  were  used to inoculate  an  additional  50  ml  of LB-carbenicillin  medium. 
When the OD600 reached 0.4 A.U., the cells were pelleted (3000 rpm,  10 minutes) and 
resuspended in  100 ml of M9 media containing the relevant isotopes. When the OD600 
of this culture reached 0.4 A.U., it was used to inoculate the final  1  L of M9 media. 
Protein expression  was induced with  50 pg/mL of IPTG when the OD600 of the final 
culture  reached  0.6-0.8  A.U.  The  expression  was  allowed  to  proceed  at  30°C  for  6  
hours  when  the  M9  medium  was  [I5N]-enriched,  for  8  hours  when  the  medium 
contained carbon-13 and nitrogen-15 isotopes, and for 12 hours when the cells grew in 
D2O, enriched with carbon-13 and nitrogen-15.
55Purification of PaDDAH proteins
The bacterial pellets obtained after protein expression were resuspended in 20 to 30 ml 
of Buffer A (50 mM NaH2P04, 300 mM NaCl, pH 8.0) and the suspension was passed 
three times over a French press (American Instrument Company). The cell debris was 
separated by centrifugation at 20,000 rpm for 30 minutes. The supernatant containing 
the  soluble  protein  was  then  incubated  for  one  hour  at  4°C  with  nickel-charged 
nitriloacetic  acid  HisBind®  resin  (Ni-NTA  (Novagen);  approximately  2.5  ml 
resin/500 ml bacterial culture). The purification procedure included three consecutive 
washes of the resin with  3x10 ml  of Buffer A and three  additional  washes of  10 ml 
each  of  Buffer  A  with  10  mM  imidazole.  Each  wash  was  followed  by  a  quick 
centrifugation  step to separate the  supernatant from the resin  (2500 rpm,  2 minutes). 
All supernatants were kept. The elution of the protein was achieved by incubating the 
resin with 4x10 ml of Buffer B (50 mM NaH2PC> 4, 300 mM NaCl, 250 mM imidazole, 
pH  8.0).  Each  wash  and  elution  step  was  monitored  by  sodium  dodecyl  sulphate- 
polyacrylamide gel electrophoresis (SDS-PAGE) (See Figure 2.2a for a representative 
SDS-PAGE gel of the fractions obtained from the affinity chromatography step). The 
elution fractions containing the PaDDAH enzyme were combined for the removal  of 
the affinity tag. Recombinant tobacco etch virus protease (rTEV; also containing an N- 
terminal  polyhistidine  tag)  was  added  to  PaDDAH  at  a  ratio  of  1:20.  The  reaction 
mixture was then dialysed against 2 L of Buffer A for 48 hours at 4°C. The cleavage 
reaction  was  monitered by SDS-PAGE (Figure  2.2b)  and the cleaved PaDDAH was 
separated  from  both  rTEV  and  uncleaved  PaDDAH  by  a  second  Ni-NTA  affinity 
chromatography step. Fractions containing the cleaved protein were concentrated to a 
final  volume  of 6  to  12  ml  with  Vivaspin20®  sample  concentrators.  PaDDAH  was 
further purified with preparatory-scale Superdex 75 (S75) or Superdex 200 (S200) size 
exclusion chromatography (SEC) using Buffer C (20 mM sodium phosphate buffer pH 
7.0,  100 mM NaCl,  ImM EDTA).  SEC columns were attached to a Pharmacia FPLC 
(Amersham  Biosciences,  UK)  or  a  BlOcad  Sprint  perfusion  system  (Applied 
Biosystems) and washed at a flow rate of 0.5 ml/min. Protein elution was followed by 
absorbance at 280 nm (Figure 2.2c). PaDDAH-containing fractions were confirmed by 
SDS-PAGE  (Figure  2.2d).  Typically  protein  expression  in  either  2  L  of LB  or  M9 
media yielded approximately 25-30 mg of purified cleaved PaDDAH protein.
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Figure  2.2.  The  purification  strategy  employed  for  R40E-R98H  PaDDAH.  (a) 
SDS-PAGE analysis of affinity chromatography fractions of PaDDAH using His­
Bind® resin (Novagen).  Lanes  from left to right -  1:  Markl2® protein molecular 
weight standards (Novex); 2: post lysis cell extract; 3-5: washes with Buffer A (See 
Chapter 2,  Section 2.3);  6-8:  washes with Buffer A plus  10 mM imidazole;  9-11: 
elutions with Buffer B  (250 mM  imidazole).  Poly-His  tag  fused PaDDAH  elutes 
between 36 and 31.5 kD markers (indicated),  (b) Removal of the polyhistidine tag 
by rTEV protease cleavage. From left to right -  1: as in (a); 2: concentrated elutions 
9  to  11  from  (a);  3:  De-tagged  PaDDAH  after  72  hour  cleavage  reaction  with 
rTEV. De-tagged PaDDAH runs to approximately 32 kD in SDS-PAGE analysis,
(c)  An elution profile of cleaved PaDDAH following preparative scale gel filtration 
chromatography using a preparative scale S200 gel filtration column (See Chapter 
2.  Section 2.3).  Vertical  black  lines  indicate  5  ml  fractions  collected,  1  to  4.  (d) 
SDS-PAGE analysis of fractions 1  to 4 from (c).
572.4  General protocols for the biophysical characterisation of PaDDAH proteins
Measurement of PaDDAH activity
PaDDAH  catalytic  activity  was  assayed  by  colorimetric  detection  of  L-citrulline 
production  following the  addition  of L-NMMA  or ADMA  (Sigma-Aldrich)  using  an 
adaptation of the method outlined by Knipp and Vasak (Knipp and Vasak, 2000). First, 
a standard curve to correlate L-citrulline concentration  and optical  absorbance at 540 
nm  (A 5 4 0 )  was generated:  200 pL samples of L-citrulline at concentrations between 0 
and 2 mM were prepared (3 samples per L-citrulline concentration).  6 6 6  pL of colour 
developing agent (COLDER) was  added, the mixture heated at 95 °C  for  15  minutes, 
and  absorbance  at  540nm  (A54o)  recorded.  A  linear relationship  between  L-citrulline 
concentration  and  A540  was  observed  between  0  and  400  pM.  The  comparative 
catalytic activity of wild-type (WT) and mutant PaDDAH enzymes was analysed at 4 
pM  protein  concentration  in  a  single  time  point  assay  in  Buffer  C.  Following  the 
addition  of  L-NMMA  at  a  concentration  of  5.5  mM,  the  reaction  mixture  was 
incubated at  37°C  for  10 minutes  before being  assayed  for L-citrulline  concentration 
(A 5 4 0 ).
In  order  to  determine  the  Michaelis-Menten  constant  Km  value  for  the  monomeric 
PaDDAH,  the  reaction  mixtures  had  4  pM  protein  concentration  and  ADMA 
concentrations  varying from 0 to  3  mM in  Buffer C.  The A540  values  obtained were 
converted to values of L-citrulline concentration. Lineweaver-Burk and Eadie-Hofstee 
linear  regression  plots  were  used  in  the  determination  of  Km  (Fersht,  1999).  All 
experiments were performed in triplicate.
Analytical size exclusion chromatography (SEC)
100 pL samples of protein at 5 to 0.05 mg/mL were loaded onto a 10/30 HR Superdex- 
75  (S75)  analytical  gel  filtration  column  (Amersham  Biosciences)  pre-equilibrated 
with Buffer C. Protein elution was followed by absorbance at 280 nm at a flow rate of 
0.5  mL/min.  A  Gel-Filtration  Low  Molecular  Weight  Calibration  Kit  (Amersham 
Biosciences) was used for the calibration of the elution volumes.
Analytical ultracentrifugation
Sedimentation equilibrium analytical  ultracentrifugation  (SE-AUC) experiments were 
performed  using  an  Optima  XL-I  Beckman  analytical  ultracentrifuge  (Beckman
58Scientific, Palo Alto, USA).  Wild-type and mutant PaDDAH samples, with  the His6- 
tag  removed  by  proteolysis,  were  prepared  at  concentrations  ranging  from  0.2  to  4 
mg/mL in Buffer C. Samples were sequentially centrifuged at rotor speeds of 15,000, 
19,000  or  20,000,  and  24,000  rpm  at  20°C  until  equilibrium  was  reached  for  each 
individual speed. An additional run at 42,000 rpm was performed to obtain the optical 
baseline  offset.  Interference  data  were  analysed  using  XL-A/XL-I  data  analysis 
software in ORIGIN 4.1. The apparent weight-averaged molecular mass  (Mw < app) was 
obtained by fitting the  data to Equation  2.1,  which  assumes  a single ideal  molecular 
species.
Cr is the total protein concentration  at radial  distance  r,  CVo is the concentration  at a 
reference  point  r0,  R  is  the  gas  constant,  T  is  the  absolute  temperature  and  co  the 
angular  rotor  speed.  The  specific  partial  volume,  v ,  for  WT  PaDDAH  and  all 
PaDDAH  mutants  was  estimated  using  the  program  SLUV  (Perkins,  1986).  The 
solvent  density,  p,  was  calculated  from  the  buffer  composition  using  the  program 
SEDNTERP (www.rasmb.bbri.org).
The  self-association  properties  of  PaDDAH  proteins  were  investigated  by 
simultaneously  fitting  to  a  single  global  model  up  to  nine  interference  data  sets 
obtained from a range of cell loading concentrations and rotor speeds (see Appendix I). 
Protein  concentration  (Cr)  vs.  radius  (r)  plots  were  analysed  to  determine  the 
association  constant  Ka 2  (in  units  of  fringes'1,  Ka 2   =  Kfringe)  of  WT  PaDDAH  and 
PaDDAH mutants  according to the  analytical  relationship  predicted for a  monomer- 
dimer equilibrium (Equation 2.2).
where Cm is the concentration of monomeric species at the cell radius ro, and M is the 
monomer  molecular  mass,  R  is  the  gas  constant,  and  T  is  the  absolute  temperature
Equation 2.1
Equation 2.2
59(McRorie and Voelker,  1993). The association constant Ka 2 or Kfringe obtained from the 
best fit non-linear regression is converted to molar units using Equation 2.3:
cone Equation 2.3
V J
where  Kconc  is  the  association  constant  in  molar  concentration,  infringe  is  the  signal 
association  constant,  dn/dc  is  the  specific  refractive  increment  (L/g),  I  is  the 
centrepiece pathlength (cm), X is the lightsource wavelength (cm), M is the monomer 
molecular weight and n the maximum stoichiometry of the association. Most proteins 
have  a  consistent  value  of  (dn/dc  x  l/X)  of  3.31  fringes/g/L,  when  assuming  a 
wavelength of 675 nm for the laser diode, a 1.2 cm pathlength and a specific refractive 
increment of 0.186 ml/g.
2.5  Nuclear magnetic resonance spectroscopy
Spectrometers
NMR  spectra  were  recorded  at  the  UCL  NMR  laboratory  on  Varian  UnityPlus 
spectrometers at 500 and 600 MHz proton frequency equipped with triple resonance Z- 
axis  pulse  field  gradient  (PFG)  probes  with  four  and  three  radio  frequency  (RF) 
channels respectively. All pulse sequences employed on UCL spectrometers had been 
previously  adapted by  staff members  and the experiments  were  set up  by the  author 
alone or under the guidance of Dr R. Harris.
All  15N  relaxation  experiments  were  recorded  at  the MRC  Biomedical  NMR  centre, 
Mill Hill (NIMR), London on Varian spectrometers unless otherwise stated, operating 
at  proton  frequencies  of  500,  600  and  800  MHz.  The  800  MHz  spectrometer  is 
equipped with  four RF channels,  single-axis pulsed field gradients  and with  a triple­
resonance PFG probe. The experiments recorded at the NIMR were performed by Dr 
T. Frenkiel.
60Heteronuclear single quantum coherence (HSQC)
[!H,  15N]-HSQC  experiments  were  recorded  with  pulse  field  gradient  sensitivity 
enhancement  and with  the  incorporation  of water flip  back pulses  for optimal  water 
suppression (Zhang et al.,  1994)
Transverse relaxation optimised spectroscopy (TROSY)
[*H,  l5N]-TROSY pulse sequences were downloaded with permission from Prof. L.E. 
Kay  (http://pound.med.utoronto.ca/pulse_reg.html)  at  the  University  of  Toronto, 
Canada and modified in house by Dr R. Harris to incorporate the WATERGATE pulse 
sequence element for water suppression (Piotto et al.,  1992).
NMR triple resonance experiments for sequence specific resonance assignment 
All  2D  and  3D  NMR  spectra  acquired  for  sequence  specific  resonance  assignment 
were recorded with a 1 mM [2H,13C,15N]-R40E-R98H PaDDAH sample at 25°C and at 
a  proton  frequency  of  500  MHz.  The  following  experiments  were  acquired  with 
established  pulse  sequences:  HNCA,  HN(CO)CA,  HN(CA)CB,  HN(COCA)CB, 
HNCO (Yamazaki et al.,  1994a).  The parameter details of each experiment are  listed 
in Table 2.2. Sequence specific resonance assignments were found by correlating intra- 
and  inter-residue  resonances  of  CO,  Ca  and  Cp  shifts  in  order  to  create  connected 
segments  of  sequence,  which  were  then  assigned  using  the  probabilistic  method  of 
Grzesiek and Bax (Grzesiek and Bax, 1993) based on the characteristic Ca and Cp shift 
distributions of each residue type.
Measuring  15N longitudinal Rj,  transverse R2  relaxation  rates  and {!H}-15N nuclear 
Overhauser effects (NOE)
15N R\, R2 and  {‘HJ-^N nuclear Overhauser effect (NOE) experiments were recorded 
using experiments based on published pulse sequences (Kay et al., 1989) and modified 
as  shown  in  Chapter  5,  Section  5.2.  The  samples  of  the  apo-form  of  15N-labelled 
R40E-R98H  PaDDAH  were  prepared  at  1  mM  concentration  in  Buffer  C.  The 
relaxation delays and the pre-saturation periods are detailed in Table 2.3. Spectra were 
acquired at 26°C by using  1440 x 200, 2000 X 240 and 2048 X 360 complex points in 
the t2 x t\ dimensions at *H proton frequencies of 500, 600 and 800 MHz respectively, 
with  16-48  scans per t\  increment, a recycle delay of 1.4 s in Pi  and P2 experiments, 
and  a recycle  delay of  1.2  s  added prior to the  ]H  saturation  period in the  {JH}-15N
61Table 2.2. Experimental details for 2D and 3D NMR experiments acquired on [2H,13C,I3N]-R40E-R98H PaDDAH at 25°Ca
iH   13C   i5N
Experiment Points Sweep Width Points Sweep Width Points Sweep Width Transients
HSQC 1024 (116ms) 4400 256 (150ms) 1700 8
HNCA 1024 (122ms) 4200 64 (18ms) 3600 32 (19ms) 1700 8
HN(CO)CA 1024 (122ms) 4200 64 (18ms) 3600 32 (19ms) 1700 8
HN(CA)CB 1024 (122ms) 4200 64 (9ms) 7100 32 (19ms) 1700 16
HN(COCA)CB 1024 (122ms) 4200 64 (8.5ms) 7500 32 (19ms) 1700 12
HNCO 1024 (122ms) 4200 48 (27ms) 1800 32 (19ms) 1700 8
aAll spectra acquired on a Varian UnityPlus spectrometer operating at  H frequency of 500 MHzTable 2.3. Delay periods for N relaxation experiments of R40E-R98H PaDDAH recorded at 26°C
Experiments 'H Delay times for relaxation (s)a
frequency
15N Ti 500 MHz 0.0086 0.1210 0.2495 0.3940 (x2)a 0.6990 1.1000 1.6900 2.5000
600 MHz 0.0086 0.1210 0.2495 0.3940 (x2) 0.6990 1.1000 1.6900 2.5000
800 MHz 0.0086 0.1210 0.2495 0.4983 (x2) 0.996 l(x2) 2.4974 2.9951
15 n t 2 500 MHz 0.0087 0.0173 0.0347 (x2) 0.0520 0.0780 0.0953 0.1300
600 MHz 0.0086 0.0172 0.0344 (x2) 0.0516 0.0775 0.0947 0.1291
800 MHz 0.0085 0.0171  (x2) 0.0341 0.0682 (x2) 0.0767 0.0938 0.1194
{'H}-l5NNOE 500 MHz 
600 MHz 
800 MHz
0.000
0.000
0.000
3.0
3.0
3.0
aIn  NT! and  N T2 experiments, the time periods stated refer to the length of time permitted for relaxation in the pulse sequence. In {  H}-  N NOE experiments 
the delay period refers to the length of the proton saturation period. bIndicates repeated times points.NOE experiments.  The spectral widths in the direct and the indirect dimensions were 
7200 x  1670,  10000 x 2000 and 12000 x 3242 Hz at *H proton frequencies of 500, 600 
and 800 MHz respectively.
An  additional  set  of  15N  relaxation  data  was  recorded  at  UCL  for  the  2- 
chloroacetamidine-bound  PnDDAH  (1  mM  protein  concentration  in  Buffer  C).  The 
15N R\,  R2  and  ^H j-^N   NOE relaxation  parameters  were  measured  at  a  lH  proton 
frequency  of  600  MHz  at  26°C.  The  relaxation  delays  in  seconds  for  the  15N  R\ 
experiment  were  0.010  (x2),  0.351,  0.702,  1.004,  1.405,  1.807  (x2)  and  for  the  R2 
experiments they were 0.015, 0.031 (x2), 0.062, 0.078, 0.935, 0.124. The *H saturation 
period in the  ^H J-^N  NOE experiment was 3.0 s.  The spectral  widths were  8000 x 
1680 Hz in the direct and indirect dimensions. The spectra were acquired with 2048 x 
256 complex points in the *2 x t\ dimensions with 26 to 46 scans per t\ increment and a 
2 s recycle delay during the R\ and R2 experiments. A recycle delay of 0.5 s was added 
to the saturation period during the {!H}-15N NOE experiment. The 15N relaxation pulse 
sequences used in this set of experiments incorporated pulse field gradient sensitivity 
enhancement features (Kay et al,  1992a) in contrast to the ones used at the NIMR (see 
Chapter 5, Section 5.2 for details).
Measuring 15N R2 Dispersion
15N R2 relaxation rates were only measured at *H proton frequency of 800 MHz with a 
relaxation-compensated-Purcell-Meiboom-Gill (CPMG) pulse sequence  as described 
by  others  (Loria  et  al,  1999;  Tollinger  et  al  2001).  The  CPMG  period  was 
implemented in a constant time manner, with T -  40 ms. Relaxation dispersion profiles 
were generated by measuring R2 relaxation rates as a function of xcp, the time between 
successive  180°  pulses  in  the  CPMG  sequence.  Spectra  were  acquired  as  two- 
dimensional data sets at xcp intervals of 10, 5, 3.33, 2.5, 2,  1.66,  1.43,  1.25,  1  ms (data 
points  5  and  1   ms  were  duplicated).  A  reference  spectrum  with  the  CPMG  blocks 
omitted  was  also  obtained  in  duplicate. Spectra  were  recorded by  using  2400  x  256 
complex points in the t2 x t\ dimensions at 800 MHz with 64 scans per t\ increment and
1.5  s  recycle  delay.  The  spectral  widths  were  12000  x  3242  Hz  in  the  direct  and 
indirect dimensions respectively.
64NMR titration experiments
For NMR  titration  experiments  various  15N-labelled  R40E-R98H  PaDDAH  samples 
were prepared at concentrations ranging from 0.4 to 0.7 mM (Table 2.4). The ligands 
used in each titration experiment were provided by collaborators at the Department of 
Clinical  Pharmacology  at  UCL,  either  in  lyophilised  form  or  dissolved  in  H20   or 
DMSO. The concentrations of ligand reached at the end of the titration experiment are 
also shown in Table 2.4.
Table 2.4. Details of the NMR titration experiments performed with various ligands
Ligand
Total protein conc.a 
(mM)
Max. ligand conc.b 
(mM)
Titrations
pointsc
% Protein 
dilutiond
ADMA 0.55 3.58 12 18
L-citrulline 0.58 5.93 14 10
SR 140 0.44 4.12 16 17
SR 227 0.70 10.4 20 20
SR 257 0.40 1.20 3 10
HB 65 0.56 1.68 3 8
HB  102 0.50 1.50 3 8
aRefers  to  the R40E-R98H  PaDDAH  concentration  at the  beginning of the titration.  bRefers to  the 
maximal concentration of ligand reached at the last titration point. cRefers to the number of titration 
points acquired. dRefers to the % of protein dilution at the end of the titration experiment.
A comprehensive list of the structures of each titrated ligand can be found in Chapter 
6, Section 6.3.  ^ -^ N  HSQC experiments were collected for each titration point using 
either a 500 MHz or 600 MHz spectrometer. The spectral widths were 4200 x 1700 Hz 
and  5400  x  2100  Hz  at  500  and  600  MHz  respectively,  with  a  total  of  1024  x  192 
complex  points in the direct and indirect dimensions  and 4-8  scans per  increment. 
Prior to each acquisition the pH of the ligand and protein samples were painstakingly 
monitored and were adjusted to 7.0. The HN  and  15N chemical shifts of selected cross 
peaks  in  each  spectrum  acquired  were  output  for  chemical  shift  mapping  and  the 
estimation of a dissociation constant Kd where possible (see Chapter 6, Section 6.2).
The  binding  curves  were  fit  to  a  nonlinear  regression  analysis  using  the  following 
Equation 2.4 to monitor the chemical shifts in the labelled protein resonance:
*  C  (*  C  + L°  + P0  y- Vta + L 0  + P o f ~  4f,A   ..  „„
d obs  -   d  free  =   [° s a t  ~   d  free )----------------------------------------------------------~ -----------------------------------------------------------------  E q u a t i o n  2.4
2 P
65where P0 ,  Lo,  are the total protein and ligand concentrations, and 50bS  and 6free are the 
observed change in chemical shift on ligand titration and the chemical shift of the free 
state, respectively.  5sat and Kd are to be determined by the regression  analysis, where 
Kd  is  the  dissociation  constant  and  8sat  is  the  chemical  shift  of  the  complex  under 
saturating  conditions.  In  these  studies  however,  Lo  was  substituted  by  (Lo/Pe)*Po, 
where Pe is the protein concentration at each titration point.
2.6  NMR data analysis
Processing NMR data
All  raw  NMR  data  were  processed using  the  nmrPipe program  of Delaglio  and co­
workers  (Delaglio  et  al,  1995).  Standard  manipulations  of data  sets  included  zero- 
filling to the nearest 2n points, application of window functions, base line corrections, 
linear prediction of indirect dimensions where necessary and zero and first order phase 
corrections were applied using nmrPipe.  Spectra were initially visualised in nmrDraw 
(Delaglio, et al.  1995).
The processed spectra were exported into AZARA  (http://www.bio.cam.ac.uk/azara/) 
format using the PIPE2AZARA command.  Multiple  spectra were  visualised together 
and cross referenced in Plot2 (http://www.bio.cam.ac.uk/azara/). Sequential resonance 
assignment was performed using ANSIG (Kraulis,  1989) with contour and cross peak 
files generated by AZARA.
Derivation o f15N Ri, 15N R2, 15N {]H}-heteronuclear-NOE parameters 
15N R\  and  R2  experiments  yielded  a  pseudo  3D-spectrum  with  the  third  dimension 
corresponding to the 2D NH correlation plane with incremented relaxation delays (See 
Table 2.3). For each set of relaxation data recorded, a reference 2D ['H ^N ] spectrum 
was  acquired.  Only  well  resolved  NH  cross  peaks  in  the  reference  spectrum  were 
selected for further analysis. The signal intensity of each selected cross peak from the 
2D planes recorded was extracted using ANSIG scripts written in-house (Pfuhl et al., 
1999). The peak intensity values for a single cross peak were output as a function of 
relaxation delay. The decay of intensity was fit to Equation 5.7 (see Chapter 5, Section
5.2  for more details) with the Mathematica® software (Wolfram Research Inc.) using 
a two parameter least square fit (Levenberg-Marquardt method as described in Kay et
66al.,  1992b; Peng and Wagner,  1994). The error on the fit was estimated using a Monte 
Carlo  simulation  based  on  the  cross  peak  signal  intensities  acquired  for  a  pair  of 
duplicated time points.  The relaxation rates  and standard deviations stated in the text 
correspond to the mean relaxation rate and standard deviation of the distribution of two 
hundred such Monte Carlo iterations.
{1 H}-15N  heteronuclear  NOE  experiments  were  acquired  as  a  pair  of  2D  NH 
correlation  spectra in the presence and absence of proton  saturation  at three different 
magnetic  fields  (Table  2.3).  The  signal  intensity  values of selected cross peaks were 
extracted as described for the R\ and R2 relaxation experiments (See Chapter 5, Section
5.2  for more details). The steady-state NOE values were determined from the ratios of 
the intensities of the peaks with and without proton saturation. The experimental error 
Onoe was calculated based on the spectral noise value ((Jisat and <7iunsat) in each 2D NH 
plane using the following relationship (Equation 2.5):
amE/NOE = ((<T,_  IIs y  +(£T,_  )2)''2  Equation 2.5
where  /sat and /unsat  are  the  measured  intensities  of a cross  peak  in  the  presence  and 
absence of proton saturation, respectively.
67Chapter 3
The engineering of a monomeric PaDDAH
Abstract
Proteins  capable  of  self-association  benefit  from  an  increased  stability  and  the  ability  to 
perform  additional  functional  tasks  through  intersubunit  communication.  Despite  the  large 
number  of protein  oligomers  present  in  nature,  a  significant  proportion  of the  oligomeric 
structures  available  are  the  result  of non-specific  crystallographic  contacts  caused  by  the 
higher protein concentrations required for structural characterisation. The efforts to study the 
58 kD homodimeric enzyme PaDDAH by NMR were hampered by the molecular size of the 
molecule  which  led  to  substantial  line  broadening.  With  the  crystal  structure  of PaDDAH 
available, it became increasingly clear that the small interface surface area of the dimer and the 
fact that conditions could be found where PaDDAH exhibited a monomer-dimer equilibrium 
in  solution  were  indicative  of the  non-obligate  homodimeric  nature  of  the  enzyme.  This 
chapter  describes  the  exploration  of the  interface  region  of PaDDAH  through  the  careful 
analysis of the residues responsible for self-association.  The analysis led to the design  of a 
series  of  interface  mutants  with  the  ultimate  goal  to  generate  a  stable  active  monomeric 
enzyme.  These  mutants  were  extensively  characterised  by  size-exclusion  chromatography, 
analytical ultracentrifugation and NMR spectroscopy. Dissociation constants were derived for 
a  selected  set  of PaDDAH  mutants  in  order  to  quantify  effectively  the  disruption  of the 
association.  One  stable  and  active  double  mutant  R40E-R98H  PaDDAH  behaved  as  an 
exclusive monomer in solution and yielded superlative 2D [‘H^NJ-HSQC NMR spectra when 
compared  to  wild-type  PaDDAH.  Our  findings  confirm  the  initial  observations  that  the 
dimerisation of PaDDAH is not a prerequisite for biological activity and that the pursuit of a 
monomerisation strategy was well founded in order to suppress the dynamics of the monomer- 
dimer equilibrium of the protein and decrease the overall size of the protein, thereby providing 
a form of DDAH that is optimal for further analysis by NMR.
683.1 Introduction
Functional role and evolution of  protein oligomerisation
Proteins commonly act as oligomers in cells. A survey of the SWISS-PROT database 
for Escherichia coli annotated proteins shows that dimers and tetramers constitute up 
to  60%  of  the  617  entries  with  explicit  “subunit”  annotations,  whilst  monomeric 
proteins represent only 19% of the total (Goodsell and Olson, 2000). The structural and 
functional advantages conferred to proteins by oligomerisation include the opportunity 
for cooperative interaction and allosteric regulation between subunits  (Marianayagam 
et al.,  2004).  Oligomerisation  has  also been  implicated  in  the  regulation  of enzyme 
function  (Traut,  1994).  Several  enzymes  are  reported  to  self-assemble  in  order  to 
promote  catalysis,  a  classic  example  of  which  is  Escherichia  coli  aspartate 
transcarbamoylase (Wang et al., 2005). In this respect, self-association will only occur 
if a threshold protein concentration is reached within cells, so that subunit assembly is 
favoured.  Moreover, the  stable association  of protein  subunits  is required in  order to 
produce  higher  order  structural  scaffolds  such  as  viral  capsids  (Johnson  and  Speir, 
1997). The expression and assembly of identical  subunits has even been  suggested to 
act as a mechanism enabling the reduction of the viral genome size. Another advantage 
conferred  by  protein  self-association  is  an  increase  in  the  overall  stability  of  the 
oligomer by the cumulative enthalpic contributions of hydrogen bonds, van der Waals 
forces  and  hydrophobic  interactions  present  across  subunits  (Jaenicke,  2000).  An 
illustration  of  increased  stability  through  oligomerisation  has  been  suggested  in 
thermophilic enzymes that associate as dimers, whilst their mesophilic counterparts are 
monomeric  and  more  prone  to  denaturation  at  higher  temperatures  (Thoma  et  al., 
2000).
To date, all models explaining the evolution of oligomerisation share the precept that a 
monomeric form of the protein pre-dates  multimer formation.  The “mutation  model” 
put  forward  by  D’Alessio  and  colleagues  (D’Alessio,  1999)  argues  that  a  primary 
mutational event on the surface of a monomeric protein is responsible for rendering the 
mutant less  stable  and  susceptible to  adhere to  another molecule.  In  thermodynamic 
terms,  this  mutational  event translates  into  a decrease  in  the  free  energy  barrier that 
separates  free  monomers  from  associated  oligomers.  Additional  mutations  can  also 
occur and serve to strengthen the subunit association. Although it is difficult to assess
69what the primary mutational event might have been from the visual inspection of the 
3D  structures  of present day oligomers,  several  studies  of directed  in  vitro evolution 
have  generated  engineered  dimers  from  monomeric  Staphylococcal  nuclease  by  the 
simple deletion of residues in a surface loop (Green et al, 1995).
A second evolutionary model for dimerisation proposed by Xu et al.  (1998) states that 
gene mutation, deletion, and fusion of two chains are pathways to obtain foldable and 
functional proteins without the need for an intermediate stable monomeric precursor. 
This  hypothesis  is  derived  from  observations  of  oligomers  that  show  dimerisation 
kinetics that resemble the folding kinetics of monomers.
The  third  pathway  is  the  “swap  model”  in  which  the  emergence  of oligomerisation 
occurs in a single step (Bennett et al,  1994;  1995). A dimeric protein evolves from an 
interchange  of  C-  or  N-terminal  secondary  structural  elements  of  two  monomeric 
subunits.  This  domain  swap  creates  an  interdomain  interface  that  does  not  require 
random  mutations  to  occur  in  the  exposed  surface  area  of  a  protein.  However, 
D’Alessio argues that such a model should also be subject to mutational events which 
might be responsible for disrupting the favourable interactions that held the secondary 
structural elements within their original subunits. In this respect, such a model should 
not  be classified as  an  evolutionary pathway for oligomer formation,  but rather as  a 
mechanistic approach to explain the monomer to oligomer transition.
General trends of oligomer interface surfaces
The common assumption held from the studies of known X-ray structures of oligomers 
is that hydrophobic contacts in the interface are the driving force for oligomerisation in 
the same manner as the hydrophobic effect contributes to protein folding (Chothia and 
Janin,  1975; Honig and Nicholls,  1995). Consistent with this view are the findings by 
Nussinov and co-workers that show that the interface area is enriched by a moderate 
percentage (10-15%) in hydrophobic residues in comparison with their presence in the 
total  surface  area  of  oligomers  (Tsai  et  al.,  1997).  However,  the  novel  view  that 
emerged from their sampling of 362 interfaces is that the hydrophobic effect is not as 
crucial  in  protein-protein  association  as  it is in protein  folding,  as polar and charged 
amino  acids  are  more  frequent  in  protein  interfaces  than  they  are  in  protein  cores, 
although  they  remain  predominant  on  monomer  surfaces.  This  observation  can  be 
viewed  as  reflecting  a  compromise  between  achieving  high  stability  of an  interface 
with  the  presence  of  hydrophobic  residues  and  at  the  same  time  maintaining  the
70stability of the independent folded subunit with polar and charged residues (Tsai et al, 
1997).
Larsen and colleagues corroborated these views by visually inspecting the structures of 
several  protein  interfaces,  showing  that  in  about  61%  of cases,  the  interface  shared 
small patches of hydrophobicity mixed with hydrophilic residues, hydrogen bonds and 
water molecules (Larsen et al,  1998). Of particular relevance to this discussion are the 
statistical thermodynamic  studies of Xu et al  that showed that in  reality hydrophilic 
residue pairs  contribute  significantly to the binding free energy of monomers  (Xu et 
al,  1997), which is in contrast with what is observed in protein folding (Hendsch and 
Tidor,  1994).  In  general  there  will  always  be  a  destabilising effect to  any  assembly 
process  due  the  loss  of favourable  solvation  interactions  between  charged  and polar 
residues  and  the  high  dielectric  aqueous  phase.  The  favourable  electrostatic 
contribution to binding might include the entropic gain generated from the transfer of a 
hydrophilic ion-pair present on the surface exposed region of the protein to the buried 
interface  domain  of the  associated state,  overcoming the desolvation  cost  (Xu et al, 
1997). Desolvation effects are also partly overcome through the formation of networks 
of favourable Coulombic interactions between interfacial charged and polar side chains 
across or within subunits. In their studies, Honig and collaborators nicely illustrate that 
the greater the number of residues involved in inter-molecular hydrogen bonds and salt 
bridges with respect to the total number of charged and polar residues on the interface, 
the more favourable the total electrostatic contribution to binding will be (Sheinerman 
and  Honig,  2002).  These  interfacial  Coulombic  interactions  are  strong  enough  to 
mimic  the  interactions  that  hydrophilic  residues  usually  have  with  their  aqueous 
solvation shell prior to protein oligomerisation.
The  intriguing  view  that  arises  from  the  presence  or  absence  of  a  mixture  of 
hydrophobic and hydrophilic interactions in interfaces is that it does not correlate with 
any specific  functional  attribute.  The proteins that have been  sampled  so far include 
enzymes,  DNA-binding  proteins,  toxins  and  receptors,  all  of  which  can  present  a 
hydrophobic core upon oligomerisation or display a mixed interface with hydrophobic 
and hydrophilic regions (Larsen et al,  1998).
71Discriminating between functional oligomerisation and non-specific crystal contacts 
The  studies  presented  above,  which  refer  to  the  description  of  subunit  interfaces  in 
terms  of  hydrophobicity  and  preference  for  certain  amino  acid  residues,  do  not 
systematically contemplate the possibility that not all dimers or oligomers are required 
for  protein  activity.  Much  attention  has  been  given  lately  to  the  development  of 
protocols  capable  of  discriminating  between  functional  interfaces  and  non-specific 
crystal  contacts  in  the  unit  cell.  Initial  qualitative  findings  have  shown  that  the 
interfacial  solvent  accessible  surface  areas  (AASA)  are  larger in  biological  contacts 
than  in  non-biological  ones  and  usually  constitute  the  largest  lattice  contact  in  the 
crystal  (Jones  and  Thornton,  1996).  Furthermore,  since  non-obligate  oligomers  can 
exist  as  independent  molecular  entities  their  interfacial  composition  tends  to  be 
analogous to the overall protein surface, hence more polar than in biologically relevant 
interfaces.  Additionally, the interfacial contact surfaces of non-obligate oligomers are 
less complementary, as estimated by the Gap Index, a measure of the volume enclosed 
between any two interfaces (Jones and Thornton,  1996).  Valdar and Thornton further 
extended these  studies to combine the interface  surface area and the  conservation  of 
amino  acid  residues  in  interfaces  among  homologous  protein  families  to  provide  a 
robust prediction  of biologically relevant dimers  (Valdar and Thornton,  2001).  They 
found that interfaces arising from artefacts of crystal packing rarely shared any amino 
acid conservation between homologues. Recent work by Bahadur et al  analysed  188 
non-specific homodimers with large interface surface area (>800 A2), a value similar to 
that found for biologically specific interfaces. They showed that regardless of the size 
of  the  interface,  on  average  physiologically  relevant  interfaces  are  more  compact, 
better  packed  and  contain  more  hydrogen  bonds  per  polar  atom  than  non-specific 
interfaces (Bahadur et al., 2004).
Taken  together,  these  findings  provide  guidelines  for  the  effective  discrimination 
between  specific  and  non-specific  interface  contacts.  The  relevance  of such  studies 
often  lies  with  examples  of  oligomers  for  which  an  experimental  monomerisation 
strategy  is  sought.  The  availability of a monomeric  protein  entity can  in  most cases 
simplify the biophysical characterisation of a particular system and a priori knowledge 
of the type of interface that is targeted in such work certainly directs the mutagenesis 
strategy to efficiently disrupt the oligomer formation.
723.2  Analysis of PaDDAH oligomeric state and interface surface area
PaDDAH hydrodynamic behaviour
The  enzyme  PaDDAH  is  a  58  kD  homodimer  at  concentrations  necessary  for 
structural  characterisation  (Murray-Rust  et  al.,  2001).  To  successfully  apply  NMR 
methodology to the  study of this enzyme,  the challenge presented by the  size of the 
homodimer  had  to  be  surmounted.  Details  of  the  problems  encountered  will  be 
discussed in Chapter 4.  Ultimately we had to redirect our attention  to a site-directed 
mutagenesis  strategy  focused  on  the  residues  located  at  the  dimer  interface.  Point 
mutations  of  these  residues  might  weaken  the  association  of  the  dimer  without 
disrupting the active  site region  and result in the production  of an  active monomeric 
species more amenable to NMR investigations.
In  the  course  of  the  pilot  work  on  PaDDAH,  the  first  prompt  for  pursuing  the 
monomerisation  strategy  came  from  the  analysis  of the  hydrodynamic  behaviour  of 
PaDDAH.  On  close  inspection  of  the  available  data,  the  enzyme  presented  a 
monomer-dimer  equilibrium  in  solution  dependent  upon  protein  concentration. 
Analytical size exclusion chromatography (see Chapter 2, Section 2.4) was the method 
of choice for characterising the self-associative properties of wild-type PaDDAH (WT 
PaDDAH). The enzyme elutes as a single asymmetric peak and shows subtle changes 
of elution volumes from 9.9 ml to 10.2 ml as the loading concentration decreased from 
5  mg/ml to 0.05  mg/ml  (Figure 3.1a,b).  Conversion of the peak elution volumes into 
apparent  molecular  weights  (MWapp)  semi-quantitatively  revealed  a  shift  in  the 
equilibrium towards monomeric  species,  from an  initial  PaDDAH behaviour of a 50 
kD  species  at  high  concentration,  towards  a  MWapp  ~  46  kD  at  the  lowest 
concentration (Figure 3.1c). For a protein with a predicted monomeric mass of 29 kD 
these data indicate a predominance of the homodimer in this concentration range.
A description of the protomer interface of PaDDAH
Building on these findings, the notion that a mutagenesis strategy could be pursued in 
order to obtain  a monomeric  variant of PaDDAH was reinforced through the careful 
analysis of the  interface  residues  involved in  maintaining the  associated homodimer. 
Inspection of X-ray structure predicts that the interface between the two protomers is 
composed of three  secondary  structural  elements  that  form the  contact points  across 
each of the two polypeptide chains (defined here as protomers A and B; Figure 3.2a).
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Figure 3.1. Analytical size exclusion chromatography of WT PaDDAH. (a) Elution 
profile of WT PaDDAH samples at different protein loading concentrations shown 
in  the  colour  coded  legend,  (b)  Blow-up  of (a),  (c)  Apparent  molecular  weight 
(MWapp) of WT PaDDAH derived from calibration of the SEC column with known 
MW standards as a function of protein loading concentrations.
74The association is mediated by the side chain interactions of residues located in helices 
a l  and  a2  of modules  1  and  2  and residues  located  in  the  piC  strand  of module  1  
(Figure 3.2b-d).
First, the side chain-side chain interactions between residues on opposing cxla , b helices 
are arranged in an antiparallel fashion, centred on residues Asn 36a ,b -  Four residues in 
helix-alA  (Glu 33, Asn 36, Arg 40 and Gin 43) are aligned along one face and form 
reciprocal  contacts  with  the  side  chains  of residues  located on  the  opposing  subunit 
(Figure 3.2d). This arrangement allows for residues Arg 40a ,b  and Glu 33b ,A  to form 
two inter-protomer salt-bridges.
Second, on the opposite side of the interface, the side chain of Arg 98b   located in helix 
cc2b   appears  to  form  another  salt-bridge  with  Asp  48A   of  strand  PlCA.  This  inter- 
protomer contact again is reciprocated across the symmetry axis (Figure 3.2b).
The  third point  of contact  between  protomers  is  defined  by  the  interaction  between 
opposing  piC  strand  residues  (denoted  plCA  and  PICb).  The  two  strands  form  an 
antiparallel  P-sheet  arrangement  across  protomers  that comprises  the  P-sheets  of the 
two modules  1AB (Figure 3.2c). The piC  strands encompass residues Asp 48, lie 49, 
Thr 50, Leu 51  and Leu 52 whose side chains are directed in a perpendicular manner 
relative to the direction of the P-strand and form a hydrophobic contact surface at the 
centre of the interface.
Visual inspection of the surface electrostatic potential plotted on top of PaDDAR X- 
ray structure reveals two very distinct hydrophilic patches defined by residues located 
in helices a l  and a2, enclosing a small hydrophobic core composed of residues lie 49, 
Leu  51  and  Leu  52  of  the  piC-strand  (Figure  3.3a,b).  To  examine  whether  this 
interface  arrangement was  conserved in  other enzymes  of the  same  superfamily,  the 
interfaces of two arginine amidinotransferases AGAT and StrBl  were analysed in the 
same manner (Figure 3.3c-f). These two enzymes form homodimers in solution and the 
secondary  structural  arrangement  in  the  interfacial  region  is  strikingly  conserved 
(Humm et al.,  1997, Fritsche et al.,  1998). The secondary structural elements involved 
in the interaction are part of the P-propeller modules  1, 2 and 3 and are centred about 
the  3-stranded  P-sheets of module 2  (Figure  3.3c-f).  However,  these  P-sheets  do not 
extend across subunits as observed in the F^DDAH interface. Instead the two opposing
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Figure 3.2. (a) The 3D structure of PaDDAH homodimer interface, highlighting in 
red,  helices  a lAB  and  a2AB  and  in  blue,  strands  P1CAB.  (b)  Close-up  of  the 
interaction  between  residues  R98B  in  helix  a2B   and  D48A   in  strand  plCA.  The 
interaction is reciprocated across the symmetry-related protomers.  (c) Detail of the 
hydrophobic  interactions  occurring  between  residues  149,  L51,  L52  side  chains 
across strands  plCA B.  (d) Interaction between side chains occurring across helices 
al^g.  All  atoms  follow  CPK  colouring.  Figures  were  created  with  MOLMOL 
(Koradi et al., 1996).
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Figure  3.3.  (A)  Worm  diagrams  of monomeric  (a)  PaDDAH  (lh70),  (c)  AGAT 
(ljdw) and (e) StrBl  (lbwd), indicating the orientation of the molecule used in part 
(B). a-helices involved in the interface are red and P-strands are blue. The numbering 
of the helices (H) and strands (S) in (c) and (e) is taken from Fritsche et al  (1998). 
(B) 3D molecular surface of (b) PaDDAH, (d) AGAT, (f) StrBl  coloured according 
to residue electrostatic potential. The interface surface is delimited by the blue dotted 
line.  Residues  in  blue  are  positively  charged,  red  negatively  charged,  white  are 
hydrophobic  and  uncharged.  Water  molecules  when  present  in  the  pdb  files  are 
depicted as pale green oxygen atoms. Figures were created with MOLMOL (Koradi 
et al., 1996).
77sets  of  strands  (strands  S7A(b  in  AGAT  and  strands  S5a,b  in  StrBl)  form  an  angle 
relative to each other (Figure  3.4).  Despite the  lack of an inter-protomer (3-sheet,  the 
interactions of AGAT and StrB 1 conferred by the a-helices and (3-sheets of modules 2 
and 3  are  structurally homologous to those of modules  1  and 2  of PaDDAH (Figure 
3.4).  An  additional  module  is  involved  in  the  interfacial  interaction  of  AGAT  and 
StrBl -  module  1 -  positioning two opposing 2-stranded |3-sheet loops (strands S3A > B  
in AGAT and strands S3’A ,B) in an antiparallel arrangement (Figure 3.4).
Intriguingly,  although  AGAT  and  StrBl  share  similar  secondary  structural  elements 
across  interfaces,  the  analysis  of  the  putative  residue  electrostatic  potential  of  the 
buried surface area of these two enzymes indicates little conservation of the residues 
(Figure  3.3B).  AGAT  appears  to  possess  a  clear  mixture  of  hydrophilic  and 
hydrophobic exposed side chains compared to PaDDAH and StrBl  interfaces which 
show  distinct  patches  of  hydrophobicity.  Whether  the  distributions  of  charges  and 
hydrophobic  sites  on  the  surface  interface  reflect  a  difference  in  the  homodimer 
dissociation constants is unknown.
The  non-conservation  of  the  homodimer  interface  structure  in  these  otherwise 
structurally  and  functionally  related  enzymes  appears  consistent  with  the  idea  that 
PaDDAH  homodimerisation  is  not  critical  for  catalytic  function.  A  more  thorough 
analysis  is  performed  in  the  next  section  in  terms  of  the  actual  values  of  surface 
accessible surface areas of the proteins’  interfaces and the residues responsible for the 
interaction between protomers.
3.3  Targeting residues for mutation
The solvent accessible surface area of the PaDDAH interface
Results from the analysis of the homodimer interface of PaDDAH using the Protein- 
Protein  Interaction  (PPI)  server  (Jones  and  Thornton,  1996)  have  shown  that  the 
interface surface area occluded from a solvent molecule with  a radius of  1.4 A  upon 
dimer formation  is  approximately  860 A2  per  subunit.  This  value  and  several  other 
parameters  believed  to  define  the  characteristics  of an  oligomer  interface  have  been 
calculated  for  crystallographic  homodimers  of  PaDDAH,  AGAT  and  StrBl  (Table 
3.1). In their first review of protein-protein interactions which evaluated 72 homodimer
78Figure  3.4.  Worm  diagrams  of the  3D  structures  of the  homodimeric  (a)  AGAT 
(ljdw)  and  (b)  StrBl  (lbwd).  The  secondary  structure  elements  involved  in  the 
interface are indicated: the a-helices are coloured in red and the p-strands are shown 
in blue. The numbering of the helices and strands in (a) and (b) is taken from Fritsche 
et al.  (1998); S stands for p-strand and H for a-helix and the subcript letters A and B 
refer to each protomer. Figures were created with MOLMOL (Koradi et a l, 1996).
79interfaces,  Jones  and  Thornton  established  a  weak  linear  correlation  (coefficient  ~
°   2 0.69) between the size of the interface surface area (A ) and the molecular mass of the 
monomer (Daltons). From their regression analysis the PaDDAH interface area would 
have a predicted value of ca. 1650 A2 based upon the monomer molecular mass of 29 
kD and similarly, AGAT and StrBl  should have had a much larger interface areas than 
they actually do.
Table 3.1. Analysis of the homodimer interfaces from the crystal structures of WT 
PaDDAH, AGAT and StrB 1 using the Protein-Protein Interaction servera
Parameter  Protein
PaDDAH  AGAT  StrBl
PDB Code lh70 ljdw lbwd
Number of Residues 254 423 348
Protomer Mass (kD) 29.0 48.5 39.0
AASA (A2) b 857 1466 1556
AASA as % of total ASA c 7.8 10.9 11.0
Residues with AASA > 0.0 A2 23 35 39
% Polar atoms in interface 49.6 35.8 31.7
% Non-polar atoms in interface 50.4 64.1 68.2
Hydrogen bonds 8 18 13
Salt bridges 2 2 0
Gap Volume (A3) e 5709.5 4782.2 5487.9
Gap Index (A)f 3.33 1.63 1.76
ahttp://www.biochem.ucl.ac.uk/bsm/PP/server/;  AASA is the total ASA per protomer concealed on 
the formation of the homodimer; C AASA is the buried surface expressed as a percentage of the ASA 
of  the  monomer;  Calculated  with  the  program  HBPLUS  (McDonald  and  Thornton,  1994); 
Calculated with the program SURFNET (Laskowski,  1995); fGAP Index = Gap Volume/ 2AASA.
In  their more recent review, Ponstingl  and co-workers have  shown  that a power law 
better describes the correlation  found between  the  monomer molecular mass  and the 
interface  area  of the  homodimer  (Ponstingl  et  al.  2005).  Their  investigations  based 
upon  76  protein  homodimers  revealed  that  on  average  15%  of the  total  accessible 
surface area of the subunit is buried upon dimer formation. For an additional set of 56 
dimers  termed  “dummy  dimers”  to  refer to  self-associative  proteins  thought to  exist 
only under crystallographic conditions, they found that this average falls below  10%. 
In the case of PaDDAH, AGAT and StrBl, for which the percentage of total  subunit 
ASA buried is 7.8%,  10.9% and  11% respectively, it appears as though these proteins 
might be non-obligatory dimers.
80The same authors have also been able to determine that the hydrophobicity, defined as 
the fraction  of carbon  atoms  present  in  the  interface  area,  is  an  additional  parameter 
capable  of discriminating between  obligate  dimer  and non-specific  dimer interfaces. 
The fraction of carbon atoms contributing to the interface ASA in dummy interfaces is 
around  50%  whereas  in  definite  homodimers  it  increases  to  an  average  of  62%. 
However,  a more cautious analysis  shows a rather large variance for monomers with 
smaller crystal  contacts,  as  several  dimer interfaces  in  this class  were  found to have 
carbon atoms covering up to 85% of the interface area. This assessment could explain 
the  high  percentage  of non-polar atoms  found in  the interfaces  of AGAT  and StrBl 
(64% and 68% respectively, Table 3.1). For PaDDAH the low percentage of non-polar 
atoms  in  the  interface clearly places  this  protein  into  the non-obligatory  homodimer 
class as predicted by this analysis.
Another key  parameter  in  the  definition  of an  oligomer interface  is  the  topological 
complementarity between surfaces. Jones and Thornton proposed the calculation of a 
Gap  Index,  defined  in  Equation  3.1,  where  the  gap  volume  is  the  empty  volume 
between two protomers calculated with the program SURFNET (Laskowski, 1995) and 
the total AASA is the total surface area buried upon oligomerisation.
Gap Volume (A3)
Gap Index (A)  =-------------------- —--------------------------  Equation 3.1
Total AASA (A2)
In the original work on this topic, an average Gap Index of 2.2 ± 0.9 A was obtained 
from the analysis of 32 homodimers (Jones and Thornton, 1996). Despite the large Gap 
Index  value  observed  for  PaDDAH  interface  area  (3.33  A),  indicative  of  a  loose 
interfacial  packing  of  residues,  this  parameter  was  unable  to  distinguish  clearly 
obligate  from  non-obligate  dimers  in  the  latest  work  from  Thornton’s  laboratory 
(Ponstingl et al., 2005).
In summary, these observations suggest that potentially none of PaDDAH, AGAT or 
StrBl  enzymes requires  self-association  for biological  activity.  More generally, these 
considerations  clearly  demonstrate  the  general  requirement  to  carefully  assess  the 
relevance  of the  self-associated  state  that  is  often  observed  in  the  3D  structures  of 
proteins:  by  their  nature  such  depictions  of the  protein  result  from  interactions  that 
occur at high concentrations (either in the crystal  or in the NMR sample), and simple 
inspection of the structure does not reveal per se the thermodynamic characteristics of 
the association.
81Individual residue contribution to PaDDAH interface ASA
To  identify  the  residues  that  contribute  to  stabilizing  interactions  in  the  PaDDAH 
homodimer,  the  predicted  changes  in  solvent  accessible  surface  area  (ASA)  upon 
dimerisation  in  a  residue-by-residue  fashion  were  examined  (Table  3.2).  The 
contribution  of  individual  residues  was  investigated  using  the  program  NACCESS 
(Hubbard  and  Thornton,  1993).  Values  of  solvent  accessible  surface  area  of  each 
residue  i  in  both  the  monomeric  (ASA,-,*#)  and  the  homodimeric  (ASA,-,d)  species 
interface were derived and the change in  surface  area upon oligomerisation could be 
inferred for each individual residue (AASA,) (Table 3.2). The same quantity could be 
expressed  as  an  absolute  value  (A2)  or  as  a  fraction  of  AASA,a/  (/ASA,).  By  this 
assessment a total of 23 residues undergo a finite change in ASA (i.e. AASA, > 0 A2), 
of which  13 show a fractional change in ASA (/ASA,) greater than 0.6 and account for 
567 A2 per protomer (66%) of the buried ASA. Plotting the values of /ASA, on a 3D 
molecular surface of PaDDAH clearly indicates the focal point of the intermolecular 
interaction which coincides with the exposed pC strand of module  1 composed mainly 
of hydrophobic residues (Figure 3.5a). From this representation, the entirety of the side 
chain  ASA  of  lie  49  and  Leu  51  become  concealed  on  the  formation  of  the 
homodimer.  However  here,  it  is  more  helpful  to  consider  the  absolute  residue-by- 
residue AASA values, which are shown in a colour-coded manner in Figure 3.4b. Two 
arginine residues (Arg 40 and Arg 98) are the largest contributors of side chain ASA to 
the  interface,  with  a  combined  25%  of  the  total  homodimer  interface  surface  area 
between them. Both of these side chains form salt bridges with acidic residues on the 
symmetry-related protomer (Figure 3.2b,d).
The  considerations  derived  from  this  analysis  led  us  to  limit  the  monomerisation 
mutagenesis strategy to residues Glu 33, Asn 36, Arg 40 and Asn 43 located in helix 
al  and Arg 98 in  helix  a2. These residues have relatively high  values of AASA, and 
fASAi. Although the hydrophobic core residues lie 49, Leu  51  and Leu 52 located in 
piC-strand are at the centre of the interface area and do contribute to the association of 
the homodimer with  the  three highest fASAi values,  previous  work performed in  the 
laboratory indicated that point mutations aiming to disrupt these interactions led to the 
expression of insoluble protein (Plevin, 2003).
82Table  3.2.  Accessible  surface  area  (ASA)  statistics  of  residues  at  the 
homodimer  interface  of  WT  PaDDAH  from  the  Protein-Protein  Interaction 
server3
Residue ASA/,M(A2)C ASAiiD  (AY AASA/ (A2)e fASAi
Lys 3 147.06 139.16 7.90 0.05
His 4 45.51 18.87 26.64 0.59
Thr 9 32.29 7.41 24.88 0.77
Leu 32 71.89 56.49 15.40 0.21
Glu 33 117.93 95.92 22.01 0.19
His 35 6.92 2.54 4.38 0.63
Asn 36 77.65 16.27 61.38 0.79
lie 39 15.29 5.69 9.60 0.63
Arg 40 158.61 56.10 102.51 0.65
Gin 43 112.62 22.92 89.70 0.80
Asp 46 106.30 86.81 19.49 0.18
Val 47 19.08 2.92 16.16 0.85
Asp 48 81.54 19.49 62.05 0.76
lie 49 46.66 0.97 45.69 0.98
Thr 50 30.37 2.15 28.22 0.93
Leu 51 86.62 1.69 84.93 0.98
Leu 52 22.77 5.78 16.99 0.75
Pro 53 89.25 37.26 51.99 0.58
Pro 54 64.78 49.37 15.41 0.24
Glu 94 133.50 119.34 14.16 0.11
Thr 95 5.86 5.12 0.74 0.13
Arg 98 148.36 39.79 108.57 0.73
Phe 99 56.23 27.65 28.58 0.51
dsee Table 3.1; bASA of residue i in monomer; dASA of residue i in dimer; difference between 
ASAiM and ASAiD; fractional ASA calculated where /ASAj = (AS A, M - AS A, £>)/AS A lM.
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Figure  3.5.  3D  structural  analysis  of the  solvent-accessible  surface  area  of WT 
PaDDAH.  (a)  Molecular  surface  WT  PaDDAH  coloured  according  to  fractional 
ASA,-  (see  Section  3.3);  (b)  WT  PaDDAH  with  a  molecular  surface  coloured 
according to absolute AASA, (A2) (see Section 3.3). The orientation of the protomer 
is the same as the one presented in Figure 3.4a. Images were generated using GRASP 
(Nicholls et a l, 1991). Adapted from Plevin et al. (2004).
843.4  Biophysical characterisation of PaDDAH interface mutants
Site directed mutagenesis of PaDDAH: assay of solubility and activity 
On the basis of the ASA analysis, a total of ten PaDDAH single residue mutants were 
designed  in  the  lab  and  prepared  using  site-directed  mutagenesis.  All  variants  were 
selected to  alter the physicochemical  (charge  and H-bonding potential)  properties  of 
the PaDDAH protomer surface so as to undermine the self-association affinity without 
disruption of the overall fold of the protein: E33H, E33Q, N36D, N36H, N36W, R40E, 
Q43H,  Q43R,  R98H  and  R40E-R98H  (double  mutant)  (Plevin  et  al,  2004).  All 
PaDDAH  mutants  could  be  expressed  in  E.  coli  at  levels  similar  to  the  WT.  A 
qualitative  assessment  for  DDAH  activity  was  performed  and  all  of  the  soluble 
mutants were found to retain some capacity to process the substrate L-NMMA (Plevin, 
2003).  Later  on  {vide  infra),  a  more  quantitative  comparative  study  of  PaDDAH 
activity  was  performed  on  WT  enzyme,  R40E  and  R98H  PaDDAH  single  residue 
mutants  and  the  R40E-R98H  double  mutant  (Table  3.3).  No  difference  in  activity 
between  the  WT  and  these  mutant  enzymes  was  detected  within  the  limit  of  the 
precision  of  the  measurement.  The  retention  of  enzymatic  activity  and  solubility 
indicates that none  of these three  mutants  exhibit  significant  disruption  to the  active 
site of the enzyme.
Table  3.3.  Comparison  of  WT  and  selected  mutant  PaDDAH 
enzymatic activities
PaDDAH isoform Relative Activitya
WT 1.00 (0.04)
R40E 0.95 (0.12)
R98H 0.88 (0.13)
R40E-R98H 0.95 (0.04)
aRelative  yield  of  L-NMMA  to  citrulline  conversion  assay  (see  Chapter  2,
section 2.4), at a DDAH concentration of 4 pM. Values report activity relative
to WT enzyme.
Analysis of the oligomeric state of PaDDAH mutants
The  oligomeric  state  of  each  soluble  PaDDAH  mutant  was  quickly  assessed  using 
analytical SEC at a single protein concentration (1  mg/ml; data not shown). From this 
initial  characterisation,  R40E,  Q43R,  R98H and R40E-R98H PaDDAH displayed an
85elution  profile  of single  peak  with  an  elution  volume  considerably  greater than  WT 
PaDDAH (Plevin et al, 2004). Interestingly, the N36W PaDDAH mutant exhibited a 
lower elution volume than WT PaDDAH with a more symetrical elution peak (data not 
shown). These proteins N36W, R40E, Q43R, R98H and R40E-R98H PaDDAH were 
then  selected  for  further  assessment  of  the  concentration  dependence  of  their 
oligomeric  state  using  a  procedure  similar  to  that  applied  to  the  WT  enzyme.  The 
elution profile for each of these proteins was obtained at six different sample dilutions 
over the range 5  mg/mL to 50  pg/mL.  In each case the elution  volume of the major 
band was converted into an apparent molecular weight (MWapp) value by reference to 
the standard calibration plot (Figure 3.6a). At difference to what was observed for WT 
PaDDAH,  the  apparent  molecular  weights  (MWapp)  obtained  for  R40E,  Q43R  and 
R98H PaDDAH clearly decrease to values that cluster between 27-33 kD, a result that 
suggests  to  a  more  monomeric  behaviour  in  solution  but  that  is  still  dependent  on 
protein  concentration.  Intriguingly  the  mutant  N36W  PaDDAH  showed  a  constant 
MWapp at around 51 kD as it appears that this protein is essentially dimeric. Moreover, 
the  double  mutant  R40E-R98H  PaDDAH  showed  no  concentration  dependence  of 
MWapp over the concentration range sampled, consistent with an invariant MWapp of 29 
kD (Figure 3.6a).
In  order to  quantify further the  self-association  of WT,  N36W,  Q43R,  R40E,  R98H 
and  R40E-R98H  PaDDAH  proteins,  sedimentation  equilibrium  analytical 
ultracentrifugation (SE-AUC) experiments were also performed. The experiments were 
designed  to  sample  the  dependence  of  the  sedimentation  behaviour  upon  the 
centrifugation speed and protein concentration. Several protein concentrations for each 
individual protein were sampled at three different rotor speeds (see Chapter 2, Section
2.4). However, to streamline the analysis, the interference datasets collected at 20,000 
revolutions  per  minute  (rpm)  were  initially  fit  to  a  single  ideal  species  model  (see 
Equation 2.1, Chapter 2, Section 2.4). The resulting weight-averaged molecular masses 
(MW ta PP)  for each  protein  are  shown  as  a function  of protein  concentration  in  Figure 
3.6b.  Three  types  of  hydrodynamic  behaviour  are  readily  apparent.  First,  WT  and 
N36W PaDDAH yield Mw > app   values  around 55-57  kD.  Second,  the Mwapp of Q43R, 
R40E  and  R98H  PaDDAH  varied  from  36  kD  to  46  kD  with  increasing  protein 
concentration.  Finally,  the  double  mutant  R40E-R98H  PaDDAH  presented  a 
consistent MW iapp around 27 kD over the concentration range. In qualitative terms these
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Figure 3.6. (a) Apparent molecular weight of WT and mutant PaDDAHs at varying 
loading  concentrations  indicated  in  the  colour-coded  legend,  (b)  Sedimentation 
equilibrium  analytical ultracentrifugation  analysis  of WT PaDDAH  and PaDDAH 
mutants.  Apparent  weight-averaged  molecular  masses  (Mwapp)  of WT  PaDDAH, 
N36W, Q43R, R40E, R98H and R40E/R98H PaDDAH as a function of cell loading 
concentration. The plotted Mw app values were obtained by averaging the results from 
the individual curve fits to a single ideal species model of three interference subsets 
collected at either 19,000 rpm (WT PaDDAH) or 20,000 rpm (all mutant DDAHs).
87results  are  broadly consistent  with  the  SEC  data:  WT  and N36W PaDDAH  show  a 
strong tendency to homodimerization, whereas R40E-R98H PaDDAH appears to lack 
any  potential  for  self-association;  the  other  mutants  show  intermediate  behaviour 
consistent  with  a  dynamic  equilibrium  between  dimer  and  monomer  forms.  In  an 
attempt  to  establish  a  more  quantitative  basis  for  these  observations,  the  SE-AUC 
interference data were then  fit to  an explicit monomer-dimer equilibrium model  (see 
Equation 2.2, Chapter 2, Section 2.4). Representative curves of these fits are illustrated 
in Figure  3.7.  The residuals  are  low  and randomly distributed.  In  the case of R40E, 
Q43R, R98H, N36W and WT PaDDAH, when the monomer-dimer equilibrium model 
fit  was  applied  both  the  visual  quality  of the  fit  was  enhanced,  and  the  statistical 
variance of the residuals was lower when compared to the values obtained for a single 
ideal  species  model,  monomer-only,  dimer-only  models  (Table  3.4)  or  for  fits  to 
models describing higher-order self-association (data not shown).
Four  independent  monomer-dimer  equilibrium  fits  were  performed  for  R40E  and 
R98H,  six  were  performed  for  Q43R,  three  for  WT  PaDDAH  and  two  for  N36W 
PaDDAH. Each fit is composed of a dataset of nine sedimentation equilibrium curves 
at  three  different  protein  concentrations  and  three  different  rotor  speeds.  The  Ka2 
values  derived  from  the  fits  were  converted  to  yield  the  homodimer  dissociation 
constant (£d) in concentration  units  (Table  3.4;  see Equation  2.3,  Chapter 2,  Section
2.4). The SE-AUC data for R40E-R98H PaDDAH could not be fit satisfactorily to the 
monomer-dimer model and thus no Kd value was derived for this mutant. Details of the 
protein concentrations and the rotor speeds used in each fit, together with the derived 
Ka2 values can be found for R40E, Q43R and R98H PaDDAH in Appendix, Table A.I.
The  values  of  the  dissociation  constants  of  WT  and  N36W  PaDDAHs  are  in  the 
nanomolar range  and  are  indicative  of a  homodimeric  behaviour  in  solution  at  the 
protein  concentrations  sampled.  Conversely  the  single  point  mutations  Q43R,  R40E 
and  R98H  substantially  disrupted  the  association  between  protomers;  all  have  Kd 
values  in  the  micromolar  range,  on  average  100-fold  higher  than  the  equilibrium 
dissociation constant for the WT protein. More importantly, the SE-AUC data clearly 
show  that R40E-R98H PaDDAH is  a variant  of PaDDAH that lacks  evidence  for a 
monomer-dimer  equilibrium  under  the  conditions  of  these  experiments.(a) WT PaDDAH (b)  R40E PaDDAH (c) R40E-R98H PaDDAH
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Figure 3.7. Representative examples of the sedimentation equilibrium curve fits for (a) WT PaDDAH (0.94 mg/mL), (b) R40E PaDDAH 
(0.71  mg/mL),  and  (c)  R40E-R98H PaDDAH (0.82 mg/mL).  In (a)  and  (b) the interference data (blue symbols,  lower panels)  are fitted 
(continuous  red  line,  lower  panels)  to  a  monomer-dimer  equilibrium;  in  (c)  the  fit  is  to  a  single  ideal  species  model.  Each  symbol 
corresponds to a different rotor speed (in rpm) as indicated on the right hand side of the fit residuals (plotted on an expanded scale in the 
corresponding upper panels). In order to derive a single Ka2 value for R40E PaDDAH monomer-dimer equilibrium, two other concentrations 
at three different speeds were used simultaneously (see Appendix I, Table A.I).Table  3.4.  Fitting  of  equilibrium  sedimentation  data  of  WT  PaDDAH  and 
PaDDAH mutants to various global models
PaDDAH
isoform
Model3 Variance1 5 ^d(pM) Average molecular 
mass (kD)c
WT Single ideal species 1.12 x 10'4 N/A 57.0
Dimer-only 1.84 x 10'4 N/A 58.4
Monomer-dimer 1.10 x 10’4 0.5 ±0.1 29.2
N36W Single ideal species 1.66 x 10‘4 N/A 57.0
Dimer-only 2.54 x 10'4 N/A 58.6
Monomer-dimer 1.62 x 1(T4 0.3 ±0.1 29.3
Q43R Single ideal species 2.70 x 10'4 N/A 46.3
Monomer-only 1.00 x 10'2 N/A 29.2
Monomer-dimer 1.55 xlO '4 45 ±5 29.2
R40E Single ideal species 3.07 x 10'4 N/A 42.6
Monomer-only 1.19 x 10'2 N/A 29.2
Monomer-dimer 8.53 x 10 5 73 ± 11 29.2
R98H Single ideal species 2.59 x 10"4 N/A 41.6
Monomer-only 3.45 x 10'3 N/A 29.2
Monomer-dimer 1.99 x 10‘4 87 ± 14 29.2
R40E-R98H Single ideal species 1.48 x 10"4 N/A 28.6
Monomer-only 1.68 x 10’4 N/A 29.2
aUp  to  nine  sedimentation  equilibrium  curves  were  fit  simultaneously  to  one  global  model  using 
Origin. bThe lowest variance obtained from a single fit is shown. cThe molecular mass is allowed to
float  for  the  single  ideal  species  model  fit,  it  was  fixed  for  dimer-only,  monomer-only  and 
monomer-dimer fits. The fixed molecular mass values were obtained from the amino acid sequence
of each protein.
90Thermodynamic considerations
To take  these  findings  further,  the  determination  of the  dissociation  constants  of the 
various PaDDAH mutant homodimers is a prerequisite to the thermodynamic study of 
the  contribution  of  each  residue  side  chain  on  the  free  energy  of  association.  The 
common  assumption  is  that  the  energy  of  protein-protein  associations  is  strongly 
related  to  the  buried  hydrophobic  surface  area  (Chothia  and Janin,  1975,  Jones  and 
Thornton,  1996). However, when considering individual residue energy contributions 
instead of the interface  surface  as  a whole, Wells  and colleagues  have demonstrated 
through  alanine  scanning mutagenesis that a single  side chain can  contribute a large 
fraction of the binding free energy (Clackson and Wells,  1995). Moreover, Bogan and 
Thom  compiled a dataset of interface residues  mutated to  alanine in  various  protein 
complexes  (Bogan  and  Thom,  1998).  Their  analysis  has  shown  that  there  is  little 
correlation between  side chain buried surface  area and free energy of association.  In 
fact,  in  agreement  with  Wells’  studies  not  only  do  certain  side  chains  contribute 
disproportionately more to the bulk of the energy of association but a bias exists for 
tryptophan, arginine and tyrosine residues to appear in more than  10% of the cases in 
what the  authors  have termed “hot  spots”.  Following their definition,  a hot  spot is  a 
residue that when mutated to alanine gives rise to  a distinct increase of more than  2 
kcal/mol in the absolute binding free energy. The Bogan and Thom findings imply that 
residues located in a hot spot do not share similar physico-chemical properties such as 
hydrophobicity or charged state. Rather, amino acids capable of forming multiple types 
of  favourable  interactions  are  preferred  in  interface  environments.  Tryptophan  for 
example  can  contribute  to  the  binding  energy  through  aromatic  interactions,  a 
hydrogen bonding donor and a large hydrophobic contact. Likewise tyrosine offers  a 
hydrophobic surface, aromatic interactions and the potential to form a hydrogen bond 
with  the  ring  hydroxyl  group.  As  for  arginine  residues,  they  can  form  up  to  five 
hydrogen  bonds  and  a  salt  bridge  with  the  guanidinium  moiety.  In  addition,  the  71- 
electron delocalisation of the guanidinium group has a pseudo-aromatic character and 
the three methylene carbon atoms have a hydrophobic character.
In our case, the mutations of residues Arg 40 and Arg 98 contributed to a decrease in 
free  energy  of  homodimer  dissociation  A(AGd)  of  3  kcal/mol,  and  that  of  Gin  43 
contributed  2.6  kcal/mol  relative  to  the  WT  protein  (Table  3.5).  Although  these 
mutations  are  not  to  alanine  residues,  Arg  40,  Gin  43  and  Arg  98  can  equally  be 
defined as binding or interfacial hot spots.
91Table 3.5. Corresponding free energy (AGd) of binding and individual free energy 
contributions to binding A(AG^) for WT and mutant PADDAH
PaDDAH isoform Kd(pM) AG</(kcal mol"1)3 A(AGrf) (kcal mol'1 )1 5
WT 0.5 ±0.1 8.4 ± 1.7 N/A
N36W 0.3 ±0.1 8.8 ±3.4 -0.4 ±0.1
Q43R 45 ±5 5.8 ±0.6 2.6 ±0.4
R40E 73 ±11 5.5 ±0.8 2.9 ±0.3
R98H 87 ± 14 5.4 ± 0.9 3.0 ±0.4
aThe free energy of dissociation AG</  was obtained with the following equation: AG,= -RTln Kd, 
where R is the gas constant (1.987 cal-K ^m ol1 ); T is the temperature in Kelvin (293K). A(AG,) = 
AG,,  W T ~ AG, M m ant_____________________________________________________________________________
However,  in  the  case  of  the  R40E  mutation,  the  results  are  not  informative  as  to 
whether  the  destabilisation  effect  originates  from  the  disruption  of  a  salt-bridge  or 
from the electrostatic repulsion created by the insertion of a negatively charged residue 
in position 40, in close proximity to Glu 33 on the opposing helix-al  (Figure 3.2d). In 
fact,  it  is  likely that  the  destabilisation  of the  protein-protein  interactions  caused  by 
these  mutations  arises  from  numerous  sources.  In  our  mutagenesis  strategy  the 
mechanism involved is most likely the loss of electrostatic pairing, with the disruption 
of  two  pairs  of  salt-bridges  (Arg  40-Glu  33  and  Arg  98-Asp  48).  However,  it  is 
possible  that  other  mechanisms,  not  easily  recognised,  could  account  to  the  overall 
energetic contribution of destabilisation of the dimer. These include a discrete change 
in local conformation due to the accommodation of a novel residue, increased entropy 
of dissociated monomers, or a change of the ionisation state of charged residues at the 
mutated interface (DeLano, 2002).
On  a practical  note,  to our surprise, N36W PaDDAH was  found to have a lower Kd 
than  WT  PaDDAH  and  its  hydrodynamic  properties  point  to  an  exclusive  dimeric 
behaviour in  solution.  This mutation  was intended to  add a bulkier side chain in  the 
interface  and  hence  obstruct  the  proximity  of the  protomers  that  would  hinder  the 
association.  As  mentioned  above,  tryptophan  residues  are  prone  to  form  several 
interactions in  an  interface environment.  Its presence  in  position  36  of helix  aIA,  in 
close proximity to the reciprocal Trp residue in the opposing helix-alB  perhaps creates 
additional hydrophobic interactions, sufficient to account for the small increase in free
92energy of binding (Figure 3.2d, Table 3.5) and to disrupt the apparent monomer-dimer 
equilibrium as demonstrated by the SEC and SE-AUC results.
Initial analysis of monomeric PaDDAH by NMR spectroscopy
2D  [1 H,15N]-HSQC NMR spectra were recorded of [15N]-isotope labelled samples  of 
WT  PaDDAH  and  selected  mutant  forms.  WT PaDDAH  yields  a  reasonably  well- 
dispersed spectrum with ca.  160 resolvable cross peaks (Figure 3.8a). The aim was to 
obtain  spectra with  a complete tally  (241)  of cross  peaks  (i.e.  254  less  13  prolines). 
However,  the  single  PaDDAH  mutants  failed  to  improve  the  quality  of  the  NMR 
spectra (data not shown), as no additional cross peaks were observed compared to the 
number normally obtained for the WT protein (Plevin, 2003). The derived dissociation 
constants  for  these  mutants  are  in  the  micromolar  range  which  helped  us  in  the 
understanding that from an NMR perspective, they are still essentially dimeric at the 
concentrations required for NMR studies (Figure 3.9). However the HSQC spectrum of 
[15N]-labelled R40E-R98H PaDDAH (Figure  3.8b)  shows  a marked enhancement in 
the quality compared to the WT protein.  Simple inspection reveals that the individual 
NH  cross  peak  line  widths  are  significantly  reduced  and  are  accompanied  by  an 
apparent increase in, and uniformity of, signal-to-noise (S/N) ratio. The central region 
of  the  spectrum,  which  is  highly  overlapped  in  the  WT  spectrum,  shows  a  clear 
improvement  in  signal  resolution,  leading  to  a  provisional  tally  of as  many  as  241 
backbone  NH  cross  peaks,  including  two  cross  peaks  with  HN   chemical  shifts  at 
around 4.8  ppm  close  to  the  noise  band  derived  from  the  water  signal  that  had  not 
previously been properly discernible in the spectrum of the WT protein.
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Figure  3.8.  Comparison  of pH^NJ-HSQC  spectra recorded  of [15N]-labelled  WT  PaDDAH  (a)  and  R40E-R98H  PaDDAH  (b).  Each 
experiment was recorded under identical experimental parameters at a protein concentration of 1.0 mM at a proton frequency of 600 MHz. 
Each spectrum shows a region of a data matrix that consisted of 400* tx   and 2048* t2 data points (where n* refers to complex points) with 
acquisition times of 90 ms (t}) and 256 ms (t2). A total of 32 transients were recorded per tx  increment, with a repetition rate of 1.7 s and total 
experiment duration of ca.  6 h.  The spectra are not plotted at the same contour levels:  the overall lower signal-to-noise ratio of the WT 
spectrum (a) means that at the lower contour level required to make the majority of cross peaks observable in the plot, the residual solvent 
suppression noise at JH ~ 4.6 ppm is more plainly visible.AUC  NMR
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Figure  3.9.  Simulated  curves  of dimer  percentage  as  a  function  of total  protein 
concentration obtained from the derived Kds of each PaDDAH protein (see Chapter
2, Section 2.4). The red and blue rectangles highlight the protein concentration range 
needed in AUC and NMR experiments respectively.
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953.5 Discussion
The  engineering  of monomeric  proteins  from  higher  order oligomers  is  not  a  novel 
idea. Generally, these studies are based on known three-dimensional protein structures 
and  aim  to  explore  oligomer  association  and  its  relative  importance  for  biological 
activity (e.g.  Borchert et al.,  1994, Rajarathnam et al.,  1994, Sakurai and Goto, 2002, 
Cox et al.,  2003). An additional premise for the adoption of such a strategy is that it 
can  offer  simpler  protein  units  for  biophysical  characterisation.  The  attempts  to 
characterise  the  58  kD  homodimeric  enzyme  PaDDAH  stumbled  on  the  intrinsic 
physico-chemical  properties  of the  protein.  The  inherent  slow  tumbling  of  a  larger 
molecule  in  solution  together  with  a  hydrodynamic  behaviour  consistent  with  a 
monomer-dimer equilibrium resulted in an  absence of a subset of visible Hn-N cross 
peaks in the HSQC spectra recorded of the WT enzyme which hampered our ability to 
pursue further NMR studies.
The  data  presented  here  show  that  the  adoption  of  a  monomerisation  strategy  for 
PaDDAH was  a plausible  solution  in  order to obtain  a more  amenable  molecule  for 
NMR study. Considering that the active site of this enzyme lies ca.  15 A away from 
the interface region,  it was likely that the enzymatic  activity of a monomeric  variant 
would  not  be  at  risk  if  residues  at  the  interface  were  targeted  for  mutagenesis.  In 
support of this scenario, we showed, based on the available crystal  structure, that the 
interface  surface  area  of the  homodimer is  small  (860 A2)  when  compared to  other 
stable oligomers, it is not compact as demonstrated by the high Gap Index value (3.3 
A), and it has a high content of hydrophilic residues reflecting a composition similar to 
the solvent exposed protein surface (Table 3.1).  Since in many systems the biological 
role of oligomerisation is not clear, we postulated that the dimeric nature of PaDDAH 
was the result of the high concentrations needed for crystallographic and NMR studies.
Subsequent  analysis  of the  solvent  accessible  surface  area  of the  individual  residues 
involved in the association led us to target Glu 33, Asn 36, Arg 40, Gin 43 and Arg 98 
for  site-directed  mutagenesis.  These  residues  demonstrate  high  absolute  changes  in 
both ASA and in /ASA, upon dimerisation. In particular, the mutation R40E aimed to 
disrupt  a pair-wise salt-bridge formed with  Glu 33  in  the  opposing protomer.  As  for 
Q43R  mutation,  the  additional  charge  introduced  by  the  guanidino  group  of  the
96arginine  residue  is  predicted  to  increase  the  electrostatic  repulsion  between  position 
Arg 43  and the opposing Arg 40 across oil a , b  helices. The mutation of Arg 98 to His 
located  in  helix-a2  was  intended  to  disrupt  a  salt-bridge  interaction  with  the 
carboxylate group of Asp 48 in strand (31C. Under conditions in which the introduced 
His is in the deprotonated state, the electrostatic interaction with Asp 48 is unlikely to 
occur.
All  three  single  residue  mutants  showed  some  degree  of  deviation  from  the 
hydrodynamic behaviour of the WT enzyme when characterised by analytical SEC and 
SE-AUC.  The  latter  technique  revealed  a  shift  in  the  weight-averaged  apparent 
molecular mass from 57 kD as determined for WT PaDDAH to an average of 43 kD. 
The  quantitative  estimates  of  the  dimer  dissociation  constants  for  these  proteins 
showed a  100-fold decrease in their homodimer association which, nevertheless, was 
unfortunately insufficient to improve the quality of the NMR  spectra (Plevin,  2003); 
these enzymes are essentially 80% dimeric at typical NMR concentrations (~ 0.5 mM).
With regard to N36W PaDDAH, its apparent molecular mass remained unaffected by 
changes in protein concentration and the increase in free energy of association strongly 
suggests a shift of the oligomeric equilibrium towards a consistent dimeric behaviour 
in  solution.  N36W  PaDDAH  is  a  more  stable  homodimer  and  this  fact  led  us  to 
characterise this mutant by NMR spectroscopy with the notion that the slight increase 
in the association strength would lessen the effect of any chemical exchange induced 
line broadening due to monomer-dimer equilibrium at the interface. However, the 2D 
HSQC spectrum of [15N]-labelled N36W PaDDAH had similar characteristics to that 
of WT PaDDAH and several resonances were still missing.
In summary, it appears that the combination of two single point mutations efficiently 
disrupt  the  association  of PaDDAH  monomers.  The  R40E-R98H  PaDDAH  double 
mutant provides an excellent platform to study the structure-function characteristics of 
PaDDAH  as  a  stable  active  monomer  species.  The  overall  excellent  stability  and 
hydrodynamic properties of [15N]-labelled R40E-R98H PaDDAH, clearly indicate that 
it should be within the scope of triple resonance NMR spectroscopic methods to obtain 
a full resonance assignment that will provide the basis for the precise characterisation
97of  residue-by-residue  dynamics  properties  and  the  substrate  and/or  inhibitor  ligand 
binding effects.
The following chapter will describe the full assignment of the spectrum of 15N-labelled 
R40E-R98H PaDDAH which helped in the understanding of the limited utility of the 
NMR  data  for  the  WT  protein.  Despite  its  well  dispersed  2D  {^H-^NJ-HSQC 
spectrum,  the  poor  quality  of  the  spectrum  of  WT  PaDDAH  was  not  unexpected, 
considering the relatively large size of the homodimeric WT protein (MWapp ~ 58 kD). 
Any  globular  molecule  of this  size  would  be  predicted  to  exhibit  a  relatively  long 
rotational  correlation  time  leading  to  rapid  decay  of  transverse  magnetization  and 
broad  NMR  features.  However,  this  slow  tumbling  characteristic  alone  may  not  be 
sufficient to account for the apparent absence of a significant fraction of the expected 
cross peaks. Possible explanations for this phenomenon will be discussed in Chapter 4.
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PaDDAH backbone resonance assignments
Abstract
Recently  developed  NMR  techniques  such  as  transverse  relaxation  optimised  spectroscopy 
(TROSY)  applied  in  combination  with  the  routine  isotopic  enrichment  of  proteins  have 
permitted  the  detailed  NMR  characterisation  of systems  of up  to  100  kD.  These  advances 
should have enabled the study the 58 kD WT PaDDAH enzyme but the efforts were hampered 
by intrinsic physico-chemical properties of the homodimer which lead to a substantial loss of 
the  expected  resonances.  This  chapter  describes  the  application  of multidimentional  NMR 
methodology to obtain the  sequence  specific backbone resonance  assignments  of the newly 
engineered 29 kD monomeric variant of the PaDDAH enzyme. The smaller size of the protein 
compared to the wild-type protein significantly enhanced the resolution of the central region of 
the 2D spectra recorded and contributed to the overall increase of the signal-to-noise ratio. The 
improvements in the quality of the spectra enabled the full assignment of the backbone !H, 1 3 C, 
and  1 5 N  resonances  of  [2 H,1 3 C,1 5 N]-labelled  R40E-R98H  PaDDAH  with  a  series  of triple 
resonance experiments. The deuteration of the protein proved crucial to enhance the efficiency 
of  the  magnetisation  transfer  steps  in  triple  resonance  experiments.  Furthermore  the  1 3 C 
chemical  shift data were analysed as  a means  of identifying  the  locations of the secondary 
structure elements of PaDDAH and a good agreement was observed between the NMR data 
and  the  available  crystal  structure  of WT  PaDDAH.  This  level  of NMR  characterisation 
allowed for the identification of residues for which the !HN , 1 5 N resonances were absent in the 
2D spectra of the WT PaDDAH. Interestingly, this assessment clearly shows that cross peaks 
that  are  lost  in  the  fully  protonated  sample  correspond  to  residues  located  at the  interface 
region  of the  homodimer and  to residues  located  in  the  surrounding  loops,  such as  all  the 
residues involved in catalysis.
994.1  The study of large proteins by NMR
Isotopic enrichment of  proteins
The characterisation of large proteins by NMR spectroscopy has benefited over the last 
two  decades  from  significant  improvements  in  experimental  protocols  and technical 
developments. The isotopic enrichment of proteins  with  13C  and  15N isotopes is now 
employed  in  a  routine  manner  in  NMR  laboratories.  Although  seemingly  adding  a 
layer of complexity, backbone and side chain 1 HN, 13C and 15N spins can be correlated 
by transferring magnetisation from one nucleus to the other through one- or two-bond 
scalar  couplings  or  through  space,  greatly  reducing  signal  overlap.  For  many 
proteins with a molecular weight around 20 kD, the transfer of magnetisation between 
nuclei via scalar couplings is faster than the decay of magnetisation from relaxation so 
that  high  sensitivity  spectra  can  be  recorded.  Hence,  several  triple-resonance  pulse 
sequences in three and four dimensions (3D, 4D) have been developed which allow the 
full assignment of proton, nitrogen and carbon backbone and side chain chemical shifts 
of  proteins  with  molecular  weights  of  up  to  approximately  20-25  kD  (Clore  and 
Gronenbom, 1998, Sattler  a/., 1999).
Despite  the  utility  of  triple-resonance  multi-dimensional  NMR  spectroscopy  in 
structural  studies,  for  systems  larger  than  25  kD,  long  molecular  correlation  times 
result  in  rapid  relaxation  rates  of all  nuclei,  specially  of the  proton  attached  to  13C 
nuclei, which attenuates signal intensity and decreases spectral resolution (Gardner and 
Kay,  1998).  In  the  case  of the  13C-!H and  15N-!H  spin-pairs  in  a protein,  the  major 
contributor to relaxation of carbon and nitrogen magnetisation derives from the dipolar 
interaction  between  the  two  bonded  atoms  and  in  part  to  chemical  shift  anisotropy 
(CSA).  The  rate  of dipolar-mediated  relaxation  is  dependent  on  the  product  of the 
gyromagnetic ratios y of the bonded nuclei. From a simplistic point of view, the larger 
this product, the greater the rate of dipolar relaxation. In order to study larger proteins, 
one method to circumvent this phenomenon  has  been to substitute non-exchangeable 
protons with deuterium nuclei. Deuterium has a significantly lower gyromagnetic ratio 
when compared to proton (y[1 H]/y[2H] ~ 6.5). When 2H replaces  *H in carbon-bearing 
positions  in  proteins,  not  only  do  the  contributions  from  proton-proton  dipolar 
relaxation  and  scalar couplings to proton  line  widths decrease, but the dipolar
interaction between  a  13C-2H pair is  attenuated.  In  fact, the likely contribution  of the
2  1 3 dipolar  relaxation  of  H  to  the  C  line  width  for  a  protein  undergoing  isotropic
100tumbling with a rotational correlation time of 15 ns is  1.5 Hz instead of 20 Hz in the 
case  of a  ^C-’H  spin-pair,  which  consequently improves  the  sensitivity of the triple 
resonance  experiments  based  on  recording  the  NH  group  (Grzesiek  et  al,  1993). 
Similarly,  deuterating  all  non-exchangeable  sites  in  proteins  leads  to  a  decrease  in 
amide proton  transverse  relaxation  (!HN   T2)  by  a  factor of two,  as  evidenced in  the 
studies of villin  14T (Markus et al,  1994) significantly improving the sensitivity and 
resolution  of the  acquired  spectra  (Markus  et  al,  1994).  These  results  have  been 
further complemented by  the  studies  of the  37  kD  trp  repressor/DNA  complex,  for 
which  a  suite  of triple-resonance  experiments  for  the  assignments  of the  backbone 
resonances of [2H,13C,15N]-labelled proteins was developed (Yamazaki et al, 1994a,b). 
The  level  of protein  deuteration  used in  Yamazaki  et al  studies  was  70%  which  is 
proportional  to  the  level  of  D2O/H2O  used  to  culture  the  bacteria  containing  the 
expression  vector.  For  their  purposes,  which  were  to  pursue  structural  studies,  the 
preparation  of  a  fully  deuterated  sample  combined  with  reprotonation  of backbone 
amide  positions  in  H20-based  buffers  would  ultimately  preclude  its  use  for 
experiments  which  require  the  magnetisation  to  originate  or  be  detected  in  carbon- 
bearing protons.  The depletion of protons in  a perdeuterated protein  sample  strongly 
impairs nuclear Overhauser enhancement (NOE) based experiments, which rely on the 
through  space  correlation  of protons.  For instance,  perdeuteration  of the PLCC  SH2 
domain has been shown to lead to a five-fold decrease in the number of protons present 
(Gardner  et  al,  1997),  which  greatly  reduced  the  number  of  observable  distance 
restraints  between  proton  methyl  groups.  However  alternative  isotope  labelling 
strategies  have  been  elegantly  applied  to  selectively  incorporate  *H  into  non­
exchangeable sites of highly perdeuterated proteins.  To this end, the supplementation 
of  specific  protonated  amino  acid  precursors  in  D20-based  growth  media  can  be 
adopted to incorporate in proteins protonated methyl groups of alanine, valine, leucine 
and isoleucine (y2 only). These strategies have been shown to balance effectively both 
the  chemical  shift  assignments  and  the  NOE  information  necessary  to  determine 
protein  3D solution  structures  (Rosen  et al,  1996,  Gardner et al,  1997,  Goto et al, 
1999). To date, the different protein sites that can be selectively isotopically labelled 
vary according to the type of precursor added to the growth  media (Tugarinov et al, 
2004,  Ollerenshaw  et  al,  2005).  It  has  become  increasingly  clear  that  the  optimal 
labelling pattern of a protein depends upon the level of NMR characterisation required. 
Transverse relaxation  optimised spectroscopy (TROSY)
101The  recently  developed  principles  of  transverse  relaxation  optimised  spectroscopy 
(TROSY; Pervushin et al.,  1997) significantly extend the size of proteins tractable by 
NMR  to  molecular  masses  beyond  100  kD.  The  main  advantage  of TROSY  is  the 
suppression of transverse relaxation during the magnetisation transfer periods and the 
evolution  periods  that  leads  to  signal  loss  and  line  broadening  of the  NMR  signal. 
Although the relaxation rates of amide protons in proteins in the 20-25 kD range have 
been  successfully reduced by the partial  or complete replacement of protons  in  non- 
labile positions by deuterons, TROSY further suppresses transverse relaxation in lHN- 
15N moieties by constructive use of interference between  dipole-dipole coupling and 
chemical shift anisotropy (CSA). In conventional ^H^Nj-heteronuclear spectroscopy, 
the doublet that arises from the scalar coupling between the two nuclei is seen in 2D 
experiments  as  a  four-fold  multiplet  structure.  Usually,  the  four-line  component  is 
effectively  turned  into  a  single  centrally  located  line  through  broadband  15N- 
decoupling during the evolution and acquisition periods which selectively removes the 
spin-spin  splittings  in  the  final  spectrum.  The  underlying  technical  principle  of 
TROSY  is  that the NH  signal  is retained in  the  multiplet  state.  Since  the  individual 
multiplet components have different transverse relaxation rates due to cross-correlation 
and hence different line  widths,  TROSY  is  engineered to  select the  narrowest,  most 
slowly  relaxing  line  of each  multiplet  (Riek  et  al.,  2000).  For proteins  with  a  long 
correlation  time,  the  resulting  sharp  component  improves  spectral  resolution  and 
overall  sensitivity.  However,  in  order  for  the  application  of  TROSY  to  be  most 
effective,  the  contributions  to  relaxation  from  homonuclear proton-proton  couplings 
have to be considered.  In fact, the relaxation pathway of ^ -^ N  spin-pairs due to the 
dipolar couplings with remote protons cannot be influenced by TROSY. Therefore, an 
optimal TROSY effect is achieved with the use of uniformly deuterated proteins which 
significantly limits the coupling between adjacent amide and carbon-bearing protons.
In this regard, the application of TROSY-based pulsed sequences in conjunction with 
the deuteration of large proteins led to the complete backbone assignments of a 110 kD 
homooctameric protein, 7,8-dihydroneopterin aldolase (Salzmann et al., 2000) and that 
of the  human  tumor  suppressor  protein  p53  of  67  kD  (Mulder  et  al.,  2000).  More 
recently, the 3D solution structures of two eight stranded (3-barrel membrane proteins 
were solved, OmpX (Fernandez et al., 2004) and PagP (Hwang et al., 2002) dissolved 
in lipid detergents with effective molecular mass in the 50-60 kDa range.  In addition, 
the 3D structure of the 80 kD bacterial malate synthase G was successfully solved by
102the exploitation of TROSY-based approaches in combination with valine, leucine and 
isoleucine proton methyl labelling (Tugarinov et al, 2005).
4.2  Assessing the need for TROSY methodology and deuteration in the study of 
dimeric and monomeric PaDDAH
The study of WT PaDDAH by heteronuclear NMR
Previous work done in our laboratory demonstrated the  significant improvement that 
the combination of TROSY-based methods and deuteration brought to the study of the 
58  kD  homodimeric  WT  PaDDAH  (Plevin,  2003).  Examples  of  [!H,15N]- 
heteronuclear  single  quantum  coherence  (HSQC)  and  [^H^NJ-TROSY  spectra 
recorded of [^ ^ N ]- and [2H,15N]-labelled WT PaDDAH are shown in Figure 4.1 and 
clearly indicate  an increased spectral resolution  and signal-to-noise  (S/N) ratio when 
[^H^NJ-TROSY is applied to a perdeuterated PaDDAH sample (Figure 4.1c; Plevin, 
2003).  For  our  purposes,  which  were  to  obtain  the  sequence-specific  resonance 
assignments of PaDDAH, the TROSY-based triple resonance experiments (Yang and 
Kay,  1999) applied to a fully [2H,13C,15N]-triple labelled protein sample were thought 
likely  to  provide  the  highest  sensitivity  and  resolution  to  study  the  58  kD  protein. 
However, the lack of a subset of expected cross peaks in [!H,15N}-correlated spectra of 
both  fully protonated  and perdeuterated  protein  samples  together with  the  relatively 
low number of HN — >   C correlations observed in triple resonance experiments (only 
65% of the expected correlations in the  ^H^C^NJ-TROSY HNCO and 45% in the 
[1 H,13C,15N]-TROSY HNCA experiments were observed) meant that only 20% of the 
amide cross peaks in triple resonance spectra gave the full complement of possible 13C 
correlations (Plevin, 2003).
The possible reasons for this shortcoming include a common drawback of expressing 
proteins in D2O media.  In  some cases, the usual  strategy employed in order to back- 
exchange protons  into  labile  positions  (such  as  all  amide  groups),  which  consists  of 
purifying  the  entirely  deuterated  protein  in  H2O  buffers,  is  not  suitable  for  larger 
proteins.  A  significant  number  of  cross  peaks,  ca.  35  in  [2H,15N]-WT  PaDDAH 
spectra,  were  not  recovered  after  the  purification  procedure,  which  lasted 
approximately  four  days.  These  amide  groups  presented  exchange  rates  which  were
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Figure 4.1. (a) [1 H, 15N]-HSQC spectrum recorded of [!H,15N]-labelled WT .PaDDAH. Data matrices consisted of 512* (7j) and 1024* 
(t2) points (where n* refers to complex points) with acquisition times of 71.1  ms (tj) and  102.4 ms (t2). The experiment was recorded 
with 16 transients per tx  increment. [’H, 15N]-HSQC (b) and [!H, 15N]-TROSY (c) spectra recorded of [2H,15N]-labelled WT PaDDAH. 
Both [!H, 15N]-HSQC and [*H, 1 5N]-TROSY data matrices consisted of 400* (7j) and 2048* (t2) and points (where n* refers to complex 
points) with acquisition times of 100 ms (tx) and 85 ms (t2). A total of 32 transients were recorded per tx   increment. All spectra were 
recorded at 25°C and at  [H proton frequency of 500 MHz.  Protein concentration was 0.8  mM and the affinity tag was  still present. 
Adapted from Plevin, 2003.extended  to  impracticable  time  scales  and  remained  deuterated  even  after  several 
weeks following purification  (Plevin, 2003). These sites are evidently protected from 
solvent  and implicated in  stable  secondary  structure  formation.  Additional  efforts  to 
partially unfold and refold the enzyme to allow the complete back exchange to occur 
failed because of our inability to find the conditions necessary to improve the yield of 
active and refolded enzyme recovered. The refolding strategy, which proved successful 
for other proteins of the same size (Gardner et al,  1998, Tugarinov et al., 2002), was 
eventually abandoned as the yield was not satisfactory  and not yet worth risking the 
loss of considerable amounts of [2H,13C,15N]-labelled PaDDAH protein.
Alternatively, the intrinsic monomer-dimer equilibrium of the protein could be at the 
origin  of  chemical  and  conformational  exchange  occurring  at  the  dimer  interface 
region, leading to substantial line broadening of the resonances. The dynamic nature of 
the interface packing with the concomitant line broadening of the resonances located in 
this region have been shown to occur in several other systems (Lukin et al. 2003, Yung 
et al.,  2003;  Pfuhl  et al,  1999).  In  addition,  PaDDAH has  also  a flexible  loop  (LI) 
covering the active site region (Murray-Rust et al.  2001), for which residues may also 
experience exchange broadening of NMR signals.
If  the  backbone  resonance  assignments  could  be  obtained  for  the  monomeric 
PaDDAH,  a  tentative  identification  of  the  missing  !Hn,15N  correlations  in  WT 
PaDDAH ['H^NJ-TROSY spectra might offer a qualitative assessment of the regions 
of  the  protein  undergoing  conformational  exchange  and  identify  possible  slowly 
solvent-exchanging  amide  groups.  Such  an  analysis  is  discussed  in  detail  in  Section 
4.4.
The study of monomeric PaDDAH by heteronuclear NMR
As  outlined  in  the  previous  chapter,  the  more  tractable  engineered  double  mutant 
PaDDAH provided an excellent platform for future NMR studies. The initial [1 H,15N]- 
HSQC experiments recorded of [!H,15N]- and [2H,15N]-labelled R40E-R98H PaDDAH 
(Figure  4.2)  show  a  significant  improvement  of the  spectral  quality  in  terms  of the 
increased number of visible cross peaks  and of the uniformity of the S/N ratio when 
compared  to  the  WT  protein  spectra.  The  central  region  of the  spectrum,  which  is 
highly overlapped in the wild-type spectrum, also shows a clear improvement in signal 
resolution,  which  is  further  enhanced  by  deuteration  (Figure  4.2b).  Of  particular
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Figure 4.2.  pH^NJ-HSQC  spectra recorded of (a)  pH^Nj-labelled R40E-R98H PaDDAH,  and  (b)  [2H,15N]-labelled  R40E-R98H 
PaDDAH. Data matrices consisted of 240* (7j) and 1024* (t2) points (where n* refers to complex points) with acquisition times of 75.0 
ms (/j) and 122.0 ms (/2). The experiment was recorded with 8 transients per tx  increment in (a) and 4 transients per tx  increment in (b). 
Both spectra were recorded at 25°C and at  proton frequency of 500 MHz. Protein concentration was 1 mM.importance  is  the  fact  that  the  recombinant  monomeric  protein  was  less  prone  to 
incomplete reprotonation  of exchangeable  amide  group protons  than the WT protein 
when  expressed in D20-containing media.  The number of cross peaks present in  the 
[‘H^NJ-HSQC  spectra of both  protonated  and perdeuterated  samples  is  comparable 
(Figure 4.2). Unfortunately, a [‘H^NJ-TROSY spectrum of the deuterated sample was 
not recorded which would have allowed an assessment of the overall improvement the 
combination  of  this  experiment  and  deuteration  might  have  provided.  However,  a 
[1 H,15N]-TROSY spectrum of a protonated [1 H,15N]-R40E-R98H PaDDAH is  shown 
in  Figure  4.3b.  From  visual  inspection  alone,  when  compared to  the  HSQC  spectra 
recorded  at  the  same  proton  frequency  (Figure  4.3a),  the  resolution  is  slightly 
increased  in  the  central  region  of the  spectrum.  Despite  this  fact,  the  quality  of the 
HSQC-based  experiments  is  largely  sufficient  to  discard  the  use  of  TROSY-based 
methods in the characterisation of this protein. Whereas for the dimeric WT protein, 
deuteration and the application of TROSY were essential to acquire high quality data, 
the smaller overall size of the monomer makes it tractable by more conventional NMR 
experiments.
4.3  1H, 13C and 1SN backbone assignments of the monomeric PaDDAH
Description of the triple resonance experiments
A  number  of  heteronuclear  3D  and  4D  experiments  have  been  proposed  for  the 
sequential assignment of uniformly isotopically labelled proteins (Sattler et al,  1999). 
The  pulse  sequences  generally  rely  on  one-  and  two-bond  heteronuclear  scalar 
couplings  (J)  along  the  polypeptide  chain  which  arise  between  spins.  The 
establishment of sequential connectivity correlates the !HN  and 15N nuclei of residue i 
with  both  its  intra-residue  (i)  and inter-residue  (i-1)  13Ca and  side chain  13Cp nuclei. 
The  advantage  of including  the  13Ca  and  13Cp  correlations  is  that  the  characteristic 
chemical  shifts observed are often  diagnostic  of a specific  amino acid.  In this  sense, 
information about the 13Ca and 13Cp chemical shift values of the i-1, i and i+1 residues 
can potentially identify an amino acid triad within the known primary sequence of the 
protein  (Grzesiek  and  Bax,  1993).  Increasing  the  number  of  the  connected  spin 
systems increases the probability of correctly identifying a correspondence to a unique 
amino acid sequence within the protein.
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Figure 4.3. (a) ^H^NJ-HSQC and (b) ^H^N]-TROSY spectra recorded of ^H,15N]-labelled R40E-R98H PaDDAH. Data matrices 
consisted of 400% points in both (a) and (b) and 2048* t2 points in (a) and 4096% in (b) (where n* refers to complex points) with 
acquisition times of 91.0 ms %),  128.0 ms (t2) in (a) or 204.8 ms (t2) in (b). Both experiments were recorded with 32 transients per tx  
increment at 25°C and at *H proton frequency of 600 MHz. The protein concentration was 1 mM.As  mentioned before,  the  success  of the  triple  resonance  experiments  for  sequence- 
specific resonance assignments of proteins in the region of 30 kD relies on sufficiently 
long  13CaT2 and !HN  T2 relaxation times to allow the establishment of the correlation 
with  the  13Co/p  atoms.  The  most  significant contribution  to  13C  transverse  relaxation
1  3
comes  from  the  strong  dipolar  coupling  between  the  C  nucleus  and  the  directly 
attached  proton  (Grzesiek  et  al.,  1993).  Additionally,  the  dipolar  coupling  to  the 
surrounding  aliphatic  protons  has  been  shown  to  contribute  significantly  to  1 HN   T2 
relaxation.  In  large  proteins  these  relaxation  effects  can  lead  to  an  absence  of 
detectable Cp correlations in the HNCACB-based experiments (Wittekind and Mueller, 
1993, Venters et al.,  1996, Garrett et al.,  1997). One way to circumvent the decline in 
sensitivity is to deuterate the protein and incorporate deuterium decoupling in the pulse 
schemes (Yamazaki et al., 1994a,b).
In  this  context,  the  following  3D  deuterium-decoupled  gradient  sensitivity-enhanced 
triple  resonance  experiments  were  selected  for  the  assignment  of  monomeric 
PaDDAH:  HNCO, HNCA, HN(CO)CA, HN(CA)CB  and HN(COCA)CB  (Yamazaki 
et al,  1994a,b;  see  Chapter 2,  Section  2.5).  The  nomenclature  of these  experiments 
highlights  the  nuclei  involved  in  the  magnetisation  transfer  pathways  (Figure  4.4). 
Spins whose chemical shifts are not evolved are denoted by parentheses. As shown in 
Figure  4.4  and  summarised  in  Table  4.1,  the  magnetisation  transfers  in  all  these 
experiments  are of the out-and-back type both  originating  and being detected on  the 
Hn spin.  More specifically, the combination  of the HNCA,  HN(CO)CA, HN(CA)CB 
and HN(COCA)CB experiments theoretically provide for each !Hn,15N resonance pair 
a set of four correlations HN — ►   [13Ca(i), 13Ca(i-l), 13Cp(i), 13Cp(i-l)] that then enables 
the sequential assignments of the backbone resonances.
Additional  features  of  these  pulse  schemes,  in  the  form  adapted  for  studies  on 
PaDDAH,  include  the  incorporation  of pulsed  field  gradients  in  order  to  minimize 
artefacts and the residual water (Kay et al.,  1992a, Sattler et al,  1999) and the use of 
an enhanced sensitivity approach to optimize S/N (Palmer et al,  1991a). However,  a 
detailed explanation of these features lies outside the scope of this thesis.
109J  L
i  -1
J  L
i  -1
i  -1
(d) (e)
i-1 i  -1
Figure 4.4.  Experimental  strategy for the resonance  assignment  of backbone  *H, 
15N,  13Ca,  13Cp and CO nuclei in a dipeptide fragment showing residues i and i-1. 
Magnetisation  transfer  pathways  in  (a)  HNCA,  (b)  HN(CO)CA,  (c)  HNCO,  (d) 
HN(CA)CB and (e) HN(COCA)CB experiments. All five experiments shown are of 
the ‘out-and-back’ variety with magnetisation originating and ending on the amide 
proton.  The  direction  of the  magnetisation  transfer  is  indicated  by  arrows.  Spins 
whose chemical shift are not evolved are put in parentheses in the pulse sequence 
name.
110Table  4.1.  Summary  of  the  spin  correlations  observed  in  the  three-dimensional 
triple resonance experiments used for sequential assignment
Experiment name Correlation J coupling3
HNCA ‘HN(i)-l:,N(i)- IJCa(i) Vnh, ^NCa
'HN(i)-l5N(i)-13Ca(i-l) !7 n h , 27 ncci
HN(CO)CA 'HN(i) -,5N(i)-13C„(i-l) '•/NH, ^NCO* ^cOCa
HNCO lHN(i)-15N(i)-13CO(i-1) Vnh>  ]7nco
HN(CA)CB 'HN(i)-,5N(i)-13Cf,(i) 7n H>  7n c< x>  *^CaCP
1  HN(i)-1 5N(i)-1 3Cp(i-1) VnH, 27n Co,   ^CaCp
HN(COCA)CB 
"aI,...  , r;
1  HN(i)- 15N(i)-1 3Cp(i-1) VlM H , ^NCO, '^COCa, VcaCp
7xy and  7xy refer to couplings between atoms (x,y) separated by one and two bonds, respectively
Extent of the backbone resonances assigned
In our case, the assignment of the backbone resonances of monomeric PaDDAH was 
significantly facilitated by the use of a triple isotope-labelled [2H,13C,15N]-R40E-R98H 
PaDDAH  sample.  The  deuteration  of  the  non-exchangeable  amides  dramatically 
reduces the line width of the HN(CA)CB and HN(COCA)CB correlations (Figure 4.5). 
These experiments provided the missing  13Cp correlations that were not observed in a 
data set recorded of [13C,15N]-R40E-R98H PaDDAH, where only 70%  of all  Ca and 
Cp chemical  shifts  were  successfully  assigned.  As  a  result  of  deuteration,  the  net 
improvement  in  the  quality  of  the  data  permitted  the  relatively  straightforward 
resonance  assignment  of  the  backbone  of  PaDDAH,  as  illustrated  in  the  selected 
[1 H,13C]  strips shown in Figure 4.6. The improvement in  sensitivity is largely due to 
the  increase  of  13C  and  !HN  T2  relaxation  times  upon  perdeuteration.  Venters  et al. 
theoretically estimated the effect that the deuteration of the non-exchangeable protons 
exerted on the relaxation times of several nuclei in a 29 kD protein; they showed that 
on  average  a  six-fold  and  a two-fold  increase  in  13Ca T2  and  ]HN  T2  were  expected 
respectively (Venters et al.,  1996). These values have been confirmed experimentally 
for different proteins (Markus et al, 1994, Garrett et al, 1997, Gardner et al, 1998). 
The analysis of the triple resonance experiments recorded of [2H,13C,15N]-R40E-R98H 
PaDDAH allowed identification  and the sequence-specific resonance assignments for 
239 out of the 241 possible backbone 15N and ]HN  resonances (the PaDDAH sequence 
has 254 residues of which  13 are prolines, however the construct has seven additional 
N-terminal residues remaining after cleavage of the hexa histidine-tag, of which five
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Figure  4.5.  (a)  [*H,13C]  strip  plots  of  the  HNCA  (black),  HN(CO)CA  (red), 
HN(CA)CB  (blue)  and  HN(COCA)CB  (green)  spectra  of  [2H,13C,15N]-labelled 
R40E-R98H PaDDAH.  (b)  [lH,nC]  strip plots of the HNCA (black), HN(CO)CA 
(red),  HNCACB  (blue)  and  CBCA(CO)NH  (green)  spectra  of [13C,15N]-labelled 
R40E-R98H PaDDAH.  The strips  show  examples  of ^ ^ ^ N   — >   13C  correlations 
for residues K242  and  1243.  Cross peaks  are labelled  as originating from a or  (3, 
intra-  i  and inter-residue i-1  carbon  atom  correlations.  Note:  the HN(CA)CB  and 
the  HN(COCA)CB  experiments  were  only  acquired  for  the  [2H,13C,15N]-labelled 
protein, in contrast to the HNCACB and the CBCA(CO)NH experiments acquired 
for the [2H,13C,15N]-labelled protein (not discussed in the text).
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Figure 4.6. (a)  Strip plots of the HNCA (black), HN(CO)CA (green), HN(CA)CB 
(red)  and  HN(COCA)CB  (blue)  spectra  showing  examples  of  *HN,15N  — ►   13C 
correlations  from  residues  1127  to  R132.  Cross  peaks  are  labelled  as  originating 
from  a  or  (3,  intra-  i  and  inter-residue  i-1  carbon  atom  correlations.  The  dotted 
orange line depicts the sequential assignment of selected !HN,15N — ►  13Cpj and 13Cp£ _  
!  correlations,  (b)  Lateral  and  (c)  plane  view  of the  3D  structure  of PaDDAH 
module  3.  The  residues  for  which  !HN,  15N  —►   13C  resonances  are  shown  are 
depicted in a ball-and-stick model and follow CPK colouring.
113have  also been  assigned).  Definitive  assignments  have  not  been  obtained for Ser 21 
and His 22. These two residues are located in the large LI loop which covers the active 
site (Murray-Rust et al. 2001).
Figure  4.7  shows  an  assigned  2D  13C-decoupled  !H-15N  HSQC  spectrum  of 
[2H,15N,13C]-labelled R40E-R98H PaDDAH at pH 7.0, recorded at a *H frequency of 
500 MHz. From the assigned amide resonances, 99%, 99%, and 93% of Ca, Cp and CO 
chemical shifts were obtained, respectively. A number of the CO carbon-13 chemical 
shifts were absent in the HNCO experiment. This  lower number is  explained by the 
fact that the shifts from the residues preceding the 13 prolines cannot be obtained from 
the HNCO experiment alone.
All of the backbone resonances for the active site catalytic triad, composed of residues 
Glu  114, His  162 and Cys  249,  have been unambiguously assigned.  Furthermore the 
two cross peaks with HN  chemical shifts at around 4.8 ppm and a third one located at 
around 4 ppm (not shown in Figure 4.7) have also been assigned to residues Asn 209, 
Glu 210 and Glu  171  respectively. From the available crystal  structure of PaDDAH, 
Asn 209 and Glu 210 lie in close proximity of the aromatic ring of Trp 207. A detailed 
inspection reveals that the N-H bonds of both residues are situated close to the local 
symmetry axis of the ring current induced by the electrons in the aromatic ring (Figure 
4.8). This situation increases the local fields of nuclei, shielding them and decreasing 
their  HN   chemical  shift  (Levitt,  2001).  Similarly,  the  HN   chemical  shift  at  4  ppm 
assigned to residue Glu 171 can be explained by the location of the NH bond vector of 
Glu  171  on  the opposite  side  of the  plane  described by Trp  207  aromatic  ring.  The 
nuclei in this position are also exposed to the same shielding effect (Figure 4.8).
The backbone  'H,  13C, and  15N chemical  shifts of R40E-R98H PaDDAH have been 
deposited at BioMagResBank under accession number 6074 (Magalhaes et al, 2004) 
and are shown in Table A.II in Appendix.
Identification of secondary structure elements from 13 C chemical shift data 
It is well established that nuclei which are part of a secondary structure element show 
specific  chemical  shift  changes  in  relation  to  their  standardised  random  coil  values 
(Wishart  and  Sykes,  1994).  Namely,  the  chemical  shifts  of Ca nuclei  experience  an 
upfield  shift when  present in  p-sheets  and extended  structures  and a downfield shift
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Figure 4.7. Assigned 2D 13C-decoupled [H^Nj-HSQC spectrum of [2H,13C,15N]- 
labelled  R40E-R98H  PaDDAH  recorded  on  a  500  MHz  Varian  UNITYplus 
spectrometer at 298 K. Cross-peaks assigned by an asterix (*) are aliased arginine 
and  lysine  side-chain  amide  resonances.  Cross  peaks  highlighted  in  a  red  box 
correspond to residues of the catalytic triad.
115E210 W 207
N209
Figure 4.8. 3D wireframe diagram of residues Glu 171, Trp 207, Asn 209 and Glu 
210  of PaDDAH  (pdb  code:  lh70).  The N-H  bond  vectors  of E171,  N209  and 
E210 lie close to the local symmetry axis described by Trp 207 aromatic ring (blue 
line). Atoms follow CPK colouring.
116when present in  a-helices.  Conversely, Cp nuclei  chemical  shifts display the opposite 
correlation  with  local  secondary  structure  (Spera  and Bax,  1991).  In  this  respect,  in 
order to estimate the chemical  shift deviations  which in  groups  are diagnostic  of the
1 3  1 3 presence  of  secondary  structure  elements,  the  experimental  Ca  and  Cp  chemical 
shifts  obtained  from  the  PaDDAH  assignment  data  should  be  subtracted  from  the 
tabulated residue-specific  random  coil  values  to  yield  ACa  and  ACp.  However,  it  is 
noteworthy that the substitution of a proton for a deuteron in a carbon chain induces an 
isotope effect (Hansen,  1988, Majerski et al,  1985). This effect can be significant for 
nuclei that are separated by as many as three bonds in a perdeuterated protein. These 
considerations translate into additional chemical  shifts changes that have to be taken 
into  account when calculating ACa and ACp.  Therefore the values  of carbon  random 
coil  chemical  shifts  provided  by  Sykes  and  co-workers  (Wishart  and  Sykes,  1994) 
were corrected for 2H-isotope effects following Venters et al. extensive analysis of the 
deviations they have encountered in the carbon chemical  shifts between  a protonated 
and perdeuterated 29 kD protein  (Venters et al.,  1996). The correction values applied 
in our calculations are shown in Table 4.2.
Table 4.2. Correction in ppm applied to the calculated deviations ACa and
ACb
Residue3 ACab ACpb
G -0.39 -
N,D,S,H,F,W,Y,C -0.55 -0.77
K,R,P -0.69 -1.11
Q,E,M -0.69 -0.97
A -0.68 -1.00
I -0.77 -1.28
L -0.62 -1.26
T -0.63 -0.81
V -0.84 -1.20
aA one letter code is used to describe the residue in question. bACo/p= 13c exP_13c rc?  where 
exp  and  rc  stand  for  the  experimental  chemical  shifts  and  the  residue-specific
random coil chemical shifts, respectively.
Since the deviations ACa and ACp are of similar magnitude and opposite signs whether 
in  an  a-helix  or  p-sheet,  the  difference  between  the  two  deviations  (ACa  -ACp)
117enhances  the  correlation  between  the  definition  of  the  secondary  structure  and  the 
chemical  shift  deviations.  Where  the  carbon  shifts  were  available,  ACa  -ACp  values 
were then calculated for each PaDDAH residue and smoothed according to:
( A C a   - A C p ) sm0othed,«  =   (A C a ,/+ i  +   A C a ,/  + A C a ,M   -  A C p ,/+ i  -  A C p ,;  -  A C p ,M ) /3 , Where i is the 
residue number and ( A C a  - A C p ) sm0othed,/ represents an average chemical shift over three 
consecutive  residues  (Salzmann  et  al,  2000).  Figure  4.9  shows  a  plot  of  ( A C «   - 
A C p ) Smoothed  as  a function  of residue number.  Values for which  A C a  - A C p   >1.4 ppm 
identify  likely  helical  regions  and  values  for  which  A C a  - A C p   <  -1.4  ppm  identify 
likely  p-strand  regions.  The  locations  of the  secondary  structure  elements  predicted 
from the  13C   chemical shift data are, in general, well correlated with the a-helical and 
P-strand regions in the crystal structure of WT PaDDAH. All five a-helices that form 
the five-fold PPap structural motifs are well delimited and share characteristic positive 
values of ( A C a  - A C p ) smoothed-  Nonetheless helix a4 which encompasses residues  184 to 
188 remains ill defined by the NMR data. Inspection of the crystal structure however 
provides  a good rationale for the  low chemical  shift  values  obtained,  as this helix  is 
rather  small  composed  of  only  3   residues  (Figure  4.9b).  Another  point  worth 
mentioning pertains to the analysis of the chemical shifts for helix a2. The NMR data 
suggest that helix  a2  is  in  fact  defined by two  consecutive  smaller helices.  The  13C  
chemical  shifts  from  residues  lie  91  and  lie  92  deviate  from  the  ideal  values  of a- 
helical behaviour and are more proximate to random coil values. This disagreement is 
in reality verified in the crystal structure which clearly shows that helix a2 is slightly 
tilted disturbing the hydrogen-bond network (Figure 4.9c). Additionally, the header of 
the pdb entry for the X-ray structure of PaDDAH (pdb code:  lh70) defines helix a2 as 
two  separate  but  consecutive  smaller helices  from  residues  82  to  86  and  87  to  100 
which further supports the notion that helix  a2 exhibits  a slight turn in  line with the 
prediction made from the ( A C a  - A C p ) smoothed values.
Several other regions of the enzyme have been highlighted in Figure 4.9 as exhibiting 
positive  (ACa  - A C p ) smoothed  values.  These  regions  are  two  to  three  residues  long  and 
they  have been  outlined  in  the  crystal  structure  as  3io-helix  turns  and hence  display 
chemical shift deviations higher than 1.4 ppm.
In turn, the residues located in P-strands are also well represented by the chemical shift 
data. They invariably exhibit the most negative values of (A C a  -ACp)sm0othed which are 
indicative  of hydrogen  bonding.  The  only  apparent  discrepancy  is  that  the  data  for 
residues  111-113  and  157-159  predict  a  P-sheet-like  conformation  for these regions,
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Figure 4.9.  Identification  of secondary structure  elements  of the monomeric PaDDAH  from  13C  chemical  shift  analysis,  (a)  (ACa- 
ACp)smoothed  values  are  plotted  as  a  function  of residue  number.  The  dashed  lines  indicate  the  1.4  ppm  threshold  value  for  the 
identification of secondary structure elements. Values higher or lower than 1.4 ppm or -1.4 ppm indicate the presence of a-helical or 13- 
strand regions respectively. The locations of the a-helices and P-sheets in the X-ray structure are indicated as red rectangles and blue 
arrows at the top of the figure. The red dots indicate regions of the PaDDAH structure which correspond to 310-helix turns, (b) Detail 
showing the 3D structure of the small helix a4 (pdb:  lh70) (c) Detail showing the tilt of helix a2. Residues lie 91  and lie 92 are shown 
in ball-and-stick and CPK colouring.although they are not defined as such in the pdb file. However from the inspection of 
the  PaDDAH  3D  structure,  these  regions  adopt  an  extended  conformation.  Nuclei
1 3 present  in  such  extended  conformations  generally  display  the  characteristic  C 
chemical shifts commonly observed for nuclei present in p-sheets.
In  summary,  the  quality  of the  backbone  resonance  assignments  for the  monomeric 
PaDDAH  has  been  confirmed  from  the  good  agreement  reached  between  the 
prediction of the secondary structure elements by the NMR ,3C chemical shift analysis 
and  the  regular  secondary  structure  elements  recognised  in  the  crystal  structure  of 
PaDDAH.
4.4 Discussion
The  initial  aims  of  the  NMR  investigations  sought  to  characterise  the  58  kD 
homodimeric PaDDAH by heteronuclear NMR. The large size of the protein required 
the application of TROSY-based techniques in combination with uniform deuteration 
in  order  to  achieve  higher  spectral  resolution  and  S/N  levels.  However  the  efforts 
towards sequential  assignment were unsuccessful as the triple resonance experiments 
yielded a very low number of H-N-C spin correlations. The size of WT PaDDAH does 
reside in the upper limits for NMR characterisation but, it was reasonable to suppose 
that it should have been tractable with the recently developed TROSY pulse sequences. 
In the initial stage of this project the primary concern had been the lack of a subset of 
expected NH cross  peaks  in  [^H^Nj-TROSY  spectrum  which  was  only  aggravated 
with deuteration of the protein as the amide groups remained deuterated after several 
weeks  following  purification.  This  fact  renders  any  triple  resonance  experiment 
dependent on the magnetisation transfer from  !HN  protons unsuitable.  In this respect, 
much insight into the possible reasons for the lack of NH correlations for the wild-type 
protein has come from the backbone resonance assignments of the monomeric variant 
of PaDDAH.
The assignment of the backbone  *HN,  13C,  15N resonances for the R40E-R98H double 
mutant  of  PaDDAH  proved  straightforward  with  the  triple  resonance  experiments 
acquired from the triple labelled sample. The deuteration of PaDDAH was crucial for 
the  improvement  of  the  magnetisation  transfer  efficiency  in  these  experiments, 
especially in the HN(COCA)CB spectrum. The decrease in line width was substantial 
and  allowed  us  to  assign  99%  of the  !HN,  13C,  15N resonances  as  only two residues
120remained unassigned (Ser 21 and His 22). The smaller overall size of the monomer has 
dramatically  facilitated  the  study  of  the  protein,  as  the  common  drawback  of 
deuterating  the  protein  was  single-handedly  solved  with  no  adjustments  to  the 
purification  protocol.  Furthermore,  the  prediction  of the  locations  of the  secondary 
structure elements from the analysis of the  13C chemical shift data are well correlated 
with the positions of the respective  structural elements in  the crystal  structure of the 
PaDDAH homodimer (Murray-Rust et al, 2001), further supporting the reliability of 
the  data  that  enabled  us  to  obtain  manually  the  unambiguous  assignments  of  the 
backbone resonances for R40E-R98H PaDDAH.
The backbone resonance assignments of the monomeric PaDDAH enabled the attempt 
of a  “conservative”  assignment  of the  resonances  of the  WT  PaDDAH.  In
order to  assess  which  amide  NH  groups  were  likely to  remain  deuterated upon WT 
PaDDAH  expression  in  D20   media,  two  ^H^NJ-TROSY  spectra  of  [1H,15N]-  and 
[2H,15N]-WT  PaDDAH  were  superimposed  and  their  resonances  compared  (Figure 
4.10a). The cross peaks that were absent in the 2D spectra of the perdeuterated protein 
were  tentatively  identified  by  reference  to  the  assignments  of the  monomer  (Figure 
4.10b). Only residues that were confidently identified with this procedure were plotted 
on the crystal structure of the homodimer (Figure 4.10c). Interestingly, the regions of 
the protein that remained protected from solvent exchange are confined to the  set of 
three (3-strands of modules 2 through 5 and to several residues in helix-a3 of module 3. 
All of these protected residues are located in regular secondary structure elements, in 
particular in the  P-sheets  which are more likely to be involved in the formation of a 
stable  hydrogen  bond  network  and  hence  lead  to  slow  reprotonation  of  the  amide 
positions. Intriguingly, the amide groups responsible for the hydrogen bonds in the P- 
sheet of module  1  were not identified as being protected from solvent. This finding is 
counterintuitive  considering  that  the  P-strands  1A,  IB  and  1C  form  the  interfacial 
contact of the  homodimer and the extended antiparallel  p-sheet  across  protomers.  A 
potential explanation comes from the mapping of the missing resonances in  [!H,15N]- 
TROSY  spectra of the  protonated WT PaDDAH.  In  this  case,  the  I^H^Nj-TROSY 
spectra  of  15N-Iabelled  WT  and  R40E-R98H-PaDDAH  were  superimposed  (Figure 
4.11).  In  a  similar  manner,  residues  for  which  resonances  were  present  in  the  2D 
spectrum of the monomeric enzyme but absent in the wild-type spectrum were plotted 
on the crystal  structure (Figure 4.11c). By this  assessment 34  *HN,  15N missing cross 
peaks  were  confidently  identified  as  missing.  The  absent  correlations  for  the  WT
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Figure 4.10. (a) Superimposed  J^H^NJ-TROSY spectra of [1 H,15N]- 
WT PaDDAH (black) and [2N,15N]-WT PaDDAH (blue).(b) Inset of 
(a) showing the !HN,15N resonances that are present in the protonated 
WT  protein  but  are  absent  in  the  perdeuterated  sample,  (c)  3D 
structure of PaDDAH showing in blue, residues for which resonances 
were absent in the [^^N]-TROSY spectra of the perdeuterated WT 
protein after four days following purification (pdb code:  lh70)
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Figure  4.11.  (a)  Superimposed  [^^NJ-TROSY  spectra  of [!H,15N]-WT 
PaDDAH  (black)  and  R40E-R98H  PaDDAH  (red)  recorded  at  ]H 
frequency  of  600  MHz.  (b)  Inset  of  (a)  showing  the  reported  residue 
assignments of the monomeric PaDDAH for !HN,15N resonances present in 
the monomeric spectra but absent in the recorded homodimeric 2D spectra, 
(c) 3D structure of PaDDAH homodimer showing in red residues for which 
resonances are absent in the 2D spectra of the protonated WT protein  (pdb 
code:  lh70).  The  catalytic  triad  residues  are  shown  in  a  ball-and-stick 
model.
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L 1  loopprotein correspond to residues which are located in module  1  and part of the extended 
P-sheet across subunits. More importantly, in addition to the interface region, none of 
the cross peaks for residues of the active site catalytic triad or the residues in the LI 
loop  are  present  in  the  spectra  of the  protonated  homodimer.  This  examination  has 
confirmed our initial surmise that chemical and conformational exchange occurs at the 
interface  in  the  intermediate  exchange  rate  regime.  Coupled  to  this  behaviour,  it 
appears as though the monomer-dimer equilibrium of the wild-type protein could be at 
the  origin  of a concerted motion  that influences  the  exchange broadening for amide 
groups  located  in  the  surrounding  loops  including  the  region  where  the  active  site 
residues lie (Figure 4.11c).
Due  to  the  dynamics  implicit  for  a  monomer-dimer  equilibrium,  residues  in  an 
interface  between  protein  subunits  are  more  prone  to  experience  different  chemical 
environments between the monomeric and dimeric states, which is often detrimental to 
the  measurement of NMR parameters  (Tong  et al.,  2005).  In  cases  where  a nucleus 
exchanges  between  two different chemical  environments,  the  difference between  the 
two resonance frequencies, An, is dependent on the exchange rate ktx between the sites 
and the signal intensity will depend on the relative populations of spins occupying each 
environment. If kex «  An the exchange is slow on the chemical shift time scale and the 
spectrum will show signals at two distinct resonance frequencies. When kex»  An, the 
exchange  is  considered  fast,  a  single  signal  is  detected  at  the  population  weighted 
average chemical shift of the two sites. However, when kex ~ An the exchange occurs 
in the intermediate exchange regime, the signal broadens, and in the present case the 
resonance broadening results in a complete loss of the signal (Canavagh et al, 1995). 
Intermediate rate chemical exchange processes have been known to cause broadening 
of  resonances  arising  from  residues  located  at  the  interface  region  in  other 
multicomponent  molecular  systems,  indicative  of  alternative  protomer  packing 
arrangements. For example, such processes have recently been identified to give rise to 
significant  15N,]H  cross  peak  broadening  (or  absences)  in  the  spectra  of  the  (X 2P2 
tetramer of human adult hemoglobin (Lukin et al.  2003) and of the homopentamer B 
subunit  (VTB)  of the  E.  coli  0157  toxin  (Yung  et  al.  2003).  A  recent  example  of 
conformational exchange occurring within protein-protein interacting interfaces comes 
from  the  study  of a  calmodulin  (CaM)  dimer in  complex  with  the  basic-helix-loop- 
helix transcription factor SEF2-1/E2-2 (Larsson et al., 2005). Residues with significant 
exchange broadening contributions are located not only within the dimer interface of
124the  calmodulin  subunits  but  also  within  the  binding  interface  of  the  CaM:SEF2-l 
complex.  However  in  all  the  systems  cited  above  the  exchange  rates  between  the 
alternative states could be quantified.
Our  results  for the  WT  PaDDAH  only  reconcile  instances  where  the  extent  of the 
exchange broadening is so extreme that it hampers further NMR studies. In this sense, 
the  monomerisation  of  the  enzyme  has  been  central  to  effectively  abolish  the 
deleterious  consequences  of  conformational  exchange  at  the  interface  region  and 
surrounding  loops.  The  additional  “recovered”  cross  peaks  in  the  (^H^NJ-HSQC 
spectra of the double mutant  allowed for the  successful  assignment of the backbone 
resonances  of  the  monomeric  PaDDAH  and  helped  us  to  better  understand  the 
limitations  of the NMR data for the WT protein.  Altogether,  the monomerisation  of 
PaDDAH  has  provided  a  protein  variant  that  is  an  excellent  platform  for  further 
studies of the properties of the enzyme.
The following chapter will focus on the characterisation of the dynamics of the  apo- 
form  of  the  monomeric  PaDDAH  enzyme.  15N  relaxation  studies  of  R40E-R98H 
PaDDAH have been performed at three different magnetic field strengths and the data 
have been analysed with the model-free formalism to enable the quantification of the 
internal  motion  parameters.  Recently,  much  insight  into  enzyme  function  has  come 
from the linkage between the motions of the protein backbone in the microsecond to 
millisecond  timescales.  In  this  vein,  the  implementation  of  novel  15N  relaxation 
dispersion experiments has also been attempted to better assess the internal motion of 
PaDDAH.
125Chapter 5
1SN relaxation studies of the monomeric PaDDAH
Abstract
The study of protein internal dynamics over the years has established an intimate association 
between protein motion and biological function. Central to this effort has been the application 
of NMR methodology as a powerful technique to characterise motional processes  at atomic 
resolution. In particular, the measurement of nuclear spin relaxation rates provides information 
on protein movement over a wide range of timescales. As part of the efforts to investigate the 
intrinsic dynamic properties of the monomeric  fVzDDAH and the possible functional role of 
these motions in enzyme catalysis, the quantification of the internal motions of the apo- state 
of PaDDAH were sought through established 1 5 N NMR relaxation experiments. A vast array 
of protocols have been developed for the analysis of these parameters and the data have been 
interpreted  through  the  “model-free”  formalism  of  Lipari  and  Szabo  (Lipari  and  Szabo, 
1982a,b) and through reduced spectral density mapping (Farrow et al.,  1995). A general view 
that arises from the interpretation of these results is the overall stability of the (3/a propeller 
fold as evidenced by the relatively high average value of the generalised S2 order parameter of 
the  NH  bond  vector  (-0.87).  However,  local  motions  in  the  fast  pico-  to  nano-second 
timescales  have  been  observed  in  the  LI,  L3,  L6  and  L7  loops.  All  these  loops  form the 
entrance  of the  active  site  cavity.  With  regards  to  motions  in  the  micro-  to  milli-second 
timescale,  they  are  mainly  located  in  the  active  site  region  and  surrounding  residues  that 
contact  the  ligand  as  observed  in  the  PaDDAH  crystal  structure  in  complex.  Independent 
confirmation  of the  results  obtained  from  model-free  analysis  was  sought  through  a  linear 
regression protocol and reduced spectral density mapping. Finally, an analysis of the biological 
significance of these motions is presented in terms of a comparative study with other enzymes.
1265.1 Coupling NMR spin relaxation and protein dynamics
NMR spin relaxation
The study of protein dynamics by NMR is inherently linked to the relaxation of spin 
systems. In simple terms, spin relaxation is the process through which a given excited 
state of spin magnetisation returns to the equilibrium position through the interaction 
with  the  thermal  molecular  environment.  The  analysis  of  the  rates  at  which  spin 
relaxation occurs can effectively report on the internal dynamics of proteins occurring 
at  a  wide  range  of timescales.  Since  the  majority  of experiments  used to  probe  the 
dynamics of a protein backbone benefit from the relaxation rates of the  15N spin, the 
treatment of nuclear relaxation theory presented here  will  only be  focused upon  the 
headline concepts of the relaxation properties of this nucleus.
When considering an excited two-spin system (1 H-1SN) in the presence of an applied 
B0 field, several relaxation mechanisms exist to bring the system back to equilibrium 
with its surroundings. Generally, these mechanisms include the longitudinal relaxation 
defined by the rate constant R\, the transverse relaxation defined by the rate constant 
R2 and the steady state {^ J-^ N  heteronuclear Overhauser effect (NOE).
The longitudinal relaxation is the mechanism through which H or N spin magnetisation 
realign along the direction of the Bo field, by convention, the z-axis of the system. In 
this sense, 15N R\ measures the rate at which the excited T V  magnetisation is returned to 
the equilibrium position, re-establishing net Nz magnetisation. This process is dictated 
by the Boltzman distribution, which states that at equilibrium, the lowest energy level 
will have the highest probability of being occupied. In this case, the energy state with 
the  lowest  energy  is  the  one  in  which  the  magnetic  moments  of the  15N  nuclei  are 
aligned along the z-axis accounting for the net Nz magnetisation (for more details, see 
Keeler,  2005).  In  turn,  transverse  relaxation  describes  the  process  in  which  the 
magnetisation  H or N present  in  the  x-y  transverse  plane  decays  to  the  equilibrium 
position, ultimately driving Hz or Nz to zero. Hence, the 15N transverse relaxation rate 
R2 measures the time dependent loss of N^y magnetisation in the transverse plane. The 
third  relaxation  parameter  commonly  measured,  the  steady  state  {!H}-15N  NOE,  is 
dependent  upon  an  additional  mechanism of relaxation  termed cross-relaxation.  This 
mechanism  gives  rise  to  z-magnetisation  transfer  from  one  spin  to  the  other  at  a 
specific transfer rate defined as onh- Notably, the z-magnetisation of the  15N spin will 
be  affected  by  the  z-magnetisation  of  the  spin.  This  transfer  results  in  what  is
127classically referred to as an enhancement of the signal recorded from the heteronuclei. 
However in the actual case of the  15N nucleus, the magnetisation transfer results in a 
suppression of the NMR signal which is ultimately the NOE value that is quantified.
Having  defined the three relaxation  parameters  that  are  commonly measured for the 
15N nucleus, it is important to understand what causes the spins to relax. In this sense, 
the major source of spin relaxation arises from the presence of random localised fields 
in  the  surroundings  that can  act  as  pulses,  affecting  the  spins  of the  sample  locally, 
eventually bringing the magnetisation to equilibrium. These local fields are commonly 
generated from the dipolar interaction between the magnetic moments of two different 
nuclear  spins.  The  strength  of this  interaction  is  dependent  upon  the  gyromagnetic 
ratios y of the spin generating the local field and the spin experiencing it. The larger y 
is, the larger the interaction will be between the spins. In addition, the strength is also 
dependent upon the distance r between the spins (the interaction decays as a function 
of 1/r3) and upon the orientation of the vector between the dipoles with respect to the 
applied magnetic field. Alternatively, a second source of random localised fields is the 
chemical  shift  anisotropy  (CSA).  In  this  case,  the  electrons  in  motion  around  the 
nucleus are responsible for generating the local fields. For most molecules, the size of 
these electron-induced local  fields is dependent upon the  orientation of the molecule 
relative  to  the  applied  external  field,  which  gives  this  interaction  its  anisotropic 
character. The resulting field felt at the nucleus is then the sum of the applied external 
field and of the electron-induced local fields. This is at the origin of the chemical shift 
seen in NMR spectra.
In  order  for  the  dipolar  interaction  and  the  CSA  to  induce  relaxation,  the  local 
magnetic  fields  generated  by  the  surrounding  nuclear  dipoles  and  the  circulating 
electrons must oscillate at the appropriate frequency.  In the simple case of a one spin 
system  this  frequency  is  termed  the  Larmor  frequency  coo,  specific  for  the  nucleus 
under  consideration.  In  this  context,  the  types  of  molecular  motion  responsible  for 
generating  the  right  range  of  frequencies  to  induce  relaxation  are  the  rotational 
diffusion  of the molecule,  characterised by the rotational  correlation time xc,  and the 
internal  motions  within  the  molecule  due  to  the  local  fluctuations  of the  NH  bond 
vector (Keeler, 2005). It is important to note that when studying a two-spin system, in 
this  case  the  !H-15N  moiety,  the  dipolar interaction  induces  transitions  between  four
128distinct spin energy levels that exist under the influence of the static magnetic field B0. 
These transitions are all possible pathways for relaxation between specific spin energy 
states and occur at frequencies different than the ones defined for an isolated spin. In 
fact, the existence of different energy states implies that the longitudinal, the transverse 
and the cross-relaxation rates of the  15N nuclei  will depend not only upon transitions 
occurring at the Larmor frequency of both nuclei  con and cdn but will also depend on 
the motions present at frequencies such as the sum (euH  + «n) and the difference (&>h - 
& > N) of the Larmor frequencies. In the particular case of the transverse relaxation rate, it 
will  also be dependent upon molecular motions present at zero frequency.  However, 
the origin of these is beyond the scope of this thesis.
15N Ri  and R2  and  {!H}-I5N NOE parameters  are functions  of the  spectral  density 
function
In  order  to  define  the  equations  describing  the  15N  R\  and  R2  and  NOE
parameters,  it  is  necessary  to  introduce  the  concept  of the  spectral  density  function 
J(co).  Simplistically, this function effectively reports on the amount of magnetic field 
fluctuations present in the sample as a function of the frequency co.  Since R\, R2 and 
NOE relaxation parameters are sensitive to these field fluctuations, they can 
be cast as  functions  of J(co)  at the  five  different frequencies  described above.  These 
equations account for relaxation processes driven by the dipole-dipole interaction and 
the CSA of the 15N nucleus.
= (d2  / 4)[j(coH  -coN) + 3J(a)^) + 6J(coH  +ft;N)] + c27(^yN)  Equation  5.1
R2   = (d2  /8)[4/(0) + j{coH  -  <yN) + 3J(con) + 6J{con) + 6J(con +&>N)] +
(c2 / 6)[3J (a> N) + 4 / (0)]
NOE = 1  + (^h + ytt)d 2[6j{coH  +0)s )-j(o )H  -  c»N  )\l] 
where Ti=l//?j.
where d and c are constants defined as:
d = (j UoYhVn^1  !% n2)(rNH~3^  Equation 5.4
c = A cT (C yN  / a/3  Equation 5.5
Equation 5.2 
Equation 5.3
129where ju0 is the permeability constant (4n xlO"7 H m'1), h is the Planck’s constant, yH  
and tn  are  the  gyromagnetic ratios of the hydrogen  and nitrogen  atoms  respectively, 
rN H   is  the  length  of  the  N-H  intemuclear  vector,  Ao  is  the  CSA  of  the  15N  spin, 
assumed to be axially symmetric, and & )H  and cuN  are the Larmor frequencies of the !H 
and 15N nuclei respectively.
However, the values of the spectral density function at the five frequencies described 
can  not be  obtained  from the  measurement  of only  three  relaxation  parameters.  An 
assumption of the form of this function is necessary. The most common approach has 
been to assume that the dynamics of the amide bond vector derive from the product of 
two exponentially decaying correlation functions, one describing the overall isotropic 
tumbling  of  the  molecule  characterised  by  the  correlation  time  rc,  and  the  second 
describing  the  internal  motion  of  the  bond  vector  characterised  by  the  effective 
correlation time re and by a generalized order parameter S2 that reports on the spatial 
restriction of each intemuclear vector (Equation 5.6),
S 2t c  (1 -S 2)t 
(1 + c o 2 t )  (1 + co2r 2)
J i0*) -       f r r  + ~ E q u atio n   5 . 6
where x = xc xe /(xc + xe). This approach has been termed the “model-free” formalism of 
Lipari and Szabo (Lipari and Szabo,  1982a,b). With this treatment, there is no specific 
assumption on the nature of the internal motion of the NH bond vector, as was the case 
for  other  methods.  This  approach  was  later  extended  by  Clore  and  co-workers  to 
account  for cases  in  which  a  third  time  constant xs  for slower motions  is  needed  to 
describe the data (Clore et al, 1990).
An alternative approach to the analysis of NMR relaxation data of a protein has come 
from  the need to  abolish  effectively  the  premise  of the  form  of the  spectral  density 
function.  Peng  and  Wagner  first  proposed  the  spectral  density  mapping  procedure 
(Peng  and  Wagner,  1992).  Motional  information  can  be  directly  extracted  from  the 
relaxation parameters by exploiting the fact that these parameters can be expressed as a 
weighted sums of J(co) at various different frequencies. Rather than trying to estimate 
the  entire  functional  form  of  J{co),  motional  information  could  be  sampled  by
130calculating  J(a>)  at  0,  toN,  coh,  coh  ±  frequencies  which  are  ultimately  the 
frequencies  that  contribute  to  the  relaxation  process.  In  this  vein,  the  authors  have 
extracted  additional  relaxation  parameters  such  as  the  longitudinal  two-spin  order 
relaxation rate Run(HzN7 ), the anti-phase transverse relaxation rate /?NH(#zAfx,y) and the 
amide  proton  longitudinal  relaxation  rate  Rh(Hz)  in  order  to  allow  for  the  exact 
determination of the values of J(co) at all five frequencies. However, there are several 
limitations  to  this  approach,  particularly  with  the  assumption  of  the  form  of  the 
relaxation  decay  rate  of the  additional  parameters  measured.  In  fact  an  exponential 
decay  fails  to  describe  correctly  the  relaxation  of  the  HZ NZ ,  Hz Nxy  and  Hz  
magnetisations.  Moreover,  the  method  relies  on  the  differences  between  relaxation 
rates  of  similar  magnitude  which  renders  the  analysis  more  prone  to  experimental 
errors.
To  circumvent this  apparent limitation,  Farrow  et al.  (1995)  proposed  some  general 
assumptions  which  led  to  the  simplification  of the  functional  form  of J(co).  In  this 
respect,  the  high  frequency  spectral  density  terms  are  of  approximately  equal 
magnitude  i.e.  J(cau ±  &>n)  ~  With this  approximation the spectral  density can
now be sampled at three different frequencies which effectively report on motions at 
the pico- to nanosecond timescale and the slower motions at the micro- to millisecond 
timescale. This simpler treatment is termed the reduced spectral density mapping.
Overview of motional timescales characterised by NMR
The  two  protocols  proposed  above  for the  analysis  of the  15N relaxation  parameters 
have proven successful in the first order analysis of protein molecular dynamics. The 
earliest  study  able  to  show  the potential  of  15N dynamics  focused on  staphylococcal 
nuclease  (Kay  et  al.,  1989).  The  results  clearly  showed  the  propensity  of  loops  to 
demonstrate enhanced mobility in comparison with that of regular secondary structure 
elements which remained rather rigid, a view that improved our perception of available 
X-ray  structures.  Since  then,  many  experimental  advances  have  increased  the 
reliability of the pulse sequences employed in the characterisation of protein dynamics. 
The  fast motions  in the  picosecond to  nanosecond timescale  are commonly detected 
through the measurement of the 15N R\  and R2 relaxation rates and through the steady 
state  {1 H}-15N NOE parameter (Figure 5.1). These motions are generally sampled by 
flexible loops in  proteins, by the rotation of side chains in residues or by the overall 
tumbling of the molecule. The slower motions in the milli- to microsecond timescale
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Figure  5.1.  Approximate  time ranges  of biological  protein  motions  (top)  and  the 
NMR parameters which can report on them (bottom, see text).
132A-180°-A-acquire).  The  first 90°  RF pulse  generates  transverse  magnetisation  which 
decays during the period A. The  180° RF reverses the sense of the precession  of the 
spins  and  refocuses  the  evolution  due  to  the  chemical  shift  offsets  and  B0  field 
inhomogeneity.
The NMR pulse sequences used for the measurement of the  15N Ri  and R2 relaxation 
rates of PaDDAH are shown in Figure 5.2. Generally,  15N relaxation experiments are 
separated into five components, the preparation, the relaxation, the frequency labelling, 
the mixing and the acquisition periods, which will be briefly described here (Palmer et 
al.,  1996). The preparation period consists in a magnetisation transfer step from proton 
to nitrogen,  termed the insensitive nuclei  enhanced by polarisation transfer (INEPT) 
step (Keeler, 2005). The INEPT experiment was conceived as a means to increase the 
sensitivity of the  signals  observed from a nucleus  with  low  gyromagnetic ratio y,  in 
this case  15N, by transferring to it magnetisation from a spin with high gyromagnetic 
ratio, in this case  !H. The size of the equilibrium magnetisation is then referred to as 
kuHz for spin H and k^Nz for spin N, where kn and kN are parameters proportional to yn 
and yN  respectively.  In  order to  simplify the  analysis,  the  modulation  of the product 
operators  during  the  INEPT  experiment  will  only  be  described  for  the  equilibrium 
magnetisation  of  spin  H.  As  for  the  equilibrium  magnetisation  of the  Nz  spin,  it  is 
effectively abolished at the beginning of the pulse sequence with the very first 90° RF 
pulse applied on the N spin followed by the application of a purging z-gradient.
The  first  90°  RF  pulse  applied  on  the  spin  H  generates  -kHHy  magnetisation.  The 
magnetisation  then  undergoes  evolution  by  chemical  shift  offset  ( Q h )  and  scalar 
coupling during the period x. The simultaneous spin echo  180°(x) pulses on H and N 
spins refocus the offsets  and allow the coupling to evolve for a total period of 2x to 
generate the antiphase term -kH2HxNz. The following two RF 90° pulses along the y- 
axis on H and along the x-axis on N transfer the anti-phase state created on H to the 
spin N, generating the term -kH2HzNy. At this stage, the pulse sequence presented here 
diverges from the general scheme described in Palmer et al. (1996). The second part of 
the R\  and R2 relaxation experiments generally consists in the relaxation component, 
however  in  these  experiments  the  frequency  labelling  period  has  been  incorporated 
prior to the relaxation delay. During the frequency-labelling period, the chemical shifts 
due to the N spin  are recorded during the ti  delay increments to generate the indirect 
dimension  of  the  two  dimensional  (2D)  spectra.  By  mapping  the  chemical  shift 
evolution  of the  15N  spin  before  relaxation,  any possible  frequency  due  to chemical
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Figure  5.2.  Pulse  sequences  used  for  the  estimation  of  15N  (a)  Rx,  (b)  R2  spin 
relaxation  parameters  of  R40E-R98H  /VzDDAH  incorporating  WATERGATE 
(Piotto  et  al.,  1992)  solvent  suppression  (enclosed  in  the  dashed  box).  The 
experiments are commonly separated into five periods indicated in top of the figure. 
In all sequences narrow and wide pulses indicate 90° and 180° pulses, respectively. 
All pulses are applied along the x-axis unless indicated otherwise. Z-gradient pulses 
are grey. Black gradient pulses are the encoding and decoding gradients for solvent 
suppression. The phase cycling used in the Rx   experiment was Oj = x,-x; d>2 = y?-y> 
in  the  R2  experiment  Oj  =  y,-y  < t> 2  =  x> "x-  The  receiver  phase  cycling  for  both 
experiments was  x,-x,-x,x.
135exchange is also being mapped. Hence, the relaxation rates for both slow exchanging 
peaks can be estimated independently in the subsequent steps. Evidently this feature is 
only useful in cases where definite chemical exchange occurs for a particular 15N spin, 
however it has been left in R\ and R2 relaxation pulse sequences used at the NEMR.
The  INEPT transfer sequence continues  with  the  application  of two  other sequential 
RF  180°(x) pulses on both nuclei. The offsets are refocused but the coupling evolves 
for an extra period of 2t, at which stage the anti-phase term -kn2HzNy is converted to 
kH Nx.  This  additional  [-x-180°H,N-x-]  element creates  in-phase  15N  magnetisation  in 
the transverse plane. This sequence has been referred to as refocused-INEPT in which 
the in-phase signal from the N spin is proportional to kH and not  so that it is only 
derived from transferred magnetisation.
In  Ri  relaxation  experiments  (Figure  5.2a),  an  additional  90°  RF pulse  is  applied to 
spin N along the y-axis which transfers the in-phase transverse coherence knNx to the 
z-axis. In R2 experiments this pulse is not necessary since the magnetisation is already 
in the transverse plane prior to the relaxation period.
The third part of the experiments consists of the relaxation period T.  The delay T is 
increased  by  repetition  in  a  time  series  of  two  dimensional  (2D)  NMR  spectra  to 
generate the signal decay curve. During this period, the two  180° pulses applied to the 
H spin effectively abolish cross correlation effects between  !H-15N dipole-dipole and 
CSA  relaxation  mechanisms  by  interchanging  the  *H  spin  state  which  averages  the 
relaxation  rates  of  each  of  the  multiplet  components  suppressing  the  interference 
between relaxation mechanisms (Kay et al.,  1992b). In the case of the R2 experiment, 
the proton  180° pulses  are applied at an even echo midway though the Carr-Purcell- 
Meiboom-Gill  (CPMG) pulse train  [5-180°-8]3  (Figure  5.2b).  The CPMG pulse train 
applied  to  the  nitrogen  spin  is  designed  to  refocus  the  resonance  offset,  field 
inhomogeneity,  chemical  exchange  and  scalar  relaxation  (Palmer  et  al.,  1992).  In 
addition,  in-phase  magnetisation  of  the  15N  nuclei,  Ny,  left  in  the  transverse  plane 
during the relaxation delay is prone to evolve as a result of scalar coupling to generate 
the anti-phase term -2HZ NX .  The presence of proton anti-phase magnetisation can lead 
to  additional  proton-proton  dipolar  couplings  which  are  another  contributor  to 
relaxation. It is important then to minimise the evolution of the NH scalar coupling by 
setting the delay period 5 in the CMPG pulse train shorter than the inverse of the  !H- 
15N coupling constant 7NH.
136During the mixing period, the  appropriate  15N coherence is transferred to the H spin 
into  observable  signals  through  a  reverse  INEPT  sequence.  Water  suppression  is 
achieved  with  the  WATERGATE  sequence  (Piotto  et  al.,  1992).  Finally,  in  the 
acquisition period the proton transverse magnetisation is recorded to form the directly 
acquired dimension of the 2D spectrum.
A final consideration regards the application of pulsed field gradients within the pulse 
sequences.  These  gradients  are  designed  to  suppress  the  imperfections  arising  from 
pulses  when  inserted  on  opposite  sides  of  simultaneous  180°  pulses.  They
ensure that only transverse magnetisation present before  and  after the  application  of 
the pulse pair is refocused.  Similarly, they act as a z-filter when the magnetisation is 
along  z  in  order  to  aid  in  the  suppression  of  the  water  resonance.  The  final  two 
gradients  in  the pulse  sequence  are  the  encoding  and decoding  gradients  part of the 
WATERGATE pulse scheme to also enable water suppression.
The NMR pulse sequence used for the measurement of the steady-state heteronuclear 
15N NOE values of R40E-R98H PaDDAH is shown in Figure 5.3. The purpose of this 
experiment  is  to  observe  the  maximum  “enhancement”  of magnetisation  of the  15N 
nucleus as the  *H spin is saturated. This parameter is measured with two separate 2D 
heteronuclear correlation experiments. One experiment includes a presaturation period 
consisting of a train of  180°  pulses applied the  spins,  the other experiment omits 
this period.  The intensity of the  15N magnetisation  can then  be compared in the two 
spectra to determine the relative enhancement due to *H saturation. The initial INEPT 
sequence  used  in  the  Pi  and  R2  experiments  is  also  omitted  in  NOE  experiments; 
consequently 15N magnetisation excited by the first 15N 90° pulse is directly transferred 
to the proton for detection through a reverse refocused INEPT pulse scheme. Since the 
magnetisation  acquired  derives  solely  from  the  magnetisation  of  the  15N  spin, 
heteronuclear  NOE  experiments  are  generally  less  sensitive  then  15N  relaxation 
experiments.
Extracting 15N R] and R2 relaxation rates and f1  H}-15N heteronuclear NOE values 
15N R]  and R2 rates  were estimated for the  monomeric PaDDAH at  26°C  and at 
NMR frequencies  of 500,  600  and  800 MHz.  The  signal  intensities  of well  resolved 
cross  peaks  were  extracted  from  each  NH  correlation  spectrum  at  a  particular 
relaxation  delay  following  the  protocol  described  in  Chapter  2,  Section  2.4.  The 
analysis included 197 amide cross peaks obtained at 500 and 600 MHz and 224 amide
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Figure 5.3. Pulse sequence used for the estimation of  heteronuclear NOE
spin  relaxation  parameter  of R40E-R98H  PaDDAH  incorporating  WATERGATE 
(Piotto et al.,  1992) solvent suppression (enclosed in the dashed box). Narrow and 
wide pulses indicate 90° and 180° pulses, respectively. All pulses are applied along 
the  x-axis  unless  indicated  otherwise.  Z-gradient  pulses  are  grey.  Black  gradient 
pulses are the encoding and decoding gradients for solvent suppression.  The phase 
cycling used in the NOE experiment was 0! = 2(x), 2(y), 2(-x), 2(-y); 0 2 = x,-x; 0 3  
= 2(y), 2(-x), 2(-y), 2(x); 0 4 = 2(-x), 2(-y), 2(x), 2(y). The receiver phase cycling for 
both experiments was  x,-x,y,-y,-x,x,-y,y.
138cross peaks at 800 MHz (out of 241  possible). In both  ,5N R\  and R2 experiments, the 
signal intensity of the 2D cross peaks is a function of the duration of the delay period, t 
(Equation 5.7).
r- t
I (t) = /0 exp Equation 5.7
where I{t) is the measured signal intensity at time t, /o is the initial signal intensity at 
t=0, t is the delay period and Ti is the relaxation time where i  =  1  or 2 and R\ =  1/Tj. 
The measured signal  intensities  were then  fitted to Equation  5.7  (two parameter fit) 
and  the  relaxation  rates  R\  were  calculated  using  Mathematical  software. 
Representative  fits  of  the  data  to  extract  R\  and  R2  rate  constants  obtained  at  *H 
frequency of 600 MHz  are  shown  in  Figure  5.4  for several  residues.  The  intensities 
have been plotted as  a function  of relaxation  delay  and the repeated time  points  are 
also shown. The percentages of error estimated from the exponential fit to the original 
data for 15N R2 rate constants after Monte Carlo simulations were 4.2, 3.4 and 2.7% at 
500, 600 and 800 MHz respectively. The estimated errors for the  15N R\  experiments 
were slightly lower at 2.7, 2.9 and 1.4% for 500, 600 and 800 data sets respectively. 
Similarly, the steady-state NOE values for R40E-R98H PaDDAH have been estimated 
following  the  protocol  described  in  Chapter  2,  Section  2.4.  Since  the  error  was 
estimated  from  the  spectral  noise,  the  data  collected  at  800  MHz  has  the  lowest 
uncertainty  at  2.8%  whereas  500  and  600  MHz  NOE  values  have  an  average 
percentage of error around 6.4%. The values for all three relaxation parameters 15N R\, 
R2 and heteronuclear NOE are shown  at three different magnetic field strengths  as  a 
function  of residue  number in  Figure  5.5  and the  values  are  shown  in  Tables  A.III, 
A.IV and A.V in Appendix. Initial inspection of the data shows a similar pattern of Ri 
rates at the three magnetic fields, the same trend is verified for the R2 and NOE values 
(Figure 5.5). As expected the 15N R\ rates are highest at 500 MHz, the average values 
of tf,500, R,“ ° and R,m  being  1.24 ± (0.08) s'1, 0.98 (± 0.09) s'1   and 0.67 (±0.07) s'1, 
respectively.  In  terms  of  N  transverse  relaxation  rates,  theory  predicts  that  the 
contribution from dipole-dipole relaxation to R2 is expected to be identical at all fields. 
However,  the  contribution  of  chemical  shift  anisotropy  (CSA)  to  the  R2  rate  is 
proportional to (con)2-  Consequently, R2m  values should be higher than R2600 and R2500, 
a result which was verified experimentally with the average values of R2500, R2600, R2S0° 
being 15.18 (±1.47) s'1,  16.98 (±1.67) s'1  and 20.22 (±1.64) s’1, respectively. Similarly, 
the  analysis  of  Equation  5.3  predicts  that  the  {]H}-15N  NOE
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Figure 5.5. (a) Longitudinal  l5N relaxation rates R{, (b) transverse  l5N relaxation rates R2 and (c)  {'H}-l5N heteronuclear NOE values of 
R40E-R98H PaDDAH extracted at three different magnetic field strengths (blue triangle at ’H nominal frequency of 500 MHz, red circles at 
600 MHz and green squares at 800 MHz) plotted as a function of residue number. Secondary structural elements are indicated at the top of 
the Figure.The standard deviations of the heteronuclear NOE values are omitted for clarity.enhancements increase with increasing magnetic field strengths. This prediction is also 
confirmed  as  shown  by  the  average  values  of NOE500,  NOE600  and  NOE800  of 0.75 
(±0.09), 0.79 (±0.09), 0.84 (±0.07), respectively.
Taken as a whole the values of R\ and Rj rate constants are remarkably consistent over 
most of the protein chain, which is in line with the expectation that the protein has a 
stable globular fold. There is mainly one region of the protein for which either R\ or R2 
values are significantly different from the mean values over the whole protein (Figure 
5.5).  R\  values  are  higher for residues  17  through  24  and R2 values  decrease  in  the 
same region. These residues are located in a loop region of PaDDAH believed to close 
down  on  the  active  site  upon  ligand  binding.  The  steady-state  NOE  values  also 
decrease around the same loop region. In addition, residues Glu  158, Lys  159 and Val 
160 also have significantly lower NOE values than the average  ^H J-^N  NOE value 
obtained. These residues are also located on a loop region (L6).
Estimation of the isotropic rotational correlation time
As  discussed  in  Section  5.1,  the  relationship  between  the  measurable  15N relaxation 
parameters in  a two spin system and the reorientational motion of the NH vector in a 
protein  is  commonly  interpreted  in  terms  of  the  Lipari  and  Szabo  “model-free” 
formalism. The application of this model to the analysis of 15N relaxation data assumes 
that the molecule tumbles isotropically in solution and defines the parameters S2 as the 
degree of spatial restriction of the NH vector and xe as the effective internal correlation 
time  (Equation  5.6).  The  latter  is  necessary  to  account  for  the  possible  differing 
motional  timescales  of  backbone  amide  groups  in  a  protein  relative  to  the  overall 
isotropic rotational correlation time xc of the molecule itself. Moreover, the analysis of 
Equation 5.6 reveals that under certain circumstances, when xe is  small  (i.e <100 ps) 
and xc >  1 ns (i.e when both internal motion and chemical exchange are not dominant 
contributions to the relaxation rates), S2 becomes independent of the R2/R 1 ratio which 
in turn becomes a function of xc. With these conditions met, it is possible to estimate 
the  isotropic  rotational  correlation  of a molecule through  the  analysis of the average 
R2/R 1 ratio, (R2/R 1).
As described by Kay and co-workers (Kay et al,  1989), it is necessary to remove from 
these calculations data for the residues which undergo rapid internal motion which are 
characterised by low heteronuclear NOE values (i.e <0.65). In the case of PaDDAH,
142the application of this filter excluded  15 residues from the 500 MHz data,  12 residues 
from  the  600  MHz  data  and  8  residues  from  the  800  MHz  data.  Additionally,  the 
contribution of chemical exchange to P 2 rates can lead to an over estimation of (P2/P 1) 
and  consequently  an  erroneously  long  correlation  time  (Tjandra  et  al,  1995). 
Therefore a standard deviation filter is applied to exclude residues for which (P2/P 1) is 
significantly different from the sample mean (Equation 5.8), i.e. when,
<*!>  <*2>
>  1.5 x  SD  Equation 5.8
where (.R\) and (R2) are the sample average longitudinal and transverse relaxation rates 
respectively, Pi,i  and R2,\ are the individual NH  group relaxation rates  and SD is the 
standard deviation over the complete data set of unfiltered 15N P 2/P 1 values (Tjandra et 
al, 1995). This filter excluded 5 additional residues from the 500 MHz data, 7 residues 
from the 600 MHz and 8 residues from the 800 MHz data set.
With  a  suitable  data  set  filtered  as  described  above,  tc   can  be  calculated  by  a 
minimization of Equation 5.9
2
T   =
«2 (Tc)
- < R2/R 1 > Equation 5.9
L Rx  (tc)
where  P i (tc)  and  P 2(tc)  are  functions  describing  the  effect  of  molecular  tumbling 
frequency on  the respective relaxation  rates  and  (P2/P 1)  is  the  average  experimental 
rate ratio.
The  average  (P2/P 1)  ratio  values  obtained in  this  manner at three  different magnetic 
fields are R2500//J,500 of  12.55  (±0.68), R26m/Rim  of  17.89  (±1.00)  and /?280°/«i800 of 
30.54 (±1.97) (Table 5.1; Figure 5.6).  Subsequently, the values of tc  obtained at 500, 
600  and  800  MHz  after  performing  Monte  Carlo  simulations  are  13.14  (±0.16)  ns, 
13.24  (±0.16)  ns  and  13.14  (±0.19)  ns,  respectively.  These  values  correlate  well  at 
different  magnetic  field  strengths  and  are  in  the  proper  range  for  a  29  kD  protein 
(Table  5.1).  The  mean  value  13.17  (±0.13)  ns  was  then  taken  as  a  conservative 
estimate of the isotropic rotational correlation time of R40E-R98H PaDDAH at 26°C. 
In order to address the quality of the data sets acquired at different fields, theoretical 
calculations were performed to derive R2 and Pi rates in which S2 was set to 0.85, xe to 
0 and tc to 13.17 ns in Equation 5.3. The consistency of the 15N parameters obtained at 
500, 600 and 800 MHz was estimated in terms of the theoretical values predicted for
143Table 5.1 Average 15N heteronuclear spin relaxation parameters for R40E-R98H PaDDAH recorded at 26°C at 
different magnetic field strengths
500 MHz 600 MHz 800 MHz
Parameter All3 Filtered5 All3 Filtered5 All0 Filteredd
ISN (R|> (s'1) 1.24 ±0.08 1.23 ±0.05 0.98 ± 0.09 0.96 ±0.05 0.67 ± 0.07 0.66 ± 0.04
15N<*2>(S-') 15.18 ±1.47 15.35 ±0.86 16.98 ±1.67 17.18 ±0.92 20.23 ± 1.64 20.26 ±1.19
<  R2^R\) - 12.55 ±0.68 - 17.89 ±1.00 - 30.54 ±1.97
{1 H}-15N<NOE> 0.75 ± 0.09 0.78 ± 0.05 0.79 ± 0.09 0.81 ±0.05 0.84 ± 0.07 0.85 ± 0.05
tc  (ns)e 13.14 ±0.16 13.24 ±0.16 13.14 ± 0.19
aAverage values calculated from the data obtained for 199 well resolved cross peaks.
bAverage values re-estimated using NOE and R2/R\ filters (179 cross peaks left in the analysis of the  500 MHz  data and  182 residues left
in the analysis of the 600 MHz data).
cAverage values calculated from the data obtained for 226 well resolved cross peaks.
dAverage values re-estimated using NOE and R2/R\ filters (211 cross peaks left in the analysis of the  800  MHz data).
Calculated assuming isotropic rotational diffusion and using the filtered data.50
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Figure  5.6.  I5N  R2/R\  ratios  of R40E-R98H  PaDDAH  backbone  amides  plotted  as  a  function  of residue  number  and  extracted  at  three 
different magnetic field  strengths (blue triangle at  ’H  nominal  frequency of 500 MHz, red  circles  at 600  MHz  and  green  squares  at  800 
MHz). Secondary structural elements are indicated at the top of the Figure.R2m /R2600 and i?i800//?i600 ratios which were  1.17 and 0.68 respectively. The observed 
800/600 ratios agree well with the theoretical ones with an average value of R2 °°/R2 00 
of  1.18  (±0.09)  and  R\S00/Ri600  of  0.69  (±0.05).  Similarly,  the  predicted  values  of 
R2600/R2500 and R i600/Ri500 ratios were 1.07 and 0.76 respectively and were compared to 
the experimental values obtained. The observed R ^^/R ^00 and Pi600/Pi500 ratios were 
1.11  (±0.08) and 0.79 (±0.05) respectively.  Although both values of the experimental 
ratios are slightly higher than expected, they remain within experimental uncertainty. 
The consistency of the heteronuclear NOE values were also verified as the theoretical 
NOE800/NOE600  and  NOE600/NOE500  ratios  estimated  at  1.04  and  1.02  respectively, 
matched the observed NOE800/NOE600 ratio of 1.05  (±0.09) and NOE600/NOE500 ratio 
of 1.02 (±0.09).
Rotational diffusion anisotropy
The determination of a rotational correlation time for R40E-R98H PaDDAH assumed 
isotropic  tumbling  of the  molecule  in  solution.  However,  such  an  approximation  is 
generally  a  shortcoming  as  the  behaviour  of  proteins  tends  to  deviate  from  the 
idealistic  spherical  representation.  Any  deviation  from  a  sphere,  described  as 
anisotropy of the rotational diffusion tensor, will equate to different rates of rotational 
diffusion  around  the  longitudinal  and  equatorial  axes  of the  protein.  The  relaxation 
rates of the NH spins will be affected depending on the orientation of the NH vector 
with respect to the principal axis of the global diffusion tensor. In particular, the angle 
0 formed between the NH vector and the z-axis of the diffusion tensor Dzz is critical in 
the determination of the magnitude of each NH spin R2/Ri ratio. It has been shown that 
for an  axially  symmetric  oblate  ellipsoid,  the  minimum  and maximum experimental 
R2/Ri ratios correspond to a NH vector aligned parallel, i.e. 0 = 0° or perpendicular, 0 = 
90° to Dzz respectively (Clore et al,  1998). In view of these considerations and on the 
additional  evidence  provided  by  Tjandra  and  co-workers  demonstrating  that  even 
slight anisotropic diffusion in ubiquitin can lead to the artifactual identification of an 
exchange contribution Rex to the  observed transverse relaxation rates  (Tjandra et al., 
1995),  R40E-R98H  PaDDAH  15N  relaxation  data  sets  were  further  scrutinised  to 
determine  whether  a  model  allowing  for  anisotropic  diffusion  best  described  the 
enzyme rotational diffusion.
The initial calculations based on the crystal structure of PaDDAH yield an estimate of 
the  moments  of  inertia  ratio  (Wlyy-Izz)  of  1.0  :  0.97  :  0.39  for  the  homodimeric
146PaDDAH;  the corresponding ratio predicted for the  isolated protomer is  1.0  :  0.86  : 
0.80.  Based  upon  this  assessment  the  homodimer  would  be  expected  to  show 
diffusional characteristics consistent with an oblate ellipsoid with Ij_/I|| ~ 2.5, whereas 
the protomer should show only a slight deviation from isotropic tumbling (Ix/Iy ~  1.2). 
To estimate this deviation, the degree of anisotropy A (Equation 5.10) can be obtained 
from a least squares optimisation on the basis of the measured 15N R^Rx ratios and the 
orientation of the intemuclear NH vector provided by the crystal structure (Tjandra et 
al, 1995,  1996).
A = — —   Equation 5.10
D  +D xx  yy
where  Dxx,  Dyy  and  Dzz  are  the  principal  axes  of the  diffusion  tensor.  Prior  to  the 
analysis,  hydrogen  atoms  were  added to  the  crystal  structure  of the  citrulline-bound 
PaDDAH with the program X-PLOR (Brimger,  1992). In order to choose the diffusion 
model  that  best  describes  the  15N  relaxation  data  acquired  for  the  monomeric 
P 0DDAH, the programs R2Rl_diffusion and quadric_diffusion (Lee et al.,  1997) were 
used  in  the  analysis.  R2Rl_diffusion  uses  the  approach  described  in  Tjandra  et  al. 
(1995)  to  determine  the  diffusion  tensors  for  an  isotropic  and  an  axially  symmetric 
motional  regime  by  comparing  the  observed  and  predicted  R^Rx  values  for  each 
selected NH cross peak. Quadric_diffusion uses the quadratic representation approach 
to fit the experimentally derived 15N relaxation rates to the isotropic, axially symmetric 
or  fully  asymmetric  motional  regime  (Lee  et  al.,  1997).  For  the  isotropic  model  a 
single rotational correlation time is returned from both programs. In the case of axially 
symmetric rotational diffusion -  either oblate or prolate forms -  the parallel, D\\ = 2Dzz 
and perpendicular, D± = (Dxx + Dyy) components of the diffusion tensor and the angles 
0 and < p  are optimized, where 0 is the angle between the N-H interatomic  vector and 
the z-axis of the diffusion tensor, and (p the angle between the projection of the N-H 
vector on the x-y plane and the x-axis. In the case of a totally asymmetric model  six 
parameters Dzz, Dyy and Dxx, and 0, cp and \p are optimised in which the Euler angles 
define the orientation of the diffusion tensor coordinates in the chosen molecular frame 
(this  model  is  only  assessed  in  the  quadric_diffusion  program).  In  all  cases,  the 
parameters  are  extracted  by  minimising  the  error  function  characterised  by  the 
difference  between  predicted  and  experimental  R2/R1   ratios  for  each  model.  The 
predicted values are derived from Equations 5.1, 5.2 and from the extended version of
147Equation 5.6 as determined by Clore et al.  (1990) to account for rotational anisotropy 
{vide  infra).  The  Monte  Carlo  simulated  y2  distribution  and  F-statistics  are  then 
calculated in order to address the quality of the fitting procedure and the comparison of 
models.  Only  15N  relaxation  data  recorded  at  500  and  600  MHz  were  used  in  this 
assessment.  The  data  sets  were  filtered in  the  same  manner as  that employed in  the 
determination of the isotropic rotational correlation time of the molecule. However, an 
additional  round  of  data  filtering  was  performed  and  residues  which  exhibited  a 
predicted  effective  diffusion  constant  with  a  high  x2  residual  value  (x2> 1 0 0)  were 
eliminated from the fitting procedure (approximately 60 residues were removed from 
the final calculation). This step further ensures that residues with no internal motions 
are considered (Butterwick et al.,  2004). The results  are  shown  in Table  5.2  and are 
essentially the same at both magnetic field strengths.
Table  5.2.  Anisotropic  rotational  diffusion  parameters  for  monomeric 
PaDDAH
Parameter 500 MHza 600 MHza
D\j/ D±
D,so (107 s l)b 
0 (rad)c 
cp (rad)c 
F-valued
1.06 (±0 .0 1) 
1.26 (±0 .0 2)
1.3
5.4
25.1 (p < 10"4)
1.05 (±0.01) 
1.25 (±0.02) 
1.5 
5.2
14.0 (p < 10'4)
aThe analysis was performed with  132 residues at 500 MHz and  135 at 600 MHz. bDiso 
=  1/6tc   where  Diso  is  the  isotropic  diffusion  tensor.  cEuler  angles  describing  the 
orientation  of  the  components  of  the  diffusion  tensor  relative  to  the  inertial  tensor 
frame of the pdb file (lh70). dValue given when testing the significance of the axially 
symmetric diffusion model over the isotropic model.
The axial model was preferred over the isotropic model as best describing the data as 
indicated by the high F-values obtained with either 15N relaxation data sets (Table 5.2). 
The fully anisotropic model did not improve the fitting of the data. When comparing 
the x2 values  derived from the fitting of the  data  sets  to  an  axially  symmetric  and  a 
fully asymmetric rotational diffusion models, the program quadric_diffusion estimated 
an  F-value  of  1.8  (p  =  0.16)  at  500  MHz  and  an  F-value  of 0.79  (p  =  0.45)  at  600 
MHz.  These values  are not statistically significant and do not justify the adoption of 
the fully asymmetric model.
The data acquired at  800 MHz was in  general  agreement with these results however 
the  filtering  of the  data  is  further  complicated  by  exchange  contributions  that  scale 
quadratically  with  the  external  field  strengths.  As  a  result,  the  x  residual  values
148obtained  from  the  fitting  process  of  each  individual  spin  to  a  predicted  diffusion 
constant were much  higher than for the data sets recorded at the two other magnetic 
field strengths. For this reason, the diffusion tensor obtained at 500 and 600 MHz was 
used in the ensuing model-free analysis.
Although both 500 and 600 MHz 15N relaxation data sets of the monomeric PaDDAH 
predict a slight deviation from isotropic tumbling and agree well in the determination 
of the 0 and cp angles, the overall accuracy of estimating the global rotational diffusion 
parameters  remains  limited.  The  number  of  residues  involved  in  the  analysis  is 
considerably lower than the total number of residues in the protein, flexible regions are 
generally  absent  from  the  assessment  and  regions  with  large  R2/R 1  ratios  are  also 
excluded.  These  approximations  are  liable  to  an  underestimation  of  the  overall 
anisotropy of the molecule. In the particular case of PaDDAH, a last shortcoming in 
the estimation of the diffusion tensor of the molecule is the fact that the pdb file used 
in the assessment is that of the citrulline-bound state of the enzyme. To evaluate the 
overall rotation of the apo-form of the molecule, one has to assume that it will not be 
affected by the ligand present in the active site region. However, it is unlikely that this 
assumption  holds  true  for  the  entire  protein.  The  conformation  of  the  LI  loop  in 
particular for which no electron density was found in the X-ray diffraction data of the 
apo-protein (Murray-Rust et al, 2001) is affected upon binding of the substrate.
5.3  Backbone dynamics of the monomeric PaDDAH: Model-free analysis
The model-free protocol
Having established the degree of rotational anisotropy of PaDDAH, it is now possible 
to  determine  the  amplitudes  and  timescales  of  the  intramolecular  motions  of  the 
enzyme backbone  amides.  The experimentally  accessible  15N relaxation rates Pi, P 2, 
and  NOE  values  can  be  expressed  as  linear  combinations  of  the  spectral  density 
function 7(0)), which takes the form presented in Equation 5.11 in the extended model- 
free formalism of Lipari-Szabo (Clore et al,  1990). This model is formally equivalent 
to taking into account axially symmetric rotational diffusion anisotropy.
Equation 5.11
149where r  ' = r r  /(t . + r  ), x’j is the effective correlation time dependent on xe which in
7  J   ?   \  J  ^  ^
turn is the effective correlation time for internal motion; Xi, x2 and x3 are time constants
defined as xf1  =  6Z)±, X 2’1   = 5D± + D\\,  = 2Dj_ + 4Dy respectively; the terms Ai, A2
and A3 are given by A\ = (3cos20 -  l)2/4, A2 = 3 sin20cos20, A3 = (3/4)sin40, where 0 is
the angle between the N-H bond vector and the principal axis of frame of the diffusion
tensor;  S2 = S 2Ss2 is the square of the generalised order parameter characterising the
2  2 amplitude of internal motions, and Sf  and Ss  are the squares of the order parameters 
for the fast and slow timescales, respectively. The order parameter S2 derived for each
individual N-H vector in the backbone quantifies the amplitude of motion of this bond.
2  2  The S  values satisfy the inequality 0 < Sr <  1 ; lower values indicate larger amplitudes
of internal motion, revealing regions in the backbone of high flexibility and dynamics
on a ps-ns timescale.
Alternatively, conformational exchange processes  are represented by an ad-hoc extra 
parameter  Rex  that  refers  to  dynamics  on  a  ps-ms  timescale  and  is  added  to  the 
expression  defining  the  transverse  relaxation  rate, R2  = R2  + Rex  where  R2   is  the 
relaxation rate in the absence of exchange.
A complete model-free  analysis  of internal  motion  of the monomeric  PaDDAH was 
performed using the Modelfree program (version 4.16) (Palmer et al,  1991b) with 15N 
spin relaxation data acquired at 500, 600 and 800 MHz. The data sets obtained for each 
individual NH spin were fit independently to five different motional regimes under the 
assumption  of  an  axially  symmetric  diffusion  tensor  (Mandel  et  al  1995).  Each 
motional model contained the following adjustable parameters: S2 (model  1); S2 and T e 
(model 2); S2 and Rex (model 3); S2,re and Rex (model 4); and S 2, S 2  and T e (model 5). 
Furthermore, the average  ’H-^N distance tNh was assumed to be  1.02 A and the  15N 
magnitude  of the  chemical  shift  anisotropy  (CSA)  tensor was  set  to  -170  ppm.  The 
rationale  for choosing  a  larger  value  of CSA  over the  commonly  used  -160 ppm  is 
related to the potential uncertainty over the magnitude of the constant contribution of 
CSA  to  the  measured  R\  rates  and  to  lesser  extent  R2  rates  (Tjandra  et  al,  1996; 
Kroenke et al.,  1999). This contribution varies according to the environment in which 
the  amide  15N  spin  is  located  (Sitkoff and Case,  1998),  but more importantly in  our 
case, it is larger at the higher magnetic field strengths used in this study (>14.1 T).
150The  best  model  for  each  NH  group  was  determined  as  described  by  Mandel  et  al. 
(1995). The goodness of the fits of the experimental relaxation data to each motional 
model was estimated by the comparison of the x2 function at 95% confidence level of 
the x2 probability distribution determined from 500 Monte Carlo simulations. To assign 
spins to models 2 and 3, F-testing also had to be satisfied at the critical value of a = 
0.2. When assigning residues to models 4 and 5,  the  sum-squared error of the fitting 
procedure for the spin under consideration had to be equal to 0 .
Optimised diffusion tensor and internal motion parameters
For each  data set evaluated in Modelfree,  the optimised parameters for the diffusion 
tensor are shown in Table 5.3.
Table  5.3.  Optimised  anisotropic  rotational  diffusion  parameters  of
the monomeric PaDDAH after Modelfree analysis
500 MHz3 600 MHz3 800 MHz3
tc  (ns) 13.16 (±0.02) 13.27 (±0.02) 13.14 (±0.01)
DtfDL 1.06 (±0 .0 1) 1.06 (±0 .0 1) 1.07 (±0.01)
0 (rad)a 1.6 (±0 .1) 1.4 (±0.1) 1.9 (±0.1)
cp (rad)3 5.4 (±0.1) 5.2 (±0.1) 5.2 (±0.1)
“Euler  angles  describing  the  orientation  of the  components  of the  diffusion  tensor
relative to the coordinates of the inertial tensor frame in the pdb file (lh70).
The  parameters  agree  well  at  all  three  different  magnetic  fields  apart  from  a  slight 
increase  of the  0  angle  with  the  data set  acquired at  800 MHz.  The model  selection 
profiles for each NH spin are shown in Table 5.4.
Table 5.4. The profiles of model selection for the NH spins analysed3
500 MHz 600 MHz 800 MHz
Model Number of residues
1 159 157 168
2 16 13 16
3 7 13 13
4 3 1 6
5 10 11 16
aA total  of 197  spins  were analysed  at both  500 and  600 MHz and 224  spins  were 
analysed at 800 MHz. Residues 236 and 249 could not be fit to any motional model 
with either 500 or 600 MHz relaxation data sets. Residues  13,  15,  16, 46, 236 could 
not be fit with 800 MHz data.
The  vast  majority  of  residues  were  fit  to  model  1.  Several  residues  had  small  xe 
contributions (<50 ps), and the same percentage of residues (-7%) were fit to model 5
151with xe values in the range of 1  ns. In contrast, few residues exhibited both Rex and xe 
terms as only ~l-3% of residues were fit to model 4. Chemical exchange contributions 
were observed in 4-6% of residues.  Some discrepancies were observed in the case of 
the active site residue Cys 249 and the residues located prior to the LI loop. Although 
Cys  249  was  fit  to  model  1  with  the  800  MHz  data  set,  it  could  not  be  fit  to  any 
motional model with the 500 MHz and 600 MHz data sets. Conversely, residues 13, 15 
and  16  were best  described by relaxation  models  1  (residues  13  and  15)  and  5  (for 
residue  16) with both 500 and 600 MHz relaxation data sets, but these residues could 
not be fit satisfactorily to any model with the data acquired at 800 MHz.
The internal motion parameters derived from the analysis are plotted as a function of 
residue number in Figure 5.7. The main conclusion drawn from the inspection of these 
results  is  the  agreement  of  the  data  with  regards  to  the  average  values  of  the 
generalised order parameter (S2)  of the NH bond  vectors  obtained at three  magnetic 
field  strengths.  Overall  the  (S2)  values  for  the  secondary  structural  elements  of the 
protein estimated at 600 and 800 MHz are essentially the same, 0.87 (±0.07) and 0.87 
(±0.06) respectively (Table 5.5) attesting to the rigidity of the entire p/a propeller fold. 
The (S2) values estimated at 500 MHz are slightly lower than those obtained at the two 
other fields, 0.85 (±0.07). Despite this fact, several regions of the protein are identified 
as inherently flexible by this  analysis.  These  regions  display internal  motions  in the 
pico-  to  nano-  second  timescales  as  shown  in  Figure  5.7b.  Specifically,  residues 
located in loops LI, L3, L6, residue Gly 179 located in a 3io-helix and residue Asp 244 
in loop L7 have significant xe contributions. The locations of these loops are illustrated 
in Figure 5.8a. Loop LI  comprising residues  14-25 has an (S ) value of -0.6 and lies 
over the active site region. Loops L3, L6 and L7 are located at the top entrance of the 
cavity forming the active site region (Figure 5.8a). Regions of the protein with small xe 
contributions  are  also highlighted in Figure 5.8a.  In particular,  Glu  197  and Glu  199 
located in a 3io-helix are also situated at the entrance of the active site.
Identification  of  the  residues  undergoing  conformational  exchange  requires  more 
careful  scrutiny  since  the  magnitude  of the  derived  Rex  terms  from  the  model-free 
analysis  are  rather  small  (Figure  5.7c).  In  this  sense,  the  exchange  terms  were  only 
taken into account when the  15N relaxation data sets agreed at the three spectrometer 
frequencies  (Figure  5.7c).  By  this  criterion,  only  four  regions  of  the  protein  are 
identified as undergoing motions in the ps-ms timescales. These include residues Phe 2
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Figure 5.7. Model-free analysis of the internal motional parameters of R40E-R98H PaDDAH. Values of the generalised order parameter S2  
(a), values of the fast internal motions xe(b)  and values of the conformational  exchange contributions Pex  (c)  are shown as  a function of 
residue number, extracted at three different magnetic field strengths. Plotted in blue are data extracted at 'H nominal frequency of 500 MHz, 
in red at 600 MHz and in green at 800 MHz. Secondary structural elements are indicated at the top of the Figure. The designation LI refers to 
the loop LI. Residues plotted on the abscissa in (a) could not be fit to any motional model.
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Residue numberTable  5.5.  Average  <S2)  values  obtained  at  three  different  spectrometer  nominal 
frequencies for the secondary structural elements of R40R-R98H PaDDAH__________
  _____________________
Secondary
structure2 1
Residue
number
b
>*5,6 **8C 500 MHz 600 MHz 800 MHz
p/a propeller All 195 219 0.85 (±0.07)d 0.87 (±0.07) 0.87 (±0.06)
al 27-43 12 12 0.87 (±0.02) 0.90 (±0.03) 0.89 (±0.02)
a2 83-100 13 14 0.88 (±0.04) 0.91  (±0.05) 0.91 (±0.04)
a3 134-148 12 14 0.88 (±0.02) 0.90 (±0.02) 0.89 (±0.02)
a4 184-188 3 4 0.86 (±0.01) 0.87 (±0.04) 0.90 (±0.01)
a5 218-227 9 9 0.87 (±0.03) 0.88 (±0.03) 0.89 (±0.04)
pia 4-8 5 5 0.87 (±0.02) 0.88 (±0.01) 0.85 (±0.01)
(31b 49-53 3 4 0.83 (±0.01) 0.86 (±0.03) 0.85 (±0.02)
P2a 68-70 1 2 0.80 (±0.02) 0.79 (±0.01) 0.85 (±0.06)
p2b 75-77 3 3 0.86 (±0.02) 0.87 (±0.06) 0.85 (±0.02)
[32c 104-106 3 3 0.83 (±0.03) 0.84 (±0.02) 0.84 (±0.03)
(33a 118-121 4 4 0.85 (±0.03) 0.90 (±0.03) 0.89 (±0.03)
p3b 124-129 4 6 0.86 (±0.03) 0.86 (±0.03) 0.86 (±0.04)
P3c 151-156 5 6 0.83 (±0.03) 0.85 (±0.06) 0.85 (±0.04)
P4a 167-169 3 3 0.87 (±0.01) 0.90 (±0.05) 0.88 (±0.06)
p4b 174-177 1 3 0.88 (±0.02) 0.90 (±0.01) 0.86 (±0.04)
P4c 191-194 3 3 0.84 (±0.04) 0.85 (±0.04) 0.84 (±0.04)
P5a 206-208 3 4 0.86 (±0.01) 0.89 (±0.01) 0.86 (±0.03)
P5b 211-215 3 4 0.86 (±0.03) 0.88 (±0.02) 0.88 (±0.05)
P5c 231-235 5 5 0.80 (±0.04) 0.83 (±0.05) 0.82 (±0.03)
pic 252-254 3 3 0.85 (±0.01) 0.88 (±0.04) 0.86 (±0.06)
Secondary  structure  designation  as  described  in  Murray-Rust  et  al.,  (2001).  Number  of  residues 
included  in the  average  calculated  from the  data obtained  at 500  and  600  MHz.  cNumber of residues 
included in the average calculated from the data obtained at 800 MHz. dStandard deviation from average 
is shown in parentheses.
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Figure 5.8. (a) Values of xe  (ps)  and (b) values of Rex (s'1 ) contributions estimated 
from the model-free analysis of the  15N relaxation data acquired at 600 MHz have 
been  plotted  onto  the  X-ray  structure  of the  monomeric  PVzDDAH  bound  to  L- 
citrulline (pdb code:lh70). The colour coding is as follows: in (a) coloured in red are 
residues for which xe  > 1   ns, in orange are residues for which 60 ps > xe  > 1 ns and in 
light  yellow  are  residues  for  which  xe  <  60  ps.  In  (b),  coloured  in  dark  blue  are 
residues for which Rex > 5  s'1, in light blue are residues for which  1   s'1  < Rex< 5s'1. 
The active site residues Glu 114, His  162 and Cys 249 are shown in a ball-and-stick 
model. Note, residues 21  and 22 in LI have not been assigned.
155and His  4  located at the N-terminus, residue  lie  91  located at the bend of a-helix  2, 
residues  Leu  145  and  Glu  146  situated  at  the  bottom  part  of  a-helix  3,  and  more 
importantly the active site residue His  162 and the adjacent Thr  165  located in a 310- 
helix. The locations of these regions in the 3D structure are illustrated in Figure 5.8b.
5.4  Validation of the Rex terms
Linear regression analysis
Several studies have demonstrated that the Rtx terms derived from model-free analysis 
at a single frequency could be reminiscent of the degree of local diffusion anisotropy 
of the  protein  rather than  represent  actual  conformational  exchange  (Tjandra  et al., 
1996; Lee et al., 1997). Since the correct identification of residues undergoing motions 
in the ps to ms timescale is central to the effort of relating local motions in enzymes to 
the  catalytic  function,  an  independent  determination  of  the  regions  of  PaDDAH 
influenced by exchange contributions was sought. To this end, a protocol described by 
Phan and co-workers in their study of the dynamics of fibronectin at three spectrometer 
frequencies  was  followed  (Phan  et  al.,  1996).  With  their  approach  it  is  possible  to 
quantify  the  exchange  contribution  to  the  15N  relaxation  rate  by  taking  into 
consideration the prediction that Rex scales quadratically with increasing magnetic field 
strength.
From  the  expressions  defining  Ri  and  R2  rates,  the  exchange  contribution  can  be 
extracted from the calculation of the parameter {R2-Ri/2} as shown in equation 5.12.
where  d  and  c  have  been  defined  previously  in  equations  5.6  and  5.7  respectively. 
Assuming equation 5.12 describes an exponentially decaying auto-correlation function
relative  to  the  others  and  can  effectively  be  neglected.  By  introducing  the  term 
describing  the  quadratic  dependence  of Rex  = ABo2  into  the  equation,  where A  is  a 
constant  and  Bo  the  static  magnetic  field,  equation  5.12  can  be  rearranged  in  the 
following manner.
Equation 5.12
and  Rex  >  I s 1,  the  second  term  of  the  equation  which  is  field  dependent  is  small
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2 where ci  = c/B0. When plotting  {R2-R\/2}  as  a function  of Bo , J{0) can be deduced
from the intercept of the linear regression, i.e. Io = d 7(0)/3 and the exchange constant
A is given by the slope m = [J(0)ci2/3] + A:
c2l
A = m — LJL  Equation 5.14
d
This equation predicts that any NH spin for which m > (ci2Io/d2) will have an exchange 
contribution  and  a  value  for  Rex  can  consequently  be  derived.  However,  due  to 
experimental errors in data fitting and the limited number of data points in the linear 
regression analysis, A is not systematically equal to 0 for non-exchanging residues. In 
this  sense, Phan et al.  set a threshold value for the slope of  1.3(m), where (m) is the 
average slope. The residues for which the regression analysis estimated a m >  1.3(m) 
were identified as subject to conformational exchange.
Using the treatment  suggested by Phan et al.  on  the  data obtained for PaDDAH.,  10 
residues were identified as undergoing conformational exchange. The linear regression 
plots obtained for each of the  10 residues are shown in Figure 5.9. The values of Rex 
obtained were compared to the values obtained from model-free analysis (Table 5.6).
Table 5.6. Comparison of chemical exchange rates derived from linear regression (LR) 
and model-free (MF) analyses__________________________________________________
Rex (s'1) at various Bo (T)
11.74 14.09 18.79
Residue LRa,b MFa LR MF LR MF
Phe 2 1.6 (±0.6) 3.4 (±0.7) 2.3 (±0.7) 5.4 (±0.5) 4.0 (±0.9) 6.8 (±1.1)
lie 91 3.3 (±0.3) N/Ac 4.7 (±0.3) 3.1  (±0.6) 8.4 (±0.4) 4.6 (±1.3)
Gly 116 1.5 (±0.0) N/A 2.1  (±0.0) N/A 3.8 (±0.0) N/A
lie 142 2.1  (±0.2) N/A 3.0 (±0.3) N/A 5.4 (±0.3) N/A
Leu 145 1.5 (±0.1) 1.8 (±0.7) 2.1  (±0.1) 2.8 (±0.5) 3.8 (±0.2) 4.5 (±0.6)
His 162 1.6 (±0.8) 2.3 (±0.6) 2.3 (±1.0) 4.4 (±0.5) 4.1 (±1.4) 5.2 (±0.8)
Lys  164 1.4 (±0.7) N/A 2.0 (±0.8) N/A 3.5 (±1.1) N/A
Arg 241 1.6 (±0.5) N/A 2.3 (±0.6) N/A 4.1  (±0.7) N/A
Ser 248 1.6 (±0.8) N/A 2.3 (±0.9) N/A 4.1  (±1.3) N/A
Cys 249 3.9 (±1.2) N/A 5.6 (±1.4) N/A 9.9 (±1.8) N/A
Ser 251 1.6 (±0.2) N/A 2.4 (±0.3) N/A 4.2 (±0.4) 1.6 (±0.5)
aLR stands for linear regression and MF for model-free.  Rex = AB0  in which A  is defined in Equation 
5.20.cModel-free analysis does not predict exchange contributions for the residue in question.___________
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Figure 5.9.  Linear regression curves of R2-RX I2  values plotted as  a function of the 
static magnetic  field B0.  Only the  curves  for which the  slope m  is  >1.3*(m)  have 
been plotted and the corresponding residues are shown. The intercepts for all curves 
have been scaled to match the average value Iq obtained for non-exchanging residues 
so that only the slopes of the linear regressions are compared. The regression curve 
for non-exchanging residues is shown in black.
158For  comparative  reasons,  the  values  of Rex  obtained  from  the  linear  regression  and 
model-free  analyses  at  600  MHz  are  plotted  onto  the  X-ray  structure  of PaDDAH 
(Figure  5.10).  Interestingly,  the  majority  of  residues  undergoing  conformational 
exchange are located around the active site region in short loops or 3io-helices, such as 
residues  116,  162,  164,  241,  248,  249  and 251.  Notably,  two of the  active  site triad 
residues have been identified as  undergoing conformational  exchange,  however only 
His  162 has been confirmed by both assessments. Other residues subject to exchange 
include lie 91  which is  located in helix  a2, presumably the bend of the helix  at this 
exact position could explain  such a behaviour.  As for residues lie  142  and Leu  145, 
their  position  within  helix  a3  makes  it  unclear  as  to  the  possible  reasons  for  their 
exchange term, although model-free results also suggest conformational exchange for 
this region.
On a practical note, the validity of the linear regression assessment proposed by Phan 
et al.  (1996) in order to derive quantitative Rex terms has been recently questioned. In 
reality,  the  basic  assumption  that  Rex  is  quadratically  dependent  upon  the  static 
magnetic  field  B0  is  a  shortcoming.  As  pointed  out  by  Millet  and  co-workers,  Rex 
scales according to the parameter a, defined as (Millet et al., 2000):
Where  Aco  is  the  chemical  shift  difference  between  exchange  sites  A  and  B  and  a 
satisfies the constraints 0  < a <  2, providing the population of site A is much larger 
than the population of site B (pa »  Pb)• In which case, a takes the following form:
where kex is the exchange rate constant between sites A and B. From these equations 
Rex  will  only  scale  quadratically  with  the  applied  static  field if a =  2,  which  would 
indicate that all exchange contributions are in the time fast exchange limit relative the 
chemical  shift time scale.  In reality this result has been proven not to be the case for 
most NH spins in basic bovine pancreatic trypsin inhibitor (BPTI) when examined by 
15N  CPMG  measurements  of transverse relaxation  (Millet  et al.,  2000).  Despite this 
caveat,  the justification  for  assuming  that Rex  scales  quadratically with  Bo is  merely
Equation 5.12
a =
dlnR„
Equation 5.13
din A^y
a ,  2(ke JA(of 
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Figure  5.10.  Values  of Rex  (s'1)  contributions  estimated  from  the  linear regression 
analysis  (a)  and model-free analysis  (b)  of the  15N relaxation data acquired  at 600 
MHz have been plotted onto the X-ray structure of the monomeric PaDDAH (pdb 
code:lh70). The colour coding is as follows:  coloured in dark blue are residues for 
which.i?ex > 5  s'1,  in light blue  are residues  for which Rex < 5s'1.  The width of the 
tube is also proportional  to the RQ X  contributions.  The active site residues Glu  114, 
His 162 and Cys 249 are shown in a ball-and-stick model.
160qualitative  at  this  stage.  Since  15N  relaxation  is  available  at  three  magnetic  field 
strengths our purpose was mainly to identify possible residues undergoing exchange, 
however not to regard the values of Rex contributions as numerically accurate.
15N relaxation dispersion experiments
Recent advances in NMR methodologies have allowed for the direct measurement of 
chemical-exchange phenomena without the necessity of acquiring  15N relaxation data 
at  multiple  fields.  These  experiments  are  based  upon  the  dependence  of  the  15N 
transverse relaxation rate on the time delay xcp between 180° pulses in the CPMG pulse 
train. By varying this delay, information can be obtained on the differences in chemical 
shifts  (Aco)  between  the  exchanging  conformers  and  the  kinetics  of  the  exchange 
process.  For a simplified two-site exchange process in the fast exchange regime, the 
expression takes the following form (Luz and Meiboom, 1963):
R2(V tcp) = R°2  + j4 - 2 ta n h ( * „ r fp /2 ) /* „ r J   Equation 5.15
kex
where  (/)ex = /?aPbAco2 and  P°  the Ri relaxation rate in the absence of exchange, kex is
the exchange rate constant between sites A and B, and pa and pb are the populations of 
site  A  and B  respectively.  This  equation  indicates  that  spins  experiencing  exchange 
broadening will have increased R2 rates as the value of xcp increases.
So  far  most  of  the  residues  in  PaDDAH  identified  as  subject  to  conformational 
exchange have displayed rather small values of Rex. Since 15N CPMG-based relaxation 
dispersion  experiments  are  sensitive  to  Rex  values  >  3s'1,  we  reasoned  that  an 
independent  investigation  of PaDDAH slower motions  should be  sought  in  order to 
determine more accurate exchange broadening values and pursue the characterisation 
of the kinetics of the exchange process. In this respect, a constant time TROSY-based 
CPMG 15N relaxation dispersion experiment was acquired at a spectrometer frequency 
of 800  MHz  (see  Chapter 2,  Section  2.4;  Loria  et al.,  1999;  Tollinger et al.,  2001). 
Effective transverse relaxation rates (P2eff) were determined from the relation shown in 
Equation 5.16 (Mulder et al., 2001):
R f  = -  In 1(Verms'*
\
IT  Equation 5.16
7(0)
where  /(vcmpg)  represents  the  cross  peak  intensity  at  a  particular  CPMG  pulsing 
frequency.  In this case vcmpg =  1/tc p was varied from  100 to  1000 s'1. 7(0) is the peak
161intensity obtained without the CPMG pulse train.  T is the total relaxation time, in this 
case  40  ms.  In  order  to  identify  PaDDAH  residues  displaying  R2  rates  with  a 
significant  amount  of  relaxation  dispersion,  the  plot  of  {P2eff(l/xcp  =  100  s'1 )  - 
P 2eff(l/^cP =  1000 s'1 )}  as  a function of residue number is  shown in Figure 5.11. The 
first step in interpreting the results is  a coarse filtering of the data. From experience, 
residues that display R2 rates which do not differ by more than 3 s'1  over the entire 900 
s'1   range of  l/xcp  values  are  generally not affected by conformational  exchange.  The 
filtering procedure is necessary since the noise level of the experiment is close to  ± 3 
s'1, which is consistent with what is observed in other studies of this kind (Beach et al., 
2005; Valentine and Palmer, 2005; Wang et al., 2004).
From  the  inspection  of  A/?2eff  values,  no  particular  residue  of PaDDAH  displays  a 
significant amount of exchange contribution to the R2 rate. In fact, residues previously 
identified  through  model-free  and  linear regression  analyses  as  exhibiting  exchange 
terms of 2 to 3 s'1   do not stand out in this experiment. Only one residue Gin  140 has a 
value  of AP2eff >  3  s'1,  however no  attempt has been  made to  fit the  decay curve of 
^2( 1/Tcp),  as  this  experiment  is  a  first  effort  in  our  laboratory  to  implement  15N 
relaxation dispersion experiments and the confirmation of this result is still the subject 
of on-going research.
5.5  Reduced spectral density function analysis
An alternative approach to the analysis of 15N relaxation measurements is the reduced 
spectral density procedure initially described by Farrow et al. (1995). The advantage of 
this approach over the model-free formalism is that the information on the timescales 
of protein motions can be extracted without the need to assume a model for the overall 
tumbling of the molecule or the exact form of the spectral density function. Instead, it 
is possible to estimate 7(to) at seven different frequencies when  15N relaxation data is 
available at three different magnetic field strengths. In this case, 7(&>n) and 7(0.87&>h) 
estimated at 500, 600 and 800 MHz proton frequencies and 7(0), were calculated from 
the  relaxation  data  obtained  for  the  monomeric  PaDDAH  from  the  following 
equations:
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Figure 5.11. AR2eff values plotted as a function of residue number. The dashed line indicates the 3 s'1  threshold line (see text).7(0) = [fl2  -  (3d2  /4 + c2)J(coN) -  (13d2  / &)J (0.81 cou)\/(d2  +4c2/3)  Equation 5.17
7(^n) = [/?i -  (Id 2/4)J(0.$lcoH)\/\3d2/4) + c 2 \  Equation 5.18
J(0.SlcoH  ) =  (4/57 2)(/N   / Y u )(NOE  -1  )Rl   Equation 5.19
where d and c have been  defined in Equations  5.4 and 5.5  respectively.  The derived 
reduced  spectral  densities  for PaDDAH  are plotted on  a per-residue basis  in Figure 
5.12.
The 7(0) term in the reduced spectral density analysis is known to report on motions in 
the slower motional timescales (ps-ms) and is hence perturbed by chemical exchange 
contributions present in the transverse relaxation rates (Farrow et al., 1995). In order to 
correctly  estimate  the  value  of 7(0)  free  from  chemical  exchange  contributions,  the 
relaxation data acquired at multiple field strengths can be used to quantify the Pex term 
in a per-residue-basis manner. However this procedure has not been undertaken here, 
since it is based on the previous assumption that Rex should scale quadratically with Bo 
(Farrow  et al.,  1995).  More  recently,  other methods  to  calculate 7(0)  have been  put 
forward  by  Kroenke  and  co-workers  in  which  the  longitudinal  cross-correlation 
relaxation  rate  constants  qz  and  qxy  for  dipolar  and  15N  CSA  relaxation
interference  are  measured  (Kroenke  et  al.,  1998).  In  contrast  to  R2/R 1  ratios,  r)X y/qz 
ratios  are  independent  of chemical  exchange processes  and report  solely  on  internal 
and  overall  motions  that  contribute  to  relaxation.  Ultimately,  7(0)  can  then  be 
expressed as:
y(o)=4 4
2 ^ - 1
V,
7 (ft> N )  Equation 5.20
However no attempt was made to determine cross-correlation rates and the 7(0) values 
reported here at 600 and 800 MHz for individual NH spins have not been corrected for 
chemical  exchange  (Figure  5.12a).  7(0)  values  were  directly  derived  from Equation 
5.17.  From  the  inspection  of Figure  5.12a,  both  data  set  values  are  almost  identical 
with the exception of very few residues. For our purposes, values of 7(0) one standard 
deviation  higher  than  the  average  have  been  interpreted  to  indicate  the  presence  of 
motions  operating  on  the  microsecond  and  millisecond  timescales.  In  the  case  of 
PaDDAH, from the inspection of 7(0) values, residues Phe 2, lie 91, Gly 116 and the 
regions  from  residues  61-65,  145-146  and residues  162-165  have  been  identified  as
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Figure 5.12. Values of the reduced spectral densities J(co) of R40E-R98H TVzDDAH estimated at (a) 7(0), (b) 7(&>N) and (c) J(0.87ft»H ) plotted 
as a function of residue number and extracted at three different magnetic field strengths (blue triangle at 'H nominal frequency of 500 MHz, 
red circles at 600 MHz and green squares at 800 MHz).  Secondary structural elements are indicated at the top of the Figure. 7(0) was not 
estimated with data acquired at 500 MHz.subject to slow motions. Apart from residues 61-65 which lie in the L2 loop inside the 
active site cavity, the other regions presenting motions in the slower timescales are in 
agreement with the results from the field strength dependent linear regression analysis 
presented earlier.
On the other hand, the higher frequency spectral density measurements i.e. 7(0.87&>h) 
and  7(cun)  report  on  motions  occurring  at  the  ps  timescales  and  on  motions  at  the 
nanosecond timescales, respectively (Wang et al, 2004). From the analysis of Figures 
5.12b  and 5.12c,  the  ‘faster’  motions  are indicated by higher than  average  values  of 
J(0.87c uh) and to a lesser extent by higher than average values of J(coN). These regions 
include  loops  LI  (13-24),  L3  (79-82),  L6  (157-160),  residues  178-179  and  197-199 
which lie in 3io-helices. These regions are indicated by reference to the X-ray structure 
of PaDDAH in Figure 5.13. These results are in line with the model-free analysis as 
both  assessments  have  effectively  identified  the  same  regions  of  the  protein  as 
inherently flexible in the ps to ns timescales.
In  summary,  the results  obtained by choosing to  interpret the  15N relaxation  data of 
PaDDAH  by  reduced  spectral  density  mapping  are  particularly  informative  with 
regards  to  the  identification  of flexible  regions  of the  protein.  However,  the  overall 
trend of 7(0), J(con) and 7(0.87«h) values throughout the protein attests to the rigidity 
of PflDDAH  fold  as  evidenced  by  the  apparent  constancy  of the  values  across  the 
chain.  Such  a  procedure  should  be  more  adequately  applied  in  studies  where  the 
protein under consideration displays large amplitude of motions, aggregates in solution 
or  presents  a  high  degree  of anisotropy.  The  complex  dynamics  that  arises  in  such 
cases  eventually precludes  the  correct interpretation  of the  model-free  analysis.  This 
situation  has  been  encountered  in  the  dynamic  studies  of  the  basic  leucine  zipper 
domain  of GCN4  (Bracken  et al.,  1999)  and of the EGF-like domain  of heregulin-a 
(Fairbrother et al., 1998).
166Figure 5.13. Front and lateral views of the 3D structure of TtoDDAH showing in red 
residues  for which the estimated values of J(0.87cuH)  are three standard  deviations 
(SD) higher than the average value of J(0.87coH) estimated at 600 MHz. Residues for 
which  J(0.87cuh)  >  1*SD  are  shown  in  orange.  The  width  of the  tube  is  also 
proportional to the y(0.87&>H ) values. The active site residues Glu  114, His  162 and 
Cys 249 are shown in a ball-and-stick model.  Note, residues 21  and 22  in LI  have 
not been assigned.
1675.6 Discussion
The  backbone  dynamics  of the  engineered  monomeric  PaDDAH enzyme  have  been 
investigated  through  the  measurement  of  15N  Ru  R2  and  {!H}-15N  heteronuclear 
relaxation parameters. The acquisition of data at multiple magnetic field strengths has 
enabled  a  more  reliable  identification  of  the  regions  of  the  protein  susceptible  to 
undergo motions at multiple timescales.
The  three  data  sets  obtained  were  analysed  independently  through  the  model-free
formalism. In keeping the analysis of the data sets separate, the consistency of the data
2  2  sets  is  better  assessed  and  the  %   statistics  are  kept  low.  The  average  (S )  value
obtained of -0.87 for the structured regions of the protein clearly attest to the overall 
rigidity  of the  backbone  of the  protein.  However,  several  loops  have  been  found  to 
display motions in the ps to ns timescales. The locations of the “dynamic” loops LI, 
L3,  L6  and  of the  isolated  residues  Gly  179  and  Asp  244  in  loop  L7,  map  to  the 
entrance  of the  binding  pocket  of the  protein  (Figure  5.8a).  In  addition,  model-free 
analysis predicted that residues Glu  197 and Glu  199 which are located on a 3io-helix 
also at the entrance of the active also displayed fast motions. This finding is supported 
by the spectral density J(0.87o)h) values which also identified the same regions of the 
protein as undergoing dynamics in the faster timescales (Figure 5.13). Taken together, 
these  results  suggest  that  the  LI  loop  which  is  subject  to  the  largest  amplitude 
conformational  fluctuations  in  the  protein  may  play  an  important role  in  facilitating 
substrate intake and product release.  Similarly, the sampling of fast multiple alternate 
states for loops at the entrance of the binding cavity could dictate an easier access and 
release of the ligand. This mechanism has been seen for other enzymes such as in the 
metallo-P-lactamase for which the fast dynamics of the major flap and the minor loop 
at  the  entrance  of the  active  site  are  abolished  upon  inhibitor binding,  alluding  to  a 
locking  mechanism  around  the  substrate  (Huntley  et  a l,  2000).  Another  example 
comes  from  the  extended  studies  of  the  enzyme  dihydrofolate  reductase  and  the 
importance of the different  motional  timescales  sampled by the  “Met-loop”  over the 
active  site during binding,  catalysis  and release  of the ligands  (Osborne  et al,  2001; 
McElheny et al, 2005). The Met-loop also samples ps to ns timescales in the apo-state 
of the enzyme. More interestingly, the studies of the HIV protease by Torchia and co­
workers have shown that the flaps that form part of the substrate binding site sample
168sub-ns  fluctuations  in  the  free  protease  (Freedberg  et al.,  2002).  The  authors  of this 
work have inferred that these motions reflect in reality a dynamic equilibrium between 
semi-open conformations of the protein. This surmise could be applied to PaDDAH, in 
which  case  the  fast  sampling  of conformations  of the  LI  loop  over  the  active  site, 
would  corroborate  crystallographic  data.  No  defined  electron  density  was  found  for 
residues  14-25  for the  apo-form of the protein  (Murray-Rust et al.,  2001).  Since the 
presence of loops over active site regions is not unprecedented, we can speculate about 
their functional role as able to permit an induced fit between substrate and enzyme.
The  slower  motional  timescales  have  also  been  investigated  for  PaDDAH.  Since 
several enzymatic reactions occur in the microsecond to millisecond timescales, it has 
been inferred that protein motions at these timescales  are pivotal to catalysis (Fersht, 
1999).  For this reason,  particular attention was paid to the optimisation of rotational 
diffusion  model  of  the  enzyme,  as  protein  conformational  exchange  determined 
through  the  model-free  analysis  may  be  influenced  by  the  underestimation  of  the 
anisotropy of the rotational tumbling of the molecule. For comparative purposes,  15N 
relaxation  data  obtained  at  500  MHz  was  additionally  analysed  assuming  isotropic 
tumbling of the protein. The analysis of the residues which presented Pex terms showed 
that helices  a l,  a3,  and  a5  exhibited  significant  conformational  exchange  (data not 
shown).  These  exchange  contributions  are  absent  when  the  rotational  diffusion  of 
PaDDAH is taken, more correctly, to be axially symmetric. Overall only a very small 
number  of  residues  could  be  confidently  identified  as  undergoing  exchange 
contributions from the model-free results (Figure 5.8a). These included the active site 
residue His  162 and residues around the active site such as Thr 165. Building on these 
findings, additional protocols were sought in order to confirm their veracity. Although 
qualitative, the linear regression analysis performed of {R2-R\!2}  values as a function 
of B02 together with the spectral density analysis of 7(0) gave a more complete view of 
the  regions  potentially  undergoing  slower motions  (Figure  5.10).  Interestingly,  these 
included four regions around the active site, with Gly  116 lying in the same 3i0-helix 
as  the  active  site  residue  Glu  114,  residues  61-65  which  form the L2  loop,  residues 
162-165 located adjacent to the L6 loop and the region that comprises the third active 
site residue, the L7 loop (248-251). The analysis of the protein-ligand contacts based 
on  the  X-ray  structure  of PaDDAH  complexed  with  L-citrulline  has  shown  that  all
169these residues  make non-bonded interactions  with  the  ligand.  This  view  is  supported 
by  independent  studies  in  which  Pex  terms  have  been  found  around  the  active  site 
region of other enzymes, in particular those of free ribonuclease binase and free RNase 
(Wang et al.,  2001;  Beach  et al,  2005).  In  these  studies  the  ps  to ms  motions  were 
preserved both  in  the  apo-  and substrate mimicked state  of the enzyme.  The  authors 
allude to the notion that the free enzymes sample both apo- and bound conformations 
and  that  the  binding  of the  ligand  simply  shifts  the  equilibrium  towards  the  bound 
conformer. A detailed analysis of PaDDAH in the bound state is necessary in order to 
assess  the  effects  of  the  ligand  on  the  backbone  dynamics  and  whether  the  slow 
dynamics are also preserved in both states.
From a kinetic perspective, enzymes are known to undergo dynamic processes implicit 
in their catalytic cycle. The various investigations of enzyme dynamics have been able 
to link the rates of protein conformational rearrangements occurring both in the apo- 
and bound forms of the enzyme to the rates of catalytic turnover. The limiting step in 
the catalytic process is in fact protein movement. With this in mind, we also sought to 
gain insight into the kinetics of the conformation exchange process in the monomeric 
PaDDAH.  The  use  of  15N  relaxation  dispersion  experiments  would  have  ideally 
clarified the significance of many of the small Pex terms observed in the apo-state of 
PaDDAH.  So  far  our  results  are  inconclusive  and  further  attempts  are  needed  to 
determine the best choice of pulse sequence. Ultimately, it is our understanding that - 
15N relaxation  dispersion experiments  are in  fact crucial  to the full  understanding of 
PaDDAH intrinsic dynamics and its influence upon the catalytic rates. In this vein the 
dynamics of the ligand-bound state of the enzyme still need to be addressed.
In  the  next  chapter,  the  bound-state  of  the  monomeric  PaDDAH  enzyme  will  be 
investigated.  Assessing the effects of ligand addition on PaDDAH loop structure and 
mobility  will  give  additional  valuable  structural  insights.  In  collaboration  with  the 
clinical  pharmacology  department  at  UCL,  a  library  of  small  chemical  compounds 
known to inhibit both  the human DDAH I  and bacterial  DDAH enzymes  have been 
used  to  assess  different  binding  schemes.  Due  to  the  overall  weak  protein-ligand 
interactions  as revealed by the HSQC-based titration  experiments  and chemical  shift 
mapping  of  the  binding  site,  molecules  able  to  react  with  the  active  site  cysteine 
residue and remain covalently linked in the active site cavity were also investigated.
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Abstract
This chapter describes the use of small molecule ligands in the characterisation of the bound- 
state  of the bacterial  PaDDAH enzyme.  These  compounds  have  been  derived  as  part  of a 
collaborative  effort  between  several  departments  at  UCL  which  sought  to  derive  specific 
inhibitors against mammalian DDAH homologues. NMR methodology was sought as a means 
to map the binding site of the bacterial protein through chemical shift perturbation. Due it the 
sensitivity  to  weak  interactions,  heteronuclear NMR titration  experiments  were  particularly 
useful to estimate dissociation constants for both substrate and product complexes. A general 
observation obtained from these titrations is that ligands that act as inhibitors of the enzyme in 
vitro give rise to specific broadening of a subset of N-H cross peaks corresponding to residues 
around the active site region and in the LI loop that closes the ligand binding pocket. The line 
broadening is also observed with a ligand covalently bound to Cys249 of the catalytic triad. 
These  results  are  interpreted  to  imply  that  in  the  bound  state  the  dynamic  profile  of the 
backbone  of the  PaDDAH  enzyme  is  altered,  probably  with  ordering  of the  LI  loop  but 
retaining a component of conformational exchange that gives rise to residual line broadening, 
even in the saturated state. These findings challenge the current view of the LI  loop locked 
into position over the active site upon ligand binding which was given by the X-ray structure.
1716.1  NMR spectroscopy applied to the study of protein-ligand interactions
The study of protein-ligand interactions by NMR is based upon differences in physico­
chemical  properties  existing  between  the  free  and  bound  states  of the  protein  under 
consideration.  Commonly,  such  differences  are  interpreted  in  terms  of  an  overall 
increase of the relative mass between the two states, which in turn cause changes in the 
diffusion and tumbling properties of the molecule. When monitoring the ligand, these 
changes can effectively be followed by specific NMR experiments which exploit the 
differential relaxation rates of the free ligand relative to the complexed form and rely 
on  the  transfer  of  magnetisation  from  the  ligand  to  the  protein  and  vice-versa 
(Pellecchia, 2005). The advantages of monitoring the ligand are the small quantity of 
target  unlabelled  protein  necessary  to  perform  the  experiments,  together  with  the 
possibility of screening multiple ligands in the same experiment.  Alternatively, NMR 
spectroscopy can also monitor specific spin systems of the protein, which are sensitive 
to the chemical environment in which they lie.  Perturbation of this environment, e.g. 
by the  addition  of a small  molecule  ligand in  direct contact with  the  spin,  translates 
into  deviations  in  the  chemical  shifts  of  the  spin  observed  in  a  particular  NMR 
experiment. Providing that the resonance assignments for the protein are available, the 
observation  of changes  in  the  !H-15N,  !H-I3C  HSQC-  or  TROSY-based  correlation 
spectra upon ligand addition has become an important method for the determination of 
binding sites in proteins. Chemical  shift mapping can in  addition provide an estimate 
of the dissociation constants (Kd) of the protein-ligand complexes. When screening for 
lead  compounds,  this  approach  is  particularly  useful  to  detect  low  or  high  affinity 
binding,  which  has  led  to  the  development  of  NMR-based  strategies  for  drug 
discovery, such as the structure-activity relationship by NMR (SAR by NMR) (Shuker 
etal., 1996).
In  line  with  these  applications,  the characterisation  of a  small  library of compounds 
designed  to  inhibit  the  human  enzyme  DDAH  I  in  vitro  was  sought.  Since  the 
mammalian  DDAH  enzymes  are  not  obtained  in  suitable  amounts  for  NMR 
characterisation, the screening of these inhibitors for potential binding affinity towards 
the bacterial enzyme seemed reasonable.  In fact, PaDDAH was recently suggested to 
be a potential  antibacterial target (Vallance et al,  2005),  which  validates the need to 
further assess the different binding specificities these compounds exhibit towards the 
DDAH enzyme family. However, for completeness the binding site of the monomeric
172PaDDAH  will  be  investigated  at  first  through  titration  experiments  of the  substrate 
N^N^-dimethylarginine (ADMA) and the product L-citrulline.
6.2  Studying the bound state of the monomeric PaDDAH
Determination  of the  Michaelis-Menten  constant  Km  of the  monomeric  PaDDAH 
enzyme
In  the  course  of  our  investigations  of  the  structure-function  characteristics  of  the 
DDAH enzyme, we sought to confirm that the two point mutations R40E and R98H in 
the PaDDAH interface had not significantly altered the affinity and kinetic parameters 
of the  monomeric  enzyme  relative  to  the  WT  protein.  Recent  studies  on  unrelated 
enzymes  have  revealed  that  mutations  of distal  residues  could  still  have  effects  on 
enzymatic catalysis without interacting directly with the substrate (Rajagopalan et al., 
2002; Kovrigin and Loria, 2006), which is why a confirmation of catalytic rates of the 
PaDDAH monomer was pursued.
Following  the  protocol  presented  in  Chapter 2,  Section  2.4,  the  Km  value  of R40E- 
R98H  PaDDAH  for  the  substrate  N^N^-dimethylarginine  (ADMA)  has  been 
determined to be -460 pM. This value was compared to the published KM  value of WT 
PaDDAH  for  ADMA  which  is  in  the  order  of  310  pM  (Stone  et  al,  2005a).  The 
difference  observed could  attest to  an  overall  decrease  in  affinity  of the  monomeric 
enzyme  for  ADMA,  however  the  conditions  used  in  the  assays  differ  in  terms  of 
temperature and salt concentrations which could account for the difference observed. 
Nevertheless  the  kcat  values  for  both  enzymes  remain  comparable,  Stone  et  al. 
determined a kcat  value  of 0.56  s'1   for WT PaDDAH and  the  value  obtained for the 
monomeric enzyme under the conditions described in Chapter 2, Section 2.4 is - 0.42 
s'1.  It  has  to  be  noted that  the  catalytic  turnover of PaDDAH  enzymes  is  extremely 
slow when compared to other well studied enzymes such as RNase A or ribonuclease 
binase.  These enzymes have kcat values in the range of  1400-2900 s'1   for RNase (del 
Cardayre et al., 1995) and 1500 s'1  for ribonuclease (Schulga et al., 1998).
173Titration studies of  ADMA, L-citrulline
In order to assess the ligand-bound state of PaDDAH and effectively map the binding 
site of the enzyme, the molecules initially chosen for NMR titration experiments were 
the substrate ADMA and the product L-citrulline.  The transition from the free to the 
ligand-bound state of the enzyme was followed through the acquisition of a series of 
[!H-15N]-HSQC  spectra  recorded  as  a  function  of  increasing  ligand  concentration. 
Details  of the  experiment conditions  can  be  found  in  Table  2.4  (Chapter 2,  Section 
2.5).  Selected regions of the  ^H-^NJ-HSQC spectra acquired for each titration point 
illustrate the similar pattern of chemical shift perturbation obtained upon the binding of 
each ligand (Figures 6.1 and 6.2). In reality, the titration of the substrate into the active 
enzyme results in the characterisation of the binding site of the hydrolysis product L- 
citrulline. The catalytic reaction is bound to be completed prior to the acquisition of the 
HSQC experiment. Ultimately, titrating L-citrulline into the protein served as a control 
experiment to  confirm that the  chemical  shift changes  obtained upon  the  binding  of 
ADMA are in fact the outcome of the presence of L-citrulline in the active site. In fact, 
L-citrulline is known to inhibit PaDDAH activity at concentrations higher than 3 mM 
which would indicate that it can effectively bind to the active site (Stone et al., 2005a). 
Moreover, it was additionally shown by the X-ray structure of the WT protein that the 
enzyme does crystallise in complex with the product (Murray-Rust et al., 2001).
The chemical shift deviations (A5) upon ligand titration have been calculated from the
following equation  AS = ^(A Sl5^/5)2  + (A£,hN  )2  and have been plotted as a function
of residue number in Figure 6.3a.  Initial inspection of these results clearly shows that 
the  pattern  of  changes  in  chemical  shifts  upon  the  titration  of  both  molecules  is 
essentially identical  except  for the  slightly  larger chemical  shift  deviations  observed 
during the titration of the substrate.
In addition to the chemical shift perturbations, it is important to note that for a subset 
of !Hn-15N cross peaks,  the chemical  shift changes  could not be followed during the 
entire  titration  and  no  end  point  could  be  assigned.  The  ligand-dependent  line 
broadening  of  these  resonances  is  extreme  and  the  intensity  of  the  cross  peaks 
decreases  to  noise  levels  early  on  in  the  titration  which  subsequently  impairs  the 
characterisation of the chemical shift perturbation. These residues are shown in Figure 
6.3a in yellow bars. On the other hand several residue titration end points could not be
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Figure  6.1.  (a)  Superimposed  pH^NJ-HSQC  spectra  of the monomeric  [!H,15N]- 
labelled  PaDDAH  acquired  after  the  incremental  addition  of ADMA.  The  black 
spectrum corresponds to the free protein and the dark blue spectra corresponds to the 
last titration point upon saturation of the enzyme, (b) Inset of (a) as delimited by the 
red  dotted  box.  The  arrows  indicate  spectra  acquired  at  increasing  ADMA 
concentrations.  The  spectra were  acquired  at  'H  proton  frequency of 500  MHz  at 
25°C (see Chapter 2, Section 2.5 for details).
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Figure 6.2. (a)  Superimposed  ^H^NJ-HSQC spectra of the monomeric PaDDAH 
acquired  after  the  incremental  addition  of  L-citrulline.  The  black  spectrum 
corresponds  to  the  free  protein  and  the  dark  blue  spectra  corresponds  to  the  last 
titration point upon saturation of the enzyme, (b) Inset of (a) as delimited by the red 
dotted  box.  The  arrows  indicate  spectra  acquired  at  increasing  L-citrulline 
concentrations.  The  spectra were  acquired  at  JH  proton  frequency of 500  MHz  at 
25°C (see Chapter 2, Section 2.5 for details).
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(b) Figure  6.3.  (a)  Chemical  shift mapping of the monomeric TYrDDAH  !HN-l5N 
resonances upon titration of ADMA (blue bars) and  L-citrulline (red bars).  A8 
values  were  estimated  with  the  function  A8=[(A81 HN )2+(A815N/5)2]l/2.  Yellow 
bars indicate resonances that broadened beyond the detection  limit during the 
titration  of  either  ligand.  The  dashed  line  indicates  the  average  A8  value 
obtained upon ADMA titration (-0.05 ppm) and the full line indicates A8 values 
> A8average + 1*SD. The secondary structure elements are indicated at the top of 
the  figure.  The  designations  Ln  or  an  refer  to  the  loops  and  helices  of the 
structure as defined in Murray-Rust et al. (2001).  (b) TteDDAH X-ray structure 
showing in blue residues for which A8 values > A8average +  1*SD and in yellow 
residues  with  no  titration  end  point.  The  complexed  L-citrulline  molecule  is 
shown in CPK colouring.confidently determined due to resonance overlap; these residues included Glu 33, Val 
64, Val 68, Glu 83, Glu 171, Val 182, Asn 209 and Glu 210.
From  a  structural  perspective,  the  largest  chemical  shift  deviations  observed  are 
associated  with  nine  regions  of the  protein.  As  might  have  been  expected,  residues 
around the active site region are the most sensitive to ligand binding.  In broad terms, 
these residues  are  located within  all  seven  loop  regions  of the  protein,  six  of which 
constitute the active site region. Additionally residues situated in two helices al and a2 
also undergo perturbations  upon  ligand binding.  To illustrate this result, residues  for 
which A5 values are larger than the average A6aV erage value by one standard deviation 
(SD) have been mapped onto the PaDDAH crystal structure as shown in Figure 6.3b. 
Particular  attention  was  paid  to  residues  located  in  loop  LI  over  the  active  site. 
Notably  Gly  17  and  Gly  24  have  large  chemical  shift  perturbations  upon  ADMA 
titration.  Close inspection of the HSQC  spectra reveals that these two resonances are 
affected  by  severe  broadening  during  the  titration,  although  the  cross  peaks 
corresponding to the final two titration points are detected (Figure 6.4a). In contrast, no 
titration  end  point  for either Gly  17  or Gly  24  resonances  could  be  found  upon  L- 
citrulline  binding  (Figure  6.4b).  In  a  similar  fashion,  all  other  resonances 
corresponding to residues located in loop LI  undergo severe line broadening beyond 
the NMR detection limit. From the X-ray structure, only the carbonyl group of Leu  18 
in  loop  LI  interacts  with  the  ligand  (Murray-Rust  et  al,  2001),  so  that  the  large 
chemical  shift  variation  observed  for Gly  17  and  Gly  24  and  the  broadening  effect 
affecting  the  other  adjacent  residues  are  likely  to  reflect  conformational  changes 
undergone  by  the  loop  LI  upon  ligand  binding,  rather  than  report  on  the  precise 
location  of the  binding  site.  Ligand-induced  conformational  changes  are  known  to 
complicate  the  interpretation  of  the  chemical  shift  changes  of  residues  which  are 
directly  implicated  in  binding  (Zuiderweg,  2002).  This  phenomenon  is  likely  to  be 
responsible for the chemical shift perturbations observed for several residues located in 
helices al  and a2. In the latter case, residues 86 and 87 of helix a2 are located in the 
tilt of the helix preceded by residues located in loop L3, Gly 81  and Ala 82 for which 
the  NMR  signal  broadens  beyond  the  detection  limit.  This  entire  region  is  also 
perturbed upon ligand binding despite the fact of not being directly part of the binding 
pocket.
Other regions of the protein sensitive to ligand binding include residues in loop L2 and 
L5; residues Asp 60 and Arg  132 exhibit the largest A8  values in  these two regions.
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Figure  6.4.  Superimposed  sections  of  pH^NJ-HSQC  spectra  of  monomeric 
['H^N]-labelled  PaDDAH  acquired  upon  addition  of  (a)  ADMA  and  (b)  L- 
citrulline. The black spectrum corresponds to the resonances of the free protein and 
the dark blue spectrum corresponds to the last titration point upon saturation of the 
enzyme. The spectra were acquired at  proton frequency of 500 MHz at 25°C (see 
Chapter 2, Section 2.5 for details).
179From crystallographic  evidence both  these residues  interact  with  the bound citrulline 
ligand. Asp 60 forms a hydrogen bond between its carboxyl group and the L-citrulline 
a-amide group and Arg  132 forms hydrogen bonds between its guanidino moiety and 
the a-carboxyl group of the ligand molecule.
Finally,  chemical  shift  changes  are  observed  for  regions where  the  catalytic  triad
residues  lie.  In  this  respect,  the  NH  signal  of residue  Val 113  is  more  sensitive  to
ligand  binding  than  the  actual  active  site  residue  Glu  114  located  in  loop  L4. 
Conversely,  both  active  site  residues  His  162  in  loop  L6  and  Cys  249  in  loop  L7 
exhibit NH resonances with large A5 values. Nearby residues of His  162, such as Glu 
158  and  Val  160,  also  have  NH  signals  perturbed  upon  ligand  binding  and  other 
residues such as Thr 165 in loop L6 undergo severe broadening of their line shapes. In 
a similar manner a subset of NH resonances in the vicinity of Cys 249 (in loop L7) also 
undergo line broadening (lie 243, Val 247 and Met 250).
Detailed analysis of the chemical exchange regime of the NH  resonances
The first requirement when characterising the binding of a ligand to a macromolecule 
is to determine the exchange regime between bound and free forms. When considering 
a two-site, second-order exchange process between the ligand L and the protein P, the 
on  and off-rates  (kon  and & Q ff respectively) defining the  formation  of the complex PL 
are given by:
Ln    \
P + L  ^----  PL  Equation 6.1
£ (> ff
When the exchange rate between the complex and the free species is fast on the NMR 
time scale, the following conditions applies (Feeney et al., 1979):
2n\vF  ~ vB\  «   (kof{  +fcon[L])  Equation 6.2
where vF and  vb are the resonant frequencies  (Hz)  of the nucleus  in the free and the 
bound  states,  [L]  is  the  ligand concentration.  A  single  resonance  is  observed  in  this 
case at the frequency defined as  v = pFvF  -  p BvB, where pF and pB are the fractional 
populations  of  the  free  and  bound  states.  Under  these  conditions,  the  dissociation 
binding constant for this reaction is then defined as:
^  [P][L]  K t  _  ..  _
a  ,  = -----------= --------  Equation 6.3
[PL]  K„
180Hence,  a  distinct  advantage  of  screening  compounds  by  NMR  is  the  possibility  of 
determining the dissociation constants for the complex. At equilibrium, [PL] = /?Po, [P] 
= (l-p)[P0],  and  [L]  =  [Lo]  -p[PoL where  [Lo]  and  [Po]  are the total concentrations of 
ligand and protein respectively. These equations can be substituted in Equation 6.3 to 
yield:
([P„] + [L„] + [A:d]-V([Po] + [Lo] + [^d])2-4[P„][L0]  „
p =----------------------------1 --------------------------------------------  Equation 6.4
2[P„]
Where the parameter p represents the fractional populations of bound and free states at 
equilibrium  (Pellecchia,  2005): p = (Sobs ~ Sfree)l(Ssat ~ Sfree) ,  50bs  is  the  observed
chemical shift measured during the titration, and 5free and 8sat are the chemical shifts of 
the free state and the fully bound state of the protein respectively. Hence, the chemical 
shift mapping by stepwise titration of the ligand can provide an estimate of Kd through 
a nonlinear least squares fit of p as a function of total ligand concentration  [Lo]  or, in 
some  instances,  of  the  molar  ratio  between  ligand  and  protein  concentrations  (see 
Chapter 2, Section 2.5 for more details).
Alternatively, in the slow exchange regime, when the life times of the bound and free 
forms of the protein are long relative to the chemical shift difference time scale (k0ff + 
&on[L])  «   27iAu,  two  resonant  frequencies  are  ultimately  observed.  The  binding 
constant can still be determined by measuring the intensities of the resonances from the 
disappearing  peak  and/or the  appearing  peaks  as  a  function  of the  concentration  of 
added ligand.
However,  in  the  intermediate  exchange  regime,  when  (& 0ff  +  &on[L])  ~  27cAu,
differential  line broadening precludes the estimation  of a dissociation constant as the 
relevant resonances often disappear from the 2D NMR spectra.
In  the  case of PaDDAH,  the titration  of either ADMA  or L-citrulline did not reveal 
any  resonance  with  behaviour consistent  with  the  slow  exchange  regime.  However, 
several NH resonances either shift progressively without change in intensity, which is 
characteristic of the fast exchange regime, or experience just slight line broadening at 
intermediate ligand concentrations. In the latter case, the resonances were considered 
as being in a “moderately fast” exchange rate regime as defined by Lian and Roberts,
181(1993). In practice, in cases where only slight exchange contributions to the line widths 
are observed for a particular resonance,  the  fast exchange regime  is  still  assumed to 
facilitate  the  analysis.  In  this  vein,  the  amide  groups  of Cys  249  and  Gly  87  were 
assumed to  be  under time  fast exchange  kinetics  in  order to estimate  qualitatively  a 
dissociation  constant  for the  complexes  (Figure  6.5).  The  normalised chemical  shift 
changes  of  these  cross  peaks  in  either  *H  and  15N  dimensions  were  plotted  as  a 
function of the molar ratio of ligand to protein. The molar ratio was chosen instead of 
the actual  ligand concentration in Equation  6.4 to  account for protein dilution  as the 
titration proceeded (see Chapter 2, Section 2.5). The nonlinear least-squares fit to the 
data using Equation 6.4 yielded the binding curves for ADMA and L-citrulline shown 
in Figure  6.6.  From the chemical  shift changes  obtained from Gly  87  and Cys  249, 
ADMA has  a mean estimated dissociation constant of 413  ± 63  pM (n = 2).  The K&  
value  obtained  for  ADMA  is  consistent  with  the  A T M   value  of this  enzyme  for  the 
substrate which  is  around 460  pM.  In  contrast,  L-citrulline  had a mean  estimated  8- 
fold lower affinity for PaDDAH as the  obtained is 3.35 ± 0.57 mM (n = 2). This 
result is also consistent with findings that indicate L-citrulline does bind to the active 
site at very high concentrations (Murray-Rust et al., 2001).
However,  several  amide  resonances  broaden  markedly  as  ligand  concentration 
increases  becoming  undetectable.  The  signal  reappears  at  the  highest  ligand 
concentrations  and  can  still  shift  as  the  concentration  is  further  increased.  This 
behaviour  is  characteristic  of the  intermediate  exchange  regime  (Lian  and  Roberts, 
1993).  In  particular,  resonances  that  display  this  behaviour  correspond  to  residues 
involved in direct interaction with the ligand, as exemplified by the effect of ADMA 
titration on Asp 60 and His  162 shifting resonances (Figure 6.7). For resonances in the 
intermediate exchange regime, the approximation (kG ff + kon[L]) ~ 27iAu can relate the 
broadening of the cross peaks of the free  and bound forms of the protein  to the rate 
constant  k 0ff  according to  k 0ff  ~   27 cA d ,  where kon[L] is assumed to be small relative to 
k0ff (Katoh et al., 2003).
Under this assumption,  a qualitative estimate of the kD ff rates from the chemical  shift 
changes  of the NH resonances of Asp 60 and His  162 was obtained.  On  average the 
amide proton of these residues shifts 7-44 Hz in the !HN  dimension which corresponds 
to  a  dissociation  rate  kD ff  of  44  to  276  s'1.  Similarly,  several  amide  cross  peaks 
corresponding to residues in loop LI  also experience severe line broadening midway
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Figure  6.5.  Examples  of HN  resonances  under the time  fast  to  “moderately  fast” 
exchange regimes.  Superimposed sections of pH^NJ-HSQC spectra of monomeric 
[^H^N]-labelled  PaDDAH  showing  the  resonances  corresponding  to  residues  (a) 
Cys  249  and  (b)  Gly  87  upon  the  incremental  addition  of  ADMA.  The  black 
spectrum  corresponds  to  the  free  protein  resonances  and  the  dark  blue  spectrum 
corresponds  to  the  last  titration  point.  The  spectra  were  acquired  at  *H  proton 
frequency of 500 MHz at 25°C (see Chapter 2, Section 2.5 for details).
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Figure 6.6. Examples of binding-curves obtained for residues Gly 87  and Cys 249 
following the titration of ADMA (a,b) and L-citrulline (c,d) (see Chapter 2, Section 
2.5 for details). The curves were obtained from a non-least squared fitting of the data 
to equation 6.4.
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Figure  6.7.  Examples  of HN  resonances  under  the  time  intermediate  exchange 
regime.  Superimposed  sections  of pH^NJ-HSQC  spectra of monomeric  pH ^N ]- 
labelled .PuDDAH showing the resonances corresponding to residues (a) Asp 60 and 
(b)  His  162  upon  the  incremental  addition  of  ADMA.  The  black  spectrum 
corresponds to the free protein resonances and the dark blue spectrum corresponds to 
the  last  titration  point.  The  spectra  were  acquired  at  !H  proton  frequency  of 500 
MHz at 25°C (see Chapter 2, Section 2.5 for details).
185through the titration of ADMA (Figure 6.4a). Higher kQ ff values around 600 and 860 s'1  
were estimated for residues Gly  17  and Gly 24, respectively (Figure 6.4a).  Since Gly 
17  and  Gly  24  are  not  directly  involved  in  contacts  with  the  ligand,  the  £0ff  rates 
estimated are not a reflection of the local on- and off-rates between ligand and protein, 
but rather they report on the overall response of this region of the protein to the ligand 
binding  process.  In  this  respect,  the  apparent  & D ff  values  might  reflect  the  rate  of 
conversion  between  the  ligand-bound  state  and  that  of apo-form  of the  protein  and 
thus, they could be envisaged as off-rates reflecting the local dynamics induced upon 
ligand interaction (Gunther et al., 2002).
6.3  Assessing the binding schemes of different DDAH inhibitors
The classes of compounds
Several  disease  states  where excess nitric  oxide  synthase  (NOS)  activity  is  involved 
have  underlined  the  importance  of  finding  effective  routes  to  increase  the  in  vivo 
availability of NOS endogenous inhibitors,  such as ADMA and L-NMMA.  One such 
route  entails  the  pharmacological  inhibition  of the  DDAH  enzymes.  The  search  for 
DDAH inhibitors has prompted a collaborative effort between  several departments at 
UCL in order to generate a small molecule library from which these inhibitors might 
be  developed.  In  this  sense,  two recent publications  have  successfully described the 
design  of  low  micromolar  substrate-based  inhibitors  against  mammalian  DDAH 
enzymes  (Rossiter  et  al.,  2005)  and  the  use  of  sulphonamide  derivatives  in  the 
inhibition of both bacterial DDAH and arginine deiminase (ADI) enzymes (Vallance et 
al., 2005).
In  the  course  of  our  investigations,  it  became  increasingly  clear  that  bacterial  and 
mammalian  DDAH  enzymes  have  different  inhibitor  profiles.  The  screening  of 
substrate-based  inhibitors  described  as  competitive  inhibitors  of mammalian  DDAH 
enzymes failed to produce any real hit against PaDDAH. One molecule however, SR 
140  (Figure  6.8A)  did  show  low  micromolar inhibitory concentration  I C 50  ~  30  pM 
against  PaDDAH  (Dr  R.  Hurtado, personal  communication)  and  was  consequently 
chosen  as  a candidate for NMR titration  experiments.  Additionally,  SR 227  and SR 
257, described by Rossiter et al.  (2005) as being good mammalian DDAH I inhibitors, 
were further scrutinised by our NMR experiments despite their rather high  I C 50  values 
measured against PaDDAH (>1 mM; Dr R. Hurtado, personal communication', Figure
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Figure  6.8.  Molecular  structures  of the  different  compounds  used  in  the  NMR 
titration experiments. (A) The red box highlights the conservation of the guanidino 
moiety in substrate-based compounds. (B) HB 65 and HB  102 are sulphonamide and 
pentafluorophenyl sulfonate compounds respectively.
1876.8A).  Moreover,  the  discovery  that  sulphonamides  could  inhibit  PaDDAH  also 
prompted us to characterise this new class of molecules with two representatives from 
the  family,  HB  65  and  HB  102  (Figure  6.8B;  Vallance  et  al.,  2005).  The  authors 
suggest that PaDDAH could represent an additional  antibacterial target which would 
further validate the comparison of the binding schemes of these different compounds.
Titrations experiments with SR 140, SR 227 and SR 257
The details of the j^H^NJ-HSQC experiments performed are summarised in Table 2.4 
(Chapter  2,  Section  2.5).  The  series  of substrate-based  inhibitors  selected  for  these 
studies  all  share the common guanidino moiety seen  in the  substrate ADMA (Figure 
6.8A).  Specifically, SR  140 found to inhibit PaDDAH with  an IC50 of 30 pM, is one 
methylene  group  shorter than  the  substrate  and in  principle  should bind in  the  same 
cavity  as  ADMA.  This  assumption  was  verified  upon  titration  of this  ligand  using 
NMR. The corresponding chemical shift changes in the HSQC spectrum of monomeric 
PaDDAH  upon  the  addition  of  SR  140  have  been  plotted  as  a  function  of residue 
number (Figure 6.9a). The pattern of chemical shift changes obtained is comparable to 
the one observed for ADMA or L-citrulline.  Residues for which resonances  shift the 
most  during  the  titration  are  located  in  the  loop  areas  and  in  helices  al  and  a2. 
However, the overall  values of the chemical  shift perturbations are smaller and more 
resonances are affected by line broadening (Figure 6.9a). Unexpectedly, the amount of 
inhibitor necessary to reach the saturation point of the enzyme, defined by the absence 
of chemical  shift  changes  upon  further  addition  of ligand,  surpasses  the  amount  of 
ADMA used to saturate the enzyme. The molar ratio of ligand to protein reached 10:1 
at the last titration point acquired for SR  140, a value that is similar to the molar ratio 
of L-citrulline to protein reached upon saturation  (Table 2.4, Chapter 2,  Section 2.5). 
This result is counterintuitive since the small chemical shift changes observed upon SR 
140 titration and the increased degree of line broadening observed in comparison with 
the  results  obtained with  ADMA  suggest that  SR  140  is  even  a weaker binder than 
ADMA. At this stage, it is unclear whether the derived IC50 value by enzyme essay is a 
valid indication of the overall binding affinity towards the enzyme. A Kd value could 
not be  derived from the NMR titration  as the chemical  shift changes of residue  Cys 
249 or Gly 87 could not be fit satisfactorily to Equation 6.4.
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Figure 6.9. (a) Chemical shift mapping of the monomeric PaDDAH !Hn-15N resonances upon titration of SR 140 and (b) SR 227. A5 values 
were estimated with the function A8=[(A51 Hn)2+(A515N/5)2]1/2. Yellow bars indicate resonances that broadened beyond the detection limit 
during the titration of either ligand (the scaling along the y-axis is arbitrary). The dashed line indicates the average A8 value obtained upon 
titration. The secondary structure elements are indicated at the top of the figure. The designations Ln or an refer to the loops and helices of 
the structure as defined in Murray-Rust et al. (2001).With  respect  to  the  titration  of the  ether-based  compound  SR  227,  the  number  of 
PaDDAH resonances affected by exchange broadening again increased in comparison 
to the number observed during the SR  140 titration, although the observed changes in 
chemical shift are comparatively larger (Figure 6.9b). However SR 227 was not a good 
PaDDAH inhibitor as assessed by enzyme assay and it is tempting to speculate that the 
additional broadening of the resonances in the NMR experiment could reflect this fact. 
In the particular case of SR 257, the saturation of the enzyme could not be reached due 
to the limited amount of compound available and the chemical  shift mapping of this 
compound  could  not  be  achieved.  Nevertheless,  in  order  to  illustrate  the  recurring 
pattern  of  intensity  decay  of  several  !Hn,15N  cross  peaks  during  the  titrations,  the 
intensities of most 1 Hn,15N cross peaks obtained at a 1:1  ligand-protein complex were 
extracted  from  the  [’H^NJ-HSQC  spectra  of PaDDAH  upon  SR  140  and  SR  257 
addition and were plotted as a function of residue number (Figure 6.10). Clearly, at a 
1:1  complex  formation,  the  resonances  which  undergo  a  decrease  in  intensity  upon 
ligand titration correspond to residues located in the same regions of the protein which 
were perturbed by ADMA or L-citrulline addition.
Taken  together  the  titrations  of  several  substrate-based  inhibitors  of  mammalian 
DDAH enzymes against the bacterial PaDDAH enzyme clearly demonstrate that they 
can map the binding site previously defined by the ADMA and L-citrulline molecules. 
However, the smaller changes in chemical shifts observed, the increased degree of line 
broadening of the resonances and the higher ligand-to-protein molar ratio that had to 
be reached in order to saturate the enzyme attest to the overall low binding affinity of 
these compounds towards the bacterial homologue.
Titration experiments with HB 65 and HB 102
A different class of compounds, the sulphonamides (HB 65) and the pentafluorophenyl 
(PFP)  sulfonates  (HB  102),  were  recently  shown  to  inhibit the bacterial  DDAH  and 
ADI  enzymes  (Vallance  et  al.,  2005).  The  inhibition  results  for  compound  HB  65, 
based  upon  an  enzymatic  assay,  have  not  been  published but  an  I C 50  of 20  pM  has 
been  derived  for  this  compound  against  PaDDAH  (Dr  R.  Hurtado,  personal 
communication).  On the other hand, HB  102 refers to compound 3  in Vallance et al. 
(2005)  and  has  an  I C 50  of 21  pM  against  PaDDAH.  Due  to  their low  solubility  in 
aqueous buffers, both compounds were dissolved in dimethyl  sulfoxide (DMSO) and 
could only be titrated into PaDDAH up to a final molar ratio of 3:1  ligand to protein.
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Figure 6.10. Normalised intensities of the  1 HN,15N correlations extracted from the 2D-HSQC spectra of the  1:1  complex of SR  140 with 
PaDDAH  in  red  and  SR  257  with  PaDD  AW  in  blue.  The  secondary  structure  elements  are  indicated  at  the  top  of the  figure.  The 
designations Ln or an refer to the loops and helices of the structure as defined in Murray-Rust et al. (2001).Additionally,  a  control  experiment  was  performed  in  order  to  determine  whether 
DMSO would bind to the protein.  In fact, DMSO  alone does  alter the chemical  shift 
pattern of two resonances in the ^H^NJ-HSQC spectra of PaDDAH corresponding to 
the  side  chain  proton  of  residue  Trp  207  and  the  amide  group  of  Gly  229. 
Presumably a pocket exists at this location of the enzyme to accommodate such a small 
molecule.  More importantly however is the fact that neither compound perturbed the 
chemical  shifts of the protein  (Figure 6.11).  In  contrast to the titrations  of substrate- 
based compounds, these sulfonate derivatives are not targeted to the active site, at least 
not under the conditions of our NMR experiments. The authors describe HB  102 as a 
potent PaDDAH inhibitor in  vitro  and have  established that the PFP derivatives  are 
competitive inhibitors of the enzyme but are not clear as to their precise mechanism of 
inhibition. Nevertheless, they argue that the PFP-sulfonates must bind the protein more 
tightly  than  the  substrate  (Vallance  et  al.,  2005).  This  suggestion  is  clearly  in 
disagreement with our NMR results. In this respect, possible considerations aiming to 
explain  such  discrepancy  will  be  necessarily  speculative.  One  concern  lies  with  the 
potential ability of DMSO to inhibit the enzyme.  A qualitative assay did confirm that 
the presence of DMSO at concentrations higher than  10% (v/v) in the reaction mixture 
could  inhibit  the  enzyme  (data  not  shown).  Although  this  concentration  was  never 
reached in our NMR experiments or in the PaDDAH inhibition assays presented by the 
authors, this issue is still a matter to consider since the NMR titrations have shown that 
DMSO could bind PaDDAH in the fast exchange regime (Figure 6.11). Alternatively, 
due to the low solubility of the compounds, HB 65 and HB  102 could have aggregated 
in  solution  during  our  experiments  precluding  the  binding  to  the  enzyme.  Another 
possibility  for  the  discrepancies  observed  entails  the  existence  of  an  alternative 
mechanism  of  inhibition  for  this  class  of  compounds,  in  such  a  way  that  these 
compounds could interfere in the binding event of ADMA.
Control experiments with WT PaDDAH
The  NMR  titration  of  several  compounds  into  the  monomeric  PaDDAH  has  so  far 
failed to provide a clear understanding regarding the exact basis of the conformational 
exchange  that  affects  the  LI  loop  upon  binding.  Concerns  over  the  impact  of  the 
structural rearrangements that could have occurred upon the introduction of two point 
mutations in the enzyme led us to ensure that the conformational exchange broadening 
observed for several  cross peaks  is  intrinsic  to the  bound  state of the enzyme rather
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Figure  6.11.  (a)  Superimposed  ['H,15N]-HSQC  spectra  of the  monomeric  ['H^NJ-labelled  PaDDAH  acquired  after  the  incremental 
addition of HB  65  (a)  and  HB  102  (b).  The black  spectra correspond to  the free protein,  the red  spectra to  that of a  1:1  ligand-protein 
complex and the light blue spectra correspond to a 3:1  ligand-protein complex. The spectra were acquired at  *H proton frequency of 500 
MHz at 25°C (see Chapter 2, Section 2.5 for details).than an artefact of the monomerisation strategy.  In this vein, SR  140 and HB 65 were 
titrated into the ,5N-labelled WT PaDDAH protein. The results obtained were analysed 
by inspecting changes in chemical shift or cross peak intensity in the ['H,1 :)N]-TROSY 
spectra.  By reference to the titration  studies of the monomeric enzyme, the pattern of 
broadened  'Hn-1 :)N  resonances  of WT  PaDDAH  observed  upon  titration  of SR  140 
agrees  well  with  the  pattern  of cross  peaks  affected in  the  monomeric  enzyme.  This 
result  is  illustrated  in  Figure  6.12  by  several  ['H,15N]-TR0SY  sections  in  which 
resonances  could  be  easily  identified  through  the  comparison  with  ['H,1 :)N]-HSQC 
spectra of the double mutant monomeric protein  at  a ligand-to-protein  molar ratio of 
2:1  (Figure  6.12).  The  resonances  corresponding  to  residues  located  in  the LI  loop, 
such as Gly  14, Leu  18, Thr 19 and Gly 24 and residues around the active site regions 
such  as  Gly  116,  Glu  158,  Lys  164,  Thr  165  and  Met  250  are  all  subject  to 
conformational  exchange  broadening.  This  finding  confirms  that  the  structural 
rearrangements  undergone  by  the  loop  upon  binding  are  reproduced  in  both  the 
homodimeric  and  monomeric  proteins.  In  addition,  the titration  of the  sulphonamide 
HB 65 into WT PaDDAH also supports the NMR results previously obtained with the 
monomeric  enzyme.  No  cross  peaks  have  been  affected  by  the  addition  of  HB  65 
except the two amide resonances perturbed by the binding of DMSO (data not shown).
6.4  The covalent binding of 2-chloroacetamidine  and  S-nitroso-L-cysteine  to  the 
reactive Cys 249 of PaDDAH
Irreversible inhibitors of PaDDAH
The discrepancies over the binding affinities of PaDDAH inhibitors  and the inability 
to reach saturating conditions with several of these compounds has raised the question 
as  to  whether the presence  of a covalently  bound inhibitor attached to  an  active  site 
residue could in principle lessen the line broadening affecting residues in the LI  loop 
and consequently enable the study of the  dynamics of the complex.  Since the crystal 
structure of PaDDAH provided a clear view of the bound state of the enzyme and the 
temperature B-factors obtained for the region of the LI  loop were not evidently higher 
than the overall  average for the entire enzyme (data not shown), we surmised that one 
route  of  obtaining  a  definite  view  of  the  bound  state  was  to  search  for  molecules 
capable  of  reacting  with  the  active  site  Cys  249  and  consequently  locking  the 
conformation of the enzyme into the bound form.
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Figure  6.12.  (a)  Superimposed  pH^NJ-TROSY  spectra  acquired  of the  ^H,15!'!]- 
labelled WT PaDDAH in the absence (black spectra) and presence of the ligand SR 
140 (red spectra) at a molar ratio of 2:1  ligand-to-protein. (b-d) Insets of (a) showing 
sections of the spectra were resonances undergo line broadening.  The spectra were 
acquired at *H proton frequency of 500 MHz at 25°C (see Chapter 2, Section 2.5 for 
details).
195Recently,  the  small  molecule  2-chloroacetamidine  was  shown  to  irreversibly  inhibit 
not only PaDDAH but also the peptidylarginine deiminase (PAD) enzymes (Stone et 
al,  2005b). The  mechanism of inhibition  is  shown  in Figure 6.13a and involves the 
nucleophilic  attack  of  the  thiol  group  of  Cys  249  on  the  C-Cl  bond  of  2- 
chloroacetamidine. More interestingly, Knipp and co-workers suggested an alternative 
route  to  inhibit  the  DDAH  enzymes.  They  have  synthesised  reactive  S-nitroso- 
compounds, which covalently attach to the active site cysteine of DDAH I (Knipp et 
al,  2005).  In  particular,  S-nitroso-L-homocysteine  (HcyNO)  derived  from  the 
precursor  molecule  L-cysteine  irreversibly  inactivated  the  enzyme.  The  reaction 
involved  is  displayed  in  Figure  6.13b  with  S-nitroso-L-cysteine  (CyNO)  compound 
acting as the substrate instead of HcyNO. Ultimately, CyNO was chosen in our studies. 
The titration experiments of 2-chloroacetamidine and CyNO into the PaDDAH active 
site offer the prospect for a comparative  study  between the binding  schemes  of two 
additional  ligands.  The fact that these compounds  are covalently linked to the active 
site cysteine will provide additional insight into the characterisation of the bound-state 
of PaDDAH and the conformational heterogeneity of the loop LI.
Chemical shift mapping of covalently linked compounds
Increasing amounts of 2-chloroacetamidine were left to react at room temperature with 
a 0.8 mM [1 H-15N]-labelled PaDDAH sample. Following each incremental addition, a 
[^H^NJ-HSQC  spectrum  was  acquired  until  the  saturation  of  the  enzyme  was 
achieved. With regards to the experiments with CyNO, only one titration point could 
be  obtained  due  to  the  labile  nature  of  the  reactant.  S-nitroso-L-cysteine  was 
synthesized according to the method of Stamler and Feelisch  (1996).  Briefly,  CyNO 
was  obtained  from  the  5  minute  reaction  of equal  volumes  of a  0.3  M  solution  of 
NaN02 (dissolved in  1  M HC1) and of a 0.3 M solution of L-cysteine. Ultimately, an 
excess amount of the resulting CyNO solution (6 mM final concentration) was left to 
react with the 15N-labelled PaDDAH sample (0.3 mM, Buffer C) for 30 min at 37°C. 
The  subsequent  acquisition  of  several  ['H^NJ-HSQC  spectra  confirmed  the 
completion of the reaction as no further changes in the spectra could be observed. Due 
to  the  lack  of  intermediate  titration  points,  several  amide  resonances  could  not  be 
confidently re-assigned in the ligand bound state of the protein  (in this case, residues 
31, 57, 58,  123,  126, 157, 238, 249).
196Figure 6.13. Nucleophilic attack of the reactive Cys 249 (1) of PaDDAH against (a) 
2-chloroacetamidine (2) and (b) S-nitroso-L-cysteine (3).
197The mapping of the chemical shift changes induced upon the titration of the molecules 
is plotted as a function of residue number in Figure 6.14. The overall magnitude of the 
perturbations induced by 2-chloroacetamidine is comparable to the changes induced by 
L-citrulline (Figure 6.14a). However, contrary to what was observed for the substrate 
and  product  molecules,  only  four  main  regions  of  the  protein  are  significantly 
perturbed by  2-chloroacetamidine.  These  regions  are  confined  to  residues  Gly  81  in 
loop L3 at the entrance of the active site; to residues Ala  115  and Gly  116 in loop L4 
where the active site residue Glu 114 lies; to residues  158-160 and Leu 163 located in 
loop L6  with the additional  line broadening of resonances  belonging to Leu  161  and 
His  162;  and  to  residues  in  loop  L7  where  the  third  active  site  residue  Cys  249  is 
situated. Interestingly, 2-chloroacetamidine binding did not interfere with the chemical 
exchange kinetics of the  amide groups belonging to residues  located in  loop LI  and 
NH resonances corresponding to residues could easily be assigned in the bound state. 
This finding is in contrast with  what has been  observed upon  ADMA or L-citrulline 
titration which invariably led to the almost complete broadening of the resonances in 
question.
In  comparison,  the  reaction  with  CyNO,  which  is  a  larger  molecule  relative  to  2- 
chloroacetamidine,  induces  the  pattern  previously  observed  of  *Hn-15N  resonances 
which  “disappear”  for  residues  in  the  LI  loop  region  (Figure  6.14b,  residues 
represented by  yellow  bars).  When  discussing the titration  results  of ADMA,  it was 
argued that the broadening of the resonances of the LI  loop reflected some degree of 
conformational  fluctuation  of this  region  induced upon  ligand binding.  The  fact that 
CyNO is attached to the cysteine residue in the active site disallows the notion that the 
kQ f{ rates of CyNO binding could have been responsible for the line broadening effect. 
In  this  respect,  the  interpretation  of  these  data  suggests  that  the  bound  state  of 
PaDDAH is not defined by a single conformation and that the loop LI  over the active 
site is  not locked into  a  single  position  as  suggested by the X-ray structure.  The LI 
loop  might  sample  multiple  conformations  in  the  ligand-bound form  of the  enzyme 
with  an  altered  motional  regime  with  respect  to  the  apo-form  of  PaDDAH.  This 
movement seems  independent of the reversibility of ligand binding but is  apparently 
modulated by the size of the molecule occupying the binding pocket.
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Figure 6.14. Chemical shift mapping of the monomeric PaDDAH 1 HN-1 5N resonances upon the reaction with (a) 2-chloroacetamidine (red) 
and  (b)  S-nitroso-L-cysteine  (blue).  A5  values  were  estimated  with  the  function  A5=[(A81 HN)2+(A515N/5)2]1/2.  Yellow  bars  indicate 
resonances that broadened beyond the detection limit (the scaling along the y-axis is arbitrary). The full line indicates the average A5 value 
obtained upon titration. The secondary structure elements are indicated at the top of the figure. The designations Ln or an refer to the loops 
and helices of the structure as defined in Murray-Rust et al. (2001).15N relaxation studies of the monomeric PaDDAH bound to 2-chloroacetamidine 
The titration of 2-chloroacetamidine into the monomeric PaDDAH active site showed 
that  this  small  compound  did  not  significantly  affect  the  characteristic  ligand- 
dependent exchange broadening of the amide NH cross peaks assigned to residues in 
the LI  loop.  Since most resonances of the remainder of the protein are visible in the 
spectra  of  the  ligand-bound  state,  we  concluded  that  the  study  of  the  dynamic 
properties of this complex would provide additional  insight into the behaviour of the 
LI  loop  and residues in  the  active  site.  15N R2, R\  and  'H-j^NJ-heteronuclear NOE 
relaxation  parameters  of  the  monomeric  PaDDAH  enzyme  complexed  with  2- 
chloroacetamidine were measured at 600 MHz (see Chapter 2, Section 2.5 for details 
of the experiments). The results were analysed following the reduced spectral density 
mapping  procedure  (Farrow  et  al.,  1995).  7(0),  J(con)  and  7(0.87o>H)  have  been 
estimated in the same manner as previously described for the apo-state of monomeric 
PaDDAH and the values  are plotted as a function  of residue number in Figure 6.15. 
For comparative  purposes,  the  values  of 7(0),  7(&>n)  and 7(0.87cuh)  obtained for the 
apo-protein  are  also  plotted.  Clearly,  both  the  ligand-bound  and  the  apo-state  of 
PaDDAH display remarkably similar spectral density values. In the bound state of the 
protein, the presence of motions  on the ms to  ps timescale,  indicated by 7(0) values 
higher than one standard deviation from the mean are observed for residues Phe 2, Val 
62, Gly 116 and for residues  145-146 and 164-166 in the L6 loop (His  162 broadened 
beyond the detection limit and could not be assigned in the bound state). Incidentally, 
most regions that experience motions in the ms to ps timescales in the free protein still 
undergo conformational exchange contributions in the ligand-bound state.
With respect to the higher frequencies  i.e.  7(0.87cuh)  and J(cojf),  sensitive to motions 
occurring at the ps and ns timescale, they are present in loops LI  (17-24), L3 (79 and 
81),  L6  (158),  for  residues  180  and  198  which  lie  in  310-helices  (Figure  6.15b,c). 
Following the ligation of 2-chloroacetamidine, the regions of the protein experiencing 
ps to ns timescale motions are the same as those of the free protein. In particular, the 
presence of a small covalently linked molecule in the active site has not affected the 
motional regime of the LI loop over the active site.
The  view  that  emerges  from  these  observations  is  that  although  the  changes  in 
chemical  shifts  observed  upon  2-chloroacetamidine  binding  attest  to  some 
conformational  rearrangements  and  changes  in  the  chemical  environment  of several
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Figure 6.15. Values of the reduced spectral densities J(co) of R40E-R98H PaDDAH bound to 2-chloroacetamidine (full circles) and of apo- 
R40E-R98H PaDDAH (open circles) estimated at (a) J(0), (b) J(&>N) and (c) J(0.S7coH) plotted as a function of residue number and extracted 
at 600 MHz. Secondary structure elements are indicated at the top of the Figure.nuclei,  the timescales  of motional  regimes  are preserved in  most parts of the protein 
compared to the free protein.
6.5 Discussion
In  an  effort  to  characterise  the  ligand-bound  state  of  the  PaDDAH  enzyme,  small 
molecule compounds  designed to inhibit the mammalian DDAH enzymes  have been 
screened for their ability  to  bind  the  bacterial  DDAH  homologue.  We  have  applied 
NMR  methodology  to  study  the  chemical  shift  perturbations  induced  by  several  of 
these ligands in order to map the protein binding site. The initial titration experiments 
of the substrate ADMA and the product L-citrulline into the active PaDDAH enzyme 
confirmed that the chemical shift changes observed were in fact, in both instances, due 
to  the  catalytic  product.  Namely  the  chemical  shifts  correspond  to  the 
PtfDDAHicitrulline  complex.  The  regions  affected  by  ligand  binding  included  the 
actual binding pocket but also regions not directly involved in binding.
Residues directly implicated in ligand contacts
From crystallographic evidence,  the  side chains  of Asp  60,  Glu  65,  Glu  66,  Arg  85, 
Arg 132, His 162 and Cys 249 are the largest contributors to the overall contact surface 
area between the protein  and the ligand (Figure  6.16).  However,  the NMR data only 
show  significant chemical  shift changes  for the  amide  groups  of the  two  active  site 
residues, Arg  132 and Asp 60 (Figure 6.3a). The two acidic residues Glu 65  and Glu 
66,  which  lie  at  the  bottom  part  of the  active  site  cleft,  display  average  to  below- 
average  chemical  shift  perturbations.  Although  the  side  chains  of these  residues  are 
involved  in  hydrogen  bonds  with  both  ADMA  and  L-citrulline  molecules,  their 
backbone  amide  resonances  are  apparently  shielded  from  a  significant  change  in 
chemical environment upon ligand binding. The same is true for other residues located 
in the binding pocket such as Arg 85.
In  trying to relate the chemical  shift changes for residues directly involved in  ligand 
contact with the kinetics of the ligand binding process, a qualitative estimate of the off- 
rates, derived from the chemical shift changes of Asp 60 and His 162, set the & 0ff value 
at the lower range of 44 to 276 s’1. These low values are normally indicative of high 
affinity  binding  characterised  by  slower  interaction  processes  in  the  binding  site 
(Gunther et al,  2002).  However, the Kd value estimated for ADMA from a fit of the
202Figure  6.16.  3D  view  of the  active  site  region  of PaDDAH  complexed  with  L- 
citrulline (pdb code:  lh70). Residues involved in ligand-contact are shown in CPK 
colouring.  Note, the O  atom of Ser 249  in the PaDDAH X-ray structure has been 
coloured yellow to reflect the presence of the S atom of Cys 249.
203ligand-induced chemical shift changes as a function of ligand-to-protein ratio is only in 
the  high  micromolar  range,  which  is  not  characteristic  of  a  tight-binding  ligand. 
However,  Equation  6.3  states  that  Kd  =  k0ff/k0n.  For  a  low  kQ ff rate  with  a  Kd  value 
around 10'3 M, the kon rate must be around 106L mol'1  s'1, a value which is three orders 
of magnitude lower than the diffusion-controlled rates.  A low kon rate could reflect a 
low availability of protein conformers able to bind the ligand with high affinity, which 
would  ultimately  result  in  a  poor  interaction.  In  a  similar  manner,  non-productive 
binding between  several  conformers  and the  ligand would entail  the need to reverse 
these interactions before a subsequent relevant binding event could proceed.  Such an 
event would also lower the apparent on-rate.
The  possible  existence  of  two  or  more  conformational  states  of the  protein  in  the 
binding-pocket  region  does  not  rule  out  the  possibility  that  the  ligand  could  be 
sampling alternate binding modes. Evidence in support of this more complex binding 
mechanism comes from the analysis of specific backbone amide resonances around the 
active site which broaden beyond the detection limit upon ligand binding. In this case, 
Gly 116 in loop L4, Thr 165 in loop L6 and lie 243, Val 247 and Met 250 in loop L7, 
all  share the  same characteristic pattern of broadened  !Hn,15N correlations.  Although 
this behaviour is consistent with the intermediate exchange regime, it deviates from the 
classic  case,  since  these  resonances  do not  sharpen  as  a result  of protein  saturation. 
Recently,  Reibarkh  et  al.  (2006)  suggested  an  explanation  for  the  increased  line 
broadening of the resonances upon the binding of ligands under saturating conditions. 
The  authors  argue  that  the  origins  of  such  marked  broadening  effect  could  be 
associated  with  what  they  have  termed  as  multiple-mode  binding  of the  ligand.  To 
substantiate their hypothesis  and illustrate their own findings  with Bcl-xL inhibitors, 
they have been able to simulate the line shapes of resonances for which no titration end 
point could be found in the presence of excess of ligand. In our experiments, ADMA 
and L-citrulline  are clearly in  large excess  with  respect to the protein  concentration. 
Following the interpretation of Reibarkh et al.  (2006), the complete broadening of the 
set  of NH resonances  mentioned  above  indicates  that ADMA  and L-citrulline might 
adopt two or multiple bound-states of comparable energy. This mechanism of binding 
together  with  the  possible  low  availability  of  conformers  of  PaDDAH,  which  are 
competent  to  bind  ADMA  with  high  affinity,  provide  an  explanation  for  the  high 
micromolar A T m  and Kd values of ADMA estimated for this enzyme in vitro. This view 
is  compatible  with  the  notion  that  the  free  enzyme  samples  multiple  conformations
204until those resembling the transition state are achieved,  allowing catalysis to proceed 
(Tousignant and Pelletier,  2004).  In this regard,  it is  noteworthy that residues in the 
active  site  pocket  that  completely  broadened  in  the  2D-HSQC  spectra  upon  ligand 
binding are also residues identified as undergoing chemical exchange in the apo-form 
of the enzyme as shown by the 15N relaxation studies performed.
The  interpretation  of the  dynamic properties  of PaDDAH could also be extended to 
explain  the behaviour of several  human DDAH I  substrate-based inhibitors  we have 
titrated into  the  bacterial  PaDDAH.  Upon  SR  140,  SR  227  and  SR  257  binding to 
PaDDAH,  the  number  of  observed  resonances  that  undergo  extreme  broadening 
around the active site region increased when compared to the number that “disappear” 
during ADMA or L-citrulline titrations.  It is  tempting  to correlate this  fact with  the 
inability of these substrate-based inhibitors to bind PaDDAH with high affinity. 
However, the specificity of these inhibitors for the mammalian enzymes rather than the 
bacterial  enzyme  has  an  altogether  different  basis.  The  ongoing  research  led  by 
collaborators  at  Birkbeck College  aiming to  solve  the  X-ray  structure  of the  human 
DDAH I has very recently provided us with an early view of the crystal structure of the 
human  DDAH  I.  It  reveals  a  larger  active  site  cavity  in  the  human  enzyme  in 
comparison to the bacterial homologue,  which  would enable the binding of “longer” 
substrate-based  inhibitors,  such  as  SR  227  and  SR  257.  This  difference  would 
ultimately explain the much lower I C 50 of these compounds derived against hDDAH I 
(Rossiter et al., 2005).
Long range conformational changes upon ligand binding
The titration of ADMA and L-citrulline to the active site of PaDDAH induced some 
long range conformational adjustments made evident as various regions of the protein 
not directly involved in the binding event displayed significant chemical shift changes. 
These regions included the LI  loop residues (17-25) over the active site as shown by 
the rather large chemical shift deviations of residues Gly  17  and Gly 24 (Figure 6.3). 
Evidence  from  the  PaDDAH  X-ray  structure  suggests  that  only  one  hydrogen  bond 
contact  is  made  between  the  carbonyl  group  of Leu  18  and  the  amide  group  of L- 
citrulline  or  ADMA.  However Leu  18  and  adjacent  residues  experience  severe  line 
broadening of their amide resonances beyond the detection limit  suggesting that this 
region undergoes relatively large amplitude exchange processes. A qualitative estimate 
of the off-rates  for Gly  17  and Gly 24  range  from 600 to  860  s"1,  values which  are
205higher than  the ones derived for residues directly involved in  ligand binding such as 
His  162 and Asp 60. The & 0ff values are a rough estimate and current work is aiming to 
simulate the line shapes of the titration in order to obtain a better view of the kinetics 
of ADMA binding.
However,  the existence of conformational  exchange occurring for residues in the LI 
loop  contrasts  with  the  static  picture  provided  by  the  crystal  structure  of PaDDAH 
whereby a well resolved LI  loop over the active site locks into position upon ligand 
binding. This view appears unrealistic when challenged by the data we have gathered 
by NMR. The temperature crystallographic B-factors measured for this region would 
in principle agree with the notion that the LI  loop dynamics  are quenched upon the 
binding  of  either  ADMA  or  L-citrulline.  However,  even  upon  the  binding  of  a 
covalently  linked  ligand  such  as  CyNO  the  loop  still  experiences  conformational 
exchange uncoupled from the off-rates of ligand binding. It was interesting to note that 
the covalent binding of the smaller compound 2-chloroacetamidine to the reactive Cys 
249  did  not  affect  the  dynamics  of the  loop  which  still  samples  ps  to  ns  timescale 
motions. In this context, the larger size of the ligand accommodated in the active site 
region is in fact likely to be responsible for causing the subsequent broadening of the 
*Hn,15N  correlations  corresponding  to  residues  in  the  LI  loop.  In  a  similar  way, 
residues  in  helices  al  and a2 for which  backbone resonances  display above  average 
chemical  shift  changes  when  CyNO,  ADMA  or  L-citrulline  are  titrated,  are  not 
perturbed when 2-chloroacetamidine is bound.
Taken together these results provide a different view of PaDDAH ligand-bound state 
in which the LI  loop believed to close down  upon  the active  site, in reality samples 
two-  or multiple conformations  in  the  intermediate  exchange  regime.  The biological 
implications underlying the presence of conformational exchange in the ligand-bound 
form of the enzyme are still unclear and it is difficult to speculate at this stage prior to 
a more detailed view of the dynamics of the complex. Quantifying the exchange rates 
of the conformations  sampled by this  loop  will  provide  a better understanding  as  to 
how  this  movement  relates  to  the  binding  rates  and  catalytic  rates.  To  initiate  this 
analysis,  the  15N  relaxation  studies  performed  on  the  2-chloroacetamidine  complex 
showed that motions in the millisecond to microsecond timescales are still present in 
the L6 loop where the active site residue His 162 lies. These results are reconciled with 
other studies on enzyme dynamics, where apo- and bound states of the protein display
206a  conserved  network  of backbone  motions  in  the  ps  to  ms  timescale  (Beach  et  al., 
2005).  More  interesting  still  are  the  possibilities  of  linking  CPMG  relaxation 
dispersion experiments of the enzyme in the presence of a low stoichiometric amounts 
of ligand,  in  order to  avoid the  complete  broadening  of the  informative  resonances, 
with the simulation of the line shapes obtained during the titration experiments, which 
might  reveal  the  degree  of complexity  of the  binding  mechanism  such  as  has  been 
uncovered in other studies (Mittag et al, 2004; Reibarkh et al., 2006).
The following and final chapter will further discuss these possibilities and will present 
an overall view of the results described in this thesis.
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Conclusions and perspectives
Abstract
This chapter provides an overview of the main results described in this work, which aimed to 
characterise  the  bacterial  58  kD  PaDDAH  enzyme  through  the  application  of  NMR 
methodologies.  Due to the  intrinsic  physico-chemical  properties  of the native  homodimeric 
enzyme,  the  initial  goals  of the  project  had  to  be  redirected  towards  the  engineering  of a 
monomeric  protein  which proved  more  amenable  for NMR  studies.  The  findings presented 
here provide a first insight into the dynamical properties of the guanidino-modifying class of 
enzymes. In particular, the active site loop LI displays ps to ns timescale motions in the apo­
state  of PaDDAH,  whilst  motions  in  the  ps-ms  timescale  occur  in  the  active  site  region. 
Furthermore, the titrations of PaDDAH with several ligands have demonstrated that a subset 
of amide resonances for residues located in the LI loop and active site regions undergo severe 
line  broadening  upon  ligand  binding.  These results  have  been  interpreted  to  imply  that the 
bound-state of PaDDAH is subject to conformational fluctuations even upon saturation of the 
enzyme. Finally, the suggestion for several complementary studies to help in the understanding 
of the DDAH enzyme’s structure-function characteristics will be discussed.
2087.1  Pharmacological interest of the DDAH enzymes
The  asymmetric  methylarginines,  ADMA  and  L-NMMA,  are  important  endogenous 
inhibitors of all three isoforms of nitric  oxide  synthases  (NOS;  Leiper and Vallance, 
1999). By competitively displacing L-arginine from the substrate binding site of NOS, 
ADMA interferes with many of the physiological roles of nitric oxide (NO), impairing 
the overall vascular homeostasis. The significance of ADMA accumulation in plasma 
and  tissues  has  long  been  recognised  in  humans,  as  it  has  been  linked  to  several 
cardiovascular  disease  states,  including  renal  failure,  diabetes  and  pulmonary 
hypertension  (Vallance  and Leiper,  2004).  In  fact,  high  levels  of ADMA  have  now 
been proven to be a strong indicator of premature cardiovascular risk (Boger, 2004). 
The  enzymes  DDAH  I  and  DDAH  II  are  responsible  for  metabolising  asymmetric 
methylarginines.  By  controlling  the  local  cellular  levels  of  ADMA  and  L-NMMA, 
DDAH  activity is potentially involved in  the regulation  of NO  production,  although 
little evidence exists to implicate the dysfunction of these enzymes as the direct cause 
for the accumulation of ADMA in vivo.
In  order to  address  the  deleterious  effects  of the  impairment  of DDAH  I  activity  in 
vivo, Vallance and co-workers have recently been able to produce transgenic DDAH I 
+/-  knockout mice  (Leiper et al.,  submitted)  and  novel  small  molecule  inhibitors  of 
DDAH  I  (Rossiter et al.,  2005).  Their results  demonstrate  that  the  loss  of DDAH  I 
function,  through  either  genetic  or  chemical  biology  approaches,  leads  to  the 
accumulation  of  ADMA  and  the  reduction  of  NO  signalling.  Ultimately,  the 
pathophysiological  effects  observed  in  the  examined  mice  include  endothelial 
dysfunction  and  pulmonary  hypertension,  which  are  clear  signs  of  acute  ADMA 
accumulation.  These  findings  are  the  first  compelling  evidence  linking  the  elevated 
levels  of ADMA  commonly  found  in  disease  states  to  DDAH  I  dysfunction  in  vivo 
(Leiper et al., submitted).
It is noteworthy that DDAH activity should be intimately involved in the regulation of 
NO signalling.  A recent report has  suggested that a mechanism of negative feedback 
existed, in which DDAH could be inhibited in vitro by the nitric oxide S-nitrosylation 
of  the  active  site  Cys  249  (Leiper  et  al.,  2002).  The  authors  conclude  that  under 
conditions of elevated NO in cells, DDAH inhibition could be a potential mechanism 
to  up-regulate  the  ADMA  levels  and  consequently  limit  further  production  of NO 
which  is  in  some  cases  detrimental.  The  extent  of  the  “cross  talk”  between  the
209ADMA:NOS:DDAH pathways is currently the target of on-going research (Tran et al., 
2003).  Future  work  in  this  field  is  aiming  towards  a  better  understanding  of  the 
signalling  processes  involved  in  the  synthesis  and  the  regulation  of methylarginine 
turnover and how these are ultimately integrated (Leiper et al., submitted).
7.2  The engineering of a monomeric enzyme
The pharmacological  interest posed by the study of DDAH enzymes has prompted a 
collaborative  effort  between  UCL  and  Birkbeck  College  towards  the  structural 
characterisation  of  these  enzymes.  The  fact  that  neither  recombinant  mammalian 
DDAH I and DDAH II enzymes could be expressed in sufficient amounts for structural 
studies redirected the focus of our research  on the bacterial DDAH homologue from 
Pseudomonas aeruginosa. This enzyme was found to be part of a class of guanidino- 
modifying  enzymes  that  share  a  conserved  p/a-propeller  fold  (Shirai  et  al.,  2001). 
More  recently,  an  interesting  comparative  study  between  three  bacterial  hydrolases 
from this  superfamily,  including PaADl  and PaDDAH,  offered  an  insight into their 
common  origins  (Lu  et  al.,  2006).  The  authors  suggest  that  gene  recruitment  in  P. 
aeruginosa  might  have  been  involved  in  the  generation  of  a  secondary  metabolic 
pathway to facilitate environmental adaptation (Lu et al., 2006). Due to their presence 
in bacterial strains, these enzymes have also been suggested to be potential targets for 
new classes of anti-bacterial agents (Vallance et al, 2005), which further validates the 
structural studies of the PaDDAH homologue.
From an NMR perspective, the 58 kD PaDDAH enzyme provided the laboratory with 
an  ideal  case-study  for  the  application  of  NMR  methodology  to  “larger”  protein 
systems.  Furthermore,  this  project  was  in  turn  an  opportunity  to  access  the  binding 
schemes of several DDAH ligands that were provided by collaborators at the Clinical 
Pharmacology Department, to derive possible class-specific inhibitors of mammalian 
and bacterial DDAH isoforms and ultimately, to probe the dynamical properties of the 
free and ligand-bound enzyme. However, in the course of our investigations of the 58 
kD  PaDDAH  enzyme,  the  intrinsic  physico-chemical  properties  of the  homodimer 
precluded  the  sequence-specific  resonance  assignments,  which  are  a  primary 
requirement for any  structural  characterisation  by NMR.  Although the application of 
TROSY-based  pulse  sequences  in  conjunction  with  the  perdeuteration  of  the
210recombinant protein did improve the quality of the spectra, it was still not possible to 
obtain extensive unambiguous assignments for the native enzyme due to the lack of a 
complete tally of expected NH cross peaks (Plevin, 2003). A possible explanation for 
such  a drawback included the  intrinsic  monomer-dimer equilibrium  dynamics  at the 
interface region,  which could account for the broadening of the resonances of nuclei 
located in that region of the structure. Such conformational exchange, which has been 
shown  to  be  reminiscent  of  alternative  protomer  packing  configurations  in  other 
systems  (Lukin  et al.  2003;  Yung  et  al.  2003),  led  us  to  pursue  a  monomerisation 
strategy  of the  enzyme.  This  approach  was  founded  on  the  careful  analysis  of the 
interface  residues  and  the  hypothesis  that  the  dimerisation  of PaDDAH  was  not  a 
requirement for its biological function, but rather an artefact of the high concentration 
of protein needed for NMR and in crystallisation trials. The mutation of two residues 
in this interfacial domain, which were intended to disrupt two reciprocal  salt-bridges, 
proved successful in generating an  active R40E-R98H PaDDAH monomeric enzyme 
(Plevin et a l, 2004). The enzymatic assays performed of the double mutant PaDDAH 
yielded a catalytic rate constant kcat similar to the WT protein (& cat ~ 0.5 s'1), suggesting 
that the enzymatic activity of the R40E-R98H PaDDAH has not been compromised by 
the  two  point  mutations  (see  Chapter  6,  Section  6.2).  Furthermore,  the  similarity 
between  the  preliminary  [1 H,15N]-HSQC  spectra  acquired  of  the  WT  and  mutant 
proteins  showed that no  substantial  disruption  of the  overall  fold of the  enzyme  has 
occurred (Figure 3.8). Subsequently, the improved quality of all heteronuclear 2D and 
3D  spectra  recorded  for the  monomeric  protein  allowed for the  complete  backbone 
resonance assignments of the enzyme (Magalhaes et al, 2004). With the assignments 
of the monomeric protein in hand, we were able to assign tentatively the amide cross 
peaks for the WT PaDDAH.  Interestingly,  the absent cross peaks in the WT spectra 
mapped to  parts  of the extended  P-sheet  across  the  subunits,  to  residues  around the 
active  site catalytic  triad  and to residues  in the LI  loop  (see Chapter 4,  Section 4.4, 
Figure 4.11).  This  finding  confirms  our initial  surmise  that chemical  exchange  does 
occur  at the  interface region  of the  homodimer,  suggesting that the  monomer-dimer 
equilibrium could be at the basis of conformational rearrangements on the intermediate 
exchange rate regime which lead to the broadening of the amide resonances.
2117.3  Considerations on enzyme dynamics and function
To  date  most  of  the  information  available  on  the  kinetics  and  the  thermodynamic 
properties of an enzyme-catalysed reaction comes from extensive studies of substrate 
to product turnover. However, it is clear that enzyme function depends not only upon 
the  transition  state  energy  of  the  reactants  but  also  upon  the  kinetic  and  the 
thermodynamic energy landscape of the conformational rearrangements of the enzyme 
along  the  reaction  pathway.  In  this  respect,  15N  relaxation  studies  performed  of 
PaDDAH are a starting point in the characterisation of the internal  dynamics of this 
class of enzymes.
The  current  investigation  has  revealed  that  the  secondary  structure  elements  of 
PaDDAH display a high average value of NH bond vector generalised order parameter 
(S2 ~ 0.87) attesting to the overall rigidity of the p/a-propeller fold. Despite this fact, 
four loops located around the entrance of the  active  site have been  shown to  sample 
motions in the ps to ns timescale (see Chapter 5, Sections 5.3 and 5.5; Figures 5.8 and 
5.13).  In  particular  the  NH  bond  vectors  corresponding  to  residues  in  the  LI  loop 
located directly over the active site (residues  14-25) display the lowest S2 values (S2 ~ 
0.6). Moreover, slower motions in the ps to ms timescale have also been identified in 
the PaDDAH  active  site  region.  More  specifically,  the  model-free  analysis  together 
with the field-dependent linear regression analysis have derived Rex terms for residues 
Ser 61, Val 62 and Glu 65 located in loop L2, for Gly  116 in loop L4, for the active 
site residue His  162  and the surrounding residues Lys  164  and Thr  165,  and for Ser 
248,  Cys  249  and Ser 251  located in  loop L7  (see Chapter 5,  Sections  5.3  and 5.4). 
Interestingly,  although  the  sequence  similarity  scores  between  mammalian  DDAH 
enzymes and the bacterial homologue are rather low (-20-40%), the inspection of the 
sequence  alignment  between  rat  DDAH  I,  human  DDAH  I  and  PaDDAH  proteins 
reveals that residues situated in the binding pocket of the enzyme that have been found 
to  undergo  exchange  contributions  to  their  relaxation  rates  are  in  fact  remarkably 
conserved in these three enzymes. The only exception is residue Ser 251  in PaDDAH, 
for which the counterpart in the mammalian enzymes is a threonine residue.
The  importance  of the  conformational  exchange  occurring  at  slower  timescales  has 
been further underlined in other enzymes as being fundamental to promote catalysis. In 
the  NMR  studies  of  dihydrofolate  reductase  (DHFR),  cyclophilin  A,  and  RNase  A 
(Osborne et al., 2001; Eisenmesser et al., 2005; Beach et al., 2006), the conformational
212exchange rates kex derived from the apo-state of the protein  have been quantitatively 
linked  to  the  rate-limiting  step  of  the  catalytic  mechanism,  fccat.  Eisenmesser  and 
colleagues further discuss the fact that protein dynamics associated with catalysis is a 
“built-in  property”  of  the  enzyme  that  is  also  manifested  in  the  free  protein 
(Eisenmesser  et  al.,  2005).  However,  in  the  case  of  PaDDAH,  without  a  better 
estimate  of the  exchange  rates  for  the  residues  around  the  active  site,  one  can  not 
affirm  that  the  conformational  rearrangements  around  the  binding-pocket  are  rate- 
limiting  for  the  overall  function  of the  DDAH  enzymes.  In  fact  the  rather  low  fccat 
values of the DDAH enzymes (Stone et al., 2005a) around -0.5 s'1   would predict that 
only very slow conformational changes of the enzyme are prone to be the determinant 
step in the catalytic reaction.
The titration of several ligands into PaDDAH aimed to characterise the ligand-bound 
state of the protein. Our findings show that upon saturation of the enzyme with either 
ADMA or L-citrulline, a subset of the amide resonances for residues located in the LI 
loop were subject to severe line broadening resulting in ablation of cross peak intensity 
(see Chapter 6, Section 6.2). These observations suggest that the LI  loop undergoes a 
change in  dynamic  motional  regime induced upon  ligand binding.  This  situation has 
been shown to occur in other systems (Eisenmesser et al., 2005). For example, in the 
case of cyclophilin A, a loop (comprising residues 65-84) in the free enzyme displays 
faster exchange rates (kex - 2300 s’1) with respect to the overall catalytic rates (& cat ~ 
1100 s’1). However upon substrate binding the motional regime of this loop is altered 
and  it  fluctuates  collectively  with  the  rest  of  the  protein  as  catalysis  occurs 
(Eisenmesser et al., 2005).
Furthermore,  the  ligand  binding  studies  of PaDDAH  have  also  shown  that  several 
amide resonances corresponding to residues directly involved in interactions with the 
ligand exhibit severe line broadening with increasing ligand concentration to the point 
where  several  NH  resonances  remained  undetected,  even  upon  saturation  of  the 
enzyme  (see  Chapter  6,  Section  6.2).  It  is  interesting  to  note  that  these  resonances 
around the  active  site have  also been  identified as  undergoing chemical  exchange in 
the apo-state of PaDDAH. This observation is further supported by the  15N relaxation 
experiments performed on 2-chloroacetamidine-bound PaDDAH, in that both free and 
ligand-bound states of the protein display a conserved network of backbone motions in
213the  (is  to  ms  timescale  for  loop  L6,  where  the  active  site  residue  His  162  lies  (see 
Chapter 6, Section 6.4).
Despite  our best  efforts,  we  were  unable  to  obtain  a  ligand-bound  conformation  of 
PaDDAH, for which all the NH resonances for the LI  loop and the active site region 
could  be  observed  under  saturating  conditions.  This  situation  deterred  us  from 
pursuing further  15N relaxation experiments of the bound-state of the enzyme due to 
our inability to fully interpret the behaviour of these resonances.  Recently,  there has 
been evidence suggesting that the ablated NH resonances under saturating conditions 
could  be  induced by  two-  or multiple-mode  binding  of the  ligand  in  the  active  site 
(Reibarkh et a l, 2006). The possible existence of multiple ligand bound conformations 
in  the case of PaDDAH could help explain the high micromolar affinity for ADMA 
and  the  low  catalytic  efficiency  of  this  enzyme,  although  these  properties  are  not 
necessarily causually related.
7.4  CPMG relaxation dispersion and line shape analysis
The combination of 15N relaxation studies and the analysis of chemical shift changes in 
the  mapping  of PaDDAH binding  site  have  given  us  an  initial  view  of the  intrinsic 
dynamics  of PaDDAH.  To  build  on  these  preliminary  studies,  it  would  be  ideal  to 
quantify the conformational exchange rates of PaDDAH and to have a more reliable 
estimation of the ligand binding on- and off-rates. These values of kex, kon and £0ff rate 
constants  would be essential  in  order to compare  them with  the catalytic  rate of the 
enzyme kcat. To achieve this comparison,  an  interesting prospect is the application of 
CPMG relaxation dispersion experiments to probe the motions of PaDDAH on the (is 
and  ms  timescale  upon  ligand  binding.  By  choosing  to  study  the  dynamics  of the 
enzyme induced by low stoichiometric amounts of ligand, information on the exchange 
rates  undergone  by  the  LI  loop  could be  obtained,  as  the  amide resonances  for the 
residues in this region would not have completely broadened as in the saturated state. 
Under these  circumstances,  the  exchange  rate  kex  is  related  to  the  kon  and  £0ff rates 
according to kex = fc0n[L]  + kQ ff,  where  [L]  is the concentration of ligand.  Once kex is 
obtained then the ligand binding rate constants can be obtained from the equilibrium 
dissociation constant, Kd (Kd = k0n/k0tf, Rule and Hitchens, 2006).
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ligand binding might also be achieved through the independent analysis of the ligand 
NMR titration experiments. The simulation of line shapes can provide good estimates 
of the kQ ff rates for the binding kinetics  and report  on the complexity of the binding 
mechanism (Gunther and Schaffhausen, 2002).
The  complementarity  of  these  two  types  of  analysis  has  been  successfully 
demonstrated in a series of studies of the N-terminal src homology 2 domain (SH2) of 
phosphatidylinositide  3-kinase  (Mittag  et  al,  2003;  Mittag  et  al,  2004).  CPMG 
relaxation  dispersion  measurements  revealed  the  existence  of  low  populated 
conformers  that  could  not  be  detected  by  simulating  the  line  shapes  (Mittag  et  al, 
2003). Moreover, the observed line shapes were fit to different kinetic binding models 
consistent with  the  existence  of structural  intermediates  in  the binding  pathway  and 
providing a basis for understanding the different binding affinities for different ligands 
(Mittag et al, 2004).
To  complement the  dynamic  studies  of the  PaDDAH enzyme reported  here,  further 
experiments,  such  as  those  mentioned  above,  are  currently  part  of  ongoing 
collaborations  with  Dr T.  Frenkiel  at the  National  Institutes  of Medical  Research  in 
London and Dr U. Gunther at the University of Birmingham.
7.4  An  integrated  view  from  X-ray  crystallography,  NMR  spectroscopy  and 
molecular dynamics (MD)
The PaDDAH crystal  structure offered us a first insight into the structural intricacies 
of the class of guanidino-modifying enzymes (Murray-Rust et al, 2001). Comparison 
with other X-ray structures of this class of proteins reveals the basis of the specificity 
of these  enzymes  for a  specific  substrate  (see  Chapter  1,  Section  1.8;  Galkin  et al, 
2004; Lu et al, 2006). In this sense, the data acquired from X-ray crystallography is 
invaluable,  as  it  can  provide  different  and  altogether  informative  snapshots  of  the 
systems under consideration. In particular, when several ligands are available, as is the 
case  with  DDAH,  it  would  be  extremely  interesting  to  obtain  additional  structural 
information on how these ligands are accommodated in the active site. Unfortunately, 
not  all  systems  are  investigated  in  such  a  manner  and  this  caveat  undermines  the 
possibility for exploring the information contained in the structural heterogeneities that 
could  arise  from  the  collection  of a  crystallographic  ensemble.  This  point  has  been
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suitable  representation  of  the  macromolecular  crystal  structure,  whereby  the  X-ray 
structures  deposited  in  the  PDB  data  bank  should  be  accompanied  by  a  range  of 
structural models (Fumham et al, 2006).
In  adding  to  the  information  provided  by  the  PaDDAH  crystal  structure,  the 
complexity  of the  binding  mechanism  of PaDDAH  would  certainly  benefit  from  a 
more detailed investigation of the side chain dynamics implicated in interactions with 
the ligand. For this particular study, recent developments in the NMR field and in the 
isotopic  labelling  strategies  have  improved  the  sensitivity  of  deuterium-based  spin 
relaxation  studies  of selectively  2H-labelled  methyl  groups.  Several  research  groups 
have now contributed to this active area of research addressing the role of side chain 
dynamics  in  molecular  recognition,  protein  folding  and  stability  (for  reviews  see 
Tugarinov  and  Kay,  2005;  Kay,  2005);  however  currently  no  particular  study  has 
focused on enzyme side chain dynamics.
To  aid  the  investigation  of  the  dynamical  properties  of  PaDDAH,  we  have  also 
considered the possibility of applying molecular dynamics (MD) to understand the role 
of  the  active  site  loop  dynamics  upon  ligand  binding.  Classic  molecular  dynamic 
simulations  for up to  10 ns  have revealed the existence  of correlated motions in the 
backbone  of DHFR  (Radkiewicz  and  Brooks,  2000).  In  particular,  coupled  motions 
that appear in the reactive complex disappear in the product complexes, indicating that 
these motions may have a role in catalysis. In the studies of the HIV-1 protease, an all­
atom simulation revealed that the preferred structure, either closed, semiopen, or fully 
open forms of the protein,  was  strongly dependent upon the presence of an  inhibitor 
(Homak et al, 2006).  Several  other examples of MD simulations that investigate the 
dynamics  of proteins  upon  ligand  binding  exist  in  the  literature  and  it  would be  of 
interest to apply this procedure to PaDDAH.
On another note, so far our studies have not addressed the thermodynamics of ligand 
binding.  In  this  sense,  molecular  dynamic  simulations  are  also  likely  to  be  of 
increasing  importance  for  the  derivation  of  per-residue  entropies  for  side  chain 
residues (Homans, 2005). Ultimately, these studies could enable the determination of 
the  factors  governing  affinity  which  could  help  explain  the  high  Km  values  of
216PaDDAH for its substrates  and the low  affinity  displayed by the DDAH I inhibitors 
towards the bacterial homologue.
In  summary,  it  is  clear  that  apart  from  the  ongoing  collaboration  efforts  directed 
towards the determination of a more quantitative measure of the internal dynamics of 
PaDDAH,  the  integrated  approach  addressed  here  would  certainly  provide  a  more 
complete inspection of the structure-function characteristics of the enzyme. Moreover, 
it is our belief that an even more challenging and certainly very interesting avenue for 
the  understanding  of these  enzymes  would  be  the  “taming”  of the  human  DDAH  I 
enzyme  for  the  application  of  NMR  methodology.  In  this  vein,  our  colleagues  at 
Birkbeck  College  have  recently  solved  the  X-ray  structure  of DDAH  I  with  a  very 
limited amount of protein (Leiper et al., submitted). Any comparative structural study 
between  bacterial  and  mammalian  homologue  enzymes  will  ultimately  add  to  the 
understanding of how the subtle differences in the arrangement of active site residues 
modulate the different ligand binding affinities.
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Table A.I. Details of the datasets used in each fitting procedure to a monomer-dimer
equilibrium model
PaDDAH  Molecular 
isoform  weight (Da)
Fittings Concentration
(mg/ml)
Rotor speeds 
(103  rpm) Ka2a Kd(M)b
R98H  29198 1 0.92
0.61
0.32
15,20, 24 0.218 9.49 x 10'5
2 0.92
0.61
0.32
11, 15, 20 0.262 7.90 x 10'5
3 1.62
0.92
0.32
11, 15, 20 0.205 10. lx 10'5
4 2.96
1.62
0.82
11, 15,20 0.281 7.36 x 10'5
R40E  29190 1 1.46
0.71
0.34
11, 15, 20 0.276 7.5 xlO 5
2 1.46
0.71
0.34
15, 20, 24 0.248 8.35 xlO'5
3 1.46
0.61
0.34
11, 15, 20 0.356 5.81 x 10'5
4 1.46
0.61
0.32
15,20, 24 0.274 7.55 x 10'5
Q43R  29245 1 0.17
0.96
1.68
11, 15, 20 0.517 3.99 x 10'5
2 0.17
0.56
1.68
15, 20, 24 0.397 5.20 x 10'5
3 0.56
0.96
1.68
11, 15,20 0.485 4.26 x 10'5
4 0.56
0.96
1.68
15,20, 24 0.425 4.86 x 10 5
5 0.17
0.96
1.68
15,20, 24 0.471 4.37 x 10'5
6 0.37
0.96
1.68
15,20,24 0.459 4.50 x 10'5
aA dataset is composed of the sedimentation equilibrium interference curves obtained at three different 
concentrations  recorded  at  three  different  rotor  speeds.  These  nine  sedimentation  equilibrium  curves 
were fit simultaneously to the monomer-dimer equilibrium association model to obtain Ka2 values.  h Kd  
values were derived using Equation 2.3 (see Chapter 2, Section 2.4)
218Table  A.II.  Chemical  shifts  of  ‘H,  1 5 N,  1 3 Ca,  1 3 Cp   and  1 3 CO  resonances  of R40E-R98H
PaDDAH corrected for the deuterium effect (ppm)_________________________________ _
Residue N HN C « CO C p Residue N HN C „ CO c p
1 Met 121.054 7.576 56.391 176.229 36.202 51 Leu 129.26 8.833 53.973 176.053 43.802
2 Phe 119.5 9.51 56.379 175.779 40.472 52 Leu 130.3 9.442 53.43 - 41.32
3 Lys 120.089 9.566 57.65 176.425 36.027 53 Pro - - 63.152 177.861 32.479
4 His 119.196 8.709 55.479 172.175 33.572 54 Asp 119.822 8.092 54.097 176.198 44.188
5 lie 116.079 8.021 57.245 177.381 40.58 55 Glu 119.822 8.092 54.097 176.198 44.188
6 lie 124.498 8.559 60.892 174.077 41.458 56 Arg 121.382 8.649 58.447 178.958 30.437
7 Ala 128.4 8.914 51.653 174.095 24.415 57 Phe 116.243 8.178 58.256 175.957 30.968
8 Arg 121.874 9.799 56.603 172.103 34.254 58 Pro 113.922 7.506 56.28 - 41.665
9 Thr 123.875 7.882 62.768 - 72.02 59 Asp - - 66.864 177.822 33.627
10 Pro - - 62.748 174.84 32.896 60 Ser 113.826 8.574 55.478 177.535 43.072
11 Ala 126.06 8.15 51.474 177.979 20.195 61 Val 112.908 8.172 62.083 175.769 64.093
12 Arg 124.942 10.35 60.433 180.147 28.851 62 Phe 121.033 7.141 63.406 176.119 31.741
13 Ser 113.236 8.919 59.969 175.764 63.895 63 Val 125.996 8.262 54.816 177.73 35.289
14 Leu 124.951 7.826 59.547 177.978 43.402 64 Glu 115.857 7.494 63.456 173.781 31.99
15 Val 108.337 7.053 63.77 176.201 31.946 65 Asp 116.378 7.626 59.293 175.833 31.818
16 Asp 120.179 7.695 55.722 176.999 41.927 67 Pro 108.831 6.857 60.531 - 40.638
17 Gly 107.989 7.941 46.478 174.062 - 68 Val - - 65.998 173.838 33.554
18 Leu 122.164 8.707 56.589 177.953 42.57 69 Leu 114.303 6.941 61.186 170.995 36.004
19 Thr 114.259 8.215 62.298 180.213 70.784 70 Cys 122.976 8.666 53.878 175.377 45.901
20 Ser 118.173 8.59 59.22 - 65.143 71 Thr 115.834 8.158 61.244 175.481 73.016
21 Ser - - - - - 72 Ser 116.608 10.07 61.408 176.337 63.901
2 2 His - - 58.266 176.084 30.59 73 Arg 117.566 7.945 56.777 175.166 34.081
23 Leu 120.227 7.992 56.053 177.559 43.048 74 Cys 109.276 7.115 57.484 171.265 29.573
24 Gly 106.983 7.76 45.037 174.363 - 75 Ala 123.072 8.206 50.628 175.243 21.74
25 Lys 119.106 8.326 54.948 - 33.473 76 He 119.942 9.108 60.873 175.222 41.185
26 Pro - - 63.579 174.091 32.469 77 lie 128.817 9.07 61.056 176.73 36.161
27 Asp 123.82 8.928 53.429 176.309 44.008 78 Thr 115.834 8.158 61.244 175.481 73.016
28 Tyr 127.176 9.000 63.352 175.432 39.01 79 Arg 112.397 7.432 55.903 - 30.653
29 Ala 120.213 8.209 56.411 181.862 18.209 80 Pro - - 64.914 175.077 32.798
30 Lys 119.142 8.153 59.41 178.43 32.598 81 Gly 111.296 9.058 47.898 174.979 -
31 Ala 123.085 8.804 55.825 183.048 17.013 82 Ala 122.786 7.878 52.327 178.432 18.499
32 Leu 125.613 8.865 59.246 178.556 41.641 83 Glu 126.94 9.018 61.358 179.211 29.81
33 Glu 120.451 7.634 60.632 180.578 30.011 84 Ser 112.516 8.621 61.598 175.375 63.334
34 Gin 119.439 8.725 59.871 179.332 28.318 85 Arg 116.781 7.497 57.684 178.307 30.655
35 His 122.23 8.484 63.974 177.587 31.857 86 Arg 121.568 7.662 61.982 178.874 29.696
36 Asn 116.087 8.629 57.473 178.118 38.701 87 Gly 104.139 8.985 47.264 175.147 -
37 Ala 122.242 8.206 55.953 180.406 18.743 88 Glu 119.106 7.527 59.312 179.699 31.327
38 Tyr 122.618 8.092 62.099 176.048 38.653 89 Thr 107.11 7.522 65.36 176.859 67.842
39 He 119.181 8.243 63.287 178.254 35.429 90 Glu 120.522 6.852 59.428 179.554 30.272
40 Glu 118.759 8.265 60.372 179.526 29.786 91 He 106.499 6.674 63.57 176.665 37.907
41 Ala 120.32 7.723 55.691 181.64 18.924 92 He 121.519 7.201 61.066 175.551 42.216
42 Leu 121.098 7.851 59.078 178.6 42.03 93 Glu 123.635 7.225 61.765 177.305 29.464
43 Gin 116.352 8.275 58.985 177.642 28.969 94 Glu 118.117 8.957 60.928 179.27 29.738
44 Thr 108.382 7.392 63.635 175.359 70.295 95 Thr 116.224 7.547 68.012 176.326 69.088
45 Cys 117.454 7.557 61.012 172.769 28.388 96 Val 119.505 7.659 68.33 178.237 31.998
46 Asp 115.817 8.11 56.891 173.5 39.411 97 Gin 118.241 8.696 59.531 - 28.113
47 Val 105.61 6.595 59.217 174.605 36.18 98 His 115.355 7.311 59.976 176.855 29.76
48 Asp 119.037 7.836 53.402 175.271 43.328 99 Phe 114.302 7.195 61.427 175.391 42.192
49 He 120.954 8.575 61.058 176.44 39.573 100 Tyr 119.348 8.01 57.426 - 39.017
50 Thr 127.729 8.841 64.141 171.969 70.41 101 Pro - - 65.393 180.197 31.094
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Residue N HN c „ CO C p Residue N HN C„ CO C p
102 Gly 113.309 8.926 47.026 175.535 152 Gly 104.489 8.538 46.657 171.561 104.489
103 Lys 121.418 8.26 55.279 174.099 34.266 153 Ser 113.229 8.35 58.574 171.688 65.889
104 Val 119.394 7.806 63.061 176.529 33.355 154 Val 119.738 8.512 62.389 177.185 34.367
105 Glu 129.111 8.925 55.187 174.7 32.952 155 Val 128.833 9.204 61.352 174.411 35.465
106 Arg 116.246 8.992 56.263 174.503 33.393 156 Arg 126.904 8.797 57.815 176.111 30.837
107 lie 120.512 7.597 58.058 175.257 36.474 157 Leu 121.597 8.144 55.319 176.72 44.4
108 Glu 125.841 9.474 55.104 177.096 33.592 158 Glu 120.927 10.70 58.43 178.117 33.589
109 Ala 126.141 9.151 53.131 - 17.62 159 Lys 118.75 9.626 57.967 176.994 34.687
110 Pro - - 64.861 177.006 33.421 160 Val 111.021 7.078 60.698 175.517 35.655
111 Gly 113.633 9.044 46.59 172.33 - 161 Leu 120.287 8.13 58.562 175.855 42.947
112 Thr 121.418 8.26 55.279 174.099 34.266 162 His 108.225 7.138 52.968 177.208 33.963
113 Val 119.394 7.806 63.061 176.529 33.355 163 Leu 123.982 10.11 60.399 177.608 44.615
114 Glu 124.291 8.496 55.457 176.667 31.823 164 Lys 107.021 7.182 59.636 176.978 29.969
115 Ala 125.378 9.58 55.868 178.579 17.569 165 Thr 115.616 7.985 67.517 176.646 67.493
116 Gly 110.294 8.418 48.594 173.34 - 166 Gly 104.861 7.375 46.411 169.614 -
117 Asp 117.296 8.145 56.691 174.277 41.475 167 Leu 120.717 6.441 54.516 175.515 49.754
118 lie 118.929 7.648 61.65 173.11 39.683 168 Ala 118.858 7.972 53.606 175.285 24.324
119 Met 127.527 9.221 54.664 174.057 38.301 169 Tyr 123.366 10.00 58.409 177.11 38.337
120 Met 129.889 9.35 56.291 175.494 35.108 170 Leu 129.525 8.571 53.67 - 41.004
121 Val 132.166 9.263 61.361 175.826 32.434 171 Glu 104.543 4.308 58.867 173.985 28.142
122 Gly 120.545 9.402 48.326 174.323 - 172 His 111.641 8.584 56.696 174.55 26.816
123 Asp 126.969 8.386 54.867 172.883 42.176 173 Asn 108.872 8.113 55.967 173.811 41.435
124 His 119.123 7.87 55.551 172.797 34.619 174 Asn 119.317 7.683 54.586 172.019 40.52
125 Phe 124.901 7.818 56.779 174.496 40.157 175 Leu 128.212 8.76 53.799 175.064 48.128
126 Tyr 122.82 8.832 59.3 175.114 40.121 176 Leu 126.527 9.325 55.298 176.643 42.106
127 He 123.186 9.27 60.824 175.611 40.754 177 Ala 120.811 8.058 51.936 174.355 23.938
128 Gly 116.64 10.33 46.495 171.051 - 178 Ala 121.893 8.582 50.229 179.775 24.131
129 Glu 123.374 8.039 56.57 176.16 30.798 179 Gly 108.399 8.851 48.484 177.131 -
130 Ser 126.225 9.201 57.753 174.358 69.59 180 Glu 124.793 9.118 58.213 176.08 30.354
131 Ala 120.016 8.861 54.823 178.898 19.338 181 Phe 116.785 7.363 61.093 176.251 41.016
132 Arg 116.49 8.684 56.134 176.146 31.98 182 Val 114.306 6.908 67.075 176.502 32.474
133 Thr 122.132 7.771 62.642 174.044 70.115 183 Ser 109.183 7.707 58.117 175.555 64.669
134 Asn 120.739 8.168 50.985 175.597 40.32 184 Lys 123.622 7.246 56.01 - 32.169
135 Ala 121.339 8.449 56.352 181.157 18.905 185 Pro - - 66.296 178.951 32.465
136 Glu 118.995 8.538 58.628 178.32 28.876 186 Glu 117.702 10.42 60.406 177.582 28.658
137 Gly 110.256 8.842 47.984 175.505 - 187 Phe 115.469 7.302 56.878 176.007 39.48
138 Ala 123.187 8.64 56.626 178.656 18.472 188 Gin 114.997 7.205 59.063 176.411 29.236
139 Arg 117.46 8.221 60.658 180.621 30.237 189 Asp 117.034 8.63 55.833 177.533 41.273
140 Gin 118.789 8.232 60.349 179.291 30.974 190 Phe 118.611 7.602 59.592 175.363 40.588
141 Met 117.674 8.272 57.876 177.445 30.804 191 Asn 118.968 8.871 54.094 173.666 38.123
142 He 119.386 8.342 67.365 176.951 37.986 192 He 126.436 8.135 62.816 176.546 38.614
143 Ala 120.155 7.635 56.087 181.517 18.233 193 He 133.954 9.491 60.697 174.152 37.507
144 lie 120.026 7.881 66.592 178.079 38.774 194 Glu 126.081 8.302 57.042 176.324 30.306
145 Leu 119.596 8.332 59.49 180.213 40.325 195 He 130.072 8.516 56.346 - 37.602
146 Glu 118.156 8.6 60.184 181.573 29.854 196 Pro - - 63.404 178.103 32.759
147 Lys 122.517 7.721 59.641 177.945 32.3 197 Glu 123.102 8.873 61.199 179.779 30.289
148 His 115.699 7.328 57.769 174.981 31.927 198 Glu 117.54 9.749 59.738 177.519 29.144
149 Gly 107.637 7.894 47.119 173.896 - 199 Glu 118.461 8.062 55.975 175.388 30.878
150 Leu 121.869 8.145 54.043 174.655 42.471 200 Ser 113.479 7.27 64.19 176.012 64.182
151 Ser 111.879 8.466 58.461 173.841 67.118 201 Tyr 123.322 8.539 60.997 177.543 39.316
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Residue N HN C a CO C p
202 Ala 117.776 7.817 53.298 172.984 17.817
203 Ala 115.393 7.022 54.384 173.984 19.183
204 Asn 109 6.524 53.801 174.056 39.652
205 Cys 118.299 6.754 58.638 173.086 33.885
206 lie 107.369 8.228 59.054 174.235 41.467
207 Trp 124.278 8.687 57.801 177.258 32.227
208 Val 126.784 9.005 62.917 - 34.36
209 Asn 120.9 5.105 55.836 - -
210 Glu 105.288 5.037 60.202 175.796 26.637
211 Arg 120.173 7.208 56.345 175.633 32.634
212 Val 120.209 8.606 61.411 174.469 34.936
213 lie 127.956 8.772 60.901 174 38.011
214 Met 126.117 9.025 52.528 - 37.641
215 Pro - - 62.058 177.463 32.613
216 Ala 123.532 7.722 52.854 178.074 19.902
217 Gly 108.757 8.41 45.948 174.044 -
218 Tyr 122.39 9.316 57.681 - 39.2
219 Pro - - 65.778 180.84 32.972
220 Arg 123.859 10.44 60.885 180.957 29.946
221 Thr 123.41 10.30 69.76 176.221 68.571
222 Arg 121.516 8.388 61.411 178.177 30.232
223 Glu 116.09 7.69 60.033 179.183 29.884
224 Lys 117.775 7.532 60.944 179.226 33.382
225 He 117.831 8.025 66.65 179.175 39.146
226 Ala 122.093 8.866 56.078 182.696 18.569
227 Arg 117.543 8.028 59.294 178.023 30.373
228 Leu 117.825 7.427 56.163 177.931 42.888
229 Gly 104.583 7.805 45.936 174.28 -
230 Tyr 116.332 6.453 58.763 175.825 40.55
231 Arg 122.179 7.82 56.998 175.001 30.923
232 Val 126.849 8.434 63.215 176.138 33.348
233 He 130.443 9.266 61.817 174.751 41.012
234 Glu 124.931 8.628 55.777 176.987 33.197
235 Val 119.416 8.916 60.289 175.102 34.922
236 Asp 127.139 9.058 55.482 176.623 40.838
237 Thr 114.823 8.305 61.583 178.063 68.622
238 Ser 119.481 8.4 63.469 177.052 63.167
239 Glu 121.659 9.606 59.413 176.74 29.178
240 Tyr 115.568 7.102 61.713 179.496 38.493
241 Arg 124.13 8.279 60.455 179.235 29.996
242 Lys 114.798 6.875 60.395 177.286 33.933
243 lie 109.875 7.212 61.173 173.979 37.363
244 Asp 112.897 7.521 57.048 174.978 39.895
245 Gly 103.997 8.304 45.917 173.224 -
246 Gly 109.143 6.892 45.067 173.836 -
247 Val 113.247 8.399 66.73 180.345 32.965
248 Ser 122.638 10.43 63.217 176.855 61.388
249 Cys 117.889 7.163 58.842 176.165 30.954
250 Met 109.94 6.571 57.155 175.077 36.866
251 Ser 108.274 7.615 59.756 173.162 67.021
Residue  N  HN  Ca  CO  Cp
252 Leu 119.603 8.663 55.252 175.723 44.941
253 Arg 122.066 9.405 55.347 173.348 31.48
254 Phe 125.464 8.306 60.397 . 38.683
221Table A.III. 1 5 N relaxation parameters of R40E-R98H PaDDAH recorded at 500 MHz
# a * lb dR\c Rib d/?2C NOE dNOEd # a R b d  R f Rib d/?2C NOE dNOEd
1 1.244 0.021 12.58 0.35 0.576 0.038 50 1.226 0.036 14.64 0.71 0.715 0.050
2 1.158 0.032 17.87 0.90 0.735 0.066 51 1.211 0.028 13.97 0.53 0.760 0.048
3 1.185 0.050 15.33 1.12 0.831 0.079 52 1.203 0.058 14.56 0.99 0.855 0.086
4 1.238 0.027 16.80 0.50 0.821 0.051 53 - - - - - -
5 1.262 0.035 15.77 0.75 0.749 0.054 54 - - - - - -
6 1.264 0.045 15.75 0.83 0.773 0.060 55 1.259 0.046 15.87 0.72 0.782 0.053
7 1.202 0.031 14.89 0.56 0.784 0.047 56 1.218 0.041 14.53 0.71 0.891 0.061
8 1.206 0.054 15.81 1.11 0.733 0.061 57 1.235 0.044 15.62 0.82 0.826 0.054
9 1.208 0.040 14.92 0.62 0.849 0.053 58 1.263 0.037 15.11 0.71 0.763 0.045
10 - - - - - - 59 - - - - - -
11 1.299 0.061 15.54 1.04 0.713 0.065 60 1.252 0.053 14.90 0.90 0.763 0.055
12 1.237 0.041 14.55 0.61 0.725 0.058 61 1.267 0.053 15.93 1.07 0.831 0.061
13 1.258 0.029 15.15 0.51 0.756 0.036 62 1.236 0.049 16.69 1.03 0.766 0.057
14 - - - - - - 63 - - - - - -
15 1.271 0.027 15.48 0.44 0.802 0.045 64 - - - - - -
16 - - - - - - 65 1.292 0.039 17.23 0.91 0.829 0.057
17 1.689 0.047 10.62 0.27 0.481 0.025 66 1.260 0.049 16.46 0.97 0.922 0.068
18 1.489 0.025 10.57 0.29 0.492 0.030 67 - - - - - -
19 1.567 0.043 9.31 0.42 0.405 0.030 68 - - - - - -
20 1.546 0.096 11.51 1.04 0.478 0.058 69 - - - - - -
21 - - - - - - 70 1.136 0.045 14.12 0.79 0.802 0.077
22 - - - - - - 71 1.218 0.030 15.88 0.70 0.734 0.041
23 1.467 0.032 10.72 0.37 0.430 0.031 72 1.275 0.059 15.14 0.98 0.782 0.070
24 1.500 0.038 10.67 0.39 0.472 0.030 73 1.251 0.033 15.21 0.56 0.740 0.047
25 - - - - - - 74 1.063 0.023 12.34 0.41 0.618 0.042
26 - - - - - - 75 1.262 0.035 15.61 0.57 0.764 0.053
27 1.167 0.032 14.92 0.56 0.803 0.057 76 1.193 0.027 15.99 0.60 0.814 0.058
28 1.306 0.032 15.79 0.54 0.781 0.043 77 1.205 0.043 15.07 0.80 0.806 0.063
29 1.169 0.016 14.96 0.37 0.721 0.033 78 - - - - - -
30 1.209 0.018 15.68 0.39 0.758 0.039 79 1.178 0.054 14.67 0.94 0.871 0.090
31 1.212 0.024 16.06 0.46 0.799 0.045 80 - - - - - -
32 1.215 0.022 16.31 0.44 0.784 0.044 81 1.155 0.056 13.98 1.03 0.677 0.064
33 - - - - - - 82 1.222 0.028 13.60 0.46 0.665 0.036
34 1.184 0.022 16.19 0.48 0.734 0.044 83 - - - - - -
35 1.229 0.037 16.81 0.72 0.840 0.056 84 - - - - - -
36 1.237 0.023 16.34 0.46 0.770 0.040 85 1.303 0.040 15.13 0.72 0.758 0.047
37 1.205 0.020 16.41 0.46 0.768 0.040 86 1.283 0.034 15.88 0.69 0.807 0.051
38 - - - - - - 87 1.462 0.102 16.82 1.93 0.729 0.068
39 - - - - - - 88 1.279 0.043 15.57 0.81 0.802 0.058
40 - - - - - - 89 1.296 0.034 16.74 0.75 0.755 0.047
41 - - - - - - 90 1.166 0.026 15.21 0.43 0.713 0.040
42 1.205 0.026 16.15 0.53 0.747 0.043 91 1.201 0.047 16.07 1.02 0.713 0.071
43 1.231 0.021 15.75 0.41 0.796 0.040 92 1.274 0.040 15.93 0.74 0.778 0.058
44 1.214 0.029 15.07 0.59 0.740 0.050 93 - - - - - -
45 1.186 0.028 16.30 0.52 0.808 0.049 94 1.265 0.022 16.22 0.38 0.703 0.039
46 1.197 0.023 14.62 0.41 0.777 0.037 95 1.215 0.017 15.16 0.32 0.778 0.026
47 1.126 0.020 14.59 0.45 0.764 0.042 96 - - - - - -
48 1.257 0.020 16.59 0.41 0.827 0.047 97 1.244 0.024 16.41 0.47 0.805 0.047
49 - - - - - - 98 - - - - - -
aResidue number. bValue given in (s *).  cError estimated from the repeated time points. dError estimated from noise.
222Table A.III. 1 5 N relaxation parameters of R40E-R98H PaDDAH recorded at 500 MHz
# a * lb d/?ic Rib d/?2c NOE dNOEd # a R b dRic Rib d/?2c NOE dNOEd
99 1.229 0.029 15.14 0.58 0.818 0.046 148 1.214 0.015 15.52 0.31 0.773 0.028
100 1.155 0.017 15.28 0.33 0.775 0.034 149 1.243 0.025 15.09 0.47 0.790 0.044
101 _ . . . . - 150 . . . . -
102 1.301 0.049 14.95 0.81 0.730 0.039 151 1.195 0.033 14.71 0.58 0.718 0.047
103 1.280 0.023 14.67 0.39 0.757 0.039 152 1.231 0.030 15.23 0.60 0.810 0.046
104 1.152 0.016 14.95 0.30 0.769 0.033 153 . . _
105 1.161 0.034 14.59 0.66 0.812 0.060 154 1.150 0.023 14.95 0.47 0.822 0.047
106 1.214 0.024 15.23 0.43 0.772 0.039 155 1.240 0.034 14.60 0.52 0.773 0.053
107 _ - - . . 156 1.174 0.019 13.68 0.33 0.651 0.038
108 1.174 0.029 15.25 0.62 0.813 0.055 157 . _ _ _
109 1.262 0.029 14.28 0.52 0.825 0.044 158 1.333 0.036 13.82 0.61 0.524 0.050
110 _ _ . - . . 159 1.214 0.045 14.74 0.81 0.619 0.054
111 1.263 0.044 15.63 0.80 0.807 0.056 160 1.080 0.016 12.62 0.29 0.415 0.028
112 1.272 0.037 15.64 0.72 0.825 0.058 161 1.232 0.028 15.31 0.54 0.683 0.046
113 _ . - - - - 162 1.241 0.035 17.69 0.68 0.720 0.050
114 1.199 0.050 15.25 0.94 0.740 0.057 163 1.166 0.064 16.34 1.36 0.731 0.092
115 1.187 0.057 15.72 0.99 0.741 0.068 164 1.281 0.051 16.28 1.03 0.822 0.063
116 1.312 0.058 17.06 1.30 0.762 0.064 165 1.282 0.039 17.91 0.75 0.791 0.052
117 1.274 0.035 15.93 0.71 0.749 0.044 166 1.242 0.042 16.32 0.88 0.821 0.064
118 1.258 0.032 15.91 0.65 0.920 0.054 167 1.219 0.026 15.99 0.58 0.788 0.045
119 1.202 0.048 15.05 0.89 0.789 0.063 168 1.199 0.018 15.89 0.38 0.766 0.035
120 1.171 0.055 14.10 0.98 0.801 0.075 169 1.237 0.054 15.06 1.01 0.779 0.068
121 1.198 0.040 16.01 0.81 0.788 0.057 170 1.235 0.052 15.24 0.94 0.727 0.060
122 1.273 0.038 15.85 0.79 0.775 0.059 171 .
123 1.171 0.031 14.48 0.66 0.766 0.052 172 1.222 0.050 14.80 0.92 0.801 0.065
124 . . - - . - 173 . _ _
125 . . . . 174 _ .
126 1.218 0.030 15.20 0.65 0.794 0.050 175 .
127 1.187 0.038 15.66 0.71 0.792 0.056 176 1.252 0.042 15.35 0.79 0.703 0.052
128 1.341 0.064 14.81 1.21 0.851 0.084 177 . .
129 1.193 0.028 14.58 0.54 0.718 0.046 178 1.177 0.025 15.66 0.48 0.756 0.047
130 1.208 0.030 15.02 0.58 0.722 0.050 179 1.265 0.024 12.87 0.38 0.697 0.040
131 1.271 0.040 14.36 0.61 0.750 0.049 180 1.418 0.079 14.04 1.22 0.684 0.068
132 1.193 0.034 14.71 0.73 0.782 0.063 181 1.321 0.026 16.50 0.44 0.661 0.037
133 1.174 0.035 16.10 0.67 0.778 0.054 182 _ .
134 1.235 0.033 15.33 0.62 0.811 0.051 183 1.216 0.024 14.00 0.43 0.764 0.042
135 1.251 0.026 15.51 0.55 0.775 0.047 184 _ . .
136 1.237 0.027 16.03 0.50 0.810 0.049 185 _
137 1.302 0.042 16.55 0.85 0.842 0.061 186 1.219 0.027 15.40 0.52 0.780 0.046
138 1.273 0.016 16.09 0.32 0.803 0.027 187 1.193 0.022 15.46 0.42 0.758 0.034
139 1.220 0.023 16.03 0.44 0.812 0.041 188 1.227 0.020 15.35 0.39 0.796 0.041
140 - . - - . - 189 1.239 0.021 16.63 0.41 0.788 0.036
141 1.240 0.025 15.21 0.47 0.793 0.042 190 1.211 0.023 15.42 0.41 0.795 0.043
142 1.229 0.023 14.57 0.41 0.658 0.018 191 1.232 0.028 15.30 0.57 0.826 0.050
143 - - - - - . 192 1.124 0.020 14.24 0.43 0.796 0.044
144 - . - . - . 193 1.221 0.038 15.98 0.77 0.802 0.066
145 1.269 0.034 18.03 0.72 0.838 0.057 194 . .
146 1.238 0.028 16.86 0.56 0.736 0.041 195 1.192 0.036 15.83 0.72 0.726 0.063
147 1.213 0.020 16.24 0.42 0.760 0.040 196 - - - - - -
aResidue number. ‘Value given in (s *). cError estimated from the repeated time points. dError estimated from noise.
223Table A .III. 1 5 N relaxation parameters of R40' •-R98H PaDDAH recorded at 500 MHz
#a P lb dR\c R2b d/?2c NOE dNOEd
197 1.451 0.059 14.81 0.52 0.723 0.036
198 1.302 0.061 16.30 1.03 0.637 0.056
199 1.217 0.026 15.27 0.47 0.699 0.042
200 1.225 0.021 15.63 0.39 0.718 0.035
201 1.322 0.036 16.24 0.63 0.835 0.044
202 1.285 0.028 16.41 0.62 0.796 0.044
203 1.270 0.026 16.07 0.46 0.830 0.039
204 1.143 0.030 14.89 0.58 0.817 0.047
205 1.152 0.042 15.10 0.79 0.821 0.062
206 1.204 0.038 15.46 0.81 0.749 0.059
207 1.212 0.047 15.89 0.99 0.762 0.062
208 1.236 0.028 15.60 0.57 0.796 0.042
209 - - - - - -
210 - - - - - -
211 1.230 0.027 16.42 0.57 0.796 0.045
212 1.146 0.027 15.21 0.56 0.716 0.042
213 - - - - - -
214 1.244 0.039 15.53 0.63 0.829 0.052
215 - - - - - -
216 1.273 0.036 15.87 0.73 0.806 0.056
217 1.230 0.045 14.00 0.82 0.797 0.065
218 1.177 0.027 14.58 0.58 0.805 0.046
219 - - - - - -
220 1.253 0.036 15.17 0.68 0.865 0.063
221 1.189 0.047 15.72 0.94 0.803 0.071
222 1.285 0.031 16.14 0.55 0.745 0.045
223 1.259 0.024 16.85 0.49 0.766 0.041
224 1.215 0.024 15.78 0.51 0.788 0.046
225 1.202 0.019 16.33 0.38 0.730 0.033
226 1.241 0.023 15.84 0.47 0.774 0.040
227 1.202 0.016 16.03 0.30 0.759 0.034
228 1.176 0.027 15.81 0.52 0.733 0.047
229 1.203 0.029 15.28 0.57 0.773 0.046
230 1.090 0.018 13.57 0.39 0.787 0.039
231 1.076 0.020 13.97 0.41 0.765 0.038
232 1.095 0.022 13.60 0.40 0.735 0.044
233 1.177 0.033 15.31 0.65 0.801 0.054
234 1.121 0.025 14.40 0.44 0.821 0.053
235 1.213 0.028 14.84 0.53 0.787 0.047
236 1.307 0.031 14.61 0.51 0.733 0.037
237 1.254 0.039 14.61 0.66 0.723 0.054
238 1.285 0.030 16.35 0.58 0.824 0.049
239 1.268 0.042 17.13 0.74 0.768 0.060
240 1.181 0.035 15.40 0.68 0.759 0.046
241 1.310 0.050 14.85 0.82 0.800 0.060
242 1.281 0.039 16.20 0.77 0.799 0.060
243 1.302 0.041 15.44 0.72 0.792 0.055
244 1.247 0.031 12.62 0.51 0.705 0.046
245 1.250 0.035 15.41 0.62 0.742 0.045
#a dRi dR? NOE  dN O E
246
247
248
249
250
251
252
253
254
1.283
1.223
1.218
1.304
1.195
1.213
1.228
0.048
0.028
0.045
0.029
0.049
0.042
0.031
15.04 
13.63 
15.74 
16.49 
15.73 
14.69
15.04
0.82
0.45
0.89
0.60
0.91
0.83
0.59
0.798
0.590
0.797
0.818
0.767
0.744
0.803
0.058
0.028
0.064
0.041
0.058
0.065
0.041
aResidue number. ^Value given in (s  ). cError estimated from the repeated time points.  Error estimated from noise.
224Table A.IV. 1 5 N relaxation parameters of R40E-R98H PaDDAH recorded at 600 MHz
#a fllb d /V Rib d  R2c NOE dNOEd #a
•
5
°
c
r
dfl,c Rib d/?2C NOE dNOEd
1 1.057 0.019 13.90 0.26 0.598 0.037 50 0.913 0.029 16.20 0.72 0.748 0.053
2 0.882 0.031 20.87 0.92 0.786 0.073 51 0.921 0.021 16.06 0.44 0.830 0.050
3 0.932 0.038 16.92 0.85 0.822 0.086 52 0.970 0.040 17.27 0.93 0.811 0.074
4 0.962 0.023 18.42 0.58 0.830 0.050 53 - - - - - -
5 0.961 0.037 17.02 0.74 0.776 0.053 54 - - - - - -
6 0.989 0.033 16.77 0.74 0.816 0.058 55 0.964 0.038 17.41 0.88 0.803 0.053
7 0.980 0.027 16.65 0.55 0.818 0.048 56 0.962 0.035 16.71 0.68 0.824 0.060
8 0.926 0.038 17.95 0.83 0.857 0.059 57 1.034 0.038 18.54 0.77 0.801 0.050
9 0.993 0.030 17.36 0.58 0.824 0.052 58 1.022 0.030 17.28 0.51 0.831 0.042
10 - - - - - - 59 - - - - - -
11 0.951 0.042 15.94 0.90 0.817 0.062 60 0.950 0.039 16.83 0.71 0.827 0.058
12 0.946 0.028 16.26 0.50 0.818 0.057 61 1.079 0.053 18.95 1.12 0.870 0.057
13 1.013 0.025 16.92 0.52 0.753 0.045 62 1.050 0.046 19.30 0.97 0.843 0.055
14 - - - - - - 63 - - - - - -
15 1.088 0.026 17.27 0.44 0.790 0.045 64 - - - - - -
16 - - - - - - 65 1.102 0.041 19.18 0.86 0.836 0.055
17 1.528 0.056 11.55 0.28 0.600 0.032 66 1.001 0.036 17.37 0.83 0.794 0.055
18 1.183 0.025 11.66 0.33 0.513 0.036 67 - - - - - -
19 1.430 0.040 10.90 0.36 0.448 0.028 68 - - - - - -
20 1.423 0.102 11.54 0.86 0.492 0.061 69 - - - - - -
21 - - - - - - 70 0.875 0.036 15.03 0.76 0.886 0.070
22 - - - - - - 71 0.953 0.031 17.69 0.64 0.829 0.051
23 1.523 0.078 13.09 0.41 0.524 0.032 72 0.949 0.048 16.46 0.83 0.883 0.074
24 1.526 0.062 11.69 0.31 0.482 0.029 73 1.015 0.027 17.16 0.50 0.799 0.047
25 - - - - - - 74 0.850 0.020 14.02 0.39 0.637 0.041
26 - - - - - - 75 0.972 0.026 17.57 0.56 0.834 0.049
27 0.921 0.031 16.31 0.62 0.821 0.057 76 0.864 0.023 17.40 0.55 0.814 0.055
28 0.947 0.026 17.57 0.49 0.870 0.048 77 0.963 0.036 17.17 0.74 0.728 0.056
29 0.910 0.015 16.63 0.32 0.807 0.033 78 - - - - - -
30 0.944 0.019 17.34 0.35 0.839 0.039 79 0.875 0.036 17.03 0.81 0.830 0.069
31 0.974 0.022 18.42 0.42 0.815 0.044 80 - - - - - -
32 1.005 0.021 18.11 0.45 0.849 0.047 81 0.972 0.050 16.61 0.99 0.756 0.075
33 - - - - - - 82 1.043 0.024 15.24 0.37 0.681 0.039
34 0.972 0.028 18.22 0.56 0.887 0.053 83 - - - - - -
35 0.953 0.026 18.00 0.57 0.852 0.049 84 - - - - - -
36 0.943 0.019 17.78 0.40 0.793 0.038 85 1.040 0.033 17.18 0.61 0.807 0.050
37 1.010 0.020 18.14 0.39 0.876 0.041 86 1.069 0.030 18.17 0.59 0.843 0.057
38 - - - - - - 87 1.017 0.068 19.85 1.54 0.892 0.082
39 - - - - - - 88 1.107 0.039 19.39 0.76 0.878 0.061
40 - - - - - - 89 1.042 0.029 18.05 0.61 0.809 0.052
41 - - - - - - 90 0.958 0.021 16.72 0.41 0.772 0.048
42 0.919 0.019 17.89 0.47 0.793 0.044 91 0.933 0.040 18.92 0.86 0.772 0.048
43 0.936 0.017 17.24 0.35 0.784 0.039 92 0.988 0.031 17.61 0.63 0.678 0.065
44 0.940 0.022 16.30 0.41 0.751 0.042 93 - - - - - -
45 0.949 0.021 18.11 0.43 0.858 0.051 94 0.967 0.018 17.55 0.37 0.786 0.041
46 0.905 0.023 16.85 0.48 0.771 0.038 95 0.959 0.014 16.86 0.26 0.865 0.027
47 0.863 0.017 16.81 0.44 0.770 0.045 96 - - - - - -
48 0.926 0.019 17.87 0.42 0.801 0.051 97 0.972 0.021 18.18 0.46 0.759 0.049
49 0.957 0.025 17.27 0.49 0.791 0.048 98 - - - - - -
aResidue number. Value given in  (s *).  cError estimated from the repeated time points. dError estimated from noise.
225Table A.IV. 1 S N relaxation parameters of R4QE-R98H PaDDAH recorded at 600 MHz
#a dR\C Rib d/?2c NOE dNOEd #a R b d  R x c Rib d/?2c NOE dNOEd
99 0.962 0.027 17.02 0.54 0.855 0.050 148 0.941 0.013 16.99 0.27 0.883 0.034
100 0.898 0.019 17.17 0.44 0.860 0.038 149 1.018 0.025 16.99 0.50 0.794 0.046
101 - - - - - - 150 - - - - - -
102 - - - - - - 151 0.945 0.025 17.01 0.48 0.813 0.054
103 1.000 0.020 16.96 0.40 0.819 0.041 152 0.944 0.024 18.03 0.52 0.785 0.049
104 0.895 0.014 16.48 0.30 0.803 0.037 153 - - - - - -
105 0.894 0.027 16.11 0.62 0.845 0.065 154 0.909 0.020 16.29 0.38 0.815 0.047
106 0.913 0.018 16.93 0.39 0.771 0.040 155 0.965 0.025 16.81 0.53 0.737 0.045
107 - - - - - - 156 0.983 0.018 15.04 0.34 0.664 0.043
108 0.890 0.023 16.78 0.49 0.763 0.057 157 - - - - - -
109 0.952 0.022 15.96 0.41 0.782 0.043 158 1.111 0.031 15.66 0.53 0.610 0.057
110 - - - - - - 159 0.969 0.031 15.95 0.51 0.675 0.058
111 1.011 0.032 17.46 0.60 0.808 0.049 160 0.981 0.018 15.76 0.34 0.438 0.031
112 1.002 0.031 16.87 0.63 0.863 0.061 161 0.927 0.025 16.67 0.50 0.772 0.050
113 - - - - - - 162 0.949 0.029 21.14 0.83 0.793 0.057
114 0.924 0.037 16.15 0.85 0.732 0.056 163 0.926 0.054 19.76 1.38 1.019 0.105
115 0.907 0.040 17.65 1.04 0.896 0.073 164 0.999 0.047 19.18 0.87 0.866 0.066
116 1.029 0.049 18.93 1.11 0.832 0.071 165 1.002 0.039 20.05 0.86 0.882 0.056
117 0.993 0.036 18.03 0.71 0.811 0.048 166 1.003 0.033 18.27 0.70 0.801 0.059
118 0.987 0.028 17.58 0.56 0.920 0.049 167 1.006 0.024 18.60 0.55 0.833 0.041
119 0.960 0.036 17.69 0.81 0.873 0.067 168 0.951 0.022 17.76 0.48 0.841 0.044
120 0.893 0.042 16.79 0.90 0.836 0.074 169 0.898 0.037 16.68 0.83 0.869 0.066
121 0.939 0.035 18.13 0.81 0.823 0.056 170 0.884 0.035 17.90 0.75 0.797 0.061
122 1.008 0.032 18.46 0.64 0.804 0.059 171 - - - - - -
123 0.875 0.025 16.60 0.51 0.839 0.050 172 0.947 0.041 16.94 0.87 0.817 0.071
124 - - - - - - 173 - - - - - -
125 - - - - - - 174 - - - - -
126 0.955 0.029 16.02 0.58 0.874 0.049 175 - - - - - -
127 0.902 0.025 16.55 0.55 0.762 0.050 176 0.970 0.032 17.28 0.61 0.905 0.064
128 0.958 0.045 17.25 0.87 0.881 0.080 177
129 0.899 0.024 16.15 0.51 0.773 0.051 178 0.927 0.020 16.83 0.39 0.818 0.048
130 1.014 0.030 17.31 0.61 0.790 0.058 179 1.030 0.022 14.38 0.31 0.662 0.040
131 0.968 0.031 16.62 0.56 0.770 0.054 180 1.079 0.057 16.42 0.96 0.786 0.081
132 0.871 0.029 16.30 0.76 0.820 0.081 181 1.030 0.018 17.00 0.36 0.795 0.044
133 0.960 0.038 16.34 0.76 0.770 0.059 182 - - - - - -
134 1.014 0.031 17.38 0.62 0.859 0.051 183 0.923 0.017 16.29 0.34 0.793 0.042
135 0.935 0.019 17.21 0.39 0.839 0.046 184 - - - - - -
136 0.937 0.018 17.37 0.41 0.783 0.041 185 - - - - - -
137 0.948 0.032 17.21 0.73 0.874 0.061 186 0.925 0.020 16.12 0.43 0.817 0.049
138 1.034 0.016 18.26 0.34 0.850 0.033 187 0.925 0.018 16.53 0.39 0.849 0.037
139 0.962 0.018 17.88 0.42 0.829 0.038 188 1.006 0.021 17.28 0.41 0.807 0.036
140 - - - - - - 189 0.953 0.015 16.48 0.35 0.802 0.041
141 0.922 0.023 17.55 0.51 0.914 0.049 190 0.970 0.020 17.19 0.43 0.820 0.044
142 0.929 0.018 16.77 0.41 0.881 0.044 191 0.925 0.026 17.36 0.56 0.806 0.050
143 - - - - - - 192 0.854 0.019 15.67 0.40 0.807 0.044
144 0.967 0.023 17.79 0.50 0.835 0.045 193 0.914 0.031 17.04 0.64 0.860 0.068
145 0.959 0.027 20.13 0.68 0.827 0.055 194 - - - - - -
146 0.999 0.022 19.57 0.51 0.843 0.046 195 0.942 0.028 17.12 0.56 0.770 0.056
147 0.941 0.016 18.03 0.33 0.782 0.041 196 - - - - - -
aResidue number. ^Value given in (s *).  cError estimated from the repeated time points. ^Error estimated from noise.
226Table A.IV. 1 5N relaxation parameters of R40E-R98H PaDDAH recorded at 600 MHz_____
~Ta   Ryb  d/?ic  Ri  d/?2C   NOE  dNOEd  #a  Rx h   d/?ic  R b   d  R2C   NOE  dNOE7
197 1.198 0.058 16.42 0.43 0.752 0.046
198 1.050 0.040 17.82 0.76 0.738 0.062
199 0.989 0.026 17.37 0.54 0.741 0.044
200 0.957 0.018 16.66 0.36 0.836 0.038
201 1.042 0.025 17.98 0.46 0.931 0.053
202 0.978 0.022 18.15 0.46 0.854 0.046
203 1.054 0.026 17.81 0.44 0.833 0.040
204 0.952 0.026 17.51 0.57 0.797 0.043
205 0.888 0.027 17.37 0.69 0.824 0.057
206 0.972 0.039 17.14 0.69 0.818 0.051
207 0.944 0.045 17.29 0.84 0.816 0.069
208 0.943 0.024 17.41 0.53 0.853 0.042
209 - - - - - -
210 - - - - - -
211 0.953 0.023 17.72 0.48 0.798 0.040
212 0.927 0.020 16.48 0.47 0.771 0.043
213 - - - - - -
214 0.975 0.029 16.49 0.62 0.825 0.048
215 - - - - - -
216 0.977 0.028 17.95 0.65 0.870 0.057
217 0.933 0.031 16.36 0.63 0.937 0.068
218 0.931 0.022 16.21 0.49 0.877 0.049-
219 - - - - - -
220 0.909 0.025 17.27 0.58 0.786 0.054
221 0.922 0.035 16.74 0.73 0.901 0.074
222 0.968 0.020 17.91 0.52 0.792 0.046
223 0.965 0.019 18.12 0.41 0.830 0.043
224 1.002 0.022 17.93 0.42 0.783 0.045
225 1.018 0.020 17.96 0.40 0.776 0.042
226 0.956 0.018 17.96 0.40 0.834 0.043
227 0.955 0.014 17.72 0.30 0.778 0.035
228 0.903 0.017 17.47 0.38 0.787 0.046
229 0.923 0.022 16.55 0.49 0.794 0.051
230 0.932 0.017 15.55 0.35 0.813 0.043
231 0.853 0.018 15.69 0.39 0.785 0.051
232 0.852 0.015 15.44 0.35 0.768 0.043
233 0.947 0.030 17.14 0.57 0.825 0.054
234 0.861 0.018 14.89 0.40 0.857 0.050
235 0.964 0.025 16.95 0.54 0.821 0.046
236 1.037 0.026 16.72 0.47 0.867 0.044
237 0.973 0.032 16.91 0.57 0.759 0.054
238 0.994 0.026 18.08 0.51 0.846 0.048
239 0.955 0.029 17.75 0.60 0.865 0.067
240 0.906 0.031 17.10 0.68 0.798 0.047
241 0.982 0.037 17.32 0.77 0.797 0.056
242 1.102 0.035 17.71 0.65 0.821 0.062
243 0.986 0.029 16.41 0.64 0.809 0.056
244 1.022 0.025 16.03 0.45 0.724 0.040
245 0.928 0.026 17.97 0.62 0.790 0.048
aResidue number, ^alue given in (s '). cError estimated from
246 - - - - - -
247 - - - - - -
248 0.961 0.035 18.12 0.82 0.896 0.064
249 1.006 0.028 13.98 0.41 0.740 0.036
250 0.932 0.035 18.08 0.72 0.821 0.054
251 1.048 0.025 17.90 0.52 0.845 0.042
252 0.938 0.037 17.29 0.69 0.787 0.059
253 0.891 0.033 15.93 0.63 0.837 0.072
254 0.978 0.024 17.62 0.56 0.853 0.044
repeated time points. dError estimated from noise.
227Table A.V. 15N relaxation parameters of R40]E-R98H /^DDAH recorded at 800 MHz
#a Rb d/?,c Ri d/?2c NOE dNOEd #a Rb dR\ Rl d/?2c NOE dNOEd
1 0.740 0.006 16.18 0.27 0.679 0.017 50 0.611 0.011 19.21 0.72 0.797 0.028
2 0.610 0.015 25.37 1.31 0.842 0.042 51 0.640 0.008 19.44 0.45 0.891 0.025
3 0.604 0.016 19.71 0.93 0.864 0.041 52 0.656 0.014 20.28 0.91 0.895 0.035
4 0.637 0.010 22.45 0.64 0.899 0.027 53 - - - - - -
5 0.649 0.010 19.67 0.60 0.849 0.027 54 - - - - - -
6 0.634 0.011 19.10 0.72 0.879 0.030 55 0.632 0.011 19.73 0.72 0.894 0.029
7 0.633 0.009 20.11 0.55 0.842 0.023 56 0.649 0.011 18.63 0.56 0.907 0.026
8 0.638 0.014 19.94 0.77 0.842 0.029 57 0.728 0.013 21.29 0.78 0.872 0.024
9 0.657 0.010 19.69 0.62 0.859 0.024 58 0.652 0.007 19.24 0.46 0.928 0.020
10 - - - - - - 59 - - - - - -
11 0.655 0.014 20.30 1.02 0.836 0.032 60 0.649 0.012 20.86 0.84 0.842 0.026
12 0.692 0.010 19.54 0.62 0.778 0.026 61 0.676 0.015 20.96 1.09 0.836 0.028
13 0.721 0.010 19.76 0.64 0.848 0.023 62 0.702 0.013 22.15 0.93 0.831 0.028
14 0.693 0.008 21.35 0.42 0.873 0.015 63 0.685 0.009 21.24 0.63 0.849 0.021
15 0.748 0.009 21.78 0.64 0.801 0.020 64 - - - - - -
16 0.759 0.005 18.74 0.32 0.760 0.017 65 0.745 0.012 23.52 0.69 0.820 0.021
17 0.994 0.009 14.47 0.23 0.634 0.013 66 0.636 0.011 21.56 0.85 0.888 0.024
18 0.978 0.010 17.31 0.48 0.606 0.016 67 - - - - - -
19 1.056 0.013 14.00 0.28 0.545 0.012 68 - - - - - -
20 1.105 0.033 15.68 0.86 0.480 0.021 69 0.677 0.007 19.89 0.46 0.810 0.022
21 - - - - - - 70 0.596 0.013 18.91 0.82 0.937 0.033
22 - - - - - - 71 0.609 0.008 19.59 0.49 0.862 0.024
23 0.965 0.011 14.27 0.28 0.593 0.015 72 0.689 0.019 19.83 0.85 0.853 0.033
24 1.000 0.009 14.06 0.25 0.580 0.012 73 0.686 0.009 19.80 0.45 0.787 0.021
25 0.685 0.004 17.48 0.18 0.695 0.010 74 0.571 0.007 16.78 0.33 0.692 0.021
26 - - - - - - 75 0.654 0.008 20.03 0.48 0.852 0.025
27 0.628 0.009 18.94 0.56 0.843 0.027 76 0.615 0.009 19.46 0.52 0.887 0.025
28 0.674 0.009 20.91 0.52 0.870 0.025 77 0.622 0.012 20.89 0.69 0.882 0.031
29 0.646 0.005 20.41 0.25 0.868 0.017 78 0.644 0.004 21.27 0.28 0.834 0.012
30 0.642 0.005 20.97 0.33 0.841 0.019 79 0.601 0.015 20.15 0.98 0.916 0.036
31 0.678 0.007 21.17 0.46 0.873 0.022 80 - - - - - -
32 0.679 0.007 21.58 0.43 0.880 0.023 81 0.737 0.018 18.58 0.92 0.687 0.030
33 0.682 0.004 21.97 0.31 0.782 0.012 82 0.749 0.009 17.45 0.39 0.802 0.017
34 0.645 0.008 21.91 0.58 0.846 0.023 83 - - - - - -
35 0.672 0.009 21.54 0.50 0.870 0.022 84 0.747 0.050 20.44 1.57 0.807 0.044
36 0.630 0.005 20.74 0.34 0.835 0.018 85 0.716 0.011 20.54 0.66 0.856 0.022
37 0.655 0.005 21.35 0.37 0.869 0.018 86 0.684 0.009 21.42 0.63 0.897 0.023
38 - - - - - - 87 0.723 0.025 21.35 1.27 0.758 0.030
39 0.649 0.008 21.22 0.52 0.872 0.024 88 0.729 0.011 21.58 0.71 0.877 0.024
40 - - - - - - 89 0.723 0.009 21.57 0.59 0.885 0.022
41 0.664 0.004 21.33 0.24 0.799 0.015 90 0.658 0.007 19.97 0.43 0.794 0.019
42 0.662 0.008 21.05 0.43 0.856 0.021 91 0.697 0.017 24.95 1.56 0.729 0.036
43 0.649 0.006 19.56 0.37 0.862 0.019 92 0.722 0.011 21.55 0.80 0.801 0.026
44 0.693 0.008 20.72 0.46 0.821 0.022 93 0.687 0.005 20.60 0.42 0.857 0.020
45 0.666 0.007 20.38 0.45 0.797 0.020 94 0.701 0.007 21.09 0.42 0.805 0.019
46 0.670 0.007 19.28 0.42 0.818 0.020 95 0.625 0.004 19.37 0.26 0.909 0.014
47 0.605 0.007 20.01 0.45 0.831 0.022 96 0.689 0.005 20.90 0.41 0.849 0.019
48 0.646 0.008 21.08 0.56 0.904 0.026 97 0.656 0.006 21.91 0.45 0.873 0.021
49 0.636 0.008 20.55 0.57 0.866 0.026 98 0.660 0.007 19.27 0.40 0.927 0.023
Residue number. hValue given in (s *).  cError estimated from the repeated time points. dError estimated from noise.
228Table A.V. 1 5 N relaxation parameters of R40 3-R98H PaDDAH recorded at 800 MHz
#a Rib dR]C Rib d/?2C NOE d N O E * 1 #a R b d/?]C Rzb d  R2 c NOE d N O E d
99 0.632 0.008 20.45 0.49 0.864 0.024 148 0.628 0.006 19.69 0.35 0.885 0.022
100 0.611 0.006 19.47 0.38 0.858 0.020 149 0.668 0.008 20.79 0.43 0.847 0.022
101 - - - - - - 150 0.659 0.005 20.71 0.32 0.768 0.014
102 0.666 0.015 18.58 0.55 0.807 0.029 151 0.670 0.010 20.49 0.51 0.839 0.022
103 0.647 0.005 19.25 0.33 0.882 0.019 152 0.633 0.006 20.39 0.39 0.857 0.022
104 0.627 0.004 19.53 0.24 0.823 0.015 153 0.678 0.008 20.07 0.44 0.898 0.019
105 0.607 0.009 19.26 0.57 0.877 0.031 154 0.615 0.006 19.65 0.33 0.872 0.020
106 0.639 0.006 19.95 0.32 0.824 0.019 155 0.635 0.009 19.43 0.51 0.875 0.024
107 0.623 0.010 19.69 0.43 0.819 0.029 156 0.696 0.006 17.94 0.32 0.696 0.019
108 0.650 0.009 20.02 0.45 0.826 0.024 157 - - - - - -
109 0.681 0.008 19.70 0.34 0.844 0.020 158 0.842 0.016 17.56 0.53 0.645 0.026
110 - - - - - - 159 0.701 0.012 18.57 0.56 0.730 0.027
111 0.727 0.013 21.14 0.64 0.893 0.025 160 0.747 0.007 18.66 0.31 0.535 0.017
112 0.679 0.010 20.54 0.58 0.870 0.025 161 0.643 0.009 19.57 0.53 0.817 0.025
113 0.672 0.004 20.16 0.23 0.849 0.016 162 0.677 0.011 25.33 0.87 0.791 0.027
114 0.618 0.012 19.31 0.76 0.886 0.029 163 0.634 0.024 20.88 1.48 0.842 0.045
115 0.664 0.018 19.87 1.06 0.893 0.034 164 0.693 0.014 23.01 1.01 0.761 0.031
116 0.735 0.020 23.75 1.50 0.861 0.028 165 0.690 0.013 24.00 0.84 0.891 0.027
117 0.693 0.010 21.90 0.73 0.899 0.023 166 0.692 0.013 21.43 0.80 0.851 0.029
118 0.682 0.008 21.13 0.50 0.902 0.021 167 0.711 0.011 21.88 0.65 0.809 0.025
119 0.685 0.014 20.54 0.75 0.889 0.030 168 0.644 0.007 19.97 0.46 0.851 0.021
120 0.648 0.017 20.12 1.07 0.887 0.034 169 0.624 0.015 19.01 0.76 0.884 0.031
121 0.642 0.011 21.00 0.72 0.823 0.026 170 0.679 0.011 20.23 0.70 0.895 0.027
122 0.666 0.010 21.04 0.66 0.856 0.027 171 - - - - - -
123 0.624 0.008 19.81 0.52 0.902 0.024 172 0.658 0.013 19.57 0.85 0.893 0.032
124 0.697 0.008 22.21 0.46 0.816 0.017 173 0.651 0.010 20.27 0.62 0.850 0.025
125 0.705 0.008 21.35 0.56 0.863 0.016 174 0.662 0.005 21.07 0.32 0.904 0.014
126 0.636 0.011 19.06 0.54 0.830 0.025 175 0.619 0.010 20.25 0.56 0.887 0.025
127 0.636 0.010 19.08 0.62 0.837 0.025 176 0.654 0.011 20.49 0.57 0.867 0.026
128 0.664 0.016 20.20 0.90 0.903 0.036 177 - - - - - -
129 0.677 0.009 18.23 0.47 0.774 0.022 178 0.654 0.007 19.68 0.41 0.892 0.022
130 0.645 0.010 20.22 0.67 0.805 0.022 179 0.792 0.009 16.93 0.32 0.730 0.018
131 0.695 0.012 19.12 0.61 0.812 0.026 180 0.733 0.023 19.00 0.80 0.797 0.033
132 0.666 0.015 19.78 1.01 0.831 0.033 181 0.767 0.010 21.41 0.49 0.745 0.020
133 0.623 0.011 18.89 0.67 0.846 0.027 182 - - - - - -
134 0.633 0.008 20.03 0.54 0.866 0.024 183 0.668 0.006 19.92 0.33 0.795 0.017
135 0.655 0.007 20.39 0.39 0.858 0.020 184 0.690 0.005 19.95 0.30 0.820 0.017
136 0.656 0.006 21.53 0.33 0.836 0.019 185 - - - - - -
137 0.665 0.010 22.08 0.71 0.916 0.029 186 0.680 0.009 20.02 0.47 0.839 0.023
138 0.668 0.005 21.39 0.33 0.821 0.015 187 0.674 0.007 21.11 0.35 0.840 0.019
139 0.643 0.006 21.17 0.37 0.847 0.019 188 0.670 0.006 19.25 0.32 0.861 0.020
140 - - - - - - 189 0.680 0.006 20.04 0.32 0.854 0.018
141 0.647 0.008 20.96 0.53 0.911 0.022 190 0.684 0.006 20.36 0.30 0.854 0.018
142 0.663 0.007 21.42 0.50 0.830 0.022 191 0.657 0.010 19.97 0.47 0.873 0.025
143 0.670 0.004 21.71 0.25 0.828 0.017 192 0.598 0.007 18.19 0.32 0.835 0.022
144 0.671 0.007 20.99 0.43 0.902 0.024 193 0.638 0.010 20.25 0.67 0.879 0.032
145 0.667 0.010 25.08 0.71 0.898 0.028 194 0.607 0.005 19.19 0.28 0.844 0.019
146 0.647 0.008 23.25 0.57 0.807 0.022 195 0.680 0.009 20.93 0.63 0.794 0.026
147 0.682 0.006 21.15 0.29 0.836 0.017 196 - - - - - -
aResidue number. hValue given in (s *). cError estimated from the repeated time points. dError estimated from noise.
229Table A.V. 1 5 N relaxation parameters of R40E-R98H PaDDAH recorded at 800 MHz
# a Klb d  Rf * 2 b d/?2 c NOE dNOEd #a /?,b d/?,c Rih d/?2 c NOE dNOEd
197 0.669 0.008 18.59 0.32 0.799 0.020 246 - - - - - -
198 0.738 0.018 20.50 0.59 0.748 0.026 247 0.651 0.014 19.03 0.76 0.846 0.030
199 0.670 0.008 20.35 0.41 0.835 0.022 248 0.673 0.014 21.79 0.92 0.893 0.029
200 0.702 0.008 19.57 0.39 0.834 0.019 249 0.684 0.009 21.47 0.61 0.894 0.021
201 0.742 0.009 21.69 0.51 0.890 0.020 250 0.662 0.015 21.24 0.92 0.844 0.027
202 0.710 0.008 21.39 0.48 0.852 0.019 251 0.715 0.007 23.04 0.53 0.882 0.017
203 0.669 0.007 20.70 0.34 0.899 0.018 252 0.630 0.011 19.42 0.75 0.826 0.029
204 0.604 0.009 20.15 0.49 0.884 0.025 253 0.607 0.012 17.90 0.64 0.912 0.030
205 0.590 0.009 19.43 0.57 0.854 0.024 254 0.706 0.009 20.97 0.50 0.818 0.018
206 0.647 0.011 20.58 0.70 0.821 0.027
207 0.615 0.013 19.57 0.87 0.862 0.030
208 0.649 0.009 20.49 0.51 0.838 0.022
209
210
211 0.654 0.008 21.87 0.52 0.844 0.021
212 0.620 0.007 19.10 0.39 0.827 0.021
213 0.633 0.009 20.06 0.62 0.909 0.028
214 0.719 0.011 21.08 0.61 0.863 0.025
215 - - - - - -
216 0.652 0.009 20.85 0.60 0.861 0.023
217 0.668 0.012 19.00 0.47 0.867 0.026
218 0.620 0.007 18.64 0.38 0.844 0.020
219 - - - - - -
220 0.643 0.012 21.04 0.78 0.911 0.030
221 0.625 0.013 20.71 0.80 0.883 0.035
222 0.688 0.008 22.19 0.48 0.866 0.021
223 0.658 0.006 20.85 0.37 0.857 0.019
224 0.673 0.006 21.11 0.36 0.883 0.020
225 0.652 0.007 20.29 0.43 0.880 0.024
226 0.664 0.006 21.01 0.40 0.828 0.020
227 0.709 0.005 20.94 0.29 0.850 0.017
228 0.644 0.007 20.52 0.38 0.795 0.022
229 0.682 0.009 19.65 0.46 0.878 0.023
230 0.641 0.006 18.58 0.34 0.752 0.021
231 0.612 0.006 17.70 0.31 0.814 0.020
232 0.597 0.005 18.20 0.25 0.820 0.020
233 0.621 0.009 20.06 0.53 0.858 0.024
234 0.585 0.005 18.20 0.31 0.860 0.021
235 0.645 0.008 19.97 0.47 0.867 0.024
236 0.742 0.009 19.99 0.43 0.826 0.019
237 0.656 0.010 18.47 0.56 0.767 0.023
238 0.713 0.009 21.74 0.54 0.872 0.020
239 0.713 0.013 21.53 0.83 0.838 0.028
240 0.646 0.010 20.12 0.70 0.842 0.023
241 0.696 0.013 21.29 0.75 0.878 0.026
242 0.735 0.011 21.35 0.68 0.866 0.025
243 0.655 0.011 20.49 0.66 0.895 0.028
244 0.697 0.008 18.79 0.42 0.802 0.020
245 0.684 0.011 21.23 0.63 0.837 0.021
aResidue number. Value given in (s'1 ). cError estimated from the repeated time points. dError estimated from noise.
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